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Abstract  
In diploid cells, genes are presumed to be expressed from both alleles to maintain gene 
dosage for normal development. However, a small number of genes reach haplosufficiency even 
with only one functional allele per cell. Most of these genes are regulated through genomic 
imprinting and X chromosome inactivation (XCI). DNA methylation is an essential epigenetic 
regulation for developmental programming in embryogenesis and play crucial roles in genomic 
imprinting and XCI. This dissertation presents 1) effects of maternal diets on genome imprinting 
in fetal sheep (Chapter Two), 2) dosage compensation of the X chromosomes in bovine germline, 
embryos and somatic tissues (Chapter Three), 3) Whole genome DNA methylation in bovine in 
vivo preimplantation development (Chapter Four).  In chapter two, we report the first throughput 
study of genomic imprinting in sheep and report the identification of 13 new imprinted genes as 
well as demonstrating that maternal diets affect expression of imprinted genes in fetuses. Our 
results determine maternal diets influence imprinted gene expression while the parental-of-origin 
expression pattern was not affected, further suggesting that gene expression levels and imprinted 
patterns may be regulated through different epigenetic mechanisms. In chapter three, we reported 
the up-regulation of X chromosome in bovine germline, embryos and somatic tissues, supporting 
a balanced expression between a single active X and autosome pairs. However, deviating from 
Ohno’s theory, dosage compensation to rescue X haploinsufficiency appears to be an incomplete 
process for expressed genes but a complete process for “dosage-sensitive” genes. In chapter four, 
we adopted the scWGBS-seq method to comprehensive profile 5-MeC in single-cytosine 
Jingyue (Ellie) Duan – University of Connecticut, 2018  
 
resolution in bovine sperm, immature oocyte, in vivo/vitro mature single oocyte, and in vivo 
developed 2-, 4-, 8-, 16-cell single embryos. We observed global demethylation during bovine 
embryo cleavage up to 8-cell stage and de novo methylation at 16-cell stage. Our results refined 
the current knowledge on bovine embryo DNA methylation dynamics and provide valuable 
resources for future studies.  
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1.1. Epigenetics  
The term ‘epigenetics’ was first coined by Waddington, who defined epigenetics as a 
bridge that connects between genotype and phenotype (Waddington, 1942). In a broad view, 
epigenetics phenomenon is the transmittable changes governed by modifications on the 
chromatin rather than the alterations of the DNA sequences (Goldberg et al., 2007). These 
changes include DNA methylation, post-translational modification of histone tails (methylation, 
acetylation, phosphorylation, etc.), chromatin remodeling and noncoding RNAs (Kaikkonen et 
al., 2011; De Majo and Calore, 2018). Within all cells of the body, the DNA sequences are 
almost identical, while the epigenetic modifications are very different in different cell types 
(Canovas and Ross, 2016). Epigenetics modifications are not only mitotically transmitted, but 
also may affect several generations (Rakyan et al., 2003; Dolinoy et al., 2007). They mainly 
exerts their effects via regulation of gene expression (O’Neill, 2015). During development and 
cell differentiation, epigenetic markers reinforce cell-fate and form barriers that keep the cell 
specification in an irreversible process (Shi and Wu, 2009). However, robust and genome-wide 
epigenetic erasure, known as epigenetic reprogramming, occurs at two stages of mammalian 
development: post-fertilization pre-implantation embryogenesis and primordial germ cell 
specification (Gao et al., 2017). During these events, the epigenetic information is reset to the 
ground state, from which differentiation of more advanced cell linage occurs with new epigenetic 
markers (Seisenberger et al., 2012; Hackett and Surani, 2013). 
Epigenetics modifications regulate many cellular process, such as proliferation, 
differentiation, cell cycle (Guo et al., 2015), cancer development (Sharma et al., 2010; Jansson 
and Lund, 2012), chromatin architecture (Choy et al., 2010; Siddiqi et al., 2010), genomic 




through regulations of gene expression (Handy et al., 2011). Epigenetic marks vary by genome 
locations, different types of epigenetics modifications and chromatin accessibility associate with 
different states of transcription (Cao et al., 2018).  For example, methylation of the fifth carbon 
of cytosine (5mC) within CpG island in a gene promoter reduces gene expression by recruiting 
repressors or inhibiting the binding of transcription factors (Siegfried et al., 1999; Moore et al., 
2013), whereas DNA methylation in gene body is associated to gene active transcription (Suzuki 
and Bird, 2008; Yang et al., 2014). Enrichment of histone lysine methylation can correlate to 
either chromatin silencing (H3K9me3, H3K27me3 and H4K20me3) or transcription activation 
(H3K4me3, H3K36me3 and H3K79me3) (Vakoc et al., 2006; Black et al., 2012; Hyun et al., 
2017). Acetylation modification of histone tails, such as H3K27ac and H4K16ac, is generally 
associated with open chromatin favoring gene expression (Morales and Richard-Foy, 2000; 
Clayton et al., 2006). 
High throughput next generation sequencing (NGS) has provided detailed and 
comprehensive views of epigenetics modifications, such as DNA methylation, histone 
modification and chromatin architectures, on a genome scale (Meaburn and Schulz, 2012; Shen 
et al., 2014). To study DNA methylation, Whole Genome Bisulfite Sequencing (WGBS) is the 
gold standard method (Li et al., 2010a). It could detect the methylated CpG and calculate DNA 
methylation level in a high throughput manner (Lister et al., 2009; Li et al., 2010a, 2010b). 
Sodium bisulfite treatment changes unmethylated cytosines to thymines without altering the 
methylated cytosines, and NGS allows quantification of changes at the single cytosine level (Li 
et al., 2010a). Other methods to detect and quantify DNA methylation levels include Reduced 
Representation Bisulfite Sequencing (RRBS) (Smith et al., 2009), MethylC-sequencing 




(MeDIP-seq) (Bock et al., 2010). Tet-assisted Bisulfite Sequencing (TAB-seq) has been 
developed for mapping and quantifying 5-hydroxylmethylcytosinces (5hmC), a Ten-eleven-
translocation (TET) oxidation derivative of 5mC, at a single-base resolution on a genome-wide 
scale (Yu et al., 2012). Moreover, Chromatin Immunoprecipitation-Sequencing (ChIP-seq) 
combines ChIP and NGS for genome-wide DNA-protein interaction (Terrenoire et al., 2010). 
ChIP-seq  generates high-resolution profiles of histone modifications in the genome (O’Geen et 
al., 2011). To determine the higher order spatial organization of the genomes and chromatin, a 
robust technology Chromosome Conformation Capture (3C) technology is developed (Wit and 
Laat, 2012). The 3C method studies the ‘one-to-one’ interaction between selected pairs of 
sequences (Denker and Laat, 2016). Several variations of the 3C technology have been 
developed, such as ‘one-to-all’ 4C (circularized 3C) (Dekker, 2006), ‘many-to-many’ 5C (3C 
carbon copy) (Dostie and Dekker, 2007), and ‘all-to-all’ Hi-C technology (Belton et al., 2012). 
Additionally, Chromatin Interaction Analysis with Paired-End-Tag (ChIA-PET) technology 
combines the 3C technology with ChIP-seq, and enables the enrichment and observation of rare 
specific interactions mediated by specific chromatin factors (Fullwood et al., 2009).  
1.2. Preimplantation embryonic development 
Preimplantation embryonic development starts with fertilization, undergoes cell cleavage, 
morula formation, blastulation, and ends with implantation (Shi and Wu, 2009).  Fertilization 
takes place in the ampulla of the oviduct, and is followed by rapid cell proliferation in one cell 
embryo – zygote (Niakan et al., 2012). While the embryo travels down the oviduct to the uterus, 
three rounds of cleavages occur and produce the totipotent blastomeres (8-cell stage), which hold 
the potential to form all cell types in embryo and extra-embryonic membranes (O’Neill, 2015). 




the first critical morphological event during embryogenesis and forms the morula stage embryo 
(White et al., 2016). The blastomeres in the morula develop the axis of polarity, they relocate to 
form inner and outer cells and start to express differential cell fate markers (Johnson and Ziomek, 
1981). The first cellular differentiation occurs at the blastulation stage and cells specify into two 
populations: the inner cell mass (ICM) and the trophectoderm (TE) (Marikawa and Alarcón, 
2009). The ICM consists of pluripotent cells that can develop to all cell types of the embryo, 
while TE cells have restricted developmental potentiality that could only form the extra-
embryonic membranes (De Paepe et al., 2014). At the late blastocyst stage, the embryo matures 
and hatches from the outer membrane (zona pellucidae), and gains the implantation capability 
(Wang and Dey, 2006).  
 A unique feature of preimplantation embryonic development is that the early embryos 
almost entirely dependent on the maternal subcellular organelles and maternally stored mRNAs 
and proteins (Li et al., 2010c). These maternal components are loaded into a matured oocyte 
during the oogenesis, directing the first mitotic divisions and specifying cell fate and patterning 
(Tadros and Lipshitz, 2009). When the maternal mRNAs are gradually degraded while the robust 
activation of the embryonic genome (EGA) initiate, the maternal to zygotic genome transition 
(MZT) starts (Lee et al., 2014). The timing of EGA has been described as species specific: this 
happens at the 2-cell stage in mice and 8- to 16-cell stage in humans and domestic species, 
including cattle, sheep, pigs, rabbits (Telford et al., 1990). Recent whole transcriptome analysis 
indicated that the EGA in bovine in vivo produced embryos at the 4- to 8-cell stage (Kues et al., 
2008; Jiang et al., 2014). The activation of the genome is accompanied by the alteration of 
chromatin structure and a drastic initiation of gene expression (Vastenhouw et al., 2010; Funaya 




1.3. DNA methylation 
In mammals, methylation of DNA is an essential epigenetic regulation with a key role 
during embryo development and germline differentiation (Canovas et al., 2017). It is essential in 
chromatin compaction (Choy et al., 2010), heterochromatin formation (Rountree and Selker, 
2010), gene silencing (Curradi et al., 2002), transposon element repression (Slotkin and 
Martienssen, 2007), genomic imprinting (Li et al., 1993), and X chromosome inactivation (in 
females) (Sharp et al., 2011).  
Stable inheritance of tissue-specific DNA methylation patterns during DNA replication 
and cell division are maintained by DNA methyltransferase 1 (DNMT1) (Hata et al., 2002) and 
its cofactor UHRF1 (Bostick et al., 2007). Mutation of DNMT1 results in the global loss of 
methylation and embryonic lethality (Li et al., 1992). Another form of DNMT1 is DNMT1o, 
which has similar function to DNMT1, it is specific to oocyte and preimplantation embryos (Ko 
et al., 2013). Members of the DNMT3 protein family (DNMT3A, DNMT3B, and DNMT3L) are 
primarily responsible for the DNA de novo methylation in pre-implantation embryos (Chédin, 
2011). DNMT3A and DNMT3B are the active enzymes for DNA de novo methylation. 
DNMT3L interacts with DNMT3A or DNMT3B, is required for the establishment of 
methylation on imprinted genes in germ cell development, and lacks enzymatic activity (Hata et 
al., 2002). Moreover, expression data indicates that DNMT3A and DNMT3B are highly expressed 
during germ cell development and blastocyst stage, and DNMT3L is highly expressed in 
embryonic stem cells (Chédin, 2011). 
The DNA demethylation process can be either active or passive (Kohli and Zhang, 2013). 
Active DNA demethylation is a cell replication independent process (Hahn et al., 2014). This 




methylcytosine (5mC) oxidation. The product of this active demethylation is 5-
hydroxymethylcytosine (5hmC), which is a prominent intermediate epigenetic marker in the 
cytosine demethylation (Auclair and Weber, 2012). TETs can further oxidize 5hmC to 5-
formylcytosine (5fC) and 5-carboxylcytosine (5caC) (Ito et al., 2011). TET3-dependent 
oxidation of 5mC has been found in demethylation of both the paternal and maternal genomes 
after fertilization (Canovas et al., 2017). On the other hand, the presence of a strong inhibitor of 
DNMT1 catalyzation, 5hmC, results in passive DNA demethylation over subsequent cell 
replication cycles (Valinluck and Sowers, 2007; Bhutani et al., 2011).   
There are two major developmental dynamic reprogramming events of DNA 
demethylation (Gao et al., 2017). One in primordial germ cells (PGCs) specification and another 
in pre-implantation embryo stage development (Canovas et al., 2017). In mice, PGCs lineages 
originate from the epiblast of the embryo and commit to germline at embryonic day 6.5 (E6.5).  
Therefore, they have to erase the somatic fate epigenetic marks (Hayashi et al., 2007; 
Seisenberger et al., 2013). Around E10.5 to E11.5, the fetal gonadal sex is determined (Leitch et 
al., 2013) and PGCs are migrating into the developing genital ridge (Bao and Bedford, 2016). At 
the genital ridge, PGCs undergo virtually complete genomic DNA demethylation (Hanna et al., 
2018), and establish the sex-specific epigenetic signatures and transcription profiles, which 
further enable the meiotic maturation process of male and female germ cells and then gametes 
(Smallwood and Kelsey, 2012). In sperms, the paternal genome DNA is highly methylated and 
exchanged most of its histone protein to protein protamine, which allows DNA to be compactly 
packaged into sperm head (Balhorn et al., 2000). In contrary, most of DNA methylation sites in 
oocyte are distinctly located over the intragenetic region of active genes (Kobayashi et al., 2012; 




PGCs is mediated by DNA demethylases and methyltransferases with remodeling of histone 
marks, the parent-specific-imprints are added as a results of reprograming (Hanna and Kelsey, 
2014).  
After oocyte fertilized by sperm, another drastic reprogramming occurs in the zygote 
stage (Messerschmidt et al., 2014). A distinct asymmetric DNA demethylation occurs on 
paternal and maternal pronucleus in the same cytoplasm (Iqbal et al., 2011). Paternal genome 
undergoes a rapid and active remodeling, starting with replacing the protamine to acetylated 
histones (Reik et al., 2001), following by global DNA demethylation, which actively catalyze the 
5mC to 5hmC by Ten-eleven-translocation (TET) dioxygenase (Gu et al., 2011; Iqbal et al., 
2011). Previous study demonstrated that the maternal genome demethylation is mainly passive 
replication-dependent dilution of 5mC, in the absence of DNMT1 (Rougier et al., 1998; Oswald 
et al., 2000). However, recent genome wide methylation profiles the presence of 5hmC in the 
female pronuclei (Bakhtari and P. J. Ross, 2014; Wang et al., 2014), indicating the active 
demethylation also onset. Additionally, some genes, such as imprinted genes, their germline 
differentially methylated regions (gDMRs) are resistant to the demethylation process in a parent-
of-origin specific manner (Sanz et al., 2010; Stewart et al., 2016). At blastocyst stage, DNA 
methylation reaches the basal level and starts to establish de novo methylation, while the first cell 
differentiation occurs (Smallwood and Kelsey, 2012).   
DNA methylation status is more dynamic in embryos and germlines than in somatic cells 
(Smith et al., 2012). Classical studies by immunofluorescence analysis of 5mC, H3K4me3 and 
H3K9me2 modifications have revealed a conserved genome DNA demethylation in embryo 




Recent studies used more precise techniques, such as RRBS, WGBS, or TAB-seq, are able to 
profile 5mC and 5hmC in high resolution (Canovas et al., 2017).   
1.4. Genomic imprinting  
Mammals are diploid organisms which have two matched sets of chromosomes inherited 
from both parents (Barlow and Bartolomei, 2014). Diploidy has many genetic beneficial such as 
protection organisms from somatic mutation and heterozygous advantage (Otto and Gerstein, 
2008). Most of genes have the same potential for their parental copies to be active, while a few 
hundred of the total ~25,000 genes are expressed in a parent-of-origin-specific manner. These 
genes only have one single parental allele expressed, they are termed “imprinted” (Bartolomei 
and Ferguson-Smith, 2011). However, although only small number of genes have been 
categorized as imprinted genes, they have very dramatic effects in the phenotype (Ishida and 
Moore, 2013).  
Genomic imprinting is an epigenetic regulatory phenomenon that have been first 
described in 1980s by the Solter and Surani laboratories (Surani and Barton, 1983; Surani et al., 
1984).  Their uniparental embryo experiments revealed that both parental genome are required 
for a normal mammalian development (Lyon, 1993). In maternal uniparental embryos 
(gynogenotes or pathogenotes), embryonic tissues develop normally, but the extraembryonic 
tissue fail to grow, whereas paternal uniparental embryos (androgenotes) develop dominantly 
extraembryonic lineages. These results suggested that there might be conflicts between 
parentally inherited genes influence the embryo development (Moore and Haig, 1991). This 
pioneer study formed the basis for the notion that the paternal genome is non-equivalent and 




Since monoallelic expression increased vulnerability to recessive mutations, the evolution 
of genomic imprinting is still an mystery (Tian, 2012). The co-presence of genomic imprinting 
and placenta indicates its function in controls nutrition flow from mother to fetuses (Piedrahita, 
2011). Numerous hypotheses have attempted to explain the evolutionary origin and the meaning 
of genomic imprinting (Morison et al., 2005). Currently, there are four plausible evolutionary 
theories, including 1) kinship or parental genetic conflict hypothesis (Haig and Graham, 1991; 
Moore and Haig, 1991), 2) ovarian time bomb hypothesis (Varmuza and Mann, 1994; Weisstein 
et al., 2002), 3) X-linked sex-specific selection hypothesis (Iwasa and Pomiankowski, 2001; Van 
Cleve and Feldman, 2007), and 4) sexually antagonistic selection hypothesis (Wolf and Hager, 
2006; Fairbairn et al., 2007). Among these theories, the most popular one is kinship or parental 
genetic conflict hypothesis, which considers the genetic imprinting is a selective advantage by 
which paternally expressed genes involved in resource extraction (more resources flow from 
mother to enhance fetal growth), while maternally expressed genes in conserve resources 
(restrain the maternal resources flow to fetus) (Haig, 1992). For instances, paternal genes (i.e. 
IGF2, PEG1, PEG3, RASGRF1, DLK1, DIO3, MAGEL2, HYMAL, and PLAG11) are tend to 
promote fetal growth, whereas maternal genes play as growth inhibitor (i.e. IGF2R, GNAS, 
CDKN1C, H19, GRB10, and PHLDA2) to increase mother’s chance for future offspring (Barlow 
and Bartolomei, 2014). Despite the essential fetal growth and development regulation functions, 
imprinted genes also involved in behavior after birth, such as nurturing behaviors (PEG1 and 
PEG3), milk ejection, caring of newborns (Piedrahita, 2011). However, with increasing number 
of imprinted genes have been identified recently, all hypotheses were challenged of fitting in all 
imprinted gene functions (Morison et al., 2005). Moreover, recent study generated the tissue-




embryonic development were either retain or totally lost their parent-of-origin expression in 
adults (Babak et al., 2015).  
One intriguing characteristic of imprinted genes are they tend to locate in one megabase 
clusters. 163 (Blake et al., 2010) mouse imprinted genes have been mapped to 17 chromosomes 
and in 16 clusters that contain two or more genes (Wan and Bartolomei, 2008). All clusters 
contain imprinting control regions (ICRs) that regulate the entire domain through differentially 
methylated CpG islands between two parental chromosomes (Wutz et al., 1997) or at least one 
long noncoding RNA (ncRNA) that mediates chromatin repression (Pauler et al., 2007). Another 
mechanisms for imprinted gene regulation are through histone markers such as H3K27me3, or 
by CCCTC binding factor (CTCF) binds insulator to block the shared enhancer element (Engel 
and Bartolomei, 2003).  
To date, there are 255 imprinted genes in mammals have been identified or predicted, 
mostly in humans (114) (Morison et al., 2001) and mice (163), very fewer were in farm animals. 
However, only 51 imprinted genes are common between humans and mice. The high level of 
discordance between these two species indicate the need for more comparative data (Morison et 
al., 2005). Therefore, identification of the full catalog of imprinted genes in non-model 
mammalian species will greatly facilitate the understanding of the evolutionary roles of genomic 
imprinting (Wang and Clark, 2014).   
1.5. X chromosome dosage compensation 
In diploid mammals, maintenance of  the correct gene dosage is essential for normal 
cellular function and development (Graves and Disteche, 2007). Aneuploidies were responsible 
for 46.3% of spontaneous abortions in humans (Jia et al., 2015). Few (~0.3%) live-born babies 




(988 genes), or 13 (1,381 genes), or on the relatively large X chromosomes (2,158 genes) 
(Hassold and Hunt, 2001) (gene counts including coding and non-coding gens are from human 
current genome assembly GRCh38.p11: 
https://www.ncbi.nlm.nih.gov/genome/51?genome_assembly_id=322645.)  Live born babies 
with milder phenotypes effects of X chromosome aneuploidies were found in Turner syndrome 
(XO females, 1/2,500) or Klinefelter syndrome (XXY males, 1/660) than mortal autosomal 
aneuploidies (Payer and Lee, 2008). What made X chromosome aneuploidies are more tolerant 
than other chromosomes?   
From book Sex Chromosomes and Sex-Linked Genes (Ohno, 1966).  
“During the course of evolution, an ancestor to the placental mammals must have 
escaped a peril resulting from the hemizygous existence of all the X-linked genes in the male by 
doubling the rate of product output of each X-linked gene. Once this step was accomplished, the 
female no longer needed two X’s in her somatic cells. Hence, the dosage compensation 
mechanisms by random inactivation of one or the other X evolved."  
Dr. Susumu Ohno hypothesized that to solved the dosage imbalance of X-linked genes in 
males, upregulation of X-linked genes in the heterogametic sex would be necessary to return its 
gene expression to the levels from the normal diploid autosomes. X upregulation in female is 
counteracted by inactivation of a single X chromosome in every cell, to balances gene dosage 
between males and females as well as X and autosome (Ohno, 1966). Both X chromosome 
expression upregulation and X chromosome inactivation (XCI) are necessary components of the 
dosage compensation mechanism in mammals. Which one was developed first, or coevolved, is 




X-chromosome inactivation, the process by which one of two X chromosomes in 
mammalian female somatic cells is transcriptional inactivated (Lyon, 1961), equalizing the X 
chromosome dosage to the mammalian XY males (Erwin and Lee, 2008). Although, this 
chromosome-wide silencing has been studied for six decades, the underlying mechanisms still 
remain poorly understood (Augui et al., 2011). There are two forms of XCI: imprinted and 
random (Jeon et al., 2012). Imprinted XCI refer to the inactivation of the paternal X chromosome 
during early female embryo cleavage stage (Okamoto and Heard, 2006). The imprinted X 
chromosome was proposed to inherit from the paternal germ line and transmitted to the zygote 
(Huynh and Lee, 2003). After the first differentiation in blastocyst, the imprinted XCI is 
maintained in the outer trophectoderm (TE) cells, which developed to extra-embryonic tissues, 
while the inner cell mess (ICM), where the fetus come from, the XCI erased and then 
reestablished at a random manner (Payer et al., 2011). Random XCI is achieved by a series of 
events, including: counting, choice, initiation, spreading and maintenance (Avner and Heard, 
2001). The region that cis-regulate the XCI on the inactivate X (Xi) is called ‘X-inactivation 
center’ (Xic) (Van Bemmel et al., 2016). This 1 Mb region contains several key noncoding (nc) 
genes that regulate XCI, including Xist, Tsix, Xite, RepA, DXPas34 and Jpx/Enox (Tian et al., 
2010). Xist encodes a 17kb noncoding RNA exclusively from the Xi and initiate the 
chromosome-wide silencing (Lee, 2009). Tsix is a 40-kb Xist antisense ncRNA that transcribe on 
active X (Xa), preventing the Xist transcribe and coating on that chromosome (Lee and Lu, 1999). 
These two pairs of sense-antisense ncRNA predominate the regulation of long-range chromatin 
on X chromosome (Lee, 2009).  
Unlike XCI, which has been actively studied for over a half century, the testing for X 




analysis become available (Nguyen and Disteche, 2006). Various tests have been performed in a 
number of species, results were more or less support for Ohno’s hypothesis (Prothero et al., 
2009). Supporters for this hypothesis was testing only a subset of genes, such as actively 
expressed genes (Deng et al., 2011), large protein-coding genes (Pessia et al., 2012), or 
ubiquitously expressed house-keeping genes (Sangrithi et al., 2017). Hyperactive of these genes 
reached an X:Autosome expression ratio close to or higher than 1 in somatic cells. Therefore, 
they were considered as “dosage-sensitive” genes that could subject to doubling the expression 
(Pessia et al., 2014). However, there are also studies refute Ohno’s theory. Lin et al (2012). 
argued that due to the unavailability of the ancestral proto-X (X) and proto autosomes (A), most 
of current tests were indirectly compared between the present-day X (X) and present-day 
autosome (A) and were thus inconclusive. They claimed that by directly comparing human X 
with X orthologs identified from chicken, the expression of X-linked genes is roughly half. 
Additionally, proteomics studies in mammals also provided conflicting results for testing the 
Ohno’s hypothesis. The mice proteomics data had X:A ratio of 1 (Deng et al., 2011), whereas 
humans data had 0.5 (Lin et al., 2012).  
The debate of Ohno’s hypothesis is still going on, mostly in humans, mice, drosophila or 
other model species. Testing for dosage compensation in non-model organisms, such as bovine 
and sheep, could provide more general conclusions and help with develop new hypotheses 
(Chandler Christopher H., 2017).  
1.6. Effect of maternal nutrition on fetal epigenetics and development 
Fetal developmental programming is largely influenced by intrauterine environmental 
factors, including stress, disease, uterine capacity, and maternal nutrition (Hoffman et al., 2017). 




lifelong consequences (Godfrey and Barker, 2001). Poor maternal nutrition can be caused by 
excess or reduced nutrients during gestation (Pillai et al., 2016). For examples, management 
practices such as flushing can lead to over-nutrition, whereas inadequate feeding due to seasonal 
variations can cause nutrition restriction (Wu et al., 2006).  
It has been found that poor maternal nutrition during gestation can influence fetal body 
size (Reynolds et al., 2010), muscle and adipose tissue gene expression (Peñagaricano et al., 
2014), as well as skeletal muscles fiber composition and development (Reed et al., 2014) in 
offspring. Moreover, epigenetic modifications, including DNA methylation, histone modification, 
and microRNA, were also changed in the fetal tissues (Vickers, 2014). Similarly, human 
metastable epialleles, which are variably expressed in genetically identical individuals, have also 
been persistently changed in epigenetic by maternal nutritional status in early pregnancy 
(Dominguez-Salas et al., 2014). Therefore, more and more evidences for associations between 
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Genomic imprinting is an epigenetic phenomenon of differential allelic expression based 
on parental origin. To date, 263 imprinted genes have been identified among all investigated 
mammalian species. However, only 21 have been described in sheep of which 11 are annotated 
in the current ovine genome. Here we aim to 1) use DNA/RNA high throughput sequencing to 
identify new monoallelically expressed and imprinted genes in day 135 ovine fetuses, and 2) 
determine whether maternal diet (100%, 60%, or 140% of National Research Council Total 
Digestible Nutrients) influences expression of imprinted genes. We also reported strategies to 
solve technical challenges in the data analysis pipeline. We identified 80 monoallelically 
expressed, 13 new putative imprinted genes, and five known imprinted genes in sheep using the 
263 genes stated above as a guide. Sanger sequencing confirmed allelic expression of seven 
genes, CASD1, COPG2, DIRAS3, INPP5F, PLAGL1, PPP1R9A and SLC22A18. Among the 13 
putative imprinted genes, five were localized in the known sheep imprinting domains of MEST 
on chromosome 4, DLK1/GTL2 on chromosome 18 and KCNQ1 on chromosome 21, and three 
were in a novel sheep imprinted cluster on chromosome 4 known in other species as 
PEG10/SGCE.  The expression of DIRAS3, IGF2, PHLDA2, and SLC22A18 was altered by 
maternal diet, albeit without allelic expression reversal. Together, our results expanded the list of 
sheep imprinted genes to 34 and demonstrated that while the expression levels of four imprinted 
gene were changed by maternal diet, the allelic expression patterns were un-changed for all 
imprinted genes studied. 





Genomic imprinting refers to the epigenetic phenomenon that certain genes are expressed 
in a parent-of-origin-specific manner and play critical roles in fetal growth as well as post-natal 
development and metabolism (Bartolomei and Ferguson-Smith, 2011). The imprinted alleles are 
silenced or reduced in expression compared to the non-imprinted and expressed alleles 
(O’Doherty et al., 2015a). Imprinted genes tend to be located in clusters. Those in the same 
cluster are usually regulated by the same imprinting control region (ICR) (Koerner et al., 2009). 
Several mechanisms are involved in the control of allelic expression, including DNA allelic 
methylation, non-coding RNA and/or histone modifications (Delaval and Feil, 2004). Genomic 
imprinting is an evolutionary puzzle because monoallelic expression can expose deleterious 
recessive mutations, which are normally protected by diploidy (Wilkins and Haig, 2003). 
However, imprinting may have a selective advantage because it has been maintained throughout 
mammalian evolution (Tian, 2012).  The identification of the full catalog of imprinted genes in 
different mammalian species will greatly facilitate the understanding of the evolutionary roles of 
genomic imprinting (Wang and Clark, 2014).  
To date, 186 (Andergassen et al., 2017; Blake et al., 2010) and 112 (Morison et al., 2001) 
(http://www.geneimprint.com/site/genes-by-species) imprinted genes have been identified in 
mice and humans, respectively. However, only 49, 25, and 21 have been reported in cattle (Chen 
et al., 2016), pigs (Bischoff et al., 2009) and sheep (O’Doherty et al., 2015a; Wei et al., 2014), 
respectively. Although the general properties and regulations of imprinting are conserved across 
species (Hanna and Kelsey, 2014), the identities of imprinted genes often are not. For example, 
only 51 imprinted genes are common between humans and mice. Therefore, it is imperative to 




Next generation sequencing (NGS) technologies, including genome-wide DNA 
sequencing (DNA-seq) and transcriptome-wide RNA sequencing (RNA-seq), have been 
increasingly utilized for in-depth analysis and detection of novel imprinted genes in both humans 
and mice (Barbaux et al., 2012; Luedi et al., 2007; Wang et al., 2011). While high throughput, 
such studies require completion of genome sequencing and annotation, intensive bioinformatics 
and careful independent validation (e.g. Sanger sequencing) to reduce false positives (Chen et al., 
2016; DeVeale et al., 2012; Wang and Clark, 2014). The recent completion of the sheep genome 
and improved annotation abilities provide a great opportunity to identify new imprinted genes in 
this understudied species.  
Poor maternal nutrition, either over- or restricted feeding during pregnancy (Hoffman et 
al., 2017), has been shown to cause abnormal DNA methylation and expression of a few 
imprinted genes such as IGF2R and H19 in ovine fetuses (Lan et al., 2013).  NGS, however, has 
the power to simultaneously determine expression changes of all known imprinted genes, which 
has yet to be conducted in sheep. The objectives of this study were to identify new sheep 
imprinted genes and to investigate the impact of maternal diets on the expression of all ovine 
imprinted genes by fetal organs at days 135 of gestation, when the fetuses undergo rapid growth 




2.3. Materials and Methods 
2.3.1. Tissue sample collection  
All animal protocols (Jones et al., 2016; Pillai et al., 2017) were reviewed and approved 
by the University of Connecticut Institutional Animal Care and Use Committee. Animal 
breeding, feeding and sample collection were described in Pillai et al., 2017. Briefly, Western 
white-faced ewes (n=12) were mated with Dorset rams (n=4). Ewes were individually housed 
beginning 20 days after mating. Pregnancy was confirmed by ultrasound at day 28.5  0.4 of 
gestation (Jones et al., 2016) if a ewe was not re-marked by a ram; day 0 represents the initial 
marking of the ewe by the ram. On day 30 of gestation, pregnant ewes were randomly assigned 
to control 100% (Con), restricted 60% (Res) or overfed 140% (Over) based on the National 
Research Council (NRC) total digestible nutrients (TDN) for ewes pregnant with twins. Ewes 
were euthanized at day 135 of gestation (n = 4 per diet), and 15 fetuses were used (Con: n=7, 
including 3 sets of twins; Res: n=4; Over: n=4). Brain, kidney and lung samples were collected 
from all fetuses. Whole blood samples were obtained from the four rams. Tissues were flash 
frozen in liquid nitrogen and were stored at -80°C until RNA extraction. 
2.3.2. Whole genome DNA- and RNA-sequencing 
Genomic DNA of ram whole blood samples and fetal tissues were isolated using Qiagen 
DNeasy Blood & Tissue Kits (Qiagen, 69504). The ram DNA was sent to Novogene (Novogene 
Co., Ltd) for library preparation and sequencing. In brief, the DNA-seq library was prepared 
using the Illumina Truseq Nano DNA HT sample preparation kit (Illumina, FC-121-4003) with a 
350 bp target insert size. Libraries were sequenced with 2 × 150 bp paired-end reads on HiSeq 
2000 platform (Illumina). On average, 186.7 million raw read pairs were obtained for genotyping 




Total RNA was extracted from day 135 fetal brain, lung and kidney, using Trizol and 
RNAeasy kit (Qiagen, 74104) with three quality controls: NanoDrop (Thermo Fisher Scientific), 
agarose gel electrophoresis and Qubit 2.0 (Thermo Fisher). Library preparation was carried out 
using TruSeq RNA library prep kit (Illumina, RS-122-2001, RS-122-2002), which selected 
mRNA using Oligo d(T) with magnetic beads and built 2 × 75 bp paired-end cDNA libraries. 
The libraries were quantified using real-time PCR. Agilent 2100 Bioanalyzer (Agilent) was used 
to assess the size distribution and to determine the RNA integrity number (RIN) in each sample 
(Table S5). All RNA samples for sequencing had the RIN value greater or equal to 7. Overall, 
we obtained 2,149 million raw sequencing reads that passed filtering from three sequencing runs 
of 45 fetal tissue samples. A total of 1,160, 576 and 413 million raw sequencing reads that 
passed filtering were obtained for sequencing runs 1, 2 and 3, respectively. An average of 23.8 
million read pairs per sample was generated on a NextSeq 500 System (Illumina).  
2.3.3. SNP calling from DNA- and RNA-seq data 
We adapted the computational pipeline from the SNPiR (single nucleotide 
polymorphisms (SNPs) in RNA-seq data) (Chen et al., 2016; Piskol et al., 2013) to solve several 
technical challenges in the identification of monoallelically expressed genes from RNA-seq data. 
Among those challenges are alignment bias of RNA-seq reads and filtering potential false 
positive SNPs. Heterozygosity can increase mapping bias because a read from the non-reference 
allele is considered a mismatch, resulting in a low mapping rate (Wang and Clark, 2014). To 
minimize such alignment bias to the reference allele in the genome, we artificially built a 
pseudo-genome (named “alternative genome”) by flipping the reference/alternative alleles in all 
SNP sites based on known sheep dbSNP (sheep 9940).  Raw genomic DNA-seq reads were 




adaptors of Illumina with a minimum Phred score of 20 and minimal length of 30 bp. We then 
mapped the filtered DNA-seq reads using Hisat2 aligner (version 2.0.5) (Pertea et al., 2016) to 
both sheep reference genome Oar_v4.0 and the alternative genome. Only uniquely aligned reads 
were kept. The mapped reads and mapping rates of rams and fetuses in the two genomes were 
summarized in Table S6. The Picard Tool Mark Duplicates (2.12.0) ([CSL STYLE ERROR: 
reference with no printed form.]) was used to remove the PCR duplicates. SNVQ (NGS Tools 
version 2.0.0) (Duitama et al., 2012) was used to accurately detect the SNPs in the ram genome. 
To reduce potential false positive calls, the following parameters were used for SNP filtering 
(Figure 1): 1) a minimum quality score of 50 at the SNP position, 2) a minimum of three reads 
aligned at the SNP using both the reference and alternative genomes, 3) reversed genotypes of 
called SNP when reference/alternative genomes were switched (e.g., A/G in reference genome; 
while G/A in alternative genome), 4) SNP present and consistent with that in the sheep dbSNP 
(sheep 9940) database, and 5) SNP located in an exon. 
Methods similar to the DNA-seq analysis for trimming, mapping and duplication removal 
were used for the RNA-seq data. The SNPs in fetuses were called at the individual fetus level, 
i.e., RNA-seq reads in the three tissue samples (brain, kidney and lung) of the same fetus were 
pooled to increase read coverage at each SNP site. The same SNP filtering criteria were applied 
as in the ram DNA-seq data.  
2.3.4. Identification of informative SNPs  
After genotyping SNPs of both the rams and their fetuses, we designated SNPs that were 
homozygous in the rams but heterozygous in their respective fetuses as informative SNPs (SNP1 




(version 1.4) (Li, 2011) and averaged the allele-specific read counts using the 
reference/alternative genomes.  
2.3.5. Differential allele-specific gene expression and statistical analysis   
When calculating the allele-specific gene expression (Figure 1), we only used 
informative SNPs that had total read counts of 20 or greater from each of the two parental alleles. 
This is because low read coverage may have a large variance in differential allelic expression 
estimation, potentially generating false positive differences (Wang and Clark, 2014).  We then 
identified the expressed parental allele of all SNPs in the same gene and removed genes which 
contained discordant parental allele expression (i.e., a mixture of maternally and paternally 
expressed informative SNPs in the same gene). Next we aggregated the allele-specific reads for 
all informative SNPs in each gene to increase the sensitivity of imprinted gene prediction, as 
previously suggested (Chen et al., 2016), and pooled allelic expression of the same gene in 
biological replicates. The Fisher’s exact test was used to examine if an allele was expressed by 
more than 70% of total read counts from both alleles combined with a false discovery rate (FDR) 
≤ 0.05.  
2.3.6. Mammalian imprinted gene lists 
The known mammalian (human, mouse, bovine, sheep and pig) imprinted genes were 
obtained from three well-defined databases, including Imprinted Gene Database, 
(http://www.geneimprint.com/site/genes-by-species). Catalogue of Parent of Origin Effects 
(http://igc.otago.ac.nz/Search.html) and Mouse Book database 
(http://www.mousebook.org/imprinting-gene-list). Additionally, we incorporated 18 novel 




al., 2016) to create a more current and comprehensive list of imprinted genes (Table S2). This 
list was used to limit the number of imprinted genes found in the sheep. 
2.3.7. Differential gene expression analysis across maternal diets 
RNA-seq reads from 15 fetuses (Con: n=7; Res: n=4; Over: n=4) were trimmed and 
aligned to Oar_v4.0 using Hisat2 version 2.0.5 aligner (Pertea et al., 2016). The percentages of 
mapped reads for all samples are summarized in Table S7 and the average multiple aligned rate 
is 90.3%. IsoEM version 1.1.5 (Nicolae et al., 2011a) was used to quantify levels of gene 
expression to transcripts per kilobase million (TPM) using default parameters. TPM normalizes 
for gene length first and then for sequencing depth. This unit was preferred to RPKM because it 
normalizes transcriptome sizes.  When comparing levels of gene expression across different 
samples, TPM allows more appropriate comparisons (Soneson et al., 2015). Differentially 
expressed genes (DEGs) between Con and Over or Con and Res were determined using IsoDE 
version 2 (Al Seesi et al., 2014). The test was preformed separately in brain, kidney and lung. In 
each comparison, genes were deemed differentially expressed if they showed a P-value < 0.05 
and Confident log2 fold change (FC) > 1. DEGs that are in the lists of sheep known/putative 
imprinted genes (Table 2), the 80 monoallelically expressed genes (Table S8.1), and the 
mammalian known imprinted genes (Table S8.2) were subsequently pulled from the total DEG 
list. 
2.3.8. Sanger sequencing 
The DNA of fetuses and their respective rams and the cDNA of the specific fetal tissue in 
which the gene was expressed monoallelically were all amplified by PCR. All primers used are 




2.3.9. Data access 
The raw read FASTQ files for DNA/RNA-seq reads and informative SNP averaged read 
count files are available at Gene Expression Omnibus (GEO https://www.ncbi.nlm.nih.gov/geo/) 






2.4.1. High throughput identification of informative single nucleotide polymorphisms  
Using single nucleotide polymorphisms (SNPs), the parental origin of an allele in the 
fetus can be assigned. Informative SNPs are those 1) present in mRNAs (expressed), 2) 
homozygous in ram and heterozygous in fetuses, and 3) expressed at read counts of 20 or greater.  
They are essential in determining the origin of a parental allele of genes. However, mapping at 
SNP locations can introduce alignment bias towards the reference alleles because the reads of the 
alternative alleles may be treated as mismatches and discarded by the mapping tool (Wang and 
Clark, 2014). To minimize such bias, we artificially built a pseudo-genome (named “alternative 
genome”) by flipping the reference/alternative alleles at all SNP sites from the dbSNP database 
(sheep 9940) of the sheep reference genome. DNA-seq reads of rams and RNA-seq reads of their 
respective fetuses were aligned to both the reference and alternative genomes for SNP calling 
(Figure 1). By comparing the homozygous SNPs in each ram to the heterozygous SNPs in his 
fetuses, we identified a total of 146,487 unique informative SNPs (represented by SNP1 in 
Figure S1). These informative SNP were annotated to 15,298 genes, yielding on average of 9.6 
informative SNPs per gene. The parental origins of these informative SNPs were determined 
using the rams’ genotypes as shown in Figure S1. To further reduce alignment bias, we used 
Samtools mpileup (version 1.4) (Li, 2011) to calculate the allele-specific read counts for each 
informative SNP which were then averaged between the two genomes. Using this approach, we 
successfully reduced the mapping bias at informative SNP locations to < 1% (Figure 2). 
2.4.2. Allele-specific gene expression 
Fisher’s exact test was programmed to identify genes with allelic expression bias of ≥ 70% 




identified 4,537 such allelic-differentially expressed genes with a q-value < 0.05. Eighty of these 
genes had significant allelically biased expression of the same parental alleles in all examined 
tissues (brain, kidney and lung) and were thus classified as monoallelically expressed (Table S1). 
Among these, 19 and 61 preferentially expressed the paternal and maternal alleles, respectively. 
To decrease potential false positives, we conservatively used previously identified imprinted 
gene as a guide. By combining all imprinted genes in the human, mouse, cow, pig and sheep we 
obtained a total of 263 unique imprinted genes, 119 of which have been annotated in the sheep 
genome (Table S2). Between these 119 and the 4,537 allelic differentially expressed genes, 18 
were common and eight and ten were paternally and maternally expressed, respectively (Table 
1). Five of the 18 were known to be imprinted in sheep, the other 13 were known to be imprinted 
in other species and were here designated as putatively imprinted (Table 1). Although there are 
21 previously reported imprinted genes in sheep, only 11 of them are annotated in Oar_v4.0. 
Therefore 5 out of 11 (45.6%) of imprinted genes were verified using just three tissues at one 
developmental stage. Each of the 18 genes were individually inspected using the Integrative 
Genomics Viewer (IGV) (Robinson et al., 2011) to confirm their correct alignments. Read counts 
from parental alleles of  informative SNPs within the genes in each tissue were summarized in 
Table S3. Nine of these–COPG2, GATM, GRB10, IGF2R, INPP5F, PEG3, PON3, PPPIR9A 
and WARS–had more than three informative SNPs that showed significant differential allelic 
expression in multiple tissues and animals, firmly demonstrating their consistent parent-of-origin 
specific expression status, and therefore mostly likely imprinted.  
The rest of the 80 monoallelically expressed genes may include genes that are only 




us to make such determination. Yet this conservative approach avoids any potential false 
positives while expanding ovine imprinting information.  
2.4.3. Validation of the putative imprinted genes 
To confirm the 13 putative imprinted genes identified above, we quantified their allelic 
expression using an independent method–Sanger sequencing. PCR products of seven genes: 
maternally expressed CASD1, COPG2, PPP1R9A and SLC22A18 (Figure 3) and paternally 
expressed DIRAS3, INPP5F and PLAGL1 (Figure 4) were successfully generated and their 
allelic expression patterns were verified. The other six genes could not be independently verified 
by this alternative approach because of the close proximity of informative SNPs to the edge of 
exons and difficulty in primer design.   
2.4.4. A novel imprinted cluster in sheep 
Most of imprinted genes were found to reside in clusters of approximately one megabase 
(Bartolomei and Ferguson-Smith, 2011), therefore, discovery of novel imprinted genes often 
uses the already established clusters as a guide (Chen et al., 2016). We generated a genome 
visualization of the known ovine imprinted, monoallelically expressed and putative imprinted 
genes identified in our analysis (Figure 5). The 80 monoallelically expressed genes were mostly 
distributed sporadically throughout the genome.  Due to the limited information on imprinted 
clusters in sheep, we do not exclude the possibility that some of the 80 monoallelically expressed 
genes may be located in imprinted clusters yet to be identified.  
Among the 13 putative imprinted genes, maternally expressed genes CASD1, PPP1R9A 
and paternally expressed PON3 formed a novel sheep imprinted cluster located close to but not 
in the sheep known maternally expressed domain MEG1/GRB10 (Figure 6). This novel large 




human (Monk et al., 2008), indicating it is conserved and likely important in development 
(Nakabayashi et al., 2004). Moreover, COPG2 and WARS are located in the MEST domain and 
DLK1/GTL2 domain on chromosomes 4 and 18 (which also contains five other known imprinted 
genes; Figure 6), respectively. PHLDA2, SLC22A18 and KCNQ1 are located in KCNQ1 domain, 
next to IGF2/H19 domain on chromosome 21, known to be imprinted in sheep (Figure 6). The 
remaining five genes are located sporadically throughout the sheep genome and their 
associations with imprinted clusters, if any, are yet to be defined.  
2.4.5. Tissue-specific Expression of imprinted genes in fetal organs 
 Imprinted genes have unique tissue- and developmental stage-specific expression patterns.  
Nearly all are established during fetal development (Babak et al., 2015) (Thurston et al., 2008). 
Day 135 of gestation in sheep corresponds to the maximal fetal growth which allows ample 
tissue quantities (Peñagaricano et al., 2014). To be conservative and avoid false positives, we did 
not intend to identify genes imprinted in some but not in other tissues in this study.  We did, 
however, determine the tissue-specific expression levels of imprinted genes in control (Con) 
fetuses (Figure 7), overfed (Over) and restricted (Res) fetuses (Figure S2, Table S4.2). 
Expression levels (Transcripts Per Million (TPM); Table S4) of sheep known (Figure 7) 
and putative coding imprinted (Figure 7) genes in the brain, kidney, and lung of fetuses from 
mothers of control diet exhibited tissue-specificity. The fetal mitogen IGF2, for example, was 
expressed at the highest level in the lung and kidney among all imprinted genes. The genes 
DLK1 and GATM in the kidney, DIRAS3, INPP5F and BLCAP in the brain were also among the 
highest expressed. While the tissue-specific expression of imprinted genes (Baran et al., 2015) 
have been reported previously in various species, they were mostly conducted using real time 




the absolute expression values after correcting for transcriptome size and gene length, allowing 
the visualization of expression differences among different genes across samples.  
2.4.6. Effects of maternal nutrition on expression of imprinted genes in ovine fetuses 
We compared the allelic expression of the 18 imprinted genes in fetal organs from the 
three maternal nutrition groups (Table 1). Although not all 18 had informative SNPs or 
expression values in all groups, no allelic expression reversal was observed in any fetal organ 
under any nutrition status.  However, maternal nutrition did affect the levels of expression of the 
imprinted genes DIRAS3, IGF2, PHLDA2, and SLC22A18, in fetal organs (Table 2 & Figure 
S2). Specifically, the paternally expressed IGF2 gene, which promotes fetal growth (Reik et al., 
2000), was down-regulated in the brain of fetuses from mothers of restricted diet (Res) compared 
to controls (Con). The maternally expressed PHLDA2 was also down-regulated in fetal brains 
but up-regulated in fetal lungs of both Res and overfed (Over) groups compared to Con. This 
gene has been shown to be involved in placental growth (Frost and Moore, 2010) and its 
overexpression led to low birth weight in humans (Lewis et al., 2012).  The paternally expressed 
DIRAS3 and maternally expressed SLC22A18 are inhibitors for cell proliferation and growth 
(Huang et al., 2009c; Zhang et al., 2015), and were both down-regulated in lungs of the Res 
group and kidneys of the Over group compared to controls, respectively. Interestingly, three of 
the four affected genes-PHLDA2, SLC22A18, and IGF2- are located near the imprinted cluster of 
KCNQ1 and IGF2/H19 on chromosome 21, indicating this domain is highly responsive to 






Genomic imprinting in sheep is an under-developed area of research, despite the 
importance of the sheep in agriculture in many regions of the world and its frequent use as a 
model for human pregnancy and fetal development (Barry and Anthony, 2008). Our study is the 
first to employ NGS and bioinformatics to identify sheep imprinted genes and the effects of 
maternal diets on fetal imprinting.  We identified 80 genes that consistently monoallelically 
expressed the same parental allele more than the other in all fetal tissues from all treatment 
groups. These 80 contain potential candidate imprinted genes in the sheep for future studies. 
Recent NGS studies identified more than 1,300 imprinted loci in mouse brain (Gregg et al., 
2010a, 2010b), however, most were due to false positives (DeVeale et al., 2012).  To avoid such 
problems, we used the combined list of imprinted genes from all studied species to 
conservatively guide our data-mining. This approach, however, does not permit us to discover 
genes that are only imprinted in the ovine.  Nonetheless, the list is the most comprehensive by 
combining information from five species and the conservative method generated five sheep 
known and 13 new putative imprinted genes, increasing the prior list of 21 by as much as 62%.  
Our results demonstrate the power of bioinformatics in genomic imprinting studies.  
2.5.1. Imprinted domains 
A unique feature of genomic imprinting is that imprinted genes tend to cluster as a result 
of long-range regulation by the imprinting control regions (Bartolomei and Ferguson-Smith, 
2011). In sheep, the previously identified 21 imprinted genes are mostly clustered on 
chromosomes 18 and 21. From the 13 new putative imprinted genes, we identified a new sheep 
imprinted cluster on chromosome 4 (Figure 6), known as the PEG10/SGCE domain in humans 




did not have informative SNPs to study the expression of the two core genes, PEG10/SGCE, in 
this domain. Putative new imprinted genes CASD1, PPP1R9A and PON3 were located in this 
large imprinting domain. The imprinted status of these three genes was supported by many 
informative SNPs from multiple tissues and animals in our data, strong evidence for their 
parental expression bias. All three are maternally expressed in mice (Babak et al., 2008) and 
located adjacent to the paternally expressed SGCE and PEG10 (Ono et al., 2003). CASD1, like 
other maternally expressed genes in this domain such as CALAR, is highly expressed in the brain 
and encodes for a glycosyl transferase (Babak et al., 2008). However, in humans, CASD1 and 
PON3 are biallelically expressed (Monk et al., 2008), and PPP1R9A is imprinted in skeletal 
muscle but not in the brain (Nakabayashi et al., 2004).  The data in sheep are more similar to 
those in the mouse (Babak et al., 2008). Although CASD1 was expressed in all three tissues 
studied (Figure 7), only the kidney had sufficient read counts at this informative SNP for the 
determination of maternal allele expression. This pattern of expression was also confirmed by 
Sanger sequencing. PPP1R9A is important for early development of extraembryonic tissues 
(Nakabayashi et al., 2004) and is similarly expressed in all tissues examined (Figure 7). PON3 
belongs to an enzyme family associated with high-density lipoprotein that is believed to protect 
against the onset of atherogenesis (Ono et al., 2003). Although it was nearly negligible in the 
brain and kidney, it was highly expressed in the lung in ovine fetuses (Figure 7). Such 
expression was also observed in human tissues (Fagerberg et al., 2014). 
COPG2 was located in the MEST cluster on chromosome 4 (Figure 6), which was 
previously known as the MEST/COPG2 imprinted domain in humans and mice (Lee et al., 2000). 
The maternal allele of COPG2 gene is expressed in mice but the human COPG2 escapes genome 




was found to biallelically express in fetal tissues (Khatib, 2005). However, in our analysis of 
ovine fetuses, COPG2 showed preferential expression from the maternal allele in both brain and 
lung. Such lack of conservation of genomic imprinting in closely related species may lead to 
challenges and modification of the currently most plausible imprinting hypothesis - “the parental 
conflict hypothesis” (Khatib, 2005) because not all imprinted genes fit in this model.  
Our analysis placed the gene WARS near the DLK1/GTL2 imprinting domain on 
chromosome 18 (Figure 6), which also contains the widely-studied sheep Callipyge (CLPG) 
locus (Jiang and Yang, 2009), expressed from the dominant paternal allele (Freking et al., 2002). 
Six other imprinted genes have been identified in this region: paternally expressed DLK1, DAT, 
and RTL1 (also known as PEG11), and maternally expressed GTL2 (also known as MEG3), 
PEG11AS and MEG8. Another paternally expressed gene BEGAIN, albeit located 138kb 
proximally from the imprinted DLK1 gene, is not controlled by the ICR of the DLK1/GTL2 
domain (Smit et al., 2005). Paternally expressed WARS is located 150kb downstream of BEGAIN 
in sheep and encodes for a protein linking amino acids with nucleotide triplets in tRNA. It is 
believed to be one of the first proteins that appeared in evolution [provided by RefSeq, Jul 2008]. 
In the mouse WARS is also paternally expressed (DeVeale et al., 2012).  However, it may not be 
controlled by the DLK1/GTL2 LRCE in the sheep due to its relative location to the gene BEGAIN 
(Figure 6).  
Three other putative imprinted genes, SCL22A18, PHLDA2 and KCNQ1, are located on 
chromosome 21 (Figure 6) in the KCNQ1 domain, which contains several maternally expressed 
genes (Lewis et al., 2006; Umlauf et al., 2004). In our analysis, these three ovine genes also 
showed preferential expression from the maternal allele. The region is highly involved in fetal 




Although members of this cluster are subjected to regulation by the same ICR, their expression 
levels varied dramatically. For example, PHLDA2 situates close to the KCNQ1 gene, yet they 
had the highest and lowest expression levels, respectively, in the kidney among all imprinted 
genes (Figure 7). This may suggest that allelic expression pattern and overall gene expression 
levels are regulated by different mechanisms.  
2.5.2. Effects of maternal diets on expression of imprinted gene 
Maternal stressors induce changes in expression of the fetal genome which can 
permanently alter the offspring’s physiology, development, metabolism and growth (Wu et al., 
2006) as reported in mice and rats (Cooney et al., 2002; Waterland et al., 2008). Understanding 
the effect of poor maternal nutrition in ovine fetal development is not only relevant to agriculture 
(Begum et al., 2012), but also to modeling for human pregnancy and fetal development. 
Restricted and over-feeding of pregnant ewes were found to alter gene expression (Peñagaricano 
et al., 2014).  As seasonal breeders, ewes enter pregnancy in late fall or early winter, and usually 
have sufficient food in both quantity and quality. During late gestation when fetal growth is the 
most rapid, however, food becomes scarce, leading to nutrition restriction. Alternatively, the 
practice of flushing before and during the breeding season can result in overfeeding (Wu et al., 
2006). Such nutrient imbalance has been shown to severely impair fetal and placental 
development (Wu et al., 2006). Interestingly, we found most of the disturbed gene expression 
were located in the KCNQ1 and IGF2/H19 clusters, consistent with the role of IGF2 as a major 
fetal growth regulator (Demetriou et al., 2014).  Diets of pregnant ewes containing different 
starch/fiber/protein portions have been shown to change the CpG methylation levels of specific 
imprinted genes such as IGF2R and H19 (Lan et al., 2013). Our data also showed that despite the 




that gene expression levels and imprinted patterns may be regulated through different epigenetic 
mechanisms. 
2.5.3. Recommendations for future throughput imprinting studies 
First, to avoid false positives raised by potential allelic drop-outs during amplification-
based RNA-seq library preparation (Jennings et al., 2017), we conservatively removed 
heterozygous SNPs between nucleotides that were not complementary even though parents were 
homozygous for the nucleotides (e.g., GG in fetus and TT in ram, SNP2 in Figure S1). This 
filtering reduced the numbers of informative SNP per gene. It is suggested that a non-
amplification based hybrid capture NGS may circumvent this issue in library preparation 
(Jennings et al., 2017). Moreover, a number of informative SNPs were located too close to the 
edge of exons, making it difficult to design PCR primers. Consequently, validating them by 
Sanger sequencing proved difficult.  Under this circumstance, new animals with different 
informative SNPs can be used. Allelic drop-outs may also affect PCR of Sanger sequencing. 
Digital Droplet PCR for absolute quantification of target informative SNPs may avoid this 
problem (Gutiérrez-Aguirre et al., 2015).   
Second, a number of SNPs that were heterozygous in fetuses were also heterozygous in 
the parents (e.g., CA in fetus and CA in ram, SNP3 in Figure S1). These SNPs were not 
informative which reduced the number of informative SNPs and partially caused the lack of 
confirmation of the 6 known imprinted genes in the sheep genome. Alleviating this problem 
requires more animals with different genetic background, as well as a better version of sheep 
genome annotation. 
Thirdly, most studies for the discovery of imprinted genes employ reciprocal crosses 




of informative SNPs, parental allelic expression may be caused by species differences, not just 
imprinting. To overcome this problem, increasing the number of crosses from animals of the 
same species is the most relevant and preferred design.    
Fourthly, cis-expression quantitative trait loci (eQTL) confers monoallelic expression in 
all crosses. Even using known mammalian imprinted genes as a guide, we cannot rule out that 
the putative imprinted genes may contain eQTL. On the other hand, the list of 80 monoallelically 
expressed genes likely contain more imprinted genes in addition to eQTL because they 
consistently expressed the same parental allele among several different crosses. Nonetheless, 
reciprocal crosses are necessary to firmly distinguish these two types of monoallelic expression. 
 Lastly, in the original experimental design, we included the fetal cotyledons because 
many genes are only imprinted in the placenta.  However, cotyledon samples are mostly 
contaminated with caruncles (Bridger et al., 2007). We also found similar cross contaminations 
in our samples and were not able to include them in our study.  Therefore, other strategies such 






Table 1. Summary of the confirmed/putative imprinted genes in sheep 





Tissues Brain Kidney Lung 
 
Brain Kidney Lung 
 
Brain Kidney Lung 
BEGAIN ND 91% 100% 
 
- - - 
 
- - - 
BLCAP - - - 
 
79% 80% 85% 
 
- - - 
DIRAS3 - - - 
 
- - - 
 
80% 87% ND 
INPP5F 97% ND 70% 
 
98% ND ND 
 
97% ND ND 
PEG3 86% 85% 86% 
 
88% 87% 86% 
 
84% 86% 88% 
PLAGL1 ND 100% 86% 
 
- - - 
 
- - - 
PON3 ND 73% ND 
 
ND ND 75% 
 
ND 78% 76% 
WARS 74% 72% ND 
 
ND 74% 70% 
 
78% 73% ND 
CASD1 - - -  ND 30% ND  ND 29% ND 
COPG2 11% 27% ND  17% 21% ND  20% 29% 29% 
GATM 29% 30% 29%  19% 25% ND  ND 28% ND 
GRB10 ND  19% 25%  29% 23% 22%  ND  26% 18% 
GTL2 - - -  0 0 24%  - - - 
IGF2R ND  4% 16%  ND  9% 10%  ND  8% 7% 
KCNQ1 - - -  ND  ND  19%  ND  20% ND  
PPP1R9A ND  ND  24%  ND  23% ND   28% 21% 23% 
SLC22A18 ND  ND  18%  ND  30% ND  - -  - 
PHLDA2 - - -  - - -  ND 27% ND 
‘-’: no informative SNPs in this animal at this gene. ‘ND’: expression of the informative SNP is Not Detectable (read counts lower 
than 20; not reliable for allelic expression determination). 
Pink or blue: exclusively/predominately expressing the maternal or the paternal allele. Numbers: % of paternal allele expression 




Table 2. Levels of differentially expressed imprinted genes in tissues of fetal sheep 
from mothers of different nutrition 
  
Tissue Genes Control (TPM) Overfed (TPM) Log2 FC* Restricted (TPM) Log2 FC* 
Brain PHLDA2 19.36 0.44 -1.71 0.47 -6.32 
Brain IGF2 23.61 38.3 0.69 5.22 -2.07 
Kidney SLC22A18 16.40 9.55 -1.24 10.56 -0.64 
Lung PHLDA2 0.19 8.28 6.58 1.31 2.23 
Lung DIRAS3 3.06 2.37 -0.37 1.28 -1.11 
FC*: fold change over the expression levels in controls. Log2 FC: calculated by using 






Figure 1. Data analysis pipeline used in this study 
 
Left panels are the bioinformatics pipeline for SNP calling and informative SNPs identification. 
Right panels show the determination of monoallelically expressed genes in ovine fetuses and 
validation of putative imprinted genes.  Details are presented in sections of Materials and 
Methods: SNP calling from DNA- and RNA-seq data, Identification of informative SNPs, and 
Differential allele-specific gene expression and statistical analysis. SNP: single nucleotide 
polymorphism; ref: reference genome; alt: alternative genome; B: Brain; K: Kidney; L: Lung; 
dup: duplication; M: maternally expressed; P: paternally expressed. Blue and red boxes: genomic 
DNA and exons; blue lines with blue boxes: RNA sequence reads; dash lines: mapped gaps in 
RNA-seq reads; Hisat2: Alignment software; SNVQ: SNP calling software; Samtools mpileup: 





Figure 2. Correction of the RNA-seq alignment bias in the genome 
 
Density plot of the percentage of reference allele’s read counts in the reference genome (blue), 






Figure 3. Validation of putative imprinted genes (maternally expressed) using ram and 
fetal DNA as well as fetal cDNA: CASD1, COPG2, PPP1R9A, and SLC22A18 
 
Red arrows: locations of the informative SNPs.  All SNPs were confirmed homozygous in rams 






Figure 4. Validation of putative imprinted genes (paternally expressed) using ram and fetal 
DNA as well as fetal cDNA: DIRAS3, INPP5F, and PLAGL1 
 
Red arrows: locations of the informative SNPs.  All SNPs were confirmed homozygous in rams 





Figure 5. Visualization of the 11 known sheep imprinted genes in the ovine genome 
Oar_v4.0 annotation (orange) 
 
The five genes verified in our study (orange mark, blue text), the 13 putative imprinted genes 
identified here (red mark), the 80 monoallelically expressed genes (purple lines, some are 






Figure 6. Genes and their parental expression patterns in the four imprinted clusters in 
sheep 
 
Pink: maternally expressed; blue: paternally expressed. Arrow indicates the gene expression 






Figure 7. Expression levels (Transcripts Per Million, TPMSD) of sheep imprinted genes in 
the brain, kidney, and lung tissue of day 135 ovine fetuses from ewes fed a control diet 
 
A. The 
10 coding and previously known imprinted genes in the sheep genome. B. The 13 putative 







2.6. Supplementary information 
Table S1.1. Summary of the 80 monoallelically expressed genes in sheep 
Treatment Control group  Overfed group  Restrict group  
Tissuetype Brain Kidney Lung   Brain Kidney Lung   Brain Kidney Lung 
ACOT13 84% 85% 88%  83% 79% 84%  88% 81% 82% 
C2H9orf3 77% 75% 76%  73% 85% 75%  75% 76% 74% 
CCBL1 96% 83% 90%  85% 91% 85%  86% 89% 87% 
CHMP2A 93% 92% 92%  94% 91% 94%  89% 95% 94% 
EIF2S3 88% 91% 83%  89% 90% 91%  90% 87% 89% 
EIF4G1 88% 92% 84%  91% 90% 87%  93% 92% 84% 
GNAQ 76% 79% 81%  77% 77% 77%  78% 78% 77% 
ITGB5 83% 80% 82%  100% 91% 79%  86% 84% 80% 
LOC101108797 86% 84% 85%  84% 81% 86%  79% 86% 85% 
LOC105602948 84% 89% 92%  84% 90% 94%  89% 90% 94% 
LOC106991149 81% 92% 94%  89% 88% 93%  85% 92% 91% 
NES 77% 72% 75%  79% 74% 78%  79% 79% 83% 
PARG 91% 83% 81%  82% 78% 80%  76% 78% 80% 
PEG3 86% 85% 86%  88% 87% 86%  84% 86% 88% 
PPP2R1A 91% 94% 89%  92% 94% 90%  92% 89% 93% 
RWDD1 76% 76% 78%  79% 77% 79%  81% 83% 82% 
SAFB 81% 77% 77%  81% 75% 74%  81% 81% 83% 
SON 79% 76% 78%  83% 78% 74%  82% 79% 79% 
UBB 87% 85% 85%  87% 85% 85%  86% 81% 83% 
            
ABHD16A 18% 23% 12%  17% 21% 26%  22% 30% 27% 
ALDH2 18% 28% 27%  15% 25% 29%  23% 26% 27% 
APOE 13% 20% 14%  11% 8% 25%  16% 9% 19% 
ARCN1 9% 19% 13%  7% 4% 19%  17% 11% 13% 
ARFGEF1 14% 22% 20%  11% 25% 29%  8% 20% 21% 
ARL2BP 22% 16% 14%  20% 7% 10%  22% 13% 22% 
ATP5G1 13% 20% 18%  10% 16% 22%  12% 17% 26% 
AUP1 13% 20% 18%  16% 17% 21%  15% 16% 19% 
BBS4 19% 24% 17%  10% 18% 25%  14% 23% 23% 
CFAP20 4% 22% 23%  10% 10% 16%  22% 8% 19% 
CLK1 21% 21% 21%  22% 19% 23%  16% 19% 20% 
CNBP 11% 23% 19%  14% 16% 22%  17% 18% 19% 
CPSF3L 16% 21% 18%  15% 12% 21%  18% 15% 19% 
CRELD1 19% 14% 18%  18% 16% 14%  21% 15% 18% 
CSNK2B 18% 13% 13%  5% 9% 16%  9% 11% 20% 
CUL7 15% 27% 28%  20% 25% 20%  19% 24% 30% 
DBN1 14% 24% 20%  16% 19% 27%  16% 21% 28% 
DCTN1 12% 18% 21%  13% 12% 23%  18% 20% 19% 
DNAJC11 8% 15% 24%  10% 9% 24%  17% 27% 7% 
DNAJC7 8% 19% 15%  8% 11% 18%  7% 17% 23% 
DPF2 24% 21% 19%  17% 19% 19%  14% 22% 15% 




FBXO9 9% 24% 18%  15% 13% 16%  10% 21% 22% 
FERMT2 12% 17% 15%  16% 17% 19%  11% 19% 17% 
FIBP 21% 24% 20%  22% 24% 21%  27% 20% 28% 
GGNBP2 13% 21% 24%  19% 21% 21%  10% 18% 19% 
GIT1 17% 17% 14%  8% 23% 26%  12% 15% 21% 
GPAA1 18% 18% 22%  13% 16% 23%  16% 21% 15% 
GPI 6% 18% 18%  8% 21% 19%  6% 17% 14% 
HNRNPM 16% 24% 23%  16% 22% 24%  16% 23% 24% 
HNRNPU 22% 16% 21%  23% 15% 19%  19% 21% 13% 
ILF2 14% 20% 20%  12% 24% 20%  5% 18% 19% 
KPNB1 17% 14% 17%  16% 11% 18%  18% 18% 15% 
LOC101109495 14% 21% 23%  20% 17% 21%  21% 23% 18% 
LOC101112480 25% 22% 19%  25% 22% 21%  25% 20% 18% 
LPCAT4 12% 14% 15%  18% 15% 18%  19% 11% 20% 
MAP4K4 14% 25% 23%  18% 28% 28%  14% 12% 27% 
MAT2A 12% 16% 10%  13% 10% 18%  14% 11% 15% 
MPRIP 23% 14% 13%  27% 19% 12%  24% 16% 13% 
MTCH1 7% 22% 20%  4% 23% 23%  8% 21% 24% 
NCOA4 16% 19% 20%  3% 13% 24%  14% 24% 20% 
NDUFA2 16% 14% 15%  16% 13% 11%  12% 19% 14% 
PAM 21% 28% 25%  22% 27% 27%  23% 27% 25% 
PRKCSH 17% 15% 16%  19% 18% 22%  22% 20% 16% 
PSMA4 16% 20% 18%  15% 18% 23%  24% 14% 16% 
PSMD2 14% 20% 14%  5% 20% 18%  7% 17% 19% 
PTOV1 11% 19% 23%  15% 21% 20%  14% 20% 21% 
RAF1 20% 23% 21%  7% 22% 23%  14% 17% 20% 
RBM5 13% 16% 16%  11% 18% 20%  16% 17% 15% 
RFXANK 16% 20% 19%  23% 12% 24%  13% 18% 18% 
RPN1 18% 18% 27%  29% 25% 25%  21% 17% 21% 
SGK1 19% 17% 22%  21% 21% 18%  18% 21% 16% 
SLC25A3 9% 21% 21%  12% 20% 24%  16% 19% 25% 
SNF8 17% 26% 22%  20% 17% 22%  21% 20% 23% 
SORT1 15% 22% 22%  19% 14% 29%  19% 24% 18% 
TBCB 11% 25% 24%  11% 24% 23%  13% 23% 26% 
TERF2 16% 24% 18%  27% 20% 19%  18% 20% 16% 
TMX2 12% 21% 26%  9% 23% 23%  10% 24% 26% 
TRMT2A 18% 24% 15%  14% 9% 24%  14% 13% 21% 
UAP1 10% 15% 17%  7% 16% 19%  17% 15% 20% 
VPS52 10% 20% 10%   12% 12% 19%   14% 11% 18% 
Pink and blue: maternally and paternally expressed, respectively. Numbers: % of paternal allele 
expression [paternal allele reads/(paternal allele reads+ maternal allele reads)]. Genes in bold: 
known sheep imprinted genes.  
 
Table S1.2. The iSNPs and the percentages of their paterntal allele expression in the 80 
monoallelically expressed genes in each animal/tissue sample 
https://www.tandfonline.com/doi/suppl/10.1080/15592294.2018.1503489?scroll=top 
 
Table S2. Summary of imprinted genes in the sheep (21), mouse (186), human (112), cow 




Among the 263, 119 genes are present in sheep genome Oar_v4.0.  
https://www.tandfonline.com/doi/suppl/10.1080/15592294.2018.1503489?scroll=top 
 
Table S3. The iSNPs and the percentages of their paternal allele expression for the 18 







Table S4.  Expression levels mean of known and putative imprinted genes in in sheep 






genes Brain Kidney Lung   
Putative 
imprinted 
genes  Brain Kidney Lung 
Control BEGAIN 86.41 16.76 8.08  COPG2 58.51 28.74 29.49 
 CDKN1C 9.77 123.68 40.19  GATM 158.17 363.23 34.52 
 DIO3 1.83 2.41 0.06  DIRAS3 520.62 21.31 3.06 
 DLK1 1.13 756.23 59.13  SLC22A18 1.07 16.40 0.38 
 GRB10 12.22 36.49 29.98  PHLDA2 19.36 253.60 0.19 
 IGF2 23.61 1907.47 3404.81  BLCAP 305.11 93.72 89.84 
 IGF2R 23.75 299.86 235.25  WARS 113.19 67.29 113.22 
 MEST 32.11 111.10 74.17  PLAGL1 20.74 208.89 111.97 
 PEG3 29.69 174.60 47.25  PPP1R9A 47.27 42.20 46.67 
 RTL1 0.49 31.27 0.74  KCNQ1 2.08 11.39 5.45 
      CASD1 22.98 20.28 14.05 
      PON3 0.54 11.89 157.89 
      INPP5F 419.06 19.75 31.61 
          
Overfed BEGAIN 93.49 14.61 10.41   COPG2 59.67 27.07 26.82 
 CDKN1C 7.06 139.19 42.01  GATM 147.21 506.73 30.74 
 DIO3 1.41 3.76 0.29  DIRAS3 412.49 21.35 2.37 
 DLK1 0.12 721.70 94.27  SLC22A18 1.15 9.55 0.72 
 GRB10 12.14 30.95 28.23  PHLDA2 0.44 130.65 8.28 
 IGF2 38.26 2096.00 3074.34  BLCAP 308.53 88.44 89.03 
 IGF2R 23.64 405.87 205.58  WARS 121.30 75.56 124.26 
 MEST 27.94 136.66 86.21  PLAGL1 19.86 216.79 103.98 
 PEG3 28.62 224.42 35.94  PPP1R9A 45.46 49.64 35.04 
 RTL1 0.24 20.37 1.42  KCNQ1 2.51 11.02 4.80 
      CASD1 22.11 20.79 12.91 
      PON3 0.68 12.19 105.34 
      INPP5F 334.57 19.57 30.29 
          
Restricted BEGAIN 54.53 19.67 9.59   COPG2 62.56 27.42 30.70 
 CDKN1C 15.27 131.04 43.48  GATM 193.92 421.41 30.54 
 DIO3 1.24 1.91 0.04  DIRAS3 407.41 32.33 1.28 
 DLK1 0.43 750.71 55.69  SLC22A18 0.53 10.56 0.17 
 GRB10 11.69 35.42 31.79  PHLDA2 0.47 206.26 1.31 
 IGF2 5.22 1965.73 3054.94  BLCAP 265.86 94.72 92.80 
 IGF2R 15.78 371.21 222.87  WARS 102.75 72.70 127.45 
 MEST 30.87 110.79 80.57  PLAGL1 19.73 216.57 109.18 
 PEG3 22.48 252.27 44.18  PPP1R9A 42.57 51.06 43.89 
 RTL1 0.36 21.90 0.69  KCNQ1 1.76 9.86 4.08 
      CASD1 19.60 21.08 14.46 
      PON3 0.50 11.19 111.54 
            INPP5F 299.25 20.70 33.22 
TPM<1 is used as a cut-off for gene expression. 




Table S5. RNA integrity number in each sample   
Tissue Treatment Sample ID RIN 260/280   Qubit RNA concentration (ng/ul) 
Brain 
Control 
1 8.3 2.2 1176 
2 8.7 2.15 230 
3 7 2.23 85.8 
4 8.1 2.22 472 
5 8.8 2.14 1170 
6 7 2.14 576 
7 8 2.14 1158 
Restricted 
1 8.3 2.19 724 
2 7.5 2.14 252 
3 8.4 2.13 103 
4 8.1 2.16 858 
Overfed 
1 8.2 2.18 720 
2 7.4 2.19 220 
3 8.5 2.19 468 
4 9 2.18 1266 
Lung 
Control 
1 9.5 2.18 796 
2 9.4 2.14 396 
3 9.4 2.18 510 
4 9 2.17 464 
5 10 2.14 573 
6 9.7 2.14 1860 
7 9.9 2.14 1920 
Restricted 
1 8.2 2.16 1448 
2 8.9 2.14 422 
3 8.8 2.13 384 
4 9.4 2.12 342 
Overfed 
1 9 2.17 988 
2 9.1 2.18 540 
3 9.3 2.19 488 
4 9.1 2.18 684 
Kidney 
Control 
1 8.9 2.12 450 
2 7.3 2.15 1264 
3 9.3 2.08 736 
4 7.8 2.11 1160 
5 9.1 2.14 1470 
6 7.3 2.14 1092 
7 8.3 2.14 2226 
Restricted 
1 8.8 2.04 2412 
2 9.1 2.1 1996 
3 7.5 2.18 1280 
4 9.3 2.16 330 
Overfed 
1 9.2 2.1 494 
2 8.4 2.1 524 
3 8.9 2.15 648 






Table S6. RNA sequencing and DNA sequencing mapping rate for unique aligned reads in 
two genomes 
  Mapping_rate   
Sample name Input reads Reference_genome Alternative_genome 
RNA sequencing 
Brain_Con1 19,338,492 87.65% 87.55% 
Brain_Con2 7,403,965 87.87% 87.91% 
Brain_Con3 16,659,394 88.73% 88.74% 
Brain_Con4 10,877,799 89.29% 89.41% 
Brain_Con5 44,248,481 88.58% 88.69% 
Brain_Con6 27,184,026 88.24% 88.33% 
Brain_Con7 22,361,399 88.07% 88.15% 
Brain_Over1 24,241,471 88.45% 88.55% 
Brain_Over2 12,234,121 89.03% 89.05% 
Brain_Over3 13,845,220 88.87% 88.96% 
Brain_Over4 30,882,144 88.67% 88.78% 
Brain_Res1 16,265,786 89.46% 89.52% 
Brain_Res2 16,451,888 89.51% 89.53% 
Brain_Res3 12,068,236 88.79% 88.86% 
Brain_Res4 19,787,096 88.72% 88.81% 
Kidney_Con1 5,309,507 88.85% 89.00% 
Kidney_Con2 19,799,155 88.45% 88.50% 
Kidney_Con3 22,380,911 88.85% 89.05% 
Kidney_Con4 26,838,096 88.56% 88.66% 
Kidney_Con5 27,727,956 88.54% 88.72% 
Kidney_Con6 19,647,949 88.18% 88.26% 
Kidney_Con7 22,924,014 88.14% 88.27% 
Kidney_Over1 8,348,235 88.67% 88.84% 
Kidney_Over2 23,979,270 88.55% 88.73% 
Kidney_Over3 7,705,718 88.89% 89.06% 
Kidney_Over4 19,777,286 88.60% 88.72% 
Kidney_Res1 22,860,452 88.61% 88.77% 
Kidney_Res2 20,851,640 88.32% 88.43% 
Kidney_Res3 26,710,129 88.16% 88.34% 
Kidney_Res4 5,475,073 88.95% 89.10% 
Lung_Con1 18,685,815 88.06% 88.30% 
Lung_Con2 22,413,568 87.68% 87.90% 
Lung_Con3 20,516,820 87.74% 87.97% 
Lung_Con4 26,061,352 87.92% 88.11% 
Lung_Con5 29,341,237 87.68% 87.90% 
Lung_Con6 33,475,352 87.16% 87.27% 
Lung_Con7 27,083,308 87.76% 87.94% 
Lung_Over1 67,688,330 87.19% 87.38% 
Lung_Over2 24,310,426 88.87% 89.14% 
Lung_Over3 15,834,344 88.24% 88.47% 
Lung_Over4 33,703,648 87.30% 87.53% 
Lung_Res1 28,273,422 87.79% 88.04% 
Lung_Res2 37,304,508 87.51% 87.69% 
Lung_Res3 14,983,923 88.03% 88.20% 
Lung_Res4 15,457,570 88.02% 88.20% 
DNA sequencing 
Ram_1 521,179,196 85.29% 85.14% 
Ram_2 164,576,169 85.30% 85.17% 
Ram_3 357,811,435 85.77% 85.68% 




Table S7. RNA Sequencing mapping rates for multiple aligned reads 
Fetus ID Input reads % Mapped Reads Number of Mapped Reads  
Brain_Con1 19,338,492 89% 17,261,538 
Brain_Con2 7,403,965 90% 6,629,510 
Brain_Con3 16,659,394 90% 15,055,094 
Brain_Con4 10,877,799 91% 9,932,518 
Brain_Con5 44,248,481 90% 40,040,450 
Brain_Con6 27,184,026 90% 24,500,963 
Brain_Con7 22,361,399 90% 20,089,481 
Brain_Over1 24,241,471 91% 14,836,023 
Brain_Over2 12,234,121 91% 14,979,444 
Brain_Over3 13,845,220 91% 10,926,581 
Brain_Over4 30,882,144 91% 17,921,173 
Brain_Res1 16,265,786 90% 21,904,593 
Brain_Res2 16,451,888 91% 11,086,560 
Brain_Res3 12,068,236 91% 12,564,537 
Brain_Res4 19,787,096 91% 27,966,870 
Kidney_Con1 5,309,507 90% 16,897,583 
Kidney_Con2 19,799,155 90% 20,199,107 
Kidney_Con3 22,380,911 90% 18,491,810 
Kidney_Con4 26,838,096 90% 23,499,521 
Kidney_Con5 27,727,956 90% 26,421,784 
Kidney_Con6 19,647,949 89% 29,926,965 
Kidney_Con7 22,924,014 90% 24,366,852 
Kidney_Over1 8,348,235 90% 25,508,281 
Kidney_Over2 23,979,270 90% 33,525,561 
Kidney_Over3 7,705,718 90% 13,539,473 
Kidney_Over4 19,777,286 90% 13,964,369 
Kidney_Res1 22,860,452 89% 60,526,905 
Kidney_Res2 20,851,640 91% 22,129,781 
Kidney_Res3 26,710,129 91% 14,345,916 
Kidney_Res4 5,475,073 90% 30,242,283 
Lung_Con1 18,685,815 91% 4,836,961 
Lung_Con2 22,413,568 90% 17,858,838 
Lung_Con3 20,516,820 91% 20,386,772 
Lung_Con4 26,061,352 90% 24,242,852 
Lung_Con5 29,341,237 91% 25,146,483 
Lung_Con6 33,475,352 90% 17,692,978 
Lung_Con7 27,083,308 90% 20,656,829 
Lung_Over1 67,688,330 91% 7,591,885 
Lung_Over2 24,310,426 91% 21,765,983 
Lung_Over3 15,834,344 91% 7,026,844 
Lung_Over4 33,703,648 91% 17,920,199 
Lung_Res1 28,273,422 91% 20,732,144 
Lung_Res2 37,304,508 90% 18,835,286 
Lung_Res3 14,983,923 90% 24,124,589 





Table S8.1.DEG of monoallellically expressed genes in sheep fetal tissues of maternal 
nutrition 




Single Log2 FC Confident Log2 FC 
Con vs. Res Brain LOC101112480 12.241 21.36 0.80 1.23 
 
Table S8.2. DEG of known mammlian imprinted genes in sheep fetal tissues of maternal 
nutrition. Red genes are imprinted genes in sheep 
Comparisons Tissue Genes Condition1 (TPM) Condition2 (TPM) Single Log2 FC Confident Log2 FC 
Con vs. Over 
Brain 
KRT7 4.35 1.58 -1.46 -1.39 
PHLDA2 19.36 0.44 -5.46 -1.71 
Kidney 
ADAM23 2.10 5.83 1.48 2.69 
AOX1 13.25 3.10 -2.10 -1.39 
RBP5 18.10 13.30 -0.44 -1.08 
SGK2 17.48 13.63 -0.36 -1.04 
SLC22A18 16.40 9.63 -0.77 -1.24 
Lung 
PHLDA2 0.21 8.22 5.29 6.58 
WT1 0.12 2.08 4.11 3.38 
Con vs. Res 
Brain 
AOX1 2.82 0.71 -1.98 -1.82 
GALNT6 5.00 39.82 2.99 1.97 
GLIS3 10.16 4.48 -1.18 -1.04 
IGF2 16.45 5.19 -1.67 -2.07 
PHLDA2 19.36 0.47 -5.36 -6.32 
SGK2 4.52 36.38 3.01 1.47 
SLC22A2 1.14 0.23 -2.33 -2.28 
SMOC2 3.15 1.37 -1.20 -1.10 
TP73 2.66 0.39 -2.76 -2.63 
TSPAN32 1.16 2.25 0.96 1.02 
Kidney AOX1 13.25 3.45 -1.94 -1.39 
Lung 
DIRAS3 3.06 1.29 -1.24 -1.11 
PHLDA2 0.21 1.29 2.61 2.23 






Table S9. Primers used for PCR and Sanger sequencing 
Gene 
Name 
Forward primer Reverse primer Product 
length 
TM 




G TCCTATAGCTACCAATGCCCCCACC 560 
60°
C 
DIRAS3 ACCCAAACCACAGCACACAAGTCAG CGACCATCGAAGATACCTACCGCCA 620 
62°
C 
INPP5F AACATAAACACATTGACTGGC ACTGGTTCAACTGACAAAAAC 263 55°
C 















Figure S1. Identification of informative SNPs (iSNPs).  
 
Four different types of SNP combination were observed and only SNP1 was considered 
informative because it is heterozygous in the fetus and homozygous in the ram. Others are either 





Figure S2.  Expression levels (TPM mean) of sheep imprinted genes in the brain, kidney, 
and lung tissue of day 135 fetal sheep from ewes fed a control diet.  
 
A-B.The 10 coding and previously known imprinted genes in the sheep genome. C. The 13 
putative imprinted genes identified in our study. Blue: brain, orange: kidney, grey: lung.   










Dosage Compensation of the X Chromosomes in Bovine Germline, Early Embryos and 
Somatic Tissues 
(Under revision, Genome Biology and Evolution)  
 
Duan J.E., Shi W., Jue N.K., Jiang Z., Kuo L., O’Neill R., Wolf E., Dong H., Zheng X., Chen J. 





Dosage compensation of the mammalian X chromosome (X) was proposed by Susumu 
Ohno as a mechanism wherein the inactivation of one X in females would lead to the doubling 
the expression of the other.  This would resolve the dosage imbalance between eutherian females 
(XX) vs. male (XY) and between a single active X vs. autosome pairs (A). Expression ratio of X- 
and A-linked genes has been relatively well-studied in humans and mice, despite controversial 
results over the existence of up-regulation of X-linked genes. Here we report the first 
comprehensive test of Ohno’s hypothesis in bovine pre-attachment embryos, germline and 
somatic tissues. Overall an incomplete dosage compensation (0.5<X:A<1) of expressed genes 
and an excess X dosage compensation (X:A>1) of ubiquitously expressed “dosage-sensitive” 
genes were seen. No significant differences in X:A ratios were observed between bovine female 
and male somatic tissues, further supporting Ohno’s hypothesis. Interestingly, pre-implantation 
embryos manifested a unique pattern of X dosage compensation dynamics. Specifically, X 
dosage decreased after fertilization, indicating that the sperm brings in an inactive X to the 
matured oocyte. Subsequently, the activation of the bovine embryonic genome enhanced 
expression of X-linked genes and increased the X dosage. As a result, an excess compensation 
was exhibited from the 8-cell stage to the compact morula stage. The X dosage peaked at the 16-
cell stage and stabilized after the blastocyst stage. Together, our findings confirm Ohno’s 
hypothesis of X dosage compensation in the bovine and extend it by showing incomplete and 
over-compensation for expressed and “dosage-sensitive” genes, respectively.  




Gene dosage is the number of copies of a given gene in cells of an organism and can be 
manifested by the amount of its products (Ercan, 2015). Maintenance of proper gene dosage is 
essential in functional cellular networks such as in embryogenesis, and fetus development. 
Aneuploidy such as monosomy or trisomy is an abnormal change in the dosage of chromosomes 
and is generally detrimental to the organism (Holtzman et al., 1992).  For example, aneuploidy 
accounts for 46.3% of spontaneous abortions in humans (Hassold et al., 1980). Small changes in 
dosage of single genes can lead to many diseases (Hurles et al., 2008) and the onset of 
tumorigenesis (Gordon et al., 2012). However, monosomy of the X chromosome in mammalian 
males is well-tolerated, although over a thousand genes important for both sexes are located on X 
(Ercan, 2015). Susumu Ohno hypothesized that to prevent the deleterious effects of 
haploinsufficiency in males, a compensatory mechanism involving the doubling expression of X-
linked genes must occur (Ohno et al., 1959). This, however, at the same time could cause a 
quadruple dosage of X in females. By transcriptionally silencing one of the two X chromosomes 
in females the dosage of the X chromosome between males and females is balanced (Veitia and 
Potier, 2015). Meanwhile, this also balances the gene dosage between sex chromosome and 
autosome pairs (A) in both sexes (Ohno, 1966).  
Although X chromosome inactivation (XCI) has been observed in all mammalian species 
studied to date (Heard et al., 1997; Lyon, 1961; Ohno et al., 1959), dosage compensation by 
doubling the expression of X-linked genes has only been studied in very few species and is still 
heavily debated (Deng et al., 2011; He et al., 2011; Kharchenko et al., 2011; Nguyen and 
Disteche, 2006; Xiong et al., 2010). Dosage compensation is determined by calculating the ratio 
of averaged expression value of X-linked genes to that of the autosomes (X:A ratio).  The ratio 
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X:A ᴝ 1 indicates the doubling of X gene expression, while X:A of 0.5 rejects Ohno’s 
hypothesis. Two previous microarray studies fully supported dosage compensation in both 
humans and mice (Gupta et al., 2006; Nguyen and Disteche, 2006). However, the first RNA 
sequencing (RNA-seq) study of humans and mice (Xiong et al., 2010) claimed that microarray-
based expression was not suitable for comparing expression levels of different genes, and 
reported X:A of approximately 0.5 i.e. a lack of dosage compensation. Subsequently, the same 
RNA-seq data were re-analyzed with all low and non-expressed genes removed because such 
genes are enriched on X chromosomes and thus could skew the comparison.  Results from such 
filtering verified the hypothesis (Deng et al., 2011; Kharchenko et al., 2011). Since then, Ohno’s 
hypothesis has been tested with many different analysis approaches including comparing the 
ratio between the modern X to the proto XX using 1:1 orthologs between humans and chickens 
(Lin et al., 2012) or comparing only genes coding for large proteins as the “dosage-sensitive 
housekeeping genes” (Pessia et al., 2014). It has been found that different experimental platforms, 
analysis methods, and cutoff values all influenced the dosage compensation results. Thus, more 
questions than answers are presented on the evolution of dosage compensation of sex 
chromosomes (He and Zhang, 2016).  
While debates persist over dosage compensation, XCI has been observed in all 
mammalian species studied to date (Okamoto et al., 2011). In the bovine, XCI was proposed by 
De La Fuente et al. (1999), and confirmed by Xue et al. (2002). In early bovine embryos 
imprinted XCI was observed at the morula stage (Ferreira et al. 2010) and random XCI occurred 
between the blastocyst and elongation stages (Bermejo-Alvarez et al., 2011). Although a recent 
study reported incomplete X dosage compensation in bovine fat, liver, muscle, and pituitary 
gland (Ka et al., 2016), further studies are needed for bovine early embryos and germ cells.  
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Here we report the first comprehensive test of Ohno’s hypothesis in the compensatory 
upregulation of the X chromosome in bovine embryos, germline and a vast array of somatic 
tissues using seven RNA-seq datasets (three from bovine pre-attachment embryos and four from 
somatic tissues), including immature and mature oocytes, in vivo and in vitro embryos up to the 
blastocyst stage (days 1-7; day 0= standing estrus), conceptuses (embryos and associated extra-
embryonic membranes) from day 7 to day 19, two adult female-specific tissues, eight adult 
female and male somatic tissues. Using median expression of the X:A ratio with its 95% 
bootstrap confidence intervals, we report incomplete compensatory up-regulation of expressed 
X-linked genes and complete dosage compensation of “dosage-sensitive” genes. Our data thus 
fully support Ohno’s hypothesis in that the compensatory upregulation of X chromosome 





3.3. Materials and Methods 
3.3.1. Paralog analysis 
To determine the unique or non-unique mapping strategy, we first calculated paralog 
enrichment on each bovine chromosome. Paralogs were identified on BioMart (Ensembl genome 
browser: http://useast.ensembl.org/biomart/; ensemble genes 85) and defined as genes with 
greater than 70% amino acid identity. This minimal cutoff for paralogs was a result of our 
pervious study, which determined that 70% was the best match of the BioMart search algorithm 
for the identification of X-linked multi-gene families (Jue et al., 2013). The total number of 
genes on each chromosome was calculated using bovine genome reference annotation UMD3.1 
(http://useast.ensembl.org/Bos_taurus/Info/Annotation?redirect=no). Enrichment of paralogs 
gene number for each autosome was calculated by Fisher’s exact test compare to that on X 
chromosome (Table 1).  
3.3.2. RNA-seq datasets and read trimming 
Raw FASTQ files were obtained from NCBI GEO database (Table 2). A total of seven 
datasets including 1) in vivo developed matured oocytes and 2-cell to blastocyst stage pre-
implantation embryos (Jiang et al., 2014), 2) immature oocyte, in vitro developed matured 
oocytes, 4-cell, 8-cell, 16-cell, and blastocyst embryos (Graf et al., 2014), 3) conceptuses at days 
7, 10, 13, 16, and 19 (embryos and associated extra-embryonic membranes) (Mamo et al., 2012), 
4) female endometria and corpora lutea (CL) (Moore et al., 2016), 5) female somatic tissues of 
brain, liver, muscle and kidney (Chen et al., 2015), 6) male somatic tissues of fat, muscle, 
hypothalamus, duodenum, liver, lung and kidney (PRJEB6377), 7) female and male somatic 
tissues of fat, liver, muscle, and pituitary gland (Seo et al., 2016).  
All RNA-seq raw reads were downloaded from NCBI using sratoolkit (version 2.5.0; 
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http://www.ncbi.nlm.nih.gov/Traces/sra/sra.cgi?view=toolkit_doc&f=std#s-2). The sequence 
read archive (sra) format files were converted to fastq format by fastq-dump (version 2.5.0; 
http://www.ncbi.nlm.nih.gov/Traces/sra/sra.cgi?view=toolkit_doc&f=fastq-dump). Quality-
trimming and control were conducted as follows before mapping to the reference genome. Firstly, 
Trimmomatic (version 0.33; http://www.usadellab.org/cms/?page=trimmomatic ) was applied to 
removing the universal sequencing adaptors of SOLiD and Illumina in respective datasets with a 
minimum Phred score of 20 and minimal length of 30bp. Subsequently, read quality was 
examined using FastQC (version 0.11.3; 
http://www.bioinformatics.babraham.ac.uk/projects/fastqc/). The summary of the numbers of 
reads in each sample after trimming is presented in supplementary table S1. The average number 
of read input for mapping across all samples is 22,814,027. 
3.3.3. Mapping and transcript assembly 
RNA-seq read mapping and transcript assembly were preformed based on the following 
pipeline. Trimmed RNA-seq reads were aligned to Ensemble bovine reference genome assembly 
UMD3.1.1 using Hisat2 version 2.0.5 aligner (Pertea et al., 2016). Transcript splice site detection 
was used and both unique and non-uniquely mapped reads were kept for the subsequent analysis. 
The percentages of non-uniquely mapped reads for each sample are summarized in 
supplementary table S1 and the averaged overall mapping rate was 83.5%. IsoEM version 1.1.5 
(Nicolae et al., 2011b) was used to quantify gene expression to transcripts per kilobase million 
(TPM) using default parameters. For non-uniquely mapped reads, IsoEM assign fractions of the 
multiple aligned reads to each location using an expectation maximization algorithm (Nicolae et 
al., 2011b). Expressed genes were defined as expression level TPM >1. “Dosage-sensitive” 




3.3.4. RNA-seq dataset overview 
Matrices of gene expression TPM for the embryo (datasets 1-3) and somatic tissues 
(datasets 4-8) were processed separately in R to identify ubiquitous genes.  Correlation plots and 
unsupervised hierarchical clustering were conducted in R for quality control and identification of 
biologically distinct subgroups. Outliers in the biological replicates were removed for the 
downstream analysis.  
The chromosome-wide gene expression distributions were isolated by gene locations on 
each chromosome in all samples using log2-transformed TPM (TPM>1), the boxplots for the 
distribution were made in R. 
3.3.5. GO analysis 
 Gene ontology enrichment analysis was performed in DAVID (Huang et al., 2009a) and 
245 and 7,603 genes on the X and autosomes, respectively, were found as ubiquitous in the 
somatic tissue datasets.  Similarly, 117 and 3,947 genes on the X and autosomes, respectively, 
were found as ubiquitous in the embryo datasets. The p-values in top 10 biological processes 
were plotted using plotly (https://plot.ly) in R. Pie charts for biological processes were generated 
as described by The Gene Ontology Consortium (2015). 
3.3.6. X:A ratio calculation 
When calculating the X:A ratio, we applied the pairwiseCI package in R (Schaarschmidt 
and Gerhard, 2015) to obtain a 95% confidence interval for the ratio of the median of X to the 
median of A as in a previous study (Sangrithi et al., 2017). It is based on 1,000 bootstrap 
replicates where sampling from the original data was done with replacement and stratified by the 
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group variables. Bootstrapping (Efron and Tibshirani, 1994) was used because it is simple to 





3.4.1. Overview of the RNA-seq datasets and paralog analysis 
We used seven bovine RNA-seq datasets, three embryonic and four somatic, generated 
by us (Jiang et al., 2014) and downloaded from NCBI (Table 2). In total, we have 40 samples 
including 19 embryos and 21 tissues from all datasets. Pearson correlation and unsupervised 
hierarchical clustering (supplementary fig. S1) show that replicates within each tissue or 
embryonic stage clustered closely to each other, suggesting even though the data were obtained 
from different studies, the data were replicable and reliable. Because we only compared the X:A 
ratio and gene expression within each dataset instead of across datasets, we were able to use the 
data from different studies and experimental platforms after data normalization.Paralogs are 
homologous genes within the same genome created by gene duplication (Gevers et al., 2004).  
This is one potential way to achieve X dosage compensation because X lacks a homolog in males 
(Jue et al., 2013). We found an approximately 1.4-fold increase in the percentage of paralogs 
(>70% amino acid identity (Jue et al., 2013)) on the bovine X chromosome (33%) compared to 
the genome averages (24%; Table 1). This enrichment is significantly higher (Table 1; p < 0.05 
by Fisher’s exact test) than to that of most chromosomes, with the exception of Chromosomes 15, 
21, and 23 (p = 0.97, 0.10, and 0.61, respectively), suggesting the potential roles of paralogs in X 
dosage compensation. Such paralog enrichment on X has also been observed in humans (32% vs. 
17%; 1.9-fold) and mice (51% vs. 35%; 1.5-fold) (Jue et al., 2013). This information 
demonstrated that unique mapping as performed in a previous RNA-seq study (Xiong et al., 2010) 
is not appropriate because many paralogs will be excluded from the analysis, and potentially 
skewing the X:A comparison. Thus, we applied the “non-unique” mapping strategy for reads 
mapping. Reads that aligned to multiple locations (such as paralog gene family) in the reference 
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genome or had alternative splice junctions were kept in all subsequent analysis. This resulted in a 
total of 959 X-linked and 20,316 autosomal protein coding genes.   
Deng et al. (2011) suggested that the low and non-expression values in RNA-seq data 
may result from background noise of sequencing and read mapping.  Inclusion of such values 
would be inappropriate and strongly influence the results. Furthermore, when we calculated the 
percentages of X-linked and autosomal genes with low transcript per million (TPM) values (Fig. 
1A and supplementary table S2), we found that on the average the X chromosome has 11.7% 
more genes with TPM ≤1 than autosomes. Somatic tissues including endometrium, fat, liver and 
muscle had the most enrichment of lowly expressed X-linked genes (supplementary table S2). 
Therefore, we used a cutoff of TPM>1 as expressed genes to remove data bias. After this 
filtering, 468 X-linked genes and 12,288 autosomal genes on average were used for X:A ratio 
calculation. The numbers of expressed genes (TPM >1) on X chromosome or autosomes in each 
sample are listed in supplementary table S2. 
3.4.2. Ranges of gene expression of all chromosomes 
We then investigated the gene expression profiles of all chromosomes to determine 
whether the transcriptional outputs from X chromosome were comparable to those of each 
autosome pairs. We performed log2-transformation of TPM to to normalize the data distribution. 
The TPM distribution of X-linked genes was not significantly different from those of all 
autosome pairs in 11 out of 40 samples using all expressed genes, and 31 out of 40 samples using 
ubiquitously expressed genes (p > 0.05, by two-sided Kolmogorov-Smirnov test, Fig. 1B and 
supplementary table S3).  Such distributions were also demonstrated by kernel density estimation 
(Fig. 1C). These observations demonstrate that regardless of the number of X chromosomes, the 
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expression levels of ubiquitously expressed genes on X were comparable to those of each 
autosome pair in all samples, suggesting dosage compensation. 
3.4.3. X chromosome up-regulation in adult somatic tissues 
To determine the X chromosome dosage compensation in adult cattle tissue, we analyzed 
RNA-seq datasets (Table 2) for two female-specific tissues, endometrium and corpus luteum, 
and other somatic tissues from both males and females including the brain (hypothalamus), liver, 
kidney, muscle, fat, pituitary gland, lung, and duodenum. Overall, the X:A ratios of these tissues 
were in the range of 0.5 to 1, suggesting up-regulation of the expression from the X chromosome, 
yet the dosage compensation is incomplete (Fig. 2A & 2B). Specifically, the liver gave the 
highest X:A ratio (1.01) in females and showed complete compensation, followed by the 
pituitary gland (0.91).  These data suggest that the X chromosome expression was enriched for 
activities in these tissues. In contrast, fat, muscle, endometrium and the lung gave relatively low 
but incomplete compensation X:A ratios (0.64 - 0.72), indicating less X chromosome activities.  
Furthermore, we compared the X chromosome expression distribution between males and 
females in common somatic tissues and observed no significant difference (p > 0.05, by two-
sided Kolmogorov-Smirnov test, supplementary table S4), except in muscle. The X:A ratio of 
common tissues between sexes was also not significantly different (p = 0.45, by paired t-test 
after log-transformation). 
Although all somatic tissues we analyzed had up-regulated expression of X-linked genes 
which support Ohno’s hypothesis, the confidence intervals of X:A ratios did not encompass 1 in 
most of the samples. As suggested in previous studies “dosage-sensitive” genes with 
housekeeping functions were more likely affected by dosage imbalance and were up-regulated 
(Pessia et al., 2012).  When non-dosage-sensitive genes were included in the X:A calculation, the 
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X:A ratio were likely lower (Sangrithi et al., 2017). Therefore, we further selected ubiquitously 
expressed genes (TPM>1) throughout all somatic samples. Gene ontology analysis showed 
strong evidence that these ubiquitously expressed genes had housekeeping roles (supplementary 
fig. S2), such as translation, RNA transcription, protein transport, and cellular and metabolic 
process (supplementary fig. S2). A total of 245 and 7,603 genes on the X chromosome and 
autosomes, respectively, were included as ubiquitously expressed genes in the recalculation of 
the X:A ratios (Fig. 2C & 2D). The confidence intervals encompassed 1 and the medians were 
greater than 1 in most of the samples. Brain and its specific regions such as the pituitary gland 
and hypothalamus had the highest X:A ratios (1.20, 1.28, and 1.22, respectively), consistent with 
previous reports in other species (Deng et al., 2011; Nguyen and Disteche, 2006).  
3.4.4. X chromosome up-regulation in immature and mature oocytes  
Germinal vesicle stage (immature) oocytes are arrested at the diplotene stage of the first 
prophase of meiosis (Pro I) (Mehlmann, 2005), and contain a duplicated genome (XXXX:AAAA) 
and two active X chromosomes (Fukuda et al., 2015). The matured oocytes, on the other hand, 
are arrested at the second metaphase of meiosis (MII) (Li and Albertini, 2013) and are haploid 
(1N) although each homologous chromosome contains two sister chromatids/complements of 
DNA (2C; XX:AA). Our analysis included immature and both in vivo and in vitro matured 
oocytes (Graf et al., 2014; Jiang et al., 2014). First, we identified expressed genes (TPM>1) and 
ubiquitously expressed genes across all pre-implantation samples.  Fewer expressed ubiquitous 
genes were found in these samples than in somatic tissues but similar gene ontology terms 
(supplementary fig. S3 & 4). A total of 117 X-linked and 3,947 autosomal genes were used as 
ubiquitous genes for X:A ratio calculation. Compared to expressed genes (TPM>1, X:A ≈0.75 
Fig. 3C) , ubiquitously expressed genes had higher X:A ratios in immature and mature oocytes at 
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1 and 0.87, respectively (Fig. 3D). Taken together, our analyses reveal a higher X:A ratio for 
ubiquitous genes, and a balanced X to autosome expression in immature diploid oocytes and an 
incomplete balance in mature haploid oocytes. 
3.4.5. X chromosome up-regulation in pre-implantation embryos 
X inactivation and reactivation happen in cycles during early embryonic development. In 
mice, the zygote contains an inactive X from the sperm but three X chromosome reactivation 
events occur subsequently: 1) embryonic genomic activation (EGA) at 2-cell, 2) pluripotency 
establishment in inner cell mass (ICM) of blastocyst, and 3) primordial germ cell generation in 
the genital ridge (Ohhata and Wutz, 2013). Using the bovine X-linked monomine oxidase type A 
(MAOA), Ferreira et al. (2010) demonstrated that transcripts from both the maternal and paternal 
MAOA were present in embryos at the 4-, 8- to 16-cell, and blastocyst stages, while only the 
maternal transcripts were present in compact morula.  These data revealed that XCI occurred in 
an imprinted fashion in the morula stage in the bovine and the paternal X was reactivated at the 
blastocyst stage. A more permanent random XCI was observed between the blastocyst and early 
elongation stages by analyzing seven X-linked genes in day14 embryos (Bermejo-Alvarez et al., 
2011). However, the expression dynamics of an individual gene cannot represent the activity of 
the whole X chromosome, global transcript analysis will generate a more definitive conclusion 
on X inactivation-reactivation dynamics.  
We therefore analyzed RNA-seq data from pre-attachment embryos. In in vivo produced 
pre-implantation embryos, we observed an incomplete dosage compensation (0.5< X:A <1) 
using expressed genes and an excess of compensation (X:A>1) from the 8-cell to compact 
morula stages using ubiquitous genes (Fig. 3A & 3B). X dosage slightly decreased after 
fertilization, with the lowest X:A ratio seen at the 4-cell stage, indicating that the sperm brought 
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in an inactive X chromosome to the matured oocyte. The X:A ratio started to increase from the 
4- to 8- cell stage, coincident with embryonic genome activation (EGA) for bovine in vivo 
embryos (Jiang et al., 2014), suggesting that EGA actives both paternal and maternal genome 
and has a more profound effect on the X chromosome. The increased X:A ratio exhibited excess 
compensation from the 8-cell to compact morula stage. A sharp decrease of X:A ratio was then 
observed between early (32-cell) and compact morula stages, corresponding to the first observed 
inactivation of the paternal X chromosome in bovine embryos. The X:A subsequently stabilized 
from days 7 to 19 of gestation, corresponding to random XCI between the blastocyst and early 
elongation stages.  
Using expressed genes, in vitro produced bovine pre-implantation embryos present a 
similar X:A dynamics from fertilization to the 8-cell stage (Fig. 3C & 3D). However, no excess 
dosage compensation was observed using ubiquitous genes at any stage but the blastocyst, 
suggesting a deviation of X compensation from in vivo embryos.  These observations are 
consistent with recent findings of aberrant X regulation in in vitro produced human and mouse 
embryos (Tan et al., 2016).  
3.4.6. Effect of PAR and putative XCI-escaping genes on X upregulation  
Pseudoautosomal regions (PARs) contain homologous genes between the X and Y 
chromosomes, and are important in homologous chromosome pairing and recombination during 
male meiosis (Das et al., 2009). A total of 20 PAR genes (Table S3) have been characterized in 
bovine, sheep, goats and other ruminants (Raudsepp and Chowdhary, 2015). Most PAR genes 
are known to escape XCI in humans (Helena Mangs and Morris, 2007). Moreover, 
approximately 15% and 3% of non-PAR X-linked genes in humans and mice, respectively, are 
known to escape XCI (Berletch et al., 2011). In the bovine, 55 such X-linked genes 
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(supplementary table S5) were classified as candidates that escape XCI (Ka et al., 2016). To 
tease out the effects of these bi-allelically expressed PAR genes and XCI-escaping genes, we 
plotted X:A ratios in the categories of “all genes”, “expressed genes”, “genes subjected to XCI 
(excluding PAR genes and putative XCI-escaping genes)” and “dosage-sensitive genes” (Fig. 4). 
The X:A ratios for “all genes” had the median value closer to 0.5, while the ratios for “expressed 
genes” were closer to 1. When we excluded PARs and putative XCI-escaping genes from 
“expressed genes”, the outliers of extremely high X:A ratios disappeared, suggesting bi-
allelically expressed X-linked genes did contribute to the high X:A ratios. Moreover, “dosage 
sensitive genes” maintained the highest X:A ratios (greater than 1), further confirming the 





In this study, we determined the X chromosome dosage profiles in 4 chromosome 
scenarios in the bovine. Immature oocytes represent diploid germline with duplicated genome/4 
complements of DNA (XXXX:AAAA); mature oocyte represent haploid germline with 
duplicated genome/2 complements of DNA (XX:AA); bovine pre-implantation embryos at 
various stages represent the gradual change from two active X (XaXa:AA) to one inactive X 
chromosome (XaXi:AA); female and male somatic tissues contain diploid cells with one already 
inactivated X (XaXi:AA or XY:AA). Our analyses showed incomplete compensation 
(0.5<X:A<1) of X chromosome to autosome pairs in all scenarios for expressed genes (TPM>1) 
and excess compensation (X:A>1) for “dosage-sensitive” genes in somatic tissues and certain 
stages in early embryos. These findings suggest that X dosage up-regulation occurs in bovine 
germlines, pre-attachment embryos and somatic tissues analyzed here. 
Our results in bovine are consistent with previous findings in other mammalian species 
using similar strategies of data filtering (Deng et al., 2011; Pessia et al., 2012). However, studies 
applying different threshold criteria on RNA-seq data generated conflicting results for 
mammalian X dosage compensation. Xiong et al. (2010) included genes with low and no 
expression and reported X:A ratio close to 0.5. Whereas many follow-up studies reanalyzing the 
same RNA-seq data after removing the “noise” concluded hyper-activation of X on expressed 
genes (Deng et al., 2011), especially dosage-sensitive ones (genes encoding protein-complex of 
seven or more members and having housekeeping roles) (Pessia et al., 2012). Thus, dosage 
compensation, unlike X chromosome inactivation, has been proposed to be a local process with 
hyper-expression by only dosage-sensitive genes (Pessia et al., 2014). In our study, we applied 
two gene selection methods in order to identify “dosage-sensitive” genes: expressed genes that 
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are TPM>1 and ubiquitous genes whose TPM’s are >1 in all somatic samples or in all embryo 
samples. We found similar results as in humans and mice that incomplete dosage compensation 
was incomplete in most scenarios when expressed genes were used, while ubiquitous genes had a 
higher X dosage, implying that the expression of a group of X-linked bovine genes are 
collectively more than doubled.  Furthermore, this level of up-regulation could not be globally 
applied to all genes on the X chromosome.  
The previous study by Xiong et al (2010) filtered out reads that mapped to multiple 
locations of the genome and those that spanned splice junctions. Such elimination may generate 
biased X: A ratio as shown by Jue et al (2013) who analyzed how the X:A ratios could be 
changed by using different mapping parameters such as unique vs. non-unique mapping. It was 
concluded that “unique” mapping excluded reads that may be from paralog gene families. 
Because paralogs are enriched on the mammalian X chromosome and gene duplication is a way 
to achieve dosage compensation for haploinsufficient genes, excluding reads for paralogs could 
produce bias in the estimation of the X:A ratios. Therefore, we used the Hisat2 software that by 
default reports both uniquely and multi-mapped reads Hisat2 is known to have the highest 
correctly multi-mapped reads compared to other aligners (Kim et al., 2015). 
Bovine female somatic tissues had a slightly higher X:A ratio than the same tissues of 
males. This difference, however, was not significantly different (p = 0.45). X chromosome 
expression distribution was also similar between sexes (p > 0.05). These demonstrated that the 
expression of the X chromosome is balanced between males and females although they have 
different numbers of the X chromosome. The slightly higher X:A ratio in females may be a result 
of genes that escape X chromosome inactivation (Couldrey et al., 2017). Although it is unclear 
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how many genes escape XCI in the bovine, a previous report documented a few X-linked genes 
escaping XCI in a mosaic fashion in the bovine (Yen et al., 2007).  
The brain tissue had the highest X:A ratio compared to the other tissues, consistent with 
previous RNA-seq studies in several mammalian species (Deng et al., 2011; Nguyen and 
Disteche, 2006).  This could be related to the fact that may genes related to brain functions, such 
as MAOA, are located on the X chromosome (Zechner et al., 2001).  On the contrary, X dosage 
of other bovine somatic tissues including fat, liver, muscle, and the pituitary gland was 
previously determined as incompletely compensated (Ka et al., 2016), which is consistent with 
results in humans, mice and ours.  
Germ cells and the developing embryos undergo drastic epigenetic changes.  We 
observed balanced expression of the X chromosome with that of the autosomes in diploid 
immature oocytes and incomplete balance in haploid matured oocytes. These data are consistent 
with those by Fukuda et al who also showed higher dosage compensation of X chromosome in 
immature than matured oocytes in the human and mouse (Fukuda et al., 2015). However, X:A 
ratio slightly decreased after fertilization probably due to the sperm brings in some mRNAs of 
autosomal origin in addition to an inactive X (Huynh and Lee, 2003).  Because early embryonic 
development is primarily dependent on stored maternal mRNAs and proteins which gradually 
degrade until embryonic genomic activation (EGA) (Memili and First, 2000), a consistent 
decrease and then increase of X:A before and after EGA, respectively, were observed.  The 
timing of the changes in X:A in in vivo embryos, however, was one cell cycle earlier than their in 
vitro counterparts due to the timing difference between these two types of embryos, which are 4-
8 and 8-16 cell stages, respectively (Graf et al., 2014; Jiang et al., 2014; Kues et al., 2008; 
Misirlioglu et al., 2006; Telford et al., 1990). 
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In conclusion, our study shows the up-regulation of X chromosome in four bovine 
genome scenarios, supporting a balanced expression between a single active X and autosome 
pairs. However, deviating from Ohno’s theory, dosage compensation to rescue X 
haploinsufficiency appears to be an incomplete process for expressed genes but a complete 
process for “dosage-sensitive” genes. Removal of PAR genes and those putatively escape XCI 
eliminated the outliers of extremely high X:A ratios. In addition, the switch from imprinted XCI 
at the compact morula stage to random XCI at the blastocyst stage may happen so rapidly that 
the potential transient state of two active X chromosome could not be captured in the current 
dataset with limited time points. Whether a transient two active X state occurs or not during 
blastulation requires frequent sampling and further study. Lastly, no relative X expression 
difference was observed between bovine female and male somatic tissues, suggesting Ohno’s 
















1 985 167 (17) 5.65e-18  16 710 129 (18) 6.56e-13 
2 1,021 229 (22) 1.88e-08  17 665 149 (22) 6.55e-07 
3 1,372 314 (23) 7.24e-09  18 1,236 207 (17) 1.20e-20 
4 855 222 (26) 0.00031  19 1,347 303 (22) 2.13e-09 
5 1,323 336 (25) 1.51e-05  20 384 91 (24) 0.00027 
6 692 156 (23) 6.65e-07  21 731 221 (30) 0.10 
7 1,396 377 (27) 0.00046  22 608 110 (18) 6.40e-12 
8 829 230 (28) 0.0059  23 785 264 (34) 0.61 
9 602 146 (24) 6.45e-05  24 347 98 (28) 0.049 
10 1,074 316 (29) 0.033  25 766 102 (13) 7.22e-24 
11 1,047 192 (18) 1.63e-15  26 437 82 (19) 5.63e-09 
12 414 98 (24) 0.00018  27 274 73 (27) 0.022 
13 850 185 (22) 1.31e-08  28 355 78 (22) 3.08e-05 
14 571 135 (24) 2.76e-05  29 705 186 (26) 0.0012 
15 1,050 387 (37) 0.97  X 1,128 374 (33)  
Genome 
Average 




Table 2. The raw FASTQ files generated by us and downloaded from NCBI GEO database 
  
Tissue Type (replicates) Breed/subspecies Number 
of 
samples 
Library type BioProject ID  Reference 
1 In vivo MII oocytes and embryos: 
2-, 4-, 8-, 16-, 32-cell, CM, and BL 
(n=2) 
Holstein 8 Single-read SOLiD PRJNA254699 Jiang et al., 2014 
2 In vitro GV & MII oocytes and 








PRJNA228235 Graf et al., 2014 
3 In vivo Conceptuses: Day 7 (n=6), 







PRJNA243569 Mamo et al., 
2012 
4 Female specific tissue: endometria 
(n=12), corpora lutea (n=14) 
Holstein 2 Paired-end Illumina PRJNA298914 Moore et al., 
2016 
5 Female somatic tissues: brain, liver, 





PRJNA268096 Chen et al., 2015 
6 Male somatic tissues: fat, muscle, 
hypothalamus, duodenum, liver, 
lung and kidney (pools of 7-14 
animals)  
Bos taurus 7 Paired-end Illumina PRJEB6377 PRJEB6377, 
2014 
7 Female and male somatic tissues: 
fat, liver, muscle, and pituitary 
gland (n=5)  
Hanwoo (Korean 
cattle) 
8 Paired-end Illumina PRJNA273164 Seo et al., 2016 
 
  
Figure 1 Expression ranges of genes on the X and autosome pairs in the bovine.  
  
 
(A) the averaged percentages of lowly expressed genes (TPM<1) on the X and autosomes in all 
samples, (B) A representative (in vivo matured oocytes) box-plot showing that the range and 
median expression levels of X-linked genes (red) (TPM > 1) were similar to those of each 
autosome pairs (blue) in the bovine, (C) A representative (in vivo matured oocyte) Kernel density 
plot showing that the distribution of X-linked gene (red) expression (TPM > 1) was similar to 







Figure 2 Median X:A ratios with 95% confidence intervals of bovine female (A, B) and 




The X:A ratios were calculated using expressed (TPM > 1) genes (A, C) and ubiquitously 
expressed (TPM > 1 and present in all somatic datasets; B, D) genes. Blue line: X:A=1, complete 







Figure 3 Median X:A ratios with 95% confidence intervals of bovine in vivo (A, B) and in 





The X:A ratios were calculated using expressed (TPM > 1) genes (A, C) and ubiquitously 
expressed (TPM > 1 and present in all embryo datasets; B, D). GV=germinal vesicle, MII: 
metaphase of second meiosis, CM=compact morula, BL=blastocyst. Blue line: X:A=1, complete 







Figure 4 Boxplot of the X:A medians for all datasets.  
 
Genes were categorized in “all genes”, “expressed (TPM > 1) genes”, “genes subjected to XCI 
(excluding PAR genes and putative XCI-escaping genes)” and “dosage-sensitive (ubiquitously 





3.6. Supplementary information 
Table S1. The numbers of reads after trimming and the percentages of multiple-mapped 
reads for each sample 
Dataset and sample ID reads after trimming mapping rate note 
PRJNA254699    
vivo_MII_1 13,344,621 67.94%  
vivo_MII_2 18,617,919 75.05%  
vivo_2C_1 14,956,109 55.95%  
vivo_2C_2 17,338,409 59.86%  
vivo_4C_1 15,023,254 59.58%  
vivo_4C_2 17,197,154 59.64%  
vivo_8C_1 15,783,933 69.73%  
vivo_8C_2 14,502,762 71.51%  
vivo_16C_1 13,396,684 64.66%  
vivo_16C_2 10,060,614 60.97%  
vivo_32C_1 10,032,365 69.07%  
vivo_32C_2 12,974,794 69.63%  
vivo_CM_1 12,589,309 65.50%  
vivo_CM_2 15,390,895 68.73%  
vivo_BL_1 14,067,130 68.06%  
vivo_BL_2 9,150,958 64.80%  
PRJNA228235    
vitro_GV_1 12,435,200 86.06%  
vitro_GV_2 18,497,510 86.05%  
vitro_GV_3 17,285,535 89.25%  
vitro_MII_1 16,015,797 83.46%  
vitro_MII_2 22,751,494 79.96%  
vitro_MII_3 17,124,799 88.56%  
vitro_4C_1 22,296,494 88.42%  
vitro_4C_2 27,796,793 77.10%  
vitro_4C_3 10,396,440 87.35%  
vitro_8C_1 27,893,112 87.97%  
vitro_8C_2 25,488,457 83.21%  
vitro_8C_3 18,606,472 85.83%  
vitro_16C_1 19,025,171 85.27%  
vitro_16C_2 9,019,897 82.69%  
vitro_16C_3 17,900,332 88.01%  
vitro_BL_1 57,889,754 88.59%  
vitro_BL_2 34,653,160 72.19%  
vitro_BL_3 35,436,710 87.67%  
PRJNA243569    
vivo_D7_1 23,635,335 59.57%  
vivo_D7_2 24,040,750 58.01%  
vivo_D7_3 23,940,535 64.70%  
vivo_D7_4 25,478,230 14.15%  
vivo_D7_5 24,569,767 61.13%  
vivo_D7_6 22,747,482 40.04%  
vivo_D10_1 15,816,819 64.35%  
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vivo_D10_2 23,320,839 17.44%  
vivo_D10_3 21,782,930 37.38%  
vivo_D10_4 25,132,063 66.69%  
vivo_D10_5 24,890,896 69.17%  
vivo_D10_6 25,740,652 41.76%  
vivo_D10_7 24,112,411 46.97%  
vivo_D13_1 23,247,754 87.40%  
vivo_D13_2 21,782,930 37.38%  
vivo_D13_3 21,779,998 79.40%  
vivo_D13_4 23,191,573 79.47%  
vivo_D13_5 21,182,412 80.76%  
vivo_D16_1 20,971,194 65.07%  
vivo_D16_2 12,156,512 80.09%  
vivo_D16_3 23,247,754 87.40%  
vivo_D16_4 21,182,412 80.76%  
vivo_D16_5 13,861,219 57.12%  
vivo_D19_1 23,643,876 90.74%  
vivo_D19_2 23,320,839 17.44%  
vivo_D19_3 23,191,573 79.47%  
vivo_D19_4 23,643,876 90.74%  
vivo_D19_5 21,779,998 79.40%  
PRJNA298914    
endometrium_1 16,651,250 82.77%  
endometrium_2 18,827,510 90.34%  
endometrium_3 13,845,319 91.11%  
endometrium_4 15,951,167 89.57%  
endometrium_5 22,393,957 93.39%  
endometrium_6 16,362,983 93.67%  
endometrium_7 17,348,883 93.21%  
endometrium_8 18,445,197 92.69%  
endometrium_9 19,283,243 93.14%  
endometrium_10 18,939,982 93.70%  
endometrium_11 20,759,413 93.37%  
endometrium_12 17,542,556 93.01%  
endometrium_13 20,884,795 91.55%  
endometrium_14 23,021,723 93.55%  
corpus luteum_1 23,265,821 94.14%  
corpus luteum_2 24,500,079 94.16%  
corpus luteum_3 17,189,314 93.58%  
corpus luteum_4 24,116,581 94.33%  
corpus luteum_5 17,455,310 94.18%  
corpus luteum_6 21,176,305 94.04%  
corpus luteum_7 17,183,335 94.33%  
corpus luteum_8 16,333,836 93.81%  
corpus luteum_9 16,040,727 94.36%  
corpus luteum_10 22,241,217 94.24%  
corpus luteum_11 15,914,273 94.02%  
corpus luteum_12 15,020,472 94.04%  
PRJNA268096    
female_brain_1 35,348,846 97.06%  
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female_brain_2 53,329,221 91.48%  
female_brain_3 41,368,457 97.14%  
female_brain_4 42,597,403 97.21%  
female_liver_1 44,445,152 97.66%  
female_liver_2 63,210,755 91.46%  
female_liver_3 42,200,070 97.57%  
female_liver_4 43,889,675 97.68%  
female_muscle_1 31,582,057 97.03%  
female_muscle_2 40,896,874 91.86%  
female_muscle_3 33,407,493 97.06%  
female_muscle_4 29,430,409 97.08%  
female_kidney_1 40,922,470 96.71%  
female_kidney_2 51,224,824 96.10%  
female_kidney_3 49,478,093 96.56%  
female_kidney_4 47,980,505 96.22%  
PRJEB6377    
male_fat 36,590,829 93.08%  
male_duodenum 50,036,922 89.50%  
male_hypothalamus 26,696,424 94.86%  
male_kidney 25,051,316 83.25%  
male_liver 29,568,966 89.11%  
male_lung 22,596,488 93.81%  
male_muscle 28,739,583 80.97%  
PRJNA273164    
female_fat1 24,789,261 96.28%  
female_fat2 20,825,485 91.31%  
female_fat3 19,286,633 96.04%  
female_fat4 22,796,156 95.36%  
female_fat5 17,233,202 89.12%  
female_liver1 25,533,421 96.30%  
female_liver2 19,424,452 95.88%  
female_liver3 22,086,390 96.40%  
female_liver4 17,088,005 97.31%  
female_liver5 18,335,813 97.64%  
female_muscle1 18,338,844 95.17%  
female_muscle2 24,154,490 95.26%  
female_muscle3 19,760,958 96.66%  
female_muscle4 22,434,484 96.68%  
female_muscle5 19,985,126 96.90%  
female_pituitary1 19,748,641 94.48%  
female_pituitary2 22,093,652 94.24%  
female_pituitary3 20,713,183 94.13%  
female_pituitary4 16,399,117 95.88%  
female_pituitary5 19,140,730 95.70%  
male_fat1 15,218,534 97.14%  
male_fat2 24,642,148 90.46%  
male_fat3 15,553,433 96.55%  
male_fat4 15,996,788 96.99%  
male_fat5 22,929,105 92.65%  
male_liver1 16,491,043 97.33%  
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male_liver2 12,611,921 84.10%  
male_liver3 15,841,117 97.48%  
male_liver4 31,342,847 95.63%  
male_liver5 24,835,352 96.81%  
male_muscle1 16,509,891 97.35%  
male_muscle2 26,746,481 89.31%  
male_muscle3 21,491,187 0.07% discarded 
male_muscle4 14,941,149 97.56%  
male_muscle5 18,804,572 96.32%  
male_pituitary1 15,953,420 96.22%  
male_pituitary2 26,312,948 88.73%  
male_pituitary3 17,196,868 95.81%  
male_pituitary4 30,868,150 95.64%  
male_pituitary5 19,610,395 94.78%  
average for all samples 23,004,544 83.4%  
  
Table S2. The numbers of lowly expressed genes (TPM≤1) on the X chromosome and autosomes in each sample 
Dataset and sample ID 
Total X-linked genes 959 Total autosome genes 20,316      
X-linked gene counts 
(TPM ≤ 1) Percentage (%) 
Autosome gene 









PRJNA254699        
vivo_MII_1 598 62.4% 10,914 53.7% 8.6% 361 9,402 
vivo_MII_2 657 68.5% 12,299 60.5% 8.0% 302 8,017 
vivo_2C_1 571 59.5% 10,065 49.5% 10.0% 388 10,251 
vivo_2C_2 557 58.1% 9,711 47.8% 10.3% 402 10,605 
vivo_4C_1 520 54.2% 9,496 46.7% 7.5% 439 10,820 
vivo_4C_2 551 57.5% 9,703 47.8% 9.7% 408 10,613 
vivo_8C_1 589 61.4% 10,782 53.1% 8.3% 370 9,534 
vivo_8C_2 586 61.1% 10,357 51.0% 10.1% 373 9,959 
vivo_16C_1 521 54.3% 10,388 51.1% 3.2% 438 9,928 
vivo_16C_2 527 55.0% 10,156 50.0% 5.0% 432 10,160 
vivo_32C_1 567 59.1% 11,064 54.5% 4.7% 392 9,252 
vivo_32C_2 554 57.8% 10,553 51.9% 5.8% 405 9,763 
vivo_CM_2 596 62.1% 11,465 56.4% 5.7% 363 8,851 
vivo_CM_1 622 64.9% 10,473 51.6% 13.3% 337 9,843 
vivo_BL_1 630 65.7% 10,396 51.2% 14.5% 329 9,920 
vivo_BL_2 616 64.2% 10,147 49.9% 14.3% 343 10,169 
PRJNA228235        
vitro_GV_1 515 53.7% 8,636 42.5% 11.2% 444 11,680 
vitro_GV_2 519 54.1% 8,928 43.9% 10.2% 440 11,388 
vitro_GV_3 505 52.7% 8,834 43.5% 9.2% 454 11,482 
vitro_MII_1 532 55.5% 9,254 45.6% 9.9% 427 11,062 
vitro_MII_2 512 53.4% 9,018 44.4% 9.0% 447 11,298 
vitro_MII_3 528 55.1% 9,466 46.6% 8.5% 431 10,850 
vitro_4C_1 534 55.7% 9,146 45.0% 10.7% 425 11,170 
vitro_4C_2 541 56.4% 9,484 46.7% 9.7% 418 10,832 
vitro_4C_3 536 55.9% 9,276 45.7% 10.2% 423 11,040 
vitro_8C_1 486 50.7% 8,916 43.9% 6.8% 473 11,400 
vitro_8C_2 563 58.7% 10,133 49.9% 8.8% 396 10,183 
vitro_8C_3 450 46.9% 8,291 40.8% 6.1% 509 12,025 
vitro_16C_1 558 58.2% 10,565 52.0% 6.2% 401 9,751 
values low to high  
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vitro_16C_2 484 50.5% 9,078 44.7% 5.8% 475 11,238 
vitro_16C_3 426 44.4% 8,465 41.7% 2.8% 533 11,851 
vitro_BL_1 466 48.6% 9,110 44.8% 3.8% 493 11,206 
vitro_BL_2 425 44.3% 8,417 41.4% 2.9% 534 11,899 
vitro_BL_3 421 43.9% 8,264 40.7% 3.2% 538 12,052 
PRJNA243569        
vivo_D7_1 272 28.4% 4,344 21.4% 7.0% 687 15,972 
vivo_D7_2 371 38.7% 6,143 30.2% 8.4% 588 14,173 
vivo_D7_3 440 45.9% 7,084 34.9% 11.0% 519 13,232 
vivo_D7_4 443 46.2% 7,450 36.7% 9.5% 516 12,866 
vivo_D7_5 469 48.9% 7,529 37.1% 11.8% 490 12,787 
vivo_D7_6 424 44.2% 6,703 33.0% 11.2% 535 13,613 
vivo_D10_1 410 42.8% 6,676 32.9% 9.9% 549 13,640 
vivo_D10_2 547 57.0% 8,747 43.1% 14.0% 412 11,569 
vivo_D10_3 522 54.4% 8,569 42.2% 12.3% 437 11,747 
vivo_D10_4 454 47.3% 7,141 35.1% 12.2% 505 13,175 
vivo_D10_5 465 48.5% 7,231 35.6% 12.9% 494 13,085 
vivo_D10_6 415 43.3% 5,661 27.9% 15.4% 544 14,655 
vivo_D10_7 434 45.3% 7,182 35.4% 9.9% 525 13,134 
vivo_D13_1 428 44.6% 6,946 34.2% 10.4% 531 13,370 
vivo_D13_2 522 54.4% 8,568 42.2% 12.3% 437 11,748 
vivo_D13_3 489 51.0% 7,679 37.8% 13.2% 470 12,637 
vivo_D13_4 486 50.7% 7,639 37.6% 13.1% 473 12,677 
vivo_D13_5 351 36.6% 4,431 21.8% 14.8% 608 15,885 
vivo_D16_1 367 38.3% 5,333 26.3% 12.0% 592 14,983 
vivo_D16_2 409 42.6% 6,451 31.8% 10.9% 550 13,865 
vivo_D16_3 428 44.6% 6,947 34.2% 10.4% 531 13,369 
vivo_D16_4 350 36.5% 4,435 21.8% 14.7% 609 15,881 
vivo_D16_5 352 36.7% 5,533 27.2% 9.5% 607 14,783 
vivo_D19_1 527 55.0% 8,673 42.7% 12.3% 432 11,643 
vivo_D19_2 547 57.0% 8,744 43.0% 14.0% 412 11,572 
vivo_D19_3 486 50.7% 7,638 37.6% 13.1% 473 12,678 
vivo_D19_4 527 55.0% 8,674 42.7% 12.3% 432 11,642 
vivo_D19_5 489 51.0% 7,679 37.8% 13.2% 470 12,637 
PRJNA298914        
endometrium_1 487 50.8% 7,262 35.7% 15.0% 472 13,054 
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endometrium_2 480 50.1% 7,302 35.9% 14.1% 479 13,014 
endometrium_3 486 50.7% 7,229 35.6% 15.1% 473 13,087 
endometrium_4 482 50.3% 7,191 35.4% 14.9% 477 13,125 
endometrium_5 472 49.2% 7,273 35.8% 13.4% 487 13,043 
endometrium_6 481 50.2% 7,228 35.6% 14.6% 478 13,088 
endometrium_7 474 49.4% 7,213 35.5% 13.9% 485 13,103 
endometrium_8 470 49.0% 7,075 34.8% 14.2% 489 13,241 
endometrium_9 483 50.4% 7,131 35.1% 15.3% 476 13,185 
endometrium_10 484 50.5% 7,414 36.5% 14.0% 475 12,902 
endometrium_11 479 49.9% 7,262 35.7% 14.2% 480 13,054 
endometrium_12 472 49.2% 7,257 35.7% 13.5% 487 13,059 
endometrium_13 498 51.9% 7,430 36.6% 15.4% 461 12,886 
endometrium_14 488 50.9% 7,333 36.1% 14.8% 471 12,983 
corpus luteum_1 460 48.0% 7,584 37.3% 10.6% 499 12,732 
corpus luteum_2 470 49.0% 7,471 36.8% 12.2% 489 12,845 
corpus luteum_3 509 53.1% 7,964 39.2% 13.9% 450 12,352 
corpus luteum_4 468 48.8% 7,694 37.9% 10.9% 491 12,622 
corpus luteum_5 470 49.0% 7,556 37.2% 11.8% 489 12,760 
corpus luteum_6 491 51.2% 8,195 40.3% 10.9% 468 12,121 
corpus luteum_7 504 52.6% 8,173 40.2% 12.3% 455 12,143 
corpus luteum_8 487 50.8% 8,114 39.9% 10.8% 472 12,202 
corpus luteum_9 506 52.8% 8,290 40.8% 12.0% 453 12,026 
corpus luteum_10 499 52.0% 8,220 40.5% 11.6% 460 12,096 
corpus luteum_11 510 53.2% 8,228 40.5% 12.7% 449 12,088 
corpus luteum_12 496 51.7% 8,014 39.4% 12.3% 463 12,302 
PRJNA268096        
female_brain_1 370 38.6% 5,977 29.4% 9.2% 589 14,339 
female_brain_2 370 38.6% 5,830 28.7% 9.9% 589 14,486 
female_brain_3 407 42.4% 6,711 33.0% 9.4% 552 13,605 
female_brain_4 392 40.9% 6,332 31.2% 9.7% 567 13,984 
female_liver_1 523 54.5% 8,155 40.1% 14.4% 436 12,161 
female_liver_2 518 54.0% 7,897 38.9% 15.1% 441 12,419 
female_liver_3 522 54.4% 8,159 40.2% 14.3% 437 12,157 
female_liver_4 526 54.8% 8,238 40.5% 14.3% 433 12,078 
female_muscle_1 431 44.9% 7,488 36.9% 8.1% 528 12,828 
female_muscle_2 399 41.6% 6,890 33.9% 7.7% 560 13,426 
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female_muscle_3 427 44.5% 7,457 36.7% 7.8% 532 12,859 
female_muscle_4 420 43.8% 7,293 35.9% 7.9% 539 13,023 
female_kidney_1 395 41.2% 6,295 31.0% 10.2% 564 14,021 
female_kidney_2 400 41.7% 6,410 31.6% 10.2% 559 13,906 
female_kidney_3 415 43.3% 6,505 32.0% 11.3% 544 13,811 
female_kidney_4 407 42.4% 6,504 32.0% 10.4% 552 13,812 
PRJEB6377        
male_fat 450 46.9% 6,799 33.5% 13.5% 509 13,517 
male_duodenum 582 60.7% 9,611 47.3% 13.4% 377 10,705 
male_hypothalamus 374 39.0% 5,970 29.4% 9.6% 585 14,346 
male_kidney 485 50.6% 7,113 35.0% 15.6% 474 13,203 
male_lung 456 47.5% 6,494 32.0% 15.6% 503 13,822 
male_muscle 525 54.7% 7,783 38.3% 16.4% 434 12,533 
male_liver 556 58.0% 8,711 42.9% 15.1% 403 11,605 
PRJNA273164        
female_fat1 472 49.2% 7,144 35.2% 14.1% 487 13,172 
female_fat2 535 55.8% 7,925 39.0% 16.8% 424 12,391 
female_fat3 537 56.0% 8,176 40.2% 15.8% 422 12,140 
female_fat4 514 53.6% 7,534 37.1% 16.5% 445 12,782 
female_fat5 479 49.9% 7,536 37.1% 12.9% 480 12,780 
female_liver1 522 54.4% 7,794 38.4% 16.1% 437 12,522 
female_liver2 520 54.2% 7,730 38.0% 16.2% 439 12,586 
female_liver3 529 55.2% 8,179 40.3% 14.9% 430 12,137 
female_liver4 567 59.1% 8,846 43.5% 15.6% 392 11,470 
female_liver5 589 61.4% 9,414 46.3% 15.1% 370 10,902 
female_muscle1 517 53.9% 8,377 41.2% 12.7% 442 11,939 
female_muscle2 521 54.3% 8,120 40.0% 14.4% 438 12,196 
female_muscle3 518 54.0% 8,513 41.9% 12.1% 441 11,803 
female_muscle4 561 58.5% 9,069 44.6% 13.9% 398 11,247 
female_muscle5 549 57.2% 8,984 44.2% 13.0% 410 11,332 
female_pituitary1 422 44.0% 6,582 32.4% 11.6% 537 13,734 
female_pituitary2 436 45.5% 6,809 33.5% 11.9% 523 13,507 
female_pituitary3 425 44.3% 6,859 33.8% 10.6% 534 13,457 
female_pituitary4 464 48.4% 7,439 36.6% 11.8% 495 12,877 
female_pituitary5 467 48.7% 7,437 36.6% 12.1% 492 12,879 
male_fat1 521 54.3% 8,104 39.9% 14.4% 438 12,212 
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male_fat2 508 53.0% 7,893 38.9% 14.1% 451 12,423 
male_fat3 501 52.2% 7,902 38.9% 13.3% 458 12,414 
male_fat4 495 51.6% 7,820 38.5% 13.1% 464 12,496 
male_fat5 591 61.6% 9,473 46.6% 15.0% 368 10,843 
male_liver1 562 58.6% 8,964 44.1% 14.5% 397 11,352 
male_liver2 534 55.7% 8,378 41.2% 14.4% 425 11,938 
male_liver3 574 59.9% 9,322 45.9% 14.0% 385 10,994 
male_liver4 540 56.3% 8,250 40.6% 15.7% 419 12,066 
male_liver5 548 57.1% 8,508 41.9% 15.3% 411 11,808 
male_muscle1 550 57.4% 9,117 44.9% 12.5% 409 11,199 
male_muscle2 560 58.4% 9,249 45.5% 12.9% 399 11,067 
male_muscle4 536 55.9% 8,727 43.0% 12.9% 423 11,589 
male_muscle5 542 56.5% 8,819 43.4% 13.1% 417 11,497 
male_pituitary1 456 47.5% 7,382 36.3% 11.2% 503 12,934 
male_pituitary2 447 46.6% 7,182 35.4% 11.3% 512 13,134 
male_pituitary3 466 48.6% 7,574 37.3% 11.3% 493 12,742 
male_pituitary4 477 49.7% 7,697 37.9% 11.9% 482 12,619 
male_pituitary5 414 43.2% 6,364 31.3% 11.8% 545 13,952 
PRJNA229443        
contl_placenta 512 53.4% 7,761 38.2% 15.2% 447 12,555 




Table S3. TPM distribution of X and autosomes expression difference in each sample 
Sample Expressed genes P-value Ubiquitously expressed genes P-value 
PRJNA254699   
00C_vivo 0.035 0.48 
2C_vivo 8.53E-06 0.012 
4C_vivo 6.31E-05 0.044 
8C_vivo 0.18 0.25 
16C_vivo 0.74 0.0076 
32C_vivo 0.63 0.10 
CM_vivo 0.029 0.98 
BL_vivo 0.0028 0.68 
PRJNA228235   
GOC_vitro 0.063 0.94 
MOC_vitro 0.094 0.36 
4C_vitro 0.03 0.26 
8C_vitro 0.0064 0.36 
16C_vitro 0.079 0.16 
BL_vitro 0.0029 0.19 
PRJNA243569   
D7_vivo 0 0.61 
D10_vivo 2.60E-07 0.16 
D13_vivo 1.00E-07 0.20 
D16_vivo 6.00E-07 0.26 
D19_vivo 0.00026 0.15 
PRJNA298914   
CL  7.95E-05 0.25 
EM  5.50E-07 0.88 
PRJNA268096   
female_brain  0.0017 0.021 
female_kidney  8.35E-05 0.04 
female_liver  0.43 0.16 
female_muscle  2.84E-06 0.10 
PRJEB6377   
male_adipose  6.46E-05 0.52 
male_duodenum  0.05 0.91 
male_hypothalamus  0.052 0.018 
male_kidney  0.00048 0.40 
male_lung  8.68E-06 0.16 
male_liver  0 0 
male_muscle  0 0 
PRJNA273164   
female_fat  6.54E-06 0.29 
female_liver  0.19 0.25 
female_muscle  1.18E-05 0.19 
female_pituitary  0.04 0.0039 
male_fat  2.56E-05 0.25 
male_liver  0.11 0.56 
male_muscle  2.00E-05 0.33 
male_pituitary  0.0067 0.0069 
green highlighed P-value greater than 0.05 for no significant difference between X and autosomes 
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Table S4. TPM distribution of X chromosome difference of common tissues between males 
and females 





































































































The color spectrum in correlation plots ranges from blue to red, indicating high to low correlations between sample replicates. 
Hierarchical Clustering was conducted with all genes. EM= endometrium, CL=corpus luteum, GV=germinal vesicle, MII= metaphase 

































The color spectrum in correlation plots ranges from blue to red, indicating high to low correlations between sample replicates. 
Hierarchical Clustering was conducted with all genes. EM= endometrium, CL=corpus luteum, GV=germinal vesicle, MII= metaphase 












(A) GO analysis of 245 genes on X chromosomes and 7,603 genes on autosomes as ubiquitous in the somatic tissue datasets. Plotted 











Figure S3. Gene ontology enrichment analysis of ubiquitously expressed genes in embryo datasets  
 
 
(A) GO analysis of the 117 genes on X chromosome and 3,947 genes on autosomes as ubiquitous in the embryo datasets. Plotted are 







 (B) Pie chart for biological process was generated in The Gene Ontology Consortium 
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Chapter Four 
Methylome Dynamics of Bovine Gametes and In Vivo Early Embryos 
Duan J.E., Jiang Z., Alqahtani F., Mandoiu I., Dong H., Zheng X., Marjani S.L.,  
Chen J. & Tian X.C.  
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4.1. Abstract 
Dynamic changes in DNA methylation are crucial in the process of early mammalian 
embryogenesis. Global DNA methylation studies in the bovine, however, remain mostly at the 
immunostaining level. We adopted the single-cell whole genome bisulfite sequencing (scWGBS) 
method to characterize stage-specific genome-wide DNA methylation in bovine sperm, 
immature oocytes, oocytes matured in vivo and in vitro, as well as in vivo developed embryos at 
the 2-, 4-, 8- and 16-cell stages. We found that the major wave of genome-wide DNA 
demethylation was complete by the 8-cell stage when de novo methylation became prominent. 
Sperm and oocytes were differentially methylated in numerous regions (DMRs), largely 
intergenic, suggesting that these noncoding regions may play important roles in gamete 
specification. DMRs were also identified between in vivo and in vitro matured oocytes, 
demonstrating environmental effects on epigenetic modifications. Moreover, virtually no (less 
than 1.5%) DNA methylation was found in mitochondrial DNA. Finally, by using RNA-seq data 
generated from embryos at the same developmental stages, we revealed a weak inverse 
correlation between gene expression and promoter methylation. These data provide insights into 
the critical features of the methylome of bovine embryos, and serve as an important reference for 
embryos produced by assisted reproduction, such as in vitro fertilization and cloning, and a 
model for the epigenetic dynamics that occur in human early embryos. 
Keywords: DNA methylation; Gametes, Single early embryo; WGBS; Bovine  
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4.2. Introduction 
Cytosine methylation plays essential roles in mammalian development, including 
transposon silencing, cell differentiation, genomic imprinting, and X chromosome inactivation 
(Hackett and Surani, 2013). DNA methylation is relatively stable in differentiated somatic cells, 
but highly dynamic during primordial germ cell development and pre-implantation 
embryogenesis (Saadeh and Schulz, 2014). Embryonic DNA methylation reprogramming 
requires genome-wide DNA demethylation, which erases the epigenetic marks of the parental 
genomes, as well as rapid de novo methylation to establish the epigenetic state of the early 
embryo (Seisenberger et al., 2012). With the recent advancement of the methylation high-
throughput sequencing technology, many methylome studies have been conducted on 
mammalian pre-implantation embryos (Gao et al., 2017; Guo et al., 2014; Jiang et al., 2018; 
Smith et al., 2012; Zhu et al., 2018). In the mouse, reduced representation bisulfite sequencing 
(RRBS) revealed rapid genome-wide demethylation in zygotes (Smith et al., 2012). In primates 
(Guo et al., 2014; Gao et al., 2017; Zhu et al., 2018), however, this major demethylation event 
did not occur until the 2-cell stage. Contrary to observations generated by immunostaining, 
which showed the highest DNA methylation in mouse blastocysts (Dean et al., 2001), the lowest 
DNA methylation levels were found at the blastocyst stage, despite that fact that de novo 
methylation had been initiated earlier than this stage (Smith et al., 2012). 
In bovine embryos, many studies have been conducted on the global methylation 
dynamics by immunostaining of 5mC (Dean et al., 2001; Beaujean et al., 2004; Park et al., 2007) 
and one by DNA methylation array with a finite numbers of probes (Salilew-Wondim et al., 
2015). While immunostaining provides important overall methylation dynamics, it does not 
provide specific sequence information of the methylated/de-methylated regions. We were the 
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first to report methylome dynamics at the single-base resolution in bovine in vivo pre-
implantation embryos using RRBS (Jiang et al., 2018). However, RRBS preferentially selects 
CpG-rich regions, such as CpG islands, while CpG shores are usually under-represented 
(Doherty and Couldrey, 2014). These shore regions are known to play important roles in tissue 
differentiation (Doi et al., 2009). Recently, the development of single-cell whole genome 
bisulfite sequencing (scWGBS-seq) allowed for the reliable and affordable revelation of all 
potentially CpG sites in a single oocyte or embryo (Smallwood et al., 2014). 
Cattle are one of the most economically valuable livestock species (Woolliams, 1996), 
and we have found that bovine embryos share more similarities with humans than mice in gene 
expression profiles and developmental timing (Jiang et al., 2014). The understanding of the 
methylome dynamics during bovine in vivo pre-implantation embryogenesis will provide the 
gold standard reference that can lead to improvements in assisted reproductive technologies and 
provide evolutionary insights across species. Importantly, bovine embryos serve as a great model 
for understanding human development where in vivo embryos are not available for research 
studies.  
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4.3. Methods 
4.3.1. Collection of bovine single gametes and embryos 
Frozen bovine sperm from a Holstein bull with proven fertility were thawed and washed 
using PureCeption gradient solution to remove somatic cell contaminations. After serial dilutions, 
three aliquots of approximately 20 sperm each were snap frozen and stored at -80C until library 
preparation.  
Ovarian stimulation and oocyte retrieval from Holsten cows (n=10) was performed as 
previously described (Hayakawa et al., 2009; Jiang et al., 2014, 2018). Briefly, superovulation 
was achieved using five doses of intramuscular injections of FSH beginning five days after 
insertion of a Controlled Intra-vaginal Drug Release (CIDR) device. Two doses of prostaglandin 
F2 alpha were given along with the last two FSH treatments, followed by CIDR removal. 
Standing estrus (Day 0) was seen approximately 48h post-prostaglandin injection. GnRH was 
then administered at estrus exhibition. Each cow was inseminated 12- and 24-hours post-
standing heat. Donor cows were sacrificed at 30 hours and 2-4 days after estrus to collect in vivo 
matured oocytes and 2- to 16-cell embryos by oviductal flushing, respectively. Cumulus-oocyte 
complexes were collected from slaughterhouse ovaries for GV oocytes. BO-IVM medium (IVF 
Bioscience) was used for oocyte in vitro maturation. This was conducted in four-well dishes for 
24 hours at 38.5 °C with 5% CO2. The stage of oocytes and embryos was then examined under 
light microscopy and only Grade 1 embryos by standards of the International Embryo 
Technology Society were selected for further study. 
All single oocytes and embryos were washed with D-PBS containing 1 mg/ml 
polyvinylpyrrolidone (PBS-PVP) and transferred into 50 l droplets of 0.1% protease to remove 
the zona pellucida. Single oocytes and embryos were rinsed three times in PBS-PVP, and the 
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absence of contaminating cells was confirmed, they then were snap frozen with minimal medium 
and stored at -80°C until library preparation.  
4.3.2. Preparation of WBGS libraries 
We obtained pools of 20 sperm (n=3), single germinal vesicle (GV) oocytes (n=4), single 
in vivo matured oocytes (n=6), single in vitro matured oocytes (n=6) and single embryos at the 2-
cell (n=4), 4-cell (n=5), 8-cell (n=4) and 16-cell (n=3) stages (Table S1).  We followed the 
protocol of single-cell WGBS library preparation by Smallwood et al. (2014) to prepare the 
single oocyte/embryo WGBS libraries. Briefly, sperm cells or a single oocyte/embryo were 
seeded into lysis buffer with 20 mg/ml of protease and 10% Trition-X 100. Genomic DNA was 
released after incubation at 50 °C for 3 hours, followed by 75 °C for 30 minutes to inactivate the 
protease.  Bisulfite treatment to convert unmethylated cytosines to uracils was conducted by 
using the MethylCode Bisulfite Conversion Kit (Thermo Fisher). The synthesis of 
complementary strands was repeated five times with Biotinylated random primer Bio-P5-N9 
(Biotin-CTACACGACGCTCTTCCGATCTNNNNNNNNN). This allowed for the maximizing 
of the tagged DNA strands and the generation of multiple copies of each fragment. The second 
strands were synthesized using another random primer, P7-N9 
(AGACGTGTGCTCTTCCGATCTNNNNNNNNN). Final libraries were prepared after 12 
cycles of PCR amplification using Illunima Universal PCR primer and indexed primer 
(NEBNext Multiplex Oligos for Illumina, New England BioLabs). Agencourt Ampure beads 
were used to purify the amplified libraries. The quality and quantity of the libraries were 
determined using high-sensitivity DNA chips on the Agilent Bioanalyzer, and KAPA Library 
Quantification Kits (KAPA Biosystems). Single-cell indexed libraries were pooled and 
sequenced on Illumina HiSeq4000 platform with 150 bp paired-end reads. The raw FASTQ files 
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are available at Gene Expression Omnibus (GEO) (www.ncbi.nlm.nih.gov/geo) under accession 
number GSE121758. 
4.3.3. Reads filtering and mapping 
After  the sequencing adapters were removed by TrimGalore-0.4.3 (Krueger, 2017) using 
the parameters of quality score higher than 20 and length greater than 36, reads that contained a 
total number of 15 Ns were removed. FastQC (Andrews, 2010) was used to assess the read 
quality. Further, 12 bp low quality reads at the 5’ end of both pairs were also removed. Trimmed 
sequences were mapped to the bovine genome UMD3.1.1 using Bismark - v.0.18.1(Krueger and 
Andrews, 2011), with parameters: --non_directional, --score_min L,0,-0.6, --un. This resulted in 
11.8 million reads uniquely mapped with a mapping efficiency of 9.3% (Table S1). This is 
higher than the average mapping efficiency (1.4%) of mouse single oocytes subjected to the 
same protocol (Smallwood et al., 2014). After mapping, we removed duplicates and non-
converted reads using deduplicate_bismark and filter_non_conversion, respectively (Krueger and 
Andrews, 2011). There were on average 4 million reads per sample for downstream analysis 
(Table S1). 
4.3.4. Quantification of methylation level and CpG density 
Using Bismark Methylation Extractor (Krueger and Andrews, 2011), methylation 
coverage for every single C was extracted and read coverage files were generated. When 
calculating the methylation level of each CpG site, the read coverage files of cytosine in CpG 
context were used. The DNA methylation level of each CpG site was calculated using 
count_methylated (“C” reads) divided by sum of count_methylated and count_unmethylated (“C” 
+ “T” or total read counts). The numbers of CpG sites with 1X, 5X or 10X total read counts of 
each stage were summarized in Table S1.  The processed CpG coverage files are available in 
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GSE121758. Data visualization and analysis were preformed using custom R and Java scripts 
and SeqMonk (Andrews, 2007). 
To facilitate the comparison of methylation levels across samples, we applied the 
consecutive genomic window method to bin the bovine genome (Zhu et al., 2018).  Briefly, we 
first filtered out CpGs that had total read counts of less than 5. Then, we bound the genome to 
300-bp tiles. Only tiles that contained greater than three CpG sites were kept. Tiles from 
replicate samples of the same developmental stage were combined to increase the coverage 
(Figure 2A). The numbers of captured 300-bp tiles in each stage are summarized in Figure S1E. 
We also identified the common 300-bp tiles among all samples as commonly methylated. 
Uniquely methylated tiles were then obtained for each sample. DNA methylation of each sample 
was calculated by averaging the 300-bp tiles’ methylation. Moreover, we calculated the CpG 
density as described by Guo et al., 2014. We determined the total number of all CpG sites 
located within 150 bp upstream and 150 bp downstream of each CpG site. Then the CpG density 
of every 300-bp tile was determined as the average of all CpG sites within this 300-bp tile. 
4.3.6. Pairwise comparison of methylation changes and gamete-specific DMRs 
Using Bedtools (Quinlan and Hall, 2010), we identified the common 300-bp tiles 
between consecutive stages and between male and female gametes. We followed the previous 
study (Guo et al., 2014) to classify changing tiles as those with methylation differences greater 
than 40% and significantly different by Fisher’s exact test (P-value ≤0.05, FDR ≤0.05), while the 
remaining tiles were defined as stable tiles. Increasing/decreasing tiles between consecutive 
stages were used to define DNA methylation increases or decreases. Differentially methylated 
regions (DMRs) were defined as common 300-bp tiles between two types of gametes/stages that 
had methylation levels ≥ 75% in one stage/type and ≤ 25% in another, and significantly different 
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by Fisher’s exact test (P-value ≤0.05, FDR ≤0.05). Hyper- and hypo-methylated tiles were those 
with DNA methylation levels ≥ 75% and ≤ 25%, respectively.  
4.3.7. Genomic feature annotation  
Genomic features, including promoters (1,000 bp upstream of Transcription Start Sites; 
TSS), exons, introns, CpG islands (CGIs), intergenic, long interspersed nuclear elements 
(LINEs), short interspersed nuclear elements (SINEs), and long terminal repeats (LTRs) were 
downloaded from University of California, Santa Cruz (UCSC) genome browser (bovine genome 
UMD3.1.1). 
4.3.8. Gene Ontology (GO) analysis 
GO analysis of genes annotated from DMRs was performed using DAVID 
( https://david.ncifcrf.gov, Huang et al., 2009a, 2009b). Biological processes with a P-value 
≤0.05 were determined to be statistically significant.  
4.3.9. Gene expression analysis  
We downloaded RNA-seq data of bovine sperm (Lesch et al., 2016), GV oocytes, in vitro 
matured oocytes (Graf et al., 2014), and in vivo matured oocytes and embryos (Jiang et al., 2014). 
Raw reads were trimmed by Trimmomatic (Bolger et al., 2014) and aligned to bovine reference 
genome assembly UMD3.1.1 using Hisat2 version 2.0.5 aligner (Pertea et al., 2016). IsoEM 
version 1.1.5 (Nicolae et al., 2011) was used to quantify gene expression to fragment per 
kilobase million (FPKM) using default parameters. Transcripts that annotated to LINEs, SINEs, 
and LTRs were determined by Bedtools (Quinlan and Hall, 2010). Spearman correlation 
coefficients between log2 transformed gene expression levels and DNA methylation levels of 
promoter, gene body, exon, intron, CGIs, LINEs, SINEs, and LTRs were calculated and plotted 
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in R (R Core Team, 2014).  
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4.4. Results and Discussion  
4.4.1. Profiles of the WGBS libraries of bovine gametes and embryos 
Using scWGBS, we analyzed a total of 35 samples of sperm, GV, in vivo and in vitro 
matured oocytes and cleavage stage in vivo developed embryos. The bisulfite conversion 
efficiency was more than 97% in each sample (Table S1). Pearson correlations indicated higher 
reproducibility within stages than between stages (Figure S1A). Captured CpGs broadly spread 
across each chromosome (Figure S1B-C). Two distinct profiles of methylation were observed: 1) 
highly methylated sperm and 2) lowly methylated oocytes and embryos (Figure S1C). However, 
virtually no (less than 1.5%) DNA methylation was found in mitochondrial DNA (Figure S1B-
C); this is in agreement with findings in humans (Hong et al., 2013; Liu et al., 2016) and mice 
(Mechta et al., 2017).   
In single oocytes and embryos, an average of 9 million reads uniquely mapped to the 
bovine genome assembly, UMD3.1.1, with an averaged 9.3% mapping rate (Table S1). This is 
higher than the average mapping efficiency (1.4%) of mouse single oocytes subjected to the 
same protocol (Smallwood et al., 2014). After removing duplicated and non-bisulfite converted 
reads, an average of 4 million reads per sample remained for downstream analysis (Table S1). 
We obtained an average of 1.8 million and 116, 655 CpG dinucleotides at 1X and 10X read 
counts, respectively (Table S1). In sperm samples, the average mapped reads (40 million), 
mapping rates (25.3%), unique reads (35.6 million) and the numbers of CpGs with 1X and 10X 
read counts (12 million and 608,253) were much higher than those of the single oocytes and 
embryos.  
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4.4.2. Unique features of methylome dynamics in bovine gametes and pre-implantation 
embryos 
A circus plot was generated to display CpG methylation levels within 300-bp tiles across 
all 30 bovine chromosomes (Figure S1D). The number of total 300-bp tiles in each stage is 
summarized in Figure S1E. Two distinct methylation patterns were found: methylation in sperm 
was much higher (72.5%; Figure 1A) than oocytes (29.0% - 31.3%) and embryos (15.3% - 
32.1%, Figure 1A and Figure S1D).  These changes are caused by the global demethylation in 
the early bovine embryos. After fertilization, CpG methylation in gametes (72.5% in sperm and 
~30% in oocyte; Figure 1A) decreased rapidly and reached the first low point at the 2-cell stage 
(25.0%; Figure 1A). Subsequently, a slight increase in DNA methylation was observed at the 4-
cell stage (26.7%; Figure 1A). As development progressed, a further and major overall 
demethylation occurred reaching the lowest point at the 8-cell stage (15.3%; Figure 1A) and 
coinciding with onset of major embryonic genome activation (Misirlioglu et al., 2006; Graf et al., 
2014; Jiang et al., 2014). A doubling of DNA methylation was then seen at the 16-cell stage 
(32.1%; Figure 1A). The timing of this major event of de novo methylation was consistent with 
our previous finding using RRBS (Jiang et al., 2018), as well as with the results generated by 
immunostaining (Dean et al., 2001; Dobbs et al., 2013; O’Doherty et al., 2015).  
Of note, the three types of oocytes studied were all different in their DNA methylation 
levels. Although the global methylation of in vivo matured oocytes (31.6%) was only about 2% 
higher than that of the GV oocytes (29.7%), this change occurred to the haploid genome in a 
relatively short time and may not be minimal.  Our data provides the molecular basis for the 
observation reported by Kono et al. (1996) that the maturation process involves addition of DNA 
methylation in mouse oocytes. Moreover, a small but noticeable difference in methylation levels 
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was also seen between in vitro (29.0%) and in vivo matured oocytes. This difference suggests 
aberrant DNA methylation during in vitro maturation. In vitro maturation, fertilization, and 
culture has been linked to abnormal embryo development (Smith et al., 2005) and large offspring 
syndrome (Young et al., 1998).   
Interestingly, the methylation levels of non-CpG (CpH) sites showed an opposite 
demethylation-remethylation patterns and remained mostly at low levels (Figure 1B and Figure 
S1F). For example, non-CpG methylation peaked at the 8-cell stage and was the lowest in sperm, 
a reverse pattern to that of CpG methylation. Although non-CpG methylation has been reported 
to be enriched in oocytes (Tomizawa et al., 2011) and pluripotent stem cells, its functions, if any, 
remain poorly understood. Our result showed that non-CpG methylation peaked when high 
expression of pluripotency genes and embryonic genome activation occurred in bovine pre-
implantation embryos (Jiang et al., 2014), suggesting an active regulatory role of non-CpG 
methylation on pluripotent gene expression.    
4.4.3. Potential mechanisms for the methylome dynamics 
To better understand the mechanisms of the DNA methylation dynamics, we analyzed the 
RNA-seq data of bovine gametes and embryos (Graf et al., 2014; Jiang et al., 2014; Lesch et al., 
2016) for genes that encode DNA methylcytosine dioxygenases (TET1, TET2, and TET3) and 
DNA methyltransferases (DNMT1, DNMT3A, DNMT3B and DNMTL). The dioxygenases 
(Huang et al., 2014), TET3 and TET2, were highly enriched in oocytes and 2-cell stage embryos, 
and their levels started to fade away at the 4-cell stage (Figure 1C), indicating a TET-mediated 
active DNA demethylation event immediately after fertilization (Wu and Zhang, 2017). 
Interestingly, expression of the other TET hydroxylase family member, TET1, was first seen at 
4-cell stage and peaked at the 16-cell stage (Figure 1C), corresponding to its known function of 
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promoting the pluripotency of the inner cell mass (ICM) in the blastocyst (Seisenberger et al., 
2013). On the other hand, the expression level of transcripts for DNMT1, the methylation 
maintenance enzyme (Goyal et al., 2006) was highest in in vivo matured oocytes, reduced 
gradually after fertilization, and reached the lowest level at the 8-cell stage (Figure 1C). This 
may be why the overall methylation levels of matured oocytes and the first two cleavage 
embryos did not dramatically decline until the 8-cell stage since bisulfite treatment cannot 
distinguish between 5-methylcytosine and the product of TET activity, 5-hydroxymethylcytosine. 
Transcripts for the de novo methyltransferase DNMT3A (Cheng and Blumenthal, 2011), and the 
cooperative homology, DNMT3L (Hata et al., 2002), were low until the 16-cell stage (Figure 
1C), when we observed a doubling of DNA methylation levels.  Another gene in the DNMT3 
family, DNMT3B, had an expression pattern similar to that of DNMT1, and may be important for 
de novo methylation at earlier stages (Liao et al., 2015). Taken together, the expression dynamics 
of methyltransferases is closed related to the dynamics of methylome in bovine oocytes and early 
embryos, and active demethylation by members of the TET family may be involved throughout 
early embryo development as opposed to the zygotic stage in the mouse (Iqbal et al., 2011).   
4.4.4. Genomic regions of dynamic methylation changes 
To determine the specific genomic regions that underwent dynamic methylation changes, 
we analyzed the methylation levels of promoters, exons, introns, CGIs, and intergenic regions of 
all annotated bovine genes (Figure 1D). We found that promoters and CGIs were consistently 
lowly methylated across all developmental stages, an observation similar to those found in other 
species (Guo et al., 2014). Interestingly, exons were hypermethylated (methylation level > 75%) 
in sperm, but hypomethylated in oocytes and cleavage stage embryos.  Methylation levels in 
exons had a minor increase at the 2-cell stage, but surged remarkably between the 8- and 16-cell 
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stages. On the other hand, changes in introns and intergenic regions closely resembled the whole 
genome dynamics (Figure 1D). In summary, the patterns of methylation dynamics in promoters 
and CGIs, which make up less than 1% of the genome, did not follow those of the whole genome 
and stayed in a hypomethylated state (methylation level < 25%).  These data suggest that the 
global methylation changes mainly reflects those of non-coding regions, such as intergenic 
regions and introns. Regulatory regions, such as promoters and CGIs, as well as coding regions 
(exons) have their own specific pattern of fluctuations.  
We further examined DNA methylation along the gene body and 15 kb up and down 
stream of all annotated bovine genes (Figure 1E). A valley in methylation levels was observed 
around the TSS of all genes, coinciding with the predominantly unmethylated promoters. 
Methylation gradually increased from TSS to TES and slightly decreased after TES in all stages. 
This pattern was repeatedly observed in all examined gametes and developmental stages (Figure 
1E) and was also seen in our RRBS study (Jiang et al., 2018). This suggests that DNA 
methylation may be used as a marker for gene TSS and TES boundaries (Naumann et al., 2009) 
in addition to its role in gene expression regulation. It also indicates a regulatory role of gene 
body methylation in transcription activation (Zilberman, 2017).  
4.4.5. CpG density and methylome dynamics  
To determine whether CpG density affects DNA demethylation and remethylation 
patterns, we plotted the DNA methylation levels of 300-bp tiles against their CpG density in all 
samples (Figure 2A).  Genome regions were categorized into high (80%-100%), intermediate 
(20%-40%, 40%-60%, and 60%-80%), and low (0-20%) methylation levels (Figure 2B) and the 
correlation to CpG density for each was plotted in Figure 2C-E. Sperm exhibited a strong 
negative correlation (r=-0.97) between CpG density and methylation levels: regions of low CpG 
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density had high methylation, while those with relatively high CpG density had low-to-
intermediate methylation (Figure 2A). Surprisingly, such a negative correlation in sperm had 
also been reported previously in differentiated somatic cells, likely because both cell types are 
highly methylated (Smith et al., 2012). However, among the other samples, only the 16-cell stage 
embryos had some trend of negative correlation (Figure 2A). Despite the negative correlation of 
CpG density and methylation levels, tiles with high CpG density, such as those in CGIs, were 
still more methylated in sperm and the 16-cell stage than in the other cleavage stages.  The high 
overall levels of methylation of the sperm was the result of containing more than 60% of highly 
methylated tiles, while oocytes and cleavage embryos only had less than 20% of such tiles 
(Figure 2B). In addition, previous studies have also found that about 70% of promoter regions 
and CGIs that had high CpG densities remained predominantly unmethylated (Xie et al., 2013; 
Guo et al., 2014; Takahashi et al., 2017), corresponding to the reverse correlation between CpG 
density and CpG methylation level observed in our results. 
4.4.6. Correlation between dynamics of transcriptomes and methylomes  
Using RNA-seq data of bovine sperm (Lesch et al., 2016), GV oocytes, oocytes matured 
in vitro (Graf et al., 2014) and in vivo as well as cleavage stage embryos (Jiang et al., 2014), we 
observed weak negative correlations, ranging from -0.30 in sperm to -0.18 in the in vivo matured 
oocyte, between methylation levels of promoters and expression of the corresponding genes 
(Figure S2A).  There were very weak negative correlations (in the range of -0.21 to -0.11) 
between the methylation and expression of the regions within gene body, exon, intron, and CGI. 
(Figure S2B).  The correlation between methylation levels of the repetitive elements and the 
expression of the corresponding transcripts, however, was positive, ranging from 0.14 to 0.18 
(Figure S2B). A previous study in mouse embryos also reported similar observations (Papin et 
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al., 2017). (Figure S2C). While both LINEs and SINEs, but not LTRs, underwent drastic de-
methylation from gametes to 8-cell stage, their overall RNA expression remained at relative low 
but constant levels (FPKM< 40) throughout development, indicating the repression of repetitive 
element expression was possibly exerted through other mechanisms (Reik, 2007).  
4.4.7. Commonly and uniquely methylated regions  
A total of 14,939 tiles of 300 bp were found across all samples and termed commonly 
methylated.  Their distribution along the 30 bovine chromosomes is illustrated in circos plots 
(Figure 3A). These tiles were characterized by low GC content, low CGI density and low gene 
density (Figure 3B). Specifically, 86% of these tiles were located in non-coding regions 
(intergenic and introns), 3% in CGIs, and 11% in repetitive regions such as LINEs (2%), SINEs 
(1%) and LTRs (8%). Because commonly methylated introns are the only regions that can lead 
to examination of functional genes in this group of tiles, we looked at their Gene Ontology (GO) 
terms and found that were enriched for involvement in cell differentiation and migration, signal 
transduction, protein localization and metabolic processes (Figure 3B and Table S2). Many of 
these were house-keeping genes suggesting the importance of consistent expression during early 
development. Interestingly, commonly methylated tiles exhibited a very similar dynamic pattern 
of methylation changes to that of the global pattern in oocytes and embryos, but not in sperm 
(Figure 3C). This difference suggests that the sperm and oocytes/embryos are differentially 
methylated even in the intergenic regions.  After fertilization, the embryos appeared to maintain 
a pattern more similar to the oocytes than the sperm.  Also, of note, commonly methylated tiles 
only have an methylation level of 19.4% in sperm, compared to the global methylation at an 
overall level of 72.5%, suggesting that these tiles although mainly intergenic, possibly resisted 
global demethylation. 
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Within commonly methylated regions, tiles that were hypermethylated in a specific stage 
and their GO categories are represented by heatmaps (Figure 3D). In the sperm, these tiles were 
enriched in genes of muscle contraction regulation, as well as oocyte development and 
differentiation (Figure 3D and Table S3), corresponding to the need for their repression. On the 
other hand, hypermethylated tiles in in vivo matured oocytes were involved in more GO terms 
than GV and in vitro matured oocytes (Table S3). A common GO term for hypermethylated tiles 
among the three types of oocytes was response to oxygen-containing compound (Figure 3D and 
Table S3). Oxygen stress in in vitro culture could generate excessive cytotoxic reactive oxygen 
species (ROS) and affect the viability of gametes (Park et al., 2005). The hypermethylation of 
these genes in oocytes is consistent with better quality when oocytes are matured in low oxygen 
conditions; perhaps the hypermethylation of these genes hampers the oocytes’ ability to adapt to 
artificial culture environments (Waldenström et al., 2009). Additionally, the hypermethylated 
regions in 8- or 16-cell embryos were mostly hypermethylated in other stages (Figure 3D), 
suggesting these regions either resisted demethylation or regained their methylation during the de 
novo process.  
We next analyzed the uniquely methylated regions in each sample (Figure S3A). Sperm 
had the highest number tiles (276,190), followed by the 16-cell embryos (31,628), with the least 
in in vivo matured oocytes (877). Those in sperm (Figure S3B) were enriched in intergenic (30%) 
and repetitive regions (31%), including 16% in SINES, 12% in LINEs and 3% in LTR, while 
only 1% fell in the promoter regions. The GO terms of genes represented by these tiles were 
immune and inflammatory responses, G-protein receptor signaling pathway, and cell adhesion 
(Figure S3B). Uniquely methylated regions in oocytes and embryos were also enriched in 
intergenic and repetitive regions (Figure S3C). The changes in the methylation levels of these 
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tiles in oocytes and embryos (Figure S3D) closely resembled the commonly methylated regions 
(Figure 3C) and global changes in methylation. However, sperm uniquely methylated regions 
(95% of the total tiles) were hypermethylated; while, sperm commonly methylated region (5% of 
the total tiles) were hypomethylated, indicating that the sperm uniquely methylated regions were 
likely targets of methylation erasure and re-establishment during embryonic development.  
4.4.8. Pairwise comparisons of methylomes at consecutive stages of development 
Overall, the methylation of the majority tiles (77.6% on average of each stage) were 
stable (differences  40%) during development (Figure 4A), indicating that methylome dynamic 
changes occurred in a small number of regions of the genome. Of the two transitions that had the 
most changing tiles (Figure 4A), a large portion (84.7%) showed decrease in methylation from 
sperm to 2-cell; while, 78.7% of tiles increased methylation from 8- to 16-cell. A total of 951 
genes were represented by the differentially methylated tiles (Figure S3E) between the 8- and 
16-cell stages, with 256 and 695 hypermethylated at the 8- and 16-cell stage, respectively 
(Figure S3E). Genes hypermethylated at the 8-cell stage were categorized into the GO terms of: 
actin cytoskeleton reorganization, negative regulation of transcription and cell adhesion; whereas, 
those associated with intracellular protein transport, cell migration and DNA-template 
transcription were hypermethylated at the 16-cell stage (Figure S3E and Table S4). Moreover, 
we have found four differentially expressed genes between 8- and 16-cell stage: ELOVL5, DEK, 
CAD, and KIAA1191 had DMRs (Table S5). The negatively correlation between gene expression 
and DNA methylation was expected.    
4.4.9. Characteristics of DMRs between different types of gametes 
We plotted heatmaps of DMRs from six comparisons: between sperm and any one of the 
three types of oocytes (Figure S4A-C), and between any two of the three oocyte types (Figure 
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S4D-F). The greatest number of DMRs and corresponding genes were found between sperm and 
in vitro matured oocytes (6,211), while the least were between GV and in vivo matured oocytes 
(755) (Figure 4B). Large numbers of DMRs (801) were also found between in vivo and in vitro 
matured oocytes. Between sperm and in vivo matured oocytes, 1,200 DMRs were highly 
methylated in in vivo matured oocytes (Figure 4C) and 1,453 were highly methylated in sperm 
(Figure 4C). These DMRs may represent parent-of-origin specific epigenetic modifications.  
Most of them, however, were distributed in intergenic regions. A high percentage of DMRs  
were LTRs (oocyte: 12%; sperm: 3%) and SINEs (oocyte: 2%; sperm: 6%), respectively. More 
highly methylated DMRs in sperm were in exons (sperm: 8%; oocyte: 3%) and CGIs (sperm: 
13%; oocyte: 8%) than those in oocytes.  
We then profiled the dynamic changes of DMRs that were highly methylated in one type 
of gametes during pre-implantation development (Figure 4D, upper left panel). Only DMRs that 
are located in the commonly methylated regions could be included across all samples. DMRs 
among the different types of oocytes were mostly intermediately methylated (25-75%).  
Interestingly, the majority of DMRs that were highly methylated in in vivo matured oocytes had 
intermediate methylation in both GV oocytes and in vitro matured oocytes, indicating that the in 
vitro environment failed to establish proper DNA methylation in these regions during the 
maturation process. Previous studies also demonstrated the suboptimal in vitro culture altered the 
DNA methylation landscape in bovine embryos (Salilew-Wondim et al., 2015). Furthermore, 
changes in DMRs that were hypermethylated in in vivo matured oocytes (Figure 4D upper left 
panel), resembled the global methylome dynamics during pre-implantation development. In 
contrast, DMRs hypermethylated in sperm (Figure 4D upper right panel) had relatively high 
methylation in the 2-cell stage compared to those hypermethylated in oocytes.  
  124 
Additionally, we identified 1,063 and 9,310 tiles that were either hypermethylated or 
hypomethylated in both sperm and in vivo matured oocytes (Figure 4D bottom left panel). The 
hypomethylated tiles were not further de-methylated in pre-implantation embryos, but increased 
their methylation at the 16-cell stage (Figure 4D bottom right panel). However, tiles that were 
hypermethylated in both gametes and localized in mostly intergenic regions became largely 
hypomethylated during subsequent development with minimal methylation levels reached at the 
8-cell stage (Figure 4D). 
The Gene Ontology of annotated genes encompassing all DMRs from the six 
comparisons were summarized in Table S6. Interestingly, only one common GO term, cell 
adhesion, was found in DMRs that were hypermethylated in sperm while hypomethylated in the 
three types of oocytes (Figure S4A-C). A previous methylome study (Perrier et al., 2018) 
compared bull sperm to somatic tissues, and also found the GO terms of cell adhesion in 
methylated region of sperm, along with migration and fertilization, which are essential functions 
of sperm. In the DMR comparison between in vivo and in vitro matured oocytes, genes in 
positive regulation of endosome, cellular component organization, and cytoplasmic transport 
were hypermethylated in in vivo matured oocytes, while those related to urogenital and 
reproductive system development and cell development were hypermethylated in in vitro 
matured oocytes. Our results provide candidate genes that were differentially methylated due to 
the suboptimal in vitro culture. These genes could be potential targets for the optimization of in 
vitro maturation and fertilization. Additionally, we analyzed the gene DMR with corresponded 
gene expression levels in the six comparisons (Table S7). Interestingly, genes with multiple 
DMRs, such as RNF122 in the comparison between GV and in vivo MII, showed the region 
specific DMR patterns along the gene body, i.e. some DMRs were hypermethylated in GV while 
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others were hypermethylated in in vivo MII, and the gene expression regulation difference could 
through complicate mechanisms.  
4.4.10. Methylation of the X chromosomes and imprinted genes 
In the mouse, the sperm carries an inactive X chromosome which is quickly reactivated 
after fertilization (Goto and Monk, 1998). We found that the bovine gametes also had 
differentially methylated X chromosomes with the one in sperm much more methylated than the 
one in matured oocytes. After fertilization, the overall DNA demethylation pattern of the X 
chromosome in the sperm closely resembled that of the whole genome (Figure 5A-B), 
suggesting reactivation of the paternal X chromosome. This is consistent with the observation 
that expression of the X-linked MaoA gene was detected from both parental X chromosomes 
until the morula stage when XCI was first observed (Ferreira et al. 2010). Interestingly, the 
methylation level of X chromosome in sperm was about 10% lower than that of the entire sperm 
genome (Figure 5B), which was also observed in our RRBS study (Jiang et al., 2018) and in a 
monkey WGBS study (Gao et al., 2017).  This is likely a result of more X-linked 
hypomethylated tiles on the X chromosome than the whole genome (Figure S1D).  
The expression of the X-linked XIST gene is essential for initiation of XCI in the mouse 
embryos (Kalantry et al., 2009). In males, XIST is expressed in testes to coat the sex body that 
forms during male meiotic sex chromosome inactivation (MSCI) (Turner, 2007). In our data, the 
CpG site in XIST gene was not well cover in every sample (Figure 5A & Figure S5). We could 
still observe that in sperm XIST gene was relatively lowly methylated compare to other regions 
of the X (Figure 5A & Figure S5). Using expression data from Lesch et al (2016) and Jiang et al. 
(2014), we found that XIST was absent in the sperm, but its transcription was initiated at the 2-
cell stage (Figure 5C), supporting the previous data by  De La Fuente et al., (1999). The major 
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elevation of XIST expression was observed between the 4- to 8- cell stage, when embryonic 
genome activation occurs, and peaked at morula stage, this is likely because XCI will be 
established soon (Figure 5C), which was first reported by Xue et al. (2002) in the bovine.   
Genome imprinting is a phenomenon of gene expression in a parent-of-origin specific 
manner (Pfeifer, 2000) and can be regulated by differential epigenetic marks on gametes 
(Plasschaert and Bartolomei, 2014). Unlike the whole genome, which undergoes a drastic 
reprogramming after fertilization, genomic imprinted genes retain their germline differentially 
methylated regions (gDMRs) through the demethylation process in a parent-of-origin specific 
manner (Sanz et al., 2010; Stewart et al., 2016). To date, 53 imprinted genes have been identified 
in the bovine (Chen et al., 2016), of which 34 are annotated in the current genome and analyzed 
in our study. 
We first characterized genes for which the imprinted control regions (ICR) (Pervjakova et 
al., 2016) are known regulatory gDMRs. The ICRs for imprinted genes PEG3 (Kim et al., 2007) 
and H19 (Robbins et al., 2012) (Figure 5D) are located at the first exon (Kim et al., 2007) and 
3kb upstream of the H19 promoter (Hansmann et al., 2011; Robbins et al., 2012), respectively. In 
bovine gametes and early embryos, the methylation of these ICRs in gametes corresponded to 
their parent-of-origin expression, for example, paternally expressed (Kim et al., 2007) gene 
PEG3 was hypomethylated in sperm at its ICR and hypermethylation in oocytes, and the 
methylation was maintained at around 50% up to the 16-cell stage (Figure 5D), as expected.  
Interestingly, we observed two distinct patterns of gamete-specific methylation for 
bovine imprinted genes. The first pattern included 20 genes, 9 paternally and 11 maternally 
expressed, whose methylation along the gene body negatively correlated with their reported 
allelic expression, as expected. For example, the paternally expressed gene SGCE was 
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hypomethylated in sperm and hypermethylated in in vivo matured oocytes, while the maternally 
expressed gene IGF2R was hypomethylated in oocytes and hypermethylated in sperm. In the 
second pattern which included 14 genes, 8 paternally and 6 maternally expressed, a positive 
correlation of gene body methylation and the known allelic expression pattern was seen (Figure 
5E). For instance, the paternally expressed genes, BEGAIN, IGF2, and RTL1, were 
hypermethylated in the gene bodies in sperm and hypomethylated in oocytes, while the maternal 
expressed OOEP and PHLDA2 were hypermethylated in oocytes in their gene bodies. Our RRBS 
study (Jiang et al., 2018) of bovine embryos also reported similar findings. The disagreement 
between methylation and expression patterns could be due to the involvement of other epigenetic 
mechanisms as well as the fact that the gene body may not contain the imprinting control region. 
The expression heatmap (Figure 5E) showed that the majority of paternally expressed genes had 
high expression levels in sperm, while a significant number of the maternally expressed genes 
had high expression in GV oocytes.  
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Figure 1. Methylome dynamics during bovine pre-implantation embryonic development.   
Line chart of averaged levels of CpG (A) and CpH (B) methylation across stages. Heatmap (C) of fragment per kilobase million 
(FPKM) expressions of DNMT and TET gene families in bovine early embryos. Line chart (D) of the average DNA methylation levels 
of annotated genomic features across stages. Trend plot (E) of averaged DNA methylation levels along the gene bodies (from 
transcription start sites (TSS) to transcription end sites (TES)) and 15,000 base pairs (bp) up- and down-stream of the gene body. GV: 
germinal vesicle oocytes; MII: matured oocytes. 
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Figure 2. CpG density and the methylome dynamics of bovine gametes and pre-implantation embryos.  
Histogram (A) of the percentages of 300-bp tiles with different DNA methylation levels at each development stage (upper panels). 
Box plots of methylation levels across different CpG densities at each stage (bottom panels). Stack bar plot (B) of the percentages of 
tiles with high (80%-100%), intermediate (60%-80%; 40%-60%, 20-40%), and low (0-20%) methylation levels. The distribution of 
high (C), intermediate (D) and low (E) methylation tiles against CpG densities at each stage. GV: germinal vesicle oocytes; MII: 
matured oocytes.   
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Figure 3. Commonly and uniquely methylated regions in bovine gametes and pre-implantation embryos. 
Circos plot (A) visualization of 14,939 commonly methylated 300-bp tiles among all samples. a. sperm, b. GV, c. in vivo MII, d. in 
vitro MII, e. 2-cell, f. 4-cell, g. 8-cell, h. 16-cell. Pie plot (B) of the distribution of commonly methylated tiles in genomic regions and 
their associated GO term representatives. Bar plot (C) of averaged DNA methylation levels across stages. Heatmap (D) of enrichment 
of hypermethylated regions in each stage and associated GO term representatives. GV: germinal vesicle oocytes; MII: matured 
oocytes. Green: hypomethylation, red: hypermethylation.   
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Figure 4. Pairwise comparisons of methylomes between consecutive development stagesand DMRs in gametes. 
Histogram (A) of the numbers of stable (dark blue) and changing (sky blue) tiles between consecutive stages. Histogram of the 
numbers of decreasing (gray) and increasing (pink) tiles between consecutive stages. The numbers (B) of DMRs and corresponding 
genes between gametes of different types. Pie plots (C) of the distribution of in vivo MII- and sperm-specific DMRs in annotated 
genomic regions. Box plots (D) of DNA methylation levels of oocyte- (upper left) or sperm- (upper right) specific DMRs in gametes 
and early embryos, as well as distributions of tiles hypomethylated (≤25%; bottom left) and hypermethylated (≥75%; bottom right) 
tiles in both gametes in each development stage. GV: germinal vesicle oocytes; MII: matured oocytes.   
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Figure 5. Methylation of the X chromosome and imprinted genes in bovine gametes and pre-implantation embryos. 
Circos plot (A) visualization of the methylation dynamics of genomic region of the X chromosome. All genes are in gray lines, Xist 
gene is in black line. CGIs are in blue lines. a. sperm, b. GV, c. in vivo MII, d. in vitro MII, e. 2-cell, f. 4-cell, g. 8-cell, h. 16-cell. Line 
plot (B) showing the DNA methylation dynamics of the X chromosome followed the global pattern of methylation changes. Line chart 
(C) of fragment per kilobase million (FPKM) expressions levels of XIST in bovine early embryos. Visualization of (D) imprinted 
control regions (ICR) of PEG3 and H19. Heatmap of (E) of the methylation and expression levels (FPKM) of 34 imprinted genes in 
pre-implantation embryos. GV: germinal vesicle oocytes; MII: matured oocytes. Blue text: paternally expressed genes, pink text: 
maternally expressed genes, Color key for heatmap: blue, hypomethylation and low expression, red, hypermethylation and high 
expression.  
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4.5. Supplementary information   
Table S1. Summary of WGBS library mapping and data processing 
Stages 
















CpG Sites (1X) 
Across Stages 
Total Unique 









Sperm_1 161,216,442 39,681,472 24.6% 4686722 (11.8%) 260,312 34,469,772 
12,993,162 1,653,714 608,253 
98.13% 
Sperm_2 211,319,602 53,205,362 25.2% 6488800 (12.2%) 345,993 46,018,888 98.78% 
Sperm_3 115,697,874 30,044,218 26.0% 2685134 (8.9%) 209,614 26,937,100 98.20% 
GV_1 65,016,220 11,138,582 17.1% 4351074 (39.1%) 590,462 5,605,132 
1,288,230 199,922 83,160 
98.60% 
GV_2 92,984,096 9,846,682 10.6% 5163658 (52.5%) 398,547 3,884,834 98.55% 
GV_3 118,194,368 16,944,488 14.3% 11235552 (66.3) 435,246 4,836,406 98.49% 
GV_4 107,145,508 7,368,766 6.9% 2635962 (35.8) 286,843 4,158,022 98.60% 
In vivo_MII_1 85,538,162 5,131,986 6.0% 2184726 (42.6%) 279,052 2,388,694 
486,489 63,628 23,081 
98.51% 
In vivo_MII_2 121,845,464 14,076,078 11.6% 9129286 (64.9%) 489,460 3,966,146 98.54% 
In vivo_MII_3 88,260,850 4,711,248 5.3% 2683234 (57.0%) 88,736 1,849,790 98.59% 
In vivo_MII_4 100,727,086 3,998,724 4.0% 1808178 (45.2%) 155,908 1,878,188 98.46% 
In vivo_MII_5 5,365,330 311,090 5.8% 16750 (5.4%) 24,940 244,444 98.90% 
In vivo_MII_6 83,411,048 2,481,584 3.0% 1503746(60.4%) 180,699 616,102 98.51% 
In vitro_MII_1 50,214,588 4,595,662 9.2% 2776720 (60.4%) 65,986 1,686,930 
775,917 146,750 67,363 
95.48% 
In vitro_MII_2 55,528,252 11,645,192 21.0% 7370920 (63.3%) 265,776 3,741,820 96.28% 
In vitro_MII_3 58,002,506 6,542,116 11.3% 5137740 (78.5%) 136,798 1,130,062 97.00% 
In vitro_MII_4 54,537,430 702,602 1.3% 299796 (42.7%) 24,107 354,532 97.72% 
In vitro_MII_5 90,523,956 6,039,752 6.7% 1558380 (25.8%) 401,697 3,677,436 97.30% 
In vitro_MII_6 114,323,238 5,606,912 4.9% 1775736 (31.7%) 413,647 3,003,244 98.18% 
2-Cell_1 129,875,908 7,163,764 5.5% 3579644 (50.0%) 160,494 3,262,596 
1,716,507 267,711 113,416 
98.37% 
2-Cell_2 164,502,830 9,436,404 5.7% 5080396 (53.8%) 226,277 3,902,624 98.40% 
2-Cell_3 91,770,914 17,880,216 19.5% 5201486 (29.1%) 514,479 11,648,538 98.46% 
2-Cell_4 70,534,008 1,289,856 1.8% 349382 (27.1%) 62,024 816,282 98.47% 
4-Cell_1 97,778,054 5,066,414 5.2% 2952796 (58.3%) 207,742 1,697,262 
1,253,797 189,680 76,240 
98.29% 
4-Cell_2 81,628,404 15,646,310 19.2% 8706226 (55.7%) 230,536 6,477,846 98.41% 
4-Cell_3 111,193,874 13,843,092 12.4% 5416762 (39.1%) 344,497 7,736,016 98.34% 
4-Cell_4 102,385,078 2,225,868 2.2% 580404 (26.1%) 80,738 1,483,814 98.22% 
4-Cell_5 110,694,850 3,642,164 3.3% 1129354 (31.0%) 91,131 2,330,144 98.64% 
8-Cell_1 112,311,296 20,399,528 18.2% 6952396 (34.1%) 982,604 11,480,484 
1,405,250 239,397 109,682 
98.36% 
8-Cell_2 94,629,426 4,341,724 4.6% 1847986 (42.6%) 240,195 2,012,882 98.22% 
8-Cell_3 90,751,254 2,211,738 2.4% 818182 (37.0%) 410,908 571,472 98.44% 
8-Cell_4 97,579,526 3,754,886 3.8% 937256 (25.0%) 62,678 2,691,994 98.53% 
16-Cell_1 106,037,758 18,636,794 17.6% 6276054 (33.7%) 235,637 11,887,768 
5,791,048 799,933 343,641 
98.33% 
16-Cell_2 104,228,166 23,488,986 22.5% 7677668 32.7%) 392,183 15,025,234 98.40% 
16-Cell_3 197,773,964 29,686,398 15.0% 6293204 (21.2%) 1,653,919 20,083,406 98.45% 
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Table S2. Gene Ontology (GO) terms for genes with commonly methylated introns among all samples 
Term Count % P-value Genes 
GO:0045638~negative regulation of myeloid cell differentiation 3 1.78 0.0083 PTK2B, MEIS1, CTR9 
GO:0007264~small GTPase mediated signal transduction 6 3.55 0.0297 PLCE1, RALGPS1, RAB37, DOCK9, RHOBTB2, RGL1 
GO:0001764~neuron migration 4 2.37 0.0366 GPM6A, PRKG1, GFRA3, KIRREL3 
GO:0090002~establishment of protein localization to plasma membrane 3 1.78 0.0369 CAV3, TNFRSF1A, TMEM150A 
GO:0030204~chondroitin sulfate metabolic process 2 1.18 0.0427 B3GAT2, B3GAT1 
Table S3.1. Gene Ontology (GO) terms for hypermethylated genes in sperm 
Term Count % P-value Genes 
GO:0060047~heart contraction 3 14.29 0.0083 CAV3, RPS6KA2, PDE5A 
GO:0003015~heart process 3 14.29 0.0086 CAV3, RPS6KA2, PDE5A 
GO:0010611~regulation of cardiac muscle hypertrophy 2 9.52 0.0219 CAV3, PDE5A 
GO:0014743~regulation of muscle hypertrophy 2 9.52 0.0230 CAV3, PDE5A 
GO:0003300~cardiac muscle hypertrophy 2 9.52 0.0370 CAV3, PDE5A 
GO:0043502~regulation of muscle adaptation 2 9.52 0.0381 CAV3, PDE5A 
GO:0014897~striated muscle hypertrophy 2 9.52 0.0392 CAV3, PDE5A 
GO:0008015~blood circulation 3 14.29 0.0392 CAV3, RPS6KA2, PDE5A 
GO:0003013~circulatory system process 3 14.29 0.0402 CAV3, RPS6KA2, PDE5A 
GO:0014896~muscle hypertrophy 2 9.52 0.0402 CAV3, PDE5A 
GO:0048599~oocyte development 2 9.52 0.0434 RPS6KA2, PDE5A 
GO:0055117~regulation of cardiac muscle contraction 2 9.52 0.0445 CAV3, PDE5A 
GO:0009994~oocyte differentiation 2 9.52 0.0477 RPS6KA2, PDE5A 
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Table S3.2. Gene Ontology (GO) terms for hypermethylated genes in GV 
Term Count % P-value Genes 
GO:1901700~response to oxygen-containing compound 12 15.58 0.0005 PIK3CG, DNMT3A, TNFRSF1A, SLC38A9, PTK2B, TNFRSF10D, MET, ATP1A1, NFKB1, MSN, CTNNA1, PLCB1 
GO:0045822~negative regulation of heart contraction 3 3.90 0.0016 PDE5A, ADRA1A, ATP1A1 
GO:1901701~cellular response to oxygen-containing compound 9 11.69 0.0021 PIK3CG, DNMT3A, SLC38A9, PTK2B, MET, NFKB1, MSN, CTNNA1, PLCB1 
GO:1903523~negative regulation of blood circulation 3 3.90 0.0041 PDE5A, ADRA1A, ATP1A1 
GO:0007610~behavior 7 9.09 0.0083 GRIA1, FBXL20, PREX2, PLCB1, MEIS1, KIRREL3, EPHB2 
GO:0048468~cell development 14 18.18 0.0113 PREX2, MET, TTPA, CTNNA1, MEIS1, EPHB2, RNF8, TNFRSF1A, GPM6A, PTK2B, PDE5A, UNC5D, MSN, KIRREL3 
GO:1901699~cellular response to nitrogen compound 6 7.79 0.0119 PIK3CG, DNMT3A, SLC38A9, NFKB1, CTNNA1, PLCB1 
GO:0001885~endothelial cell development 3 3.90 0.0150 TNFRSF1A, MET, MSN 
GO:0060284~regulation of cell development 8 10.39 0.0155 TNFRSF1A, PTK2B, PDE5A, TTPA, UNC5D, CTNNA1, MEIS1, EPHB2 
GO:0051865~protein autoubiquitination 3 3.90 0.0193 RNF8, UHRF2, ASB4 
GO:0006942~regulation of striated muscle contraction 3 3.90 0.0215 PDE5A, ADRA1A, ATP1A1 
GO:0000902~cell morphogenesis 10 12.99 0.0232 MKLN1, GPM6A, PTK2B, PREX2, MET, UNC5D, LRGUK, MSN, KIRREL3, EPHB2 
GO:0071417~cellular response to organonitrogen compound 5 6.49 0.0265 PIK3CG, DNMT3A, SLC38A9, NFKB1, CTNNA1 
GO:0009967~positive regulation of signal transduction 10 12.99 0.0265 PIK3CG, TNFRSF1A, SLC38A9, PTK2B, PDE5A, ADRA1A, NFKB1, CTNNA1, PLCB1, ADAMTS3 
GO:0048584~positive regulation of response to stimulus 12 15.58 0.0268 RNF8, PIK3CG, TNFRSF1A, SLC38A9, PTK2B, PDE5A, MET, ADRA1A, NFKB1, CTNNA1, PLCB1, ADAMTS3 
GO:0032989~cellular component morphogenesis 10 12.99 0.0332 MKLN1, GPM6A, PTK2B, PREX2, MET, UNC5D, LRGUK, MSN, KIRREL3, EPHB2 
GO:0044708~single-organism behavior 5 6.49 0.0332 GRIA1, FBXL20, PREX2, PLCB1, EPHB2 
GO:0045446~endothelial cell differentiation 3 3.90 0.0344 TNFRSF1A, MET, MSN 
GO:0071407~cellular response to organic cyclic compound 5 6.49 0.0390 PIK3CG, ATP1A1, NFKB1, MSN, CTNNA1 
GO:0051241~negative regulation of multicellular organismal process 8 10.39 0.0392 PTK2B, PDE5A, ADRA1A, ATP1A1, NFKB1, CTNNA1, MEIS1, EPHB2 
GO:0033993~response to lipid 6 7.79 0.0399 TNFRSF1A, PTK2B, TNFRSF10D, ATP1A1, NFKB1, MSN 
GO:0010647~positive regulation of cell communication 10 12.99 0.0402 PIK3CG, TNFRSF1A, SLC38A9, PTK2B, PDE5A, ADRA1A, NFKB1, CTNNA1, PLCB1, ADAMTS3 
GO:0023056~positive regulation of signaling 10 12.99 0.0415 PIK3CG, TNFRSF1A, SLC38A9, PTK2B, PDE5A, ADRA1A, NFKB1, CTNNA1, PLCB1, ADAMTS3 
GO:0007416~synapse assembly 3 3.90 0.0423 GPM6A, KIRREL3, EPHB2 
GO:0003158~endothelium development 3 3.90 0.0454 TNFRSF1A, MET, MSN 
GO:0040011~locomotion 10 12.99 0.0480 GPM6A, PTK2B, MET, UNC5D, MSN, CTNNA1, PLCB1, GFRA3, KIRREL3, EPHB2 
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Table S3.3. Gene Ontology (GO) terms for hypermethylated genes in in vivo MII 
Term Count % P-value Genes 
GO:0045822~negative regulation of heart contraction 3 4.92 0.0010 PDE5A, ADRA1A, ATP1A1 
GO:0051674~localization of cell 11 18.03 0.0011 PTPRK, GPM6A, MET, PTPN23, UNC5D, MSN, CTNNA1, PRKG1, PLCB1, GFRA3, KIRREL3 
GO:0048870~cell motility 11 18.03 0.0011 PTPRK, GPM6A, MET, PTPN23, UNC5D, MSN, CTNNA1, PRKG1, PLCB1, GFRA3, KIRREL3 
GO:1901701~cellular response to oxygen-containing compound 8 13.11 0.0018 PIK3CG, PTPRK, SLC38A9, MET, NFKB1, MSN, CTNNA1, PLCB1 
GO:0016477~cell migration 10 16.39 0.0018 PTPRK, GPM6A, MET, PTPN23, UNC5D, MSN, PRKG1, PLCB1, GFRA3, KIRREL3 
GO:1903523~negative regulation of blood circulation 3 4.92 0.0024 PDE5A, ADRA1A, ATP1A1 
GO:0040011~locomotion 11 18.03 0.0028 PTPRK, GPM6A, MET, PTPN23, UNC5D, MSN, CTNNA1, PRKG1, PLCB1, GFRA3, KIRREL3 
GO:0006937~regulation of muscle contraction 4 6.56 0.0034 PDE5A, ADRA1A, ATP1A1, PRKG1 
GO:1901700~response to oxygen-containing compound 9 14.75 0.0041 PIK3CG, PTPRK, SLC38A9, MET, ATP1A1, NFKB1, MSN, CTNNA1, PLCB1 
GO:0001764~neuron migration 4 6.56 0.0047 GPM6A, PRKG1, GFRA3, KIRREL3 
GO:0090257~regulation of muscle system process 4 6.56 0.0065 PDE5A, ADRA1A, ATP1A1, PRKG1 
GO:0006928~movement of cell or subcellular component 11 18.03 0.0066 PTPRK, GPM6A, MET, PTPN23, UNC5D, MSN, CTNNA1, PRKG1, PLCB1, GFRA3, KIRREL3 
GO:0035556~intracellular signal transduction 14 22.95 0.0069 PIK3CG, SLC38A9, DOCK9, NFKB1, PRKG1, ARFGEF1, RGL1, RAB37, PDE5A, ADRA1A, RGS7, PLCB1, ASB4, LCP2 
GO:2000145~regulation of cell motility 7 11.48 0.0084 PTPRK, MET, PTPN23, UNC5D, MSN, CTNNA1, PLCB1 
GO:0098609~cell-cell adhesion 8 13.11 0.0089 METAP1, PDE5A, PTPN23, UNC5D, MSN, CTNNA1, PRKG1, KIRREL3 
GO:0043087~regulation of GTPase activity 5 8.20 0.0092 ASAP1, RGS7, PRKG1, PLCB1, ARFGEF1 
GO:0051241~negative regulation of multicellular organismal 
process 8 13.11 0.0100 PDE5A, PTPN23, ASAP1, ADRA1A, ATP1A1, NFKB1, CTNNA1, PRKG1 
GO:0040012~regulation of locomotion 7 11.48 0.0104 PTPRK, MET, PTPN23, UNC5D, MSN, CTNNA1, PLCB1 
GO:0048584~positive regulation of response to stimulus 11 18.03 0.0105 PIK3CG, SLC38A9, PDE5A, MET, ADRA1A, NFKB1, CTNNA1, PLCB1, ADAMTS3, ARFGEF1, LCP2 
GO:0051270~regulation of cellular component movement 7 11.48 0.0117 PTPRK, MET, PTPN23, UNC5D, MSN, CTNNA1, PLCB1 
GO:0043085~positive regulation of catalytic activity 8 13.11 0.0125 PIK3CG, PDE5A, ASAP1, RGS7, WRN, PLCB1, ARFGEF1, LCP2 
GO:0006942~regulation of striated muscle contraction 3 4.92 0.0129 PDE5A, ADRA1A, ATP1A1 
GO:0071407~cellular response to organic cyclic compound 5 8.20 0.0161 PIK3CG, ATP1A1, NFKB1, MSN, CTNNA1 
GO:2000146~negative regulation of cell motility 4 6.56 0.0173 PTPRK, PTPN23, CTNNA1, PLCB1 
GO:2000643~positive regulation of early endosome to late 
endosome transport 2 3.28 0.0198 PTPN23, MSN 
GO:1901699~cellular response to nitrogen compound 5 8.20 0.0203 PIK3CG, SLC38A9, NFKB1, CTNNA1, PLCB1 
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GO:0007155~cell adhesion 9 14.75 0.0214 PTPRK, METAP1, PDE5A, PTPN23, UNC5D, MSN, CTNNA1, PRKG1, KIRREL3 
GO:0022610~biological adhesion 9 14.75 0.0219 PTPRK, METAP1, PDE5A, PTPN23, UNC5D, MSN, CTNNA1, PRKG1, KIRREL3 
GO:1903651~positive regulation of cytoplasmic transport 2 3.28 0.0230 PTPN23, MSN 
GO:0050790~regulation of catalytic activity 10 16.39 0.0249 PIK3CG, PDE5A, ASAP1, RGS7, NFKB1, WRN, PRKG1, PLCB1, ARFGEF1, LCP2 
GO:0006936~muscle contraction 4 6.56 0.0251 PDE5A, ADRA1A, ATP1A1, PRKG1 
GO:0040013~negative regulation of locomotion 4 6.56 0.0254 PTPRK, PTPN23, CTNNA1, PLCB1 
GO:0051271~negative regulation of cellular component 
movement 4 6.56 0.0254 PTPRK, PTPN23, CTNNA1, PLCB1 
GO:0030334~regulation of cell migration 6 9.84 0.0267 PTPRK, MET, PTPN23, UNC5D, MSN, PLCB1 
GO:0043547~positive regulation of GTPase activity 4 6.56 0.0293 ASAP1, RGS7, PLCB1, ARFGEF1 
GO:1903337~positive regulation of vacuolar transport 2 3.28 0.0328 PTPN23, MSN 
GO:2000641~regulation of early endosome to late endosome 
transport 2 3.28 0.0328 PTPN23, MSN 
GO:0010560~positive regulation of glycoprotein biosynthetic 
process 2 3.28 0.0360 PLCB1, ARFGEF1 
GO:1903649~regulation of cytoplasmic transport 2 3.28 0.0360 PTPN23, MSN 
GO:0051345~positive regulation of hydrolase activity 5 8.20 0.0384 ASAP1, RGS7, WRN, PLCB1, ARFGEF1 
GO:0000902~cell morphogenesis 8 13.11 0.0389 GPM6A, MET, PTPN23, ASAP1, UNC5D, LRGUK, MSN, KIRREL3 
GO:0003012~muscle system process 4 6.56 0.0398 PDE5A, ADRA1A, ATP1A1, PRKG1 
GO:1903020~positive regulation of glycoprotein metabolic 
process 2 3.28 0.0424 PLCB1, ARFGEF1 
GO:0044093~positive regulation of molecular function 8 13.11 0.0432 PIK3CG, PDE5A, ASAP1, RGS7, WRN, PLCB1, ARFGEF1, LCP2 
GO:0009967~positive regulation of signal transduction 8 13.11 0.0434 PIK3CG, SLC38A9, PDE5A, ADRA1A, NFKB1, CTNNA1, PLCB1, ADAMTS3 
GO:0006941~striated muscle contraction 3 4.92 0.0443 PDE5A, ADRA1A, ATP1A1  
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Table S3.4. Gene Ontology (GO) terms for hypermethylated genes in in vitro MII 
Term Count % P-value Genes 
GO:0007610~behavior 7 9.72 0.0040 GRIA1, FBXL20, PREX2, PLCB1, MEIS1, KIRREL3, EPHB2 
GO:1901700~response to oxygen-containing compound 9 12.50 0.0089 TNFRSF1A, SLC38A9, TNFRSF10D, MET, ATP1A1, NFKB1, MSN, CTNNA1, PLCB1 
GO:0001885~endothelial cell development 3 4.17 0.0114 TNFRSF1A, MET, MSN 
GO:0044708~single-organism behavior 5 6.94 0.0207 GRIA1, FBXL20, PREX2, PLCB1, EPHB2 
GO:0040011~locomotion 10 13.89 0.0207 LAMA4, MET, UNC5D, MSN, CTNNA1, PRKG1, PLCB1, GFRA3, KIRREL3, EPHB2 
GO:0048468~cell development 12 16.67 0.0221 TNFRSF1A, PREX2, PDE5A, MET, TTPA, UNC5D, MSN, CTNNA1, PRKG1, MEIS1, KIRREL3, EPHB2 
GO:0060284~regulation of cell development 7 9.72 0.0252 TNFRSF1A, PDE5A, TTPA, UNC5D, CTNNA1, MEIS1, EPHB2 
GO:0045595~regulation of cell differentiation 10 13.89 0.0254 RBFOX1, TNFRSF1A, PDE5A, TTPA, UNC5D, CTNNA1, PLCB1, MEIS1, ASB4, EPHB2 
GO:0045446~endothelial cell differentiation 3 4.17 0.0263 TNFRSF1A, MET, MSN 
GO:0048870~cell motility 9 12.50 0.0270 LAMA4, MET, UNC5D, MSN, CTNNA1, PRKG1, PLCB1, GFRA3, KIRREL3 
GO:0051674~localization of cell 9 12.50 0.0270 LAMA4, MET, UNC5D, MSN, CTNNA1, PRKG1, PLCB1, GFRA3, KIRREL3 
GO:0003158~endothelium development 3 4.17 0.0348 TNFRSF1A, MET, MSN 
GO:0006928~movement of cell or subcellular component 10 13.89 0.0403 LAMA4, MET, UNC5D, MSN, CTNNA1, PRKG1, PLCB1, GFRA3, KIRREL3, EPHB2 
GO:0007399~nervous system development 11 15.28 0.0443 RBFOX1, PREX2, UNC5D, CTNNA1, PRKG1, PLCB1, MEIS1, PLPPR1, GFRA3, KIRREL3, EPHB2 
GO:0006937~regulation of muscle contraction 3 4.17 0.0460 PDE5A, ATP1A1, PRKG1 
GO:0010721~negative regulation of cell development 4 5.56 0.0471 TTPA, CTNNA1, MEIS1, EPHB2 
GO:1901701~cellular response to oxygen-containing compound 6 8.33 0.0497 SLC38A9, MET, NFKB1, MSN, CTNNA1, PLCB1 
 
Table S3.5. Function for hypermethylated genes in 2-cell stage 
ASAP1 This gene encodes an ADP-ribosylation factor (ARF) GTPase-activating protein.  
HS6ST2 
Heparan sulfate proteoglycans are ubiquitous components of the cell surface, extracellular matrix, and basement membranes, and interact with various ligands to influence cell growth, differentiation, 
adhesion, and migration. 
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Table S3.6. Gene Ontology (GO) terms for hypermethylated genes in 4-cell stage 
Term Count % P-value Genes 
GO:0000902~cell morphogenesis 6 19.35 0.0174 MKLN1, PTK2B, MET, PTPN23, LRGUK, KIRREL3 
GO:0010632~regulation of epithelial cell migration 3 9.68 0.0181 PTK2B, MET, PTPN23 
GO:0032989~cellular component morphogenesis 6 19.35 0.0223 MKLN1, PTK2B, MET, PTPN23, LRGUK, KIRREL3 
GO:0030823~regulation of cGMP metabolic process 2 6.45 0.0273 PTK2B, PDE5A 
GO:0044248~cellular catabolic process 6 19.35 0.0296 PTK2B, ENPP3, PDE5A, PTPN23, SKIV2L2, RNF122 
GO:0010631~epithelial cell migration 3 9.68 0.0324 PTK2B, MET, PTPN23 
GO:0090132~epithelium migration 3 9.68 0.0331 PTK2B, MET, PTPN23 
GO:0090130~tissue migration 3 9.68 0.0351 PTK2B, MET, PTPN23 
GO:0034655~nucleobase-containing compound catabolic process 3 9.68 0.0402 ENPP3, PDE5A, SKIV2L2 
GO:0046068~cGMP metabolic process 2 6.45 0.0492 PTK2B, PDE5A 
GO:0046700~heterocycle catabolic process 3 9.68 0.0499 ENPP3, PDE5A, SKIV2L2 
 
Table S3.7. Function for hypermethylated genes in 8-cell stage 
KIRREL3 The protein encoded by this gene is a synaptic cell adhesion molecule 
MACROD2 Deacetylase involved in removing ADP-ribose from mono-ADP-ribosylated proteins. 
RGL1 Negative regulator of GA responses, member of GRAS family of transcription factors 
 
Table S3.8. Gene Ontology (GO) terms for hypermethylated genes in 16-cell stage 
Term Count % P-value Genes 
GO:0007416~synapse assembly 2 18.18 0.0435 KIRREL3, EPHB2 
GO:0050808~synapse organization 2 18.18 0.0853 KIRREL3, EPHB2 
GO:0021537~telencephalon development 2 18.18 0.0940 KIRREL3, EPHB2 
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Table S4.1. GO terms for DMRs between the 8- and 16-cell embryos that are hypermethylated in the 8-cell embryos 
Term Count % PValue Genes 
GO:0031532~actin cytoskeleton reorganization 4 1.50 0.023 MICALL2, FLNA, PARVB, INSRR 
GO:0000122~negative regulation of transcription from RNA polymerase II 
promoter 13 4.89 0.024 
EGR1, EHMT1, FOXJ1, TP53, MBD3, SUFU, CHD8, PHF19, ATN1, RARA, TBL1X, HDAC7, 
SUDS3 
GO:2000824~negative regulation of androgen receptor activity 2 0.75 0.030 FOXH1, HEYL 
GO:0007059~chromosome segregation 4 1.50 0.031 CIAO1, PPP2R1A, NAA60, CDK5RAP2 
GO:0051306~mitotic sister chromatid separation 2 0.75 0.044 PPP2R1A, DIS3L2 
GO:0001578~microtubule bundle formation 3 1.13 0.046 GAS2L2, CDK5RAP2, NCKAP5L 
GO:0007155~cell adhesion 7 2.63 0.046 PRKCA, LGALS3BP, STAB1, TTYH1, NINJ2, PARVB, CTNNA2 
GO:0050896~response to stimulus 3 1.13 0.053 CNGB1, SCNN1B, VSX1 
GO:0006468~protein phosphorylation 6 2.26 0.055 PRKCA, SCYL1, LIMK2, COQ8A, RARA, ILF3 
GO:2001046~positive regulation of integrin-mediated signaling pathway 2 0.75 0.073 LIMS2, FLNA 
GO:0090267~positive regulation of mitotic cell cycle spindle assembly 
checkpoint 2 0.75 0.073 DYNC1LI1, PCID2 
GO:0006915~apoptotic process 7 2.63 0.086 PRKCA, TP53, BAD, TRAF7, BRAT1, SUDS3, PEG3 
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Table S4.2. GO terms of DMRs between 8 vs. 16-cell that hypermethylated in 16-cell 
Term Count % PValue Genes 
GO:0006886~intracellular protein transport 18 2.55 0.0010 
VPS18, STX1A, SYNDIG1, AP1B1, SNX8, SNX17, NAPB, TSNARE1, TBC1D22A, TBC1D16, CTTN, SGSM1, TOM1L2, 
SGSM3, TBC1D14, GRTP1, TBC1D13, GGA3 
GO:0031338~regulation of vesicle fusion 7 0.99 0.0022 TBC1D16, SGSM1, SGSM3, TBC1D14, TBC1D13, GRTP1, TBC1D22A 
GO:0031175~neuron projection development 10 1.41 0.0031 NCAM1, MICALL2, EFHD1, STMN3, RASGRF1, RAB35, CAMSAP1, CAMSAP3, CAPZB, MICALL1 
GO:0090630~activation of GTPase activity 9 1.27 0.0038 TBC1D16, SGSM1, SGSM3, RASGRF1, TBC1D14, TBC1D13, GRTP1, TBC1D22A, AKT2 
GO:0040011~locomotion 4 0.57 0.0051 ATP2B2, JPH3, SPNS2, WDR1 
GO:0007613~memory 7 0.99 0.0060 JPH3, DRD1, B4GALT2, CRTC1, TH, DBH, SORCS3 
GO:0008283~cell proliferation 14 1.98 0.0080 GNAT1, PTPN6, HRAS, BYSL, RHBDF1, CSPG4, PRKDC, TACC3, BRAT1, RASGRF1, BOK, ASCC3, ERCC1, CUL1 
GO:0016477~cell migration 12 1.70 0.0107 FGFR4, NDE1, PTPRF, PTK6, FSCN1, RHBDF1, CSPG4, LIMD1, TNK2, EPHB3, CD63, BRAT1 
GO:2001046~positive regulation of integrin-mediated 
signaling pathway 3 0.42 0.0161 LIMS2, CD63, FLNA 
GO:0008286~insulin receptor signaling pathway 6 0.85 0.0204 SLC2A8, PDK2, BAIAP2L2, BAIAP2, AKT2, PIK3R2 
GO:0006351~transcription, DNA-templated 37 5.23 0.0210 
PTOV1, ZNF18, MED22, ZNF75D, KCNIP3, PCGF3, RAX2, HSF1, SMARCB1, SND1, AGO2, ZNF444, LIMD1, TCEA2, ALX4, 
TFDP1, NFATC1, CTBP2, TFPT, L3MBTL2, WDR5, RXRA, TBX4, RXRG, PRKCB, UHRF1, BRMS1, ZNF692, ASCC3, RFX2, 
MAD2L2, PUF60, HDAC7, NR5A1, SMARCA4, ZIM2, PEG3 
GO:0036010~protein localization to endosome 3 0.42 0.0236 TOLLIP, RAB35, MICALL1 
GO:0007601~visual perception 10 1.41 0.0274 PDE6B, RAX2, CDHR1, TH, CACNB2, RGS9, CNGB1, GPR179, CRX, GUCY2D 
GO:0030198~extracellular matrix organization 8 1.13 0.0289 SMOC2, FBLN1, ELF3, ADAMTSL2, COL27A1, POMT1, ELN, EMILIN1 
GO:0010976~positive regulation of neuron projection 
development 6 0.85 0.0302 FGFR1, RET, PTK6, CAMK2B, RAPGEF1, MARK2 
GO:0007043~cell-cell junction assembly 3 0.42 0.0321 FSCN1, TRPV4, HDAC7 
GO:0031115~negative regulation of microtubule 
polymerization 3 0.42 0.0321 TBCD, MAPRE1, CAPZB 
GO:0048227~plasma membrane to endosome transport 3 0.42 0.0321 SGSM3, RAB5C, RAB35 
GO:0006897~endocytosis 9 1.27 0.0350 MARCH2, HRAS, ATP9B, SNX8, RBSN, TNK2, EHD2, MICALL1, EPN2 
GO:0007257~activation of JUN kinase activity 4 0.57 0.0375 DAB2IP, MAP4K2, MAPK8IP3, AXIN1 
GO:0016485~protein processing 7 0.99 0.0392 NCSTN, ATG4B, RHBDF1, F7, PCSK7, NRDC, CPZ 
GO:0070527~platelet aggregation 5 0.71 0.0393 ACTB, PTPN6, FERMT3, CSRP1, FLNA 
GO:2000146~negative regulation of cell motility 3 0.42 0.0416 FBLN1, SLC9A3R1, PIN1 
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Table S5. Differentially expressed genes between 8- and 16- cell stage with DMRs 
Genes hypermethylated in 8-cell stage         
  RNA Seq gene expression  WGBS methylation level 
Gene Name 8-cell 16-cell Fold Change log2 of Fold Change P Value  8-cell  16-cell P Value q Value 
ELOVL5 13.48 80.03 5.94 2.57 0.03  100 12 6.45E-11 8.25E-10 
DEK 18.39 81.61 4.44 2.15 0.03  85 0 1.66E-16 5.93E-15 
           
Genes hypermethylated in 16-cell stage         
  RNA Seq gene expression  WGBS methylation level 
Gene Name 8-cell 16-cell Fold Change log2 of Fold Change P Value  8-cell  16-cell P Value q Value 
CAD 16.74 0.00 ﹣Inf NA 0.02  0 100 2.22E-19 9.29E-18 
KIAA1191 85.57 8.51 0.10 -3.33 0.00  0 100 2.22E-19 9.29E-18 
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Table S6.1. GO terms for DMRs between sperm and GV oocytes 
Hypermethylated genes in sperm 
Term Count % P-value Genes 
GO:0007166~cell surface receptor signaling pathway 13 3.10 0.0003 
EDN3, TSPAN4, ADCYAP1R1, PTH1R, CD151, GCGR, VIPR2, TSPAN11, CRHR1, TNFRSF1A,  
TSPAN32, ADGRB1, ADGRA1 
GO:0006836~neurotransmitter transport 5 1.19 0.0005 SLC6A9, CPLX1, SLC6A12, SLC6A13, SLC6A6 
GO:0009607~response to biotic stimulus 4 0.95 0.0018 IFITM1, IFITM2, IFITM3 
GO:0007612~learning 5 1.19 0.0050 SLC8A3, JPH4, JPH3, SORCS3, EPHB2 
GO:0030322~stabilization of membrane potential 4 0.95 0.0056 KCNN4, KCNK9, KCNK7, KCNK5 
GO:0071805~potassium ion transmembrane transport 6 1.43 0.0061 HPN, KCNK9, KCNK7, SLC9A3, KCNK5, KCNIP3 
GO:0007155~cell adhesion 11 2.63 0.0075 COL18A1, ISLR, LGALS3BP, TNXB, PTPRF, TTYH1, ITGAD, THBS2, SSPO, LRFN3, PARVB 
GO:0043406~positive regulation of MAP kinase activity 5 1.19 0.0087 NOX4, FGFR1, EDN3, PDE5A, PIK3R6 
GO:0007601~visual perception 8 1.91 0.0099 PDE6B, LAMB2, CABP4, COL1A1, OLFM2, RHO, GUCY2D, GRK1 
GO:0045332~phospholipid translocation 3 0.72 0.0106 KCNN4, ATP9B, ATP8A2 
GO:0043206~extracellular fibril organization 3 0.72 0.0106 TNXB, LTBP2, ADAMTS2 
GO:0051601~exocyst localization 3 0.72 0.0106 EXOC3L4, EXOC3L1, TNFAIP2 
GO:0042130~negative regulation of T cell proliferation 4 0.95 0.0123 MAD1L1, IL2RA, PDE5A, PLA2G2F 
GO:0016337~single organismal cell-cell adhesion 6 1.43 0.0129 TNXB, LIMS2, COL13A1, PKP3, TTYH1, NTN1 
GO:0043085~positive regulation of catalytic activity 4 0.95 0.0221 NCF1, DCP1B, BCL2, SFTPB 
GO:0006887~exocytosis 5 1.19 0.0221 EXOC3L4, CPLX1, EXOC3L1, VAMP2, TNFAIP2 
GO:0030198~extracellular matrix organization 6 1.43 0.0251 COL18A1, SMOC2, TNXB, ADAMTSL2, COL27A1, EMILIN1 
GO:0022898~regulation of transmembrane transporter activity 2 0.48 0.0462 INS, BCL2 
GO:0007193~adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway 4 0.95 0.0477 ADCY1, GNAI2, OPRL1, GPR37L1 
 
Hypermethylated in GV oocytes 
Term Count % P-value Genes 
GO:0034613~cellular protein localization 4 2.70 0.0019 ARMCX3, CTNNA1, AXIN2, CD63 
GO:0030097~hemopoiesis 3 2.03 0.0252 ADD2, KIRREL3, CDK13 
GO:0007275~multicellular organism development 5 3.38 0.0476 TNFRSF1A, CDX1, TNFRSF10D, SUFU, FGF4 
GO:2000643~positive regulation of early endosome to late endosome transport 2 1.35 0.0485 PTPN23, MSN 
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Table S6.2 GO terms for DMRs between sperm vs. in vivo MII 
Hypermethylated in sperm 
Term Count % P-value Genes 
GO:0007155~cell adhesion 11 4.38 0.0002 COL18A1, ISLR, NCAM1, TNXB, PTPRF, TTYH1, NINJ2, EPHB4, THBS2, SSPO, ITGA2B 
GO:0001508~action potential 3 1.20 0.0067 KCNB1, CHRNB4, CHRNA4 
GO:0007275~multicellular organism development 8 3.19 0.0089 SPEM1, TRIM54, TNFRSF10D, RTL1, COLEC11, ALX4, SUFU, QRICH1 
GO:0016337~single organismal cell-cell adhesion 5 1.99 0.0101 TNXB, LIMS2, PKP1, PKP3, TTYH1 
GO:0007626~locomotory behavior 5 1.99 0.0147 CHRNB4, APBA2, CHRNA4, DBH, OLFM2 
GO:0035094~response to nicotine 3 1.20 0.0234 CHRNB4, CHRNA4, CHRNG 
GO:0098655~cation transmembrane transport 3 1.20 0.0261 CHRNB4, CHRNA4, CHRNG 
GO:0006508~proteolysis 7 2.79 0.0377 F10, CAPN5, HTRA1, CPQ, ST14, RHBDF1, DPP6 
GO:1903038~negative regulation of leukocyte cell-cell adhesion 2 0.80 0.0417 PPARA, ASS1 
GO:0043588~skin development 3 1.20 0.0480 RYR1, ADAMTS2, SUFU 
 
Hypermethylated in in vivo MII 
Term Count % P-value Genes 
GO:0071354~cellular response to interleukin-6 3 2.59 0.0011 SBNO2, RELA, NFKB1 
GO:0034097~response to cytokine 3 2.59 0.0105 RELA, BCL2, NFKB1 
GO:0030282~bone mineralization 3 2.59 0.0105 SBNO2, GPC3, PHEX 
GO:2000630~positive regulation of miRNA metabolic process 2 1.72 0.0194 RELA, NFKB1 
GO:0006898~receptor-mediated endocytosis 3 2.59 0.0253 CUBN, ENPP3, AMN 
GO:0071316~cellular response to nicotine 2 1.72 0.0258 RELA, NFKB1 
GO:0007613~memory 3 2.59 0.0279 CHRNB2, PLCB1, SORCS3 
GO:0051963~regulation of synapse assembly 2 1.72 0.0321 CHRNB2, GHSR 
GO:0038061~NIK/NF-kappaB signaling 2 1.72 0.0321 RELA, NFKB1 
GO:0071375~cellular response to peptide hormone stimulus 2 1.72 0.0384 RELA, NFKB1 
GO:2000643~positive regulation of early endosome to late endosome transport 2 1.72 0.0384 PTPN23, MSN 
GO:0001778~plasma membrane repair 2 1.72 0.0447 DYSF, MYOF 
GO:0022612~gland morphogenesis 2 1.72 0.0447 BCL2, MSN 
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Table S6.3 GO terms for DMRs between sperm vs. in vitro MII 
Hypermethylated in sperm 
Term Count % P-value Genes 
GO:1904322~cellular response to forskolin 4 0.72 0.0010 ADCY3, ADCY1, ADCY5, EFNA5 
GO:0030198~extracellular matrix organization 9 1.61 0.0019 COL18A1, CSGALNACT1, SMOC2, TNXB, ADAMTSL2, COL27A1, ELN, VWA1, EMILIN1 
GO:0043542~endothelial cell migration 5 0.90 0.0027 PAXIP1, PTP4A3, PECAM1, NOS3, LOXL2 
GO:0002062~chondrocyte differentiation 6 1.08 0.0037 FGFR1, WNT5B, PTH1R, GLI2, RUNX1, RUNX3 
GO:0007193~adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway 6 1.08 0.0049 ADCY3, ADCY1, OPRL1, ADCY5, PSAPL1, GPR37L1 
GO:0002159~desmosome assembly 3 0.54 0.0059 JUP, PRKCA, PKP3 
GO:0019933~cAMP-mediated signaling 5 0.90 0.0089 ADCY3, ADCY1, PDE2A, ADCY5, GHRHR 
GO:0002076~osteoblast development 4 0.72 0.0091 ACHE, PTH1R, LIMD1, GLI2 
GO:0022400~regulation of rhodopsin mediated signaling pathway 4 0.72 0.0091 PRKCA, RGS9, RHO, GRK1 
GO:0006816~calcium ion transport 6 1.08 0.0096 CACNA1G, CHRNA4, ITPR3, CAMK2A, RAMP1, CDH23 
GO:0016337~single organismal cell-cell adhesion 7 1.25 0.0122 ARVCF, TNXB, LIMS2, PKP1, PKP3, TTYH1, NTN1 
GO:0006814~sodium ion transport 5 0.90 0.0131 SLC13A5, ATP4B, SLC12A3, SLC13A3, SLC5A10 
GO:0090630~activation of GTPase activity 7 1.25 0.0131 TBC1D16, TBC1D10C, FOXJ1, RASGRF1, TBC1D14, EVI5L, TBC1D22A 
GO:0007601~visual perception 9 1.61 0.0166 UNC119, AIPL1, LAMB2, TH, CABP4, RGS9, RHO, GUCY2D, GRK1 
GO:0048469~cell maturation 5 0.90 0.0184 FGFR1, SOX10, GATA2, PTH1R, GHRHR 
GO:0043117~positive regulation of vascular permeability 3 0.54 0.0193 PDE2A, PTP4A3, TRPV4 
GO:0051601~exocyst localization 3 0.54 0.0193 EXOC3L4, EXOC3L1, TNFAIP2 
GO:0045835~negative regulation of meiotic nuclear division 3 0.54 0.0193 OSM, LIF, RPS6KA2 
GO:0007626~locomotory behavior 7 1.25 0.0202 ATP2B2, ADCY5, TH, APBA2, CHRNA4, DBH, CDH23 
GO:0031338~regulation of vesicle fusion 5 0.90 0.0204 TBC1D16, TBC1D10C, TBC1D14, EVI5L, TBC1D22A 
GO:0007155~cell adhesion 12 2.15 0.0236 COL18A1, ISLR, NCAM1, PRKCA, VWF, ACHE, TNXB, FLOT2, PECAM1, TTYH1, THBS2, SSPO 
GO:0055085~transmembrane transport 9 1.61 0.0250 SLC13A5, SLC22A18, SLC16A6, SLC25A47, SLC22A6, SLC13A3, SLC25A45, SLC5A10, SLC43A3 
GO:0007189~adenylate cyclase-activating G-protein coupled receptor signaling pathway 5 0.90 0.0273 ADCY3, ADCY1, ADCY5, PTH1R, GHRHR 
GO:0001525~angiogenesis 10 1.79 0.0285 COL18A1, PRKCA, FGFR1, PECAM1, NOS3, MMP2, RAMP1, VASH1, EPHB2, ANGPTL4 
GO:0007219~Notch signaling pathway 7 1.25 0.0311 KRT19, PTP4A3, GMDS, MAML2, AGXT, ZNF423, ANGPTL4 
GO:0045746~negative regulation of Notch signaling pathway 4 0.72 0.0320 GATA2, PEAR1, DLK1, NEURL1 
GO:0007204~positive regulation of cytosolic calcium ion concentration 6 1.08 0.0354 GNA15, GALR1, OPRL1, ADCY5, TRPV4, CACNA1A 
GO:0060349~bone morphogenesis 4 0.72 0.0360 T, ACP5, IFITM5, ACTN3 
GO:0007613~memory 5 0.90 0.0383 CRTC1, TH, DBH, ITPR3, SORCS3 
GO:0048266~behavioral response to pain 3 0.54 0.0389 OSM, VWA1, CACNA1A 
GO:1901379~regulation of potassium ion transmembrane transport 3 0.54 0.0389 DPP6, KCNIP1, KCNIP3 
GO:0007416~synapse assembly 4 0.72 0.0402 CEL, NRXN2, CACNA1A, KIRREL3 
GO:0042511~positive regulation of tyrosine phosphorylation of Stat1 protein 3 0.54 0.0465 LIF, FGFR3, HPX 
GO:0007422~peripheral nervous system development 3 0.54 0.0465 OSM, SOX10, ERBB2 
GO:0045651~positive regulation of macrophage differentiation 3 0.54 0.0465 LIF, PRKCA, IL34 
GO:0035987~endodermal cell differentiation 4 0.72 0.0493 LAMB3, COL6A1, ITGB2, MMP2 
 
Hypermethylated in in vitro MII 
Term Count % P-value Genes 
GO:0006898~receptor-mediated endocytosis 4 2.84 0.0027 CD163L1, CUBN, ENPP3, SCARA5 
GO:0001764~neuron migration 4 2.84 0.0242 BARHL1, PRKG1, GFRA3, KIRREL3 
  146 
GO:1902259~regulation of delayed rectifier potassium channel activity 2 1.42 0.0292 KCNS1, VAMP2 
GO:0072112~glomerular visceral epithelial cell differentiation 2 1.42 0.0292 FOXC2, KLF15 
GO:0042058~regulation of epidermal growth factor receptor signaling pathway 2 1.42 0.0364 MVB12A, RHBDF1 
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Table S6.4 GO terms for DMRs between GV vs. in vivo MII 
Hypermethylated in GV 
Term Count % P-value Genes 
GO:1901700~response to oxygen-containing compound 8 15.38 0.0036 EGR1, TNFRSF1A, PFKL, PTK2B, TNFRSF10D, MET, MSN, CTNNA1 
GO:0001885~endothelial cell development 3 5.77 0.0055 TNFRSF1A, MET, MSN 
GO:0098609~cell-cell adhesion 7 13.46 0.0094 EGR1, PDE5A, UNC5D, MSN, CTNNA1, EBI3, KIRREL3 
GO:0045446~endothelial cell differentiation 3 5.77 0.0129 TNFRSF1A, MET, MSN 
GO:0010646~regulation of cell communication 12 23.08 0.0147 
EGR1, TNFRSF1A, MAGI3, PFKL, GRIA1, PTK2B, PREX2, PDE5A, MGLL, CTNNA1, 
ADAMTS3, SUFU 
GO:0023051~regulation of signaling 12 23.08 0.0159 
EGR1, TNFRSF1A, MAGI3, PFKL, GRIA1, PTK2B, PREX2, PDE5A, MGLL, CTNNA1, 
ADAMTS3, SUFU 
GO:0007155~cell adhesion 8 15.38 0.0166 EGR1, PTK2B, PDE5A, UNC5D, MSN, CTNNA1, EBI3, KIRREL3 
GO:0022610~biological adhesion 8 15.38 0.0170 EGR1, PTK2B, PDE5A, UNC5D, MSN, CTNNA1, EBI3, KIRREL3 
GO:0003158~endothelium development 3 5.77 0.0172 TNFRSF1A, MET, MSN 
GO:1904018~positive regulation of vasculature development 3 5.77 0.0305 EGR1, PTK2B, ASB4 
GO:0071480~cellular response to gamma radiation 2 3.85 0.0306 EGR1, WRN 
GO:0048468~cell development 9 17.31 0.0347 TNFRSF1A, PTK2B, PREX2, PDE5A, MET, UNC5D, MSN, CTNNA1, KIRREL3 
GO:0000902~cell morphogenesis 7 13.46 0.0357 PTK2B, PREX2, MET, UNC5D, LRGUK, MSN, KIRREL3 
GO:0043067~regulation of programmed cell death 7 13.46 0.0374 EGR1, TNFRSF1A, PTK2B, TNFRSF10D, MET, WRN, CTNNA1 
GO:0048699~generation of neurons 7 13.46 0.0381 PTK2B, PREX2, UNC5D, CTNNA1, DBN1, SUFU, KIRREL3 
GO:0042787~protein ubiquitination involved in ubiquitin-dependent protein catabolic 
process 3 5.77 0.0431 PTK2B, RNF122, SUFU 
GO:0030823~regulation of cGMP metabolic process 2 3.85 0.0431 PTK2B, PDE5A 
GO:2000058~regulation of protein ubiquitination involved in ubiquitin-dependent protein 
catabolic process 2 3.85 0.0431 PTK2B, SUFU 
GO:0007163~establishment or maintenance of cell polarity 3 5.77 0.0437 PTK2B, MSN, CTNNA1 
GO:0032989~cellular component morphogenesis 7 13.46 0.0464 PTK2B, PREX2, MET, UNC5D, LRGUK, MSN, KIRREL3 
GO:0010941~regulation of cell death 7 13.46 0.0467 EGR1, TNFRSF1A, PTK2B, TNFRSF10D, MET, WRN, CTNNA1 
GO:1901701~cellular response to oxygen-containing compound 5 9.62 0.0477 EGR1, PTK2B, MET, MSN, CTNNA1 
GO:2000145~regulation of cell motility 5 9.62 0.0488 PTK2B, MET, UNC5D, MSN, CTNNA1 
 
Hypermethylated in in vivo MII 
Term Count % P-value Genes 
GO:0016192~vesicle-mediated transport 6 13.95 0.0289 CUBN, CALY, ENPP3, PTPN23, LOXL4, TNFAIP2 
GO:0006897~endocytosis 4 9.30 0.0319 CUBN, CALY, ENPP3, LOXL4 
GO:0006898~receptor-mediated endocytosis 3 6.98 0.0344 CUBN, ENPP3, LOXL4 
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Table S6.5 GO terms for DMRs between GV vs. in vitro MII 
Hypermethylated in GV 
Term Count % P-value Genes 
GO:1901700~response to oxygen-containing compound 12 0.12 0.0001 TNFRSF1A, RET, SLC38A9, PTK2B, TNFRSF10D, RPS6KA2, MET, PRDX2, NFKB1, CTNNA1, SPON2, PLCB1 
GO:1901701~cellular response to oxygen-containing compound 10 0.10 0.0001 RET, SLC38A9, PTK2B, RPS6KA2, MET, PRDX2, NFKB1, CTNNA1, SPON2, PLCB1 
GO:0046068~cGMP metabolic process 3 0.03 0.0060 ATP2B2, PTK2B, PDE5A 
GO:0010646~regulation of cell communication 16 0.16 0.0094 
KLK6, RET, MAGI3, RALGPS1, SLC38A9, NFKB1, CTNNA1, ATP2B2, TNFRSF1A, 
 GRIA1, PTK2B, PDE5A, MNT, MGLL, DEPTOR, PLCB1 
GO:0043067~regulation of programmed cell death 10 0.10 0.0100 TNFRSF1A, PTK2B, BOK, TNFRSF10D, RPS6KA2, MET, MNT, DEPTOR, PRDX2, CTNNA1 
GO:0023051~regulation of signaling 16 0.16 0.0103 
KLK6, RET, MAGI3, RALGPS1, SLC38A9, NFKB1, CTNNA1, ATP2B2, TNFRSF1A, GRIA1,  
PTK2B, PDE5A, MNT, MGLL, DEPTOR, PLCB1 
GO:0010941~regulation of cell death 10 0.10 0.0139 TNFRSF1A, PTK2B, BOK, TNFRSF10D, RPS6KA2, MET, MNT, DEPTOR, PRDX2, CTNNA1 
GO:2000145~regulation of cell motility 7 0.07 0.0151 RET, PTK2B, MET, PTPN23, UNC5D, CTNNA1, PLCB1 
GO:0040012~regulation of locomotion 7 0.07 0.0187 RET, PTK2B, MET, PTPN23, UNC5D, CTNNA1, PLCB1 
GO:0008219~cell death 11 0.11 0.0202 KLK6, TNFRSF1A, PTK2B, BOK, TNFRSF10D, RPS6KA2, MET, MNT, DEPTOR, PRDX2, CTNNA1 
GO:0040011~locomotion 10 0.10 0.0207 ATP2B2, RET, PTK2B, MET, PTPN23, UNC5D, CTNNA1, PLCB1, GFRA3, KIRREL3 
GO:0051270~regulation of cellular component movement 7 0.07 0.0208 RET, PTK2B, MET, PTPN23, UNC5D, CTNNA1, PLCB1 
GO:0033993~response to lipid 6 0.06 0.0230 TNFRSF1A, RET, PTK2B, TNFRSF10D, NFKB1, SPON2 
GO:0007166~cell surface receptor signaling pathway 13 0.13 0.0237 TNFRSF1A, RET, CPE, PTK2B, BOK, TNFRSF10D, CD82, MET, NFKB1, CTNNA1, ADGRB1, PLCB1, FAM83G 
GO:0009966~regulation of signal transduction 14 0.14 0.0241 KLK6, RET, MAGI3, RALGPS1, SLC38A9, NFKB1, CTNNA1, TNFRSF1A, PTK2B, PDE5A, MNT, MGLL, DEPTOR, PLCB1 
GO:0048870~cell motility 9 0.09 0.0270 RET, PTK2B, MET, PTPN23, UNC5D, CTNNA1, PLCB1, GFRA3, KIRREL3 
GO:0042981~regulation of apoptotic process 9 0.09 0.0270 TNFRSF1A, PTK2B, BOK, TNFRSF10D, RPS6KA2, MNT, DEPTOR, PRDX2, CTNNA1 
GO:0051674~localization of cell 9 0.09 0.0270 RET, PTK2B, MET, PTPN23, UNC5D, CTNNA1, PLCB1, GFRA3, KIRREL3 
GO:0097190~apoptotic signaling pathway 6 0.06 0.0279 TNFRSF1A, BOK, TNFRSF10D, MNT, DEPTOR, CTNNA1 
GO:0032496~response to lipopolysaccharide 4 0.04 0.0302 TNFRSF1A, TNFRSF10D, NFKB1, SPON2 
GO:0097191~extrinsic apoptotic signaling pathway 4 0.04 0.0311 TNFRSF1A, BOK, TNFRSF10D, CTNNA1 
GO:0012501~programmed cell death 10 0.10 0.0364 TNFRSF1A, PTK2B, BOK, TNFRSF10D, RPS6KA2, MET, MNT, DEPTOR, PRDX2, CTNNA1 
GO:0002237~response to molecule of bacterial origin 4 0.04 0.0370 TNFRSF1A, TNFRSF10D, NFKB1, SPON2 
GO:0006928~movement of cell or subcellular component 10 0.10 0.0403 TNNT2, RET, PTK2B, MET, PTPN23, UNC5D, CTNNA1, PLCB1, GFRA3, KIRREL3 
GO:0016477~cell migration 8 0.08 0.0418 RET, PTK2B, MET, PTPN23, UNC5D, PLCB1, GFRA3, KIRREL3 
GO:0007155~cell adhesion 9 0.09 0.0420 RET, PKP1, PTK2B, PDE5A, PTPN23, UNC5D, CTNNA1, THBS2, KIRREL3 
GO:0070887~cellular response to chemical stimulus 12 0.12 0.0422 TNFRSF1A, RET, SLC38A9, PTK2B, RPS6KA2, MET, PRDX2, NFKB1, CTNNA1, SPON2, PLCB1, FAM83G 
GO:0030334~regulation of cell migration 6 0.06 0.0428 RET, PTK2B, MET, PTPN23, UNC5D, PLCB1 
GO:0022610~biological adhesion 9 0.09 0.0430 RET, PKP1, PTK2B, PDE5A, PTPN23, UNC5D, CTNNA1, THBS2, KIRREL3 
GO:0035556~intracellular signal transduction 13 0.13 0.0446 TNFRSF1A, MAGI3, RET, RALGPS1, SLC38A9, RAB37, PTK2B, BOK, RPS6KA2, PDE5A, DEPTOR, NFKB1, PLCB1 
GO:0071229~cellular response to acid chemical 3 0.03 0.0470 RET, SLC38A9, PTK2B 
GO:0055065~metal ion homeostasis 5 0.05 0.0477 ATP2B2, CNNM4, ATP2B3, PTK2B, SCNN1A 
GO:0009612~response to mechanical stimulus 3 0.03 0.0488 TNFRSF1A, ATP2B2, NFKB1 
 
Hypermethylated in in vitro MII 
Term Count % P-value Genes 
GO:0006898~receptor-mediated endocytosis 4 9.30 0.0059 RAMP3, LGALS3BP, CUBN, ENPP3 
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GO:0032835~glomerulus development 3 6.98 0.0062 FOXC2, KLF15, KIRREL3 
GO:0006897~endocytosis 5 11.63 0.0111 RAMP3, LGALS3BP, CUBN, CALY, ENPP3 
GO:0007610~behavior 5 11.63 0.0182 NRXN2, FBXL20, CHRNA4, SORCS3, KIRREL3 
GO:0001764~neuron migration 3 6.98 0.0270 PRKG1, GFRA3, KIRREL3 
GO:0072006~nephron development 3 6.98 0.0305 FOXC2, KLF15, KIRREL3 
GO:0061318~renal filtration cell differentiation 2 4.65 0.0322 FOXC2, KLF15 
GO:0072112~glomerular visceral epithelial cell differentiation 2 4.65 0.0322 FOXC2, KLF15 
GO:0044708~single-organism behavior 4 9.30 0.0324 NRXN2, FBXL20, CHRNA4, SORCS3 
GO:0072311~glomerular epithelial cell differentiation 2 4.65 0.0346 FOXC2, KLF15 
GO:0003013~circulatory system process 4 9.30 0.0360 RAMP3, PDE5A, FOXC2, PRKG1 
GO:0072010~glomerular epithelium development 2 4.65 0.0370 FOXC2, KLF15 
GO:0045932~negative regulation of muscle contraction 2 4.65 0.0394 PDE5A, PRKG1 
GO:0090075~relaxation of muscle 2 4.65 0.0419 PDE5A, PRKG1 
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Table S6.6 GO terms for DMRs between in vivo MII vs. in vitro MII 
Hypermethylated in in vivo MII     
Term Count % P-value Genes 
GO:2000643~positive regulation of early endosome to late endosome transport 2 4.55 0.0141 PTPN23, MSN 
GO:0051128~regulation of cellular component organization 10 22.73 0.0154 
FGFR1, PHLDB1, RPS6KA2, ARHGEF19, PTPN23, MSN, LMOD1,  
BIN1, ZW10, OPRD1 
GO:1903651~positive regulation of cytoplasmic transport 2 4.55 0.0164 PTPN23, MSN 
GO:1903337~positive regulation of vacuolar transport 2 4.55 0.0234 PTPN23, MSN 
GO:2000641~regulation of early endosome to late endosome transport 2 4.55 0.0234 PTPN23, MSN 
GO:1903649~regulation of cytoplasmic transport 2 4.55 0.0257 PTPN23, MSN 
GO:1903335~regulation of vacuolar transport 2 4.55 0.0417 PTPN23, MSN 
     
     
Hypermethylated in in vitro MII     
Term Count % P-value Genes 
GO:0098609~cell-cell adhesion 7 17.5 0.0051 EGR1, PDE5A, TTYH1, RARA, MSN, CTNNA1, KIRREL3 
GO:0032835~glomerulus development 3 7.5 0.0051 EGR1, KLF15, KIRREL3 
GO:0016337~single organismal cell-cell adhesion 6 15 0.0075 EGR1, PDE5A, TTYH1, RARA, MSN, CTNNA1 
GO:0007155~cell adhesion 8 20 0.0085 EGR1, PDE5A, TTYH1, RARA, MSN, CTNNA1, SSPO, KIRREL3 
GO:0022610~biological adhesion 8 20 0.0087 EGR1, PDE5A, TTYH1, RARA, MSN, CTNNA1, SSPO, KIRREL3 
GO:0098602~single organism cell adhesion 6 15 0.0106 EGR1, PDE5A, TTYH1, RARA, MSN, CTNNA1 
GO:0001822~kidney development 4 10 0.0110 EGR1, RARA, KLF15, KIRREL3 
GO:0072001~renal system development 4 10 0.0134 EGR1, RARA, KLF15, KIRREL3 
GO:0001655~urogenital system development 4 10 0.0193 EGR1, RARA, KLF15, KIRREL3 
GO:0048609~multicellular organismal reproductive process 5 12.5 0.0202 EGR1, OSBP2, PDE5A, RARA, LRGUK 
GO:0032504~multicellular organism reproduction 5 12.5 0.0212 EGR1, OSBP2, PDE5A, RARA, LRGUK 
GO:0072006~nephron development 3 7.5 0.0256 EGR1, KLF15, KIRREL3 
GO:0044702~single organism reproductive process 6 15 0.0341 EGR1, OSBP2, PDE5A, TTPA, RARA, LRGUK 
GO:0022414~reproductive process 6 15 0.0446 EGR1, OSBP2, PDE5A, TTPA, RARA, LRGUK 
GO:0000003~reproduction 6 15 0.0450 EGR1, OSBP2, PDE5A, TTPA, RARA, LRGUK 
GO:0048468~cell development 8 20 0.0496 OSBP2, PREX2, PDE5A, TTPA, RARA, MSN, CTNNA1, KIRREL3 
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Table S7.1 Gene expression for DMRs between sperm and GV oocytes 
Gene expression in DMRs from GV vs. Sperm     
Gene Chr GV_me Sperm_me p-value q-value GV expression Spmer expression 
PFKL AC_000158.1 0 100 2.22E-19 3.30E-18 0.888 0.197475 
PLCL2 AC_000158.1 0 100 2.22E-19 3.30E-18 11.425 45.9542 
NYNRIN AC_000167.1 0 80 1.24E-15 1.32E-14 0.287 3.66222 
JPH4 AC_000167.1 0 100 2.22E-19 3.30E-18 0.095 7.74329 
KATNBL1 AC_000167.1 76 0 6.99E-15 7.30E-14 17.392 19.9724 
SAMD4A AC_000167.1 0 83 3.95E-16 4.80E-15 0.229 92.4821 
SLC8A3 AC_000167.1 0 100 2.22E-19 3.30E-18 0.035 0.271869 
MERTK AC_000168.1 80 0 1.24E-15 1.32E-14 1.856 4.29607 
SEMA4C AC_000168.1 0 100 2.22E-19 3.30E-18 0.174 2.54157 
SEMA4C AC_000168.1 0 100 2.22E-19 3.30E-18 0.174 2.54157 
FHL2 AC_000168.1 0 100 2.22E-19 3.30E-18 4.781 8.26512 
DYSF AC_000168.1 75 0 1.25E-14 1.28E-13 0.372 2.59209 
DYSF AC_000168.1 100 7 2.90E-13 2.83E-12 0.372 2.59209 
DYSF AC_000168.1 80 20 6.94E-06 2.81E-05 0.372 2.59209 
ADD2 AC_000168.1 80 0 1.24E-15 1.32E-14 2.157 0.106467 
CAMKMT AC_000168.1 100 5 1.69E-14 1.73E-13 1.742 13.4428 
EMILIN1 AC_000168.1 0 100 2.22E-19 3.30E-18 0.121 2.56389 
OTOF AC_000168.1 0 100 2.22E-19 3.30E-18 0.074 0.0557878 
DNMT3A AC_000168.1 80 16 7.24E-07 3.49E-06 2.959 2.73006 
NOL10 AC_000168.1 0 100 2.22E-19 3.30E-18 20.124 20.8117 
RALGPS1 AC_000168.1 80 0 1.24E-15 1.32E-14 2.175 23.5689 
RALGPS1 AC_000168.1 80 18 2.38E-06 1.04E-05 2.175 23.5689 
ENG AC_000168.1 0 80 1.24E-15 1.32E-14 0.13 5.34783 
AIF1L AC_000168.1 0 100 2.22E-19 3.30E-18 0.079 2.89621 
NTNG2 AC_000168.1 0 100 2.22E-19 3.30E-18 0.108 0.683614 
AK8 AC_000168.1 0 80 1.24E-15 1.32E-14 0.377 44.5611 
GFI1B AC_000168.1 0 100 2.22E-19 3.30E-18 2.411 0.0413428 
GFI1B AC_000168.1 0 100 2.22E-19 3.30E-18 2.411 0.0413428 
RALGDS AC_000168.1 85 0 1.66E-16 2.20E-15 10.95 7.0163 
INPP5E AC_000168.1 0 100 2.22E-19 3.30E-18 0.551 8.13702 
AGPAT2 AC_000168.1 12 80 4.35E-08 2.36E-07 0.54 9.63912 
SARDH AC_000168.1 9 100 3.27E-12 2.95E-11 0.083 0.12003 
SARDH AC_000168.1 0 100 2.22E-19 3.30E-18 0.083 0.12003 
SARDH AC_000168.1 0 100 2.22E-19 3.30E-18 0.083 0.12003 
TPRN AC_000168.1 0 100 2.22E-19 3.30E-18 0.548 1.47106 
TPRN AC_000168.1 0 83 3.95E-16 4.80E-15 0.548 1.47106 
RXRA AC_000168.1 0 100 2.22E-19 3.30E-18 1.763 0.201091 
IFITM2 AC_000168.1 0 90 1.66E-17 2.40E-16 0.997 80.6682 
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PCDH17 AC_000169.1 83 0 3.95E-16 4.80E-15 0.277 1.29798 
ARL11 AC_000169.1 11 100 2.69E-11 2.18E-10 0.41 0.261074 
MYCBP2 AC_000169.1 75 8 7.09E-09 4.60E-08 11.59 14.5207 
DOCK9 AC_000169.1 93 10 9.09E-11 7.03E-10 21.342 5.15748 
DOCK9 AC_000169.1 88 18 2.56E-07 1.29E-06 21.342 5.15748 
RAB20 AC_000169.1 0 100 2.22E-19 3.30E-18 0.13 0.975288 
RASA3 AC_000169.1 0 100 2.22E-19 3.30E-18 0.065 1.43627 
RASA3 AC_000169.1 0 100 2.22E-19 3.30E-18 0.065 1.43627 
RASA3 AC_000169.1 0 100 2.22E-19 3.30E-18 0.065 1.43627 
RASA3 AC_000169.1 0 100 2.22E-19 3.30E-18 0.065 1.43627 
RASA3 AC_000169.1 0 100 2.22E-19 3.30E-18 0.065 1.43627 
RASA3 AC_000169.1 0 100 2.22E-19 3.30E-18 0.065 1.43627 
RASA3 AC_000169.1 0 100 2.22E-19 3.30E-18 0.065 1.43627 
PLCB1 AC_000170.1 85 21 3.15E-06 1.36E-05 2.134 1.56312 
PLCB1 AC_000170.1 80 10 8.02E-09 5.15E-08 2.134 1.56312 
PLCB1 AC_000170.1 90 25 5.95E-06 2.48E-05 2.134 1.56312 
PLCB1 AC_000170.1 100 2 5.84E-17 8.25E-16 2.134 1.56312 
PLCB1 AC_000170.1 93 21 3.73E-07 1.86E-06 2.134 1.56312 
SFMBT2 AC_000170.1 0 83 3.95E-16 4.80E-15 1.462 4.04179 
PFKFB3 AC_000170.1 0 100 2.22E-19 3.30E-18 1.697 6.93267 
IL2RA AC_000170.1 0 100 2.22E-19 3.30E-18 5.055 0.169466 
CUBN AC_000170.1 100 0 2.22E-19 3.30E-18 0.254 4.77637 
DIP2C AC_000170.1 0 100 2.22E-19 3.30E-18 0.766 12.4809 
TCEA2 AC_000170.1 20 100 2.92E-08 1.72E-07 0.957 36.3719 
SAMD10 AC_000170.1 0 100 2.22E-19 3.30E-18 0.05 0.151801 
TRIB3 AC_000170.1 0 80 1.24E-15 1.32E-14 0.076 0.121916 
NECAB3 AC_000170.1 0 100 2.22E-19 3.30E-18 0.096 3.25575 
NECAB3 AC_000170.1 83 0 3.95E-16 4.80E-15 0.096 3.25575 
CHMP4B AC_000170.1 80 5 3.50E-11 2.77E-10 10.25 17.6036 
KCNB1 AC_000170.1 0 100 2.22E-19 3.30E-18 0.011 0.595133 
BCAS4 AC_000170.1 0 100 2.22E-19 3.30E-18 2.562 1.27598 
BCAS4 AC_000170.1 0 100 2.22E-19 3.30E-18 2.562 1.27598 
SLC39A4 AC_000171.1 0 100 2.22E-19 3.30E-18 0.143 0.49789 
DGAT1 AC_000171.1 100 0 2.22E-19 3.30E-18 5.034 9.26291 
NRBP2 AC_000171.1 0 75 1.25E-14 1.28E-13 0.015 0.416031 
VAMP2 AC_000171.1 0 83 3.95E-16 4.80E-15 8.347 5.04003 
VAMP2 AC_000171.1 0 100 2.22E-19 3.30E-18 8.347 5.04003 
VAMP2 AC_000171.1 0 100 2.22E-19 3.30E-18 8.347 5.04003 
VAMP2 AC_000171.1 0 100 2.22E-19 3.30E-18 8.347 5.04003 
VAMP2 AC_000171.1 0 93 5.27E-18 7.78E-17 8.347 5.04003 
VAMP2 AC_000171.1 0 100 2.22E-19 3.30E-18 8.347 5.04003 
VAMP2 AC_000171.1 0 100 2.22E-19 3.30E-18 8.347 5.04003 
VAMP2 AC_000171.1 0 100 2.22E-19 3.30E-18 8.347 5.04003 
ARC AC_000171.1 20 100 2.92E-08 1.72E-07 0.173 0.0375706 
TSNARE1 AC_000171.1 0 100 2.22E-19 3.30E-18 1.913 0.00898524 
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TSNARE1 AC_000171.1 0 100 2.22E-19 3.30E-18 1.913 0.00898524 
TSNARE1 AC_000171.1 0 100 2.22E-19 3.30E-18 1.913 0.00898524 
TSNARE1 AC_000171.1 0 80 1.24E-15 1.32E-14 1.913 0.00898524 
TRAPPC9 AC_000171.1 0 100 2.22E-19 3.30E-18 2.403 10.3207 
ASAP1 AC_000171.1 0 100 2.22E-19 3.30E-18 39.817 4.84221 
ASAP1 AC_000171.1 10 90 2.77E-10 2.09E-09 39.817 4.84221 
TTPA AC_000171.1 76 11 6.43E-08 3.45E-07 0.139 1.44846 
PREX2 AC_000171.1 100 10 8.84E-12 7.26E-11 0.157 1.02787 
PREX2 AC_000171.1 76 15 1.29E-06 5.88E-06 0.157 1.02787 
PREX2 AC_000171.1 80 21 1.20E-05 4.73E-05 0.157 1.02787 
DEPTOR AC_000171.1 100 11 2.69E-11 2.18E-10 4.076 0.937093 
DEPTOR AC_000171.1 80 11 2.08E-08 1.27E-07 4.076 0.937093 
ALKBH8 AC_000172.1 16 75 3.16E-06 1.36E-05 3.047 3.89821 
PDE2A AC_000172.1 0 85 1.66E-16 2.20E-15 0.039 2.68373 
PDE2A AC_000172.1 0 85 1.66E-16 2.20E-15 0.039 2.68373 
ARRB1 AC_000172.1 80 0 1.24E-15 1.32E-14 0.907 0.862835 
ZNF408 AC_000172.1 16 100 1.86E-09 1.25E-08 1.262 1.9867 
MYBPC3 AC_000172.1 0 100 2.22E-19 3.30E-18 0.01 0.272787 
RGS7 AC_000173.1 80 11 2.08E-08 1.27E-07 1.014 0.674704 
RGS7 AC_000173.1 82 15 1.98E-07 1.01E-06 1.014 0.674704 
LAD1 AC_000173.1 20 100 2.92E-08 1.72E-07 3.584 0.0617539 
CSRP1 AC_000173.1 0 100 2.22E-19 3.30E-18 0.036 22.8617 
ACAP3 AC_000173.1 20 100 2.92E-08 1.72E-07 0.299 0.365091 
PLXNA2 AC_000173.1 0 100 2.22E-19 3.30E-18 0.033 2.16689 
CPE AC_000174.1 75 20 2.62E-05 9.81E-05 5.305 7.84652 
CUX2 AC_000174.1 80 0 1.24E-15 1.32E-14 45.73 0.223335 
ACADS AC_000174.1 100 0 2.22E-19 3.30E-18 3.249 3.73854 
SGSM1 AC_000174.1 100 0 2.22E-19 3.30E-18 0.268 1.15444 
EMID1 AC_000174.1 0 100 2.22E-19 3.30E-18 1.867 1.45839 
EMID1 AC_000174.1 0 100 2.22E-19 3.30E-18 1.867 1.45839 
EMID1 AC_000174.1 0 100 2.22E-19 3.30E-18 1.867 1.45839 
OSBP2 AC_000174.1 10 100 8.84E-12 7.26E-11 1.183 14.0231 
SUSD2 AC_000174.1 0 100 2.22E-19 3.30E-18 0.012 0.533469 
GGT5 AC_000174.1 20 100 2.92E-08 1.72E-07 1.886 0.631976 
GGT5 AC_000174.1 20 100 2.92E-08 1.72E-07 1.886 0.631976 
GGT1 AC_000174.1 0 100 2.22E-19 3.30E-18 0.027 0.665504 
GGT1 AC_000174.1 0 100 2.22E-19 3.30E-18 0.027 0.665504 
SLC7A4 AC_000174.1 0 100 2.22E-19 3.30E-18 0.019 0.587754 
GNB1L AC_000174.1 16 80 7.24E-07 3.49E-06 2.053 0.53128 
TXNRD2 AC_000174.1 0 100 2.22E-19 3.30E-18 1.364 0.0301001 
TXNRD2 AC_000174.1 0 100 2.22E-19 3.30E-18 1.364 0.0301001 
CTRB1 AC_000175.1 0 80 1.24E-15 1.32E-14 0.338 2.03802 
SLC7A5 AC_000175.1 20 100 2.92E-08 1.72E-07 0.103 22.6674 
SLC22A31 AC_000175.1 100 12 6.45E-11 5.03E-10 1.469 1.63851 
ZNF423 AC_000175.1 0 100 2.22E-19 3.30E-18 0.009 1.49701 
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ZNF423 AC_000175.1 0 100 2.22E-19 3.30E-18 0.009 1.49701 
ZNF423 AC_000175.1 0 88 3.94E-17 5.58E-16 0.009 1.49701 
EXOC3L1 AC_000175.1 0 100 2.22E-19 3.30E-18 1.545 1.44007 
PEPD AC_000175.1 0 100 2.22E-19 3.30E-18 0.057 3.74324 
PEPD AC_000175.1 0 100 2.22E-19 3.30E-18 0.057 3.74324 
PEPD AC_000175.1 0 100 2.22E-19 3.30E-18 0.057 3.74324 
GPI AC_000175.1 16 85 1.60E-07 8.31E-07 115.286 52.6938 
FXYD1 AC_000175.1 0 83 3.95E-16 4.80E-15 0.387 5.61115 
LRFN3 AC_000175.1 0 83 3.95E-16 4.80E-15 0.489 0.822277 
C18H19orf47 AC_000175.1 0 85 1.66E-16 2.20E-15 6.111 1.74616 
KCNN4 AC_000175.1 0 100 2.22E-19 3.30E-18 9.122 0.0324022 
KLC3 AC_000175.1 20 90 4.80E-07 2.36E-06 2.236 0.6625 
KDELR1 AC_000175.1 100 0 2.22E-19 3.30E-18 12 15.9696 
FCGRT AC_000175.1 0 88 3.94E-17 5.58E-16 3.272 0.128583 
NLRP12 AC_000175.1 100 0 2.22E-19 3.30E-18 0.013 0.0885662 
FIZ1 AC_000175.1 100 0 2.22E-19 3.30E-18 0.675 0.0353889 
TTYH1 AC_000175.1 0 100 2.22E-19 3.30E-18 0.927 53.4688 
TMC4 AC_000175.1 80 0 1.24E-15 1.32E-14 11.065 0.246617 
ZIM2 AC_000175.1 0 100 2.22E-19 3.30E-18 33.988 0.068638 
MSI2 AC_000176.1 0 81 9.35E-16 1.13E-14 1.261 3.4265 
MSI2 AC_000176.1 0 100 2.22E-19 3.30E-18 1.261 3.4265 
RNF43 AC_000176.1 0 100 2.22E-19 3.30E-18 2.151 0.584618 
GAS2L2 AC_000176.1 0 100 2.22E-19 3.30E-18 0.351 0.147563 
GAS2L2 AC_000176.1 0 100 2.22E-19 3.30E-18 0.351 0.147563 
MNT AC_000176.1 100 0 2.22E-19 3.30E-18 4.813 1.52517 
P2RX1 AC_000176.1 0 100 2.22E-19 3.30E-18 30.979 0.134512 
SLC35G6 AC_000176.1 0 100 2.22E-19 3.30E-18 0.381 14.2108 
GUCY2D AC_000176.1 16 100 1.86E-09 1.25E-08 0.207 0.0841453 
PER1 AC_000176.1 0 80 1.24E-15 1.32E-14 21.299 7.59761 
CCDC42 AC_000176.1 0 100 2.22E-19 3.30E-18 32.208 25.8806 
NTN1 AC_000176.1 0 100 2.22E-19 3.30E-18 2.205 0.550449 
SGCA AC_000176.1 0 83 3.95E-16 4.80E-15 0.551 4.48E-05 
RPL19 AC_000176.1 77 23 5.94E-05 2.11E-04 1281.436 133.855 
FBXL20 AC_000176.1 100 14 3.79E-10 2.81E-09 29.104 6.7384 
GRB7 AC_000176.1 0 100 2.22E-19 3.30E-18 0.587 0.375847 
HDAC5 AC_000176.1 0 100 2.22E-19 3.30E-18 0.54 7.63568 
PLCD3 AC_000176.1 0 81 9.35E-16 1.13E-14 2.178 1.43795 
CRHR1 AC_000176.1 0 83 3.95E-16 4.80E-15 0.075 3.05045 
RBFOX3 AC_000176.1 0 100 2.22E-19 3.30E-18 0.287 0.0541617 
RBFOX3 AC_000176.1 0 100 2.22E-19 3.30E-18 0.287 0.0541617 
RBFOX3 AC_000176.1 0 100 2.22E-19 3.30E-18 0.287 0.0541617 
LGALS3BP AC_000176.1 0 100 2.22E-19 3.30E-18 0.158 12.465 
LGALS3BP AC_000176.1 0 100 2.22E-19 3.30E-18 0.158 12.465 
LGALS3BP AC_000176.1 0 100 2.22E-19 3.30E-18 0.158 12.465 
SEC14L1 AC_000176.1 0 80 1.24E-15 1.32E-14 18.812 31.2194 
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ST6GALNAC2 AC_000176.1 0 100 2.22E-19 3.30E-18 2.707 23.0638 
RAB37 AC_000176.1 80 0 1.24E-15 1.32E-14 5.424 0.531397 
RAB37 AC_000176.1 80 10 8.02E-09 5.15E-08 5.424 0.531397 
RAB37 AC_000176.1 83 0 3.95E-16 4.80E-15 5.424 0.531397 
RAB37 AC_000176.1 87 7 3.08E-11 2.44E-10 5.424 0.531397 
RAB37 AC_000176.1 83 15 1.57E-07 8.18E-07 5.424 0.531397 
RAB37 AC_000176.1 80 20 6.94E-06 2.81E-05 5.424 0.531397 
RAB37 AC_000176.1 85 25 2.09E-05 7.94E-05 5.424 0.531397 
TTYH2 AC_000176.1 0 100 2.22E-19 3.30E-18 0.025 2.69215 
ABCA9 AC_000176.1 0 100 2.22E-19 3.30E-18 0.128 1.46739 
AXIN2 AC_000176.1 100 0 2.22E-19 3.30E-18 2.486 0.321127 
LIMS2 AC_000159.1 0 100 2.22E-19 3.30E-18 0.017 12.1793 
LIMS2 AC_000159.1 0 100 2.22E-19 3.30E-18 0.017 12.1793 
TFCP2L1 AC_000159.1 0 100 2.22E-19 3.30E-18 0.096 1.95606 
4-Mar AC_000159.1 100 0 2.22E-19 3.30E-18 0.525 0.0251621 
TNS1 AC_000159.1 0 100 2.22E-19 3.30E-18 0.613 8.80054 
TNS1 AC_000159.1 0 100 2.22E-19 3.30E-18 0.613 8.80054 
TNS1 AC_000159.1 0 100 2.22E-19 3.30E-18 0.613 8.80054 
DNPEP AC_000159.1 80 0 1.24E-15 1.32E-14 13.277 88.9103 
SLC4A3 AC_000159.1 0 100 2.22E-19 3.30E-18 0.187 1.40557 
SLC4A3 AC_000159.1 0 100 2.22E-19 3.30E-18 0.187 1.40557 
ZCCHC17 AC_000159.1 0 100 2.22E-19 3.30E-18 16.436 38.4618 
CD164L2 AC_000159.1 0 75 1.25E-14 1.28E-13 37.44 4.59861 
EPHB2 AC_000159.1 0 100 2.22E-19 3.30E-18 0.013 0.528627 
EPHB2 AC_000159.1 0 100 2.22E-19 3.30E-18 0.013 0.528627 
EPHB2 AC_000159.1 20 100 2.92E-08 1.72E-07 0.013 0.528627 
EPHB2 AC_000159.1 0 100 2.22E-19 3.30E-18 0.013 0.528627 
EPHB2 AC_000159.1 0 100 2.22E-19 3.30E-18 0.013 0.528627 
PADI4 AC_000159.1 0 100 2.22E-19 3.30E-18 0.019 0.107179 
PADI4 AC_000159.1 20 100 2.92E-08 1.72E-07 0.019 0.107179 
PADI1 AC_000159.1 0 100 2.22E-19 3.30E-18 0.565 0.00684407 
ZNF366 AC_000177.1 80 0 1.24E-15 1.32E-14 1.066 0.245052 
SLC38A9 AC_000177.1 80 5 3.50E-11 2.77E-10 23.88 12.0679 
SLC38A9 AC_000177.1 83 13 3.69E-08 2.13E-07 23.88 12.0679 
BRD9 AC_000177.1 0 100 2.22E-19 3.30E-18 8.891 7.39757 
SLC9A3 AC_000177.1 0 100 2.22E-19 3.30E-18 0.741 0.282475 
ST8SIA2 AC_000178.1 20 100 2.92E-08 1.72E-07 0.686 2.57432 
MRPS11 AC_000178.1 100 16 1.86E-09 1.25E-08 24.469 1.91452 
ARNT2 AC_000178.1 0 100 2.22E-19 3.30E-18 2.224 2.29686 
ACSBG1 AC_000178.1 0 100 2.22E-19 3.30E-18 0.042 11.0506 
ISL2 AC_000178.1 100 0 2.22E-19 3.30E-18 7.716 0.0596224 
FRMD5 AC_000178.1 91 6 1.77E-12 1.63E-11 8.882 0.203298 
FRMD5 AC_000178.1 100 21 5.72E-08 3.07E-07 8.882 0.203298 
FRMD5 AC_000178.1 75 12 2.23E-07 1.13E-06 8.882 0.203298 
FRMD5 AC_000178.1 76 23 7.24E-05 2.54E-04 8.882 0.203298 
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FRMD5 AC_000178.1 100 0 2.22E-19 3.30E-18 8.882 0.203298 
FRMD5 AC_000178.1 80 16 7.24E-07 3.49E-06 8.882 0.203298 
FRMD5 AC_000178.1 80 11 2.08E-08 1.27E-07 8.882 0.203298 
EXOC3L4 AC_000178.1 0 80 1.24E-15 1.32E-14 0.433 0.202865 
EXOC3L4 AC_000178.1 16 80 7.24E-07 3.49E-06 0.433 0.202865 
TNFAIP2 AC_000178.1 0 100 2.22E-19 3.30E-18 0.091 3.27001 
TNFAIP2 AC_000178.1 0 100 2.22E-19 3.30E-18 0.091 3.27001 
TNFAIP2 AC_000178.1 14 100 3.79E-10 2.81E-09 0.091 3.27001 
TNFAIP2 AC_000178.1 14 100 3.79E-10 2.81E-09 0.091 3.27001 
TNFAIP2 AC_000178.1 20 100 2.92E-08 1.72E-07 0.091 3.27001 
ADSSL1 AC_000178.1 0 100 2.22E-19 3.30E-18 0.028 14.3029 
ADSSL1 AC_000178.1 0 100 2.22E-19 3.30E-18 0.028 14.3029 
ADSSL1 AC_000178.1 0 100 2.22E-19 3.30E-18 0.028 14.3029 
ADSSL1 AC_000178.1 0 90 1.66E-17 2.40E-16 0.028 14.3029 
VILL AC_000179.1 0 100 2.22E-19 3.30E-18 0.021 3.56041 
SYNPR AC_000179.1 80 22 1.84E-05 7.05E-05 1.72 0.493366 
SYNPR AC_000179.1 80 4 7.32E-12 6.05E-11 1.72 0.493366 
ERC2 AC_000179.1 80 0 1.24E-15 1.32E-14 5.638 0.399069 
SFMBT1 AC_000179.1 16 80 7.24E-07 3.49E-06 9.88 17.3451 
GNAI2 AC_000179.1 0 85 1.66E-16 2.20E-15 11.738 62.7405 
APEH AC_000179.1 100 0 2.22E-19 3.30E-18 2.519 12.0954 
LAMB2 AC_000179.1 0 100 2.22E-19 3.30E-18 0.113 0.0489692 
LAMB2 AC_000179.1 0 83 3.95E-16 4.80E-15 0.113 0.0489692 
H1FOO AC_000179.1 0 100 2.22E-19 3.30E-18 638.647 1.64813 
RHO AC_000179.1 0 100 2.22E-19 3.30E-18 0.538 0.102191 
RHO AC_000179.1 0 100 2.22E-19 3.30E-18 0.538 0.102191 
SLC6A6 AC_000179.1 0 100 2.22E-19 3.30E-18 0.189 8.29457 
NUP210 AC_000179.1 0 100 2.22E-19 3.30E-18 0.119 2.69E-06 
NUP210 AC_000179.1 12 100 6.45E-11 5.03E-10 0.119 2.69E-06 
NUP210 AC_000179.1 100 16 1.86E-09 1.25E-08 0.119 2.69E-06 
NUP210 AC_000179.1 0 100 2.22E-19 3.30E-18 0.119 2.69E-06 
EEFSEC AC_000179.1 0 100 2.22E-19 3.30E-18 1.196 3.16696 
EEFSEC AC_000179.1 0 100 2.22E-19 3.30E-18 1.196 3.16696 
EEFSEC AC_000179.1 0 83 3.95E-16 4.80E-15 1.196 3.16696 
EEFSEC AC_000179.1 0 100 2.22E-19 3.30E-18 1.196 3.16696 
MGLL AC_000179.1 0 100 2.22E-19 3.30E-18 0.776 4.96885 
MGLL AC_000179.1 0 88 3.94E-17 5.58E-16 0.776 4.96885 
MGLL AC_000179.1 0 100 2.22E-19 3.30E-18 0.776 4.96885 
MGLL AC_000179.1 0 100 2.22E-19 3.30E-18 0.776 4.96885 
MGLL AC_000179.1 0 100 2.22E-19 3.30E-18 0.776 4.96885 
MGLL AC_000179.1 0 100 2.22E-19 3.30E-18 0.776 4.96885 
MGLL AC_000179.1 0 100 2.22E-19 3.30E-18 0.776 4.96885 
MGLL AC_000179.1 0 100 2.22E-19 3.30E-18 0.776 4.96885 
MGLL AC_000179.1 0 80 1.24E-15 1.32E-14 0.776 4.96885 
CHCHD6 AC_000179.1 20 100 2.92E-08 1.72E-07 1.991 0.0769569 
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ALDH1L1 AC_000179.1 0 100 2.22E-19 3.30E-18 0.018 0.125084 
MAPK13 AC_000180.1 16 100 1.86E-09 1.25E-08 0.124 1.2245 
RNF8 AC_000180.1 80 15 4.06E-07 2.01E-06 173.175 24.6931 
MRPL2 AC_000180.1 100 0 2.22E-19 3.30E-18 63.72 25.8689 
HIST1H1C AC_000180.1 80 12 4.35E-08 2.36E-07 168.516 0.347191 
MAK AC_000180.1 85 0 1.66E-16 2.20E-15 1.998 20.5848 
TUBB2B AC_000180.1 0 100 2.22E-19 3.30E-18 4.438 2.88E-07 
GMDS AC_000180.1 0 100 2.22E-19 3.30E-18 1.846 29.0845 
GMDS AC_000180.1 0 100 2.22E-19 3.30E-18 1.846 29.0845 
GMDS AC_000180.1 20 87 1.14E-06 5.21E-06 1.846 29.0845 
GMDS AC_000180.1 0 100 2.22E-19 3.30E-18 1.846 29.0845 
GMDS AC_000180.1 0 100 2.22E-19 3.30E-18 1.846 29.0845 
GMDS AC_000180.1 0 100 2.22E-19 3.30E-18 1.846 29.0845 
PARD6G AC_000181.1 0 100 2.22E-19 3.30E-18 0.18 0.705794 
ATP9B AC_000181.1 0 100 2.22E-19 3.30E-18 1.054 20.9405 
CELF4 AC_000181.1 0 100 2.22E-19 3.30E-18 0.892 0.498227 
KCTD1 AC_000181.1 100 10 8.84E-12 7.26E-11 3.893 2.85029 
ST8SIA5 AC_000181.1 100 0 2.22E-19 3.30E-18 0.098 0.267697 
ST8SIA5 AC_000181.1 0 100 2.22E-19 3.30E-18 0.098 0.267697 
BCL2 AC_000181.1 0 100 2.22E-19 3.30E-18 0.742 2.29554 
BCL2 AC_000181.1 0 100 2.22E-19 3.30E-18 0.742 2.29554 
PDIA2 AC_000182.1 0 100 2.22E-19 3.30E-18 0.193 0.0197089 
PDIA2 AC_000182.1 0 100 2.22E-19 3.30E-18 0.193 0.0197089 
AXIN1 AC_000182.1 0 87 7.02E-17 9.70E-16 8.127 2.99307 
FBXL16 AC_000182.1 100 20 2.92E-08 1.72E-07 0.915 0.756621 
FBXL16 AC_000182.1 20 83 3.33E-06 1.43E-05 0.915 0.756621 
MAPK8IP3 AC_000182.1 0 100 2.22E-19 3.30E-18 3.017 2.75834 
TBL3 AC_000182.1 0 83 3.95E-16 4.80E-15 1.21 9.98598 
DNAH3 AC_000182.1 100 20 2.92E-08 1.72E-07 0.334 6.18503 
QPRT AC_000182.1 0 80 1.24E-15 1.32E-14 0.074 1.49625 
NCF1 AC_000182.1 0 100 2.22E-19 3.30E-18 0.347 0.120512 
GTF2IRD1 AC_000182.1 0 100 2.22E-19 3.30E-18 0.277 1.03709 
GTF2IRD1 AC_000182.1 0 100 2.22E-19 3.30E-18 0.277 1.03709 
POLR2J AC_000182.1 0 87 7.02E-17 9.70E-16 939.48 5.48768 
LRWD1 AC_000182.1 0 100 2.22E-19 3.30E-18 1.981 9.38676 
COL26A1 AC_000182.1 0 100 2.22E-19 3.30E-18 0.01 0.355506 
COL26A1 AC_000182.1 0 100 2.22E-19 3.30E-18 0.01 0.355506 
TRIM56 AC_000182.1 0 85 1.66E-16 2.20E-15 0.004 0.267774 
TMEM130 AC_000182.1 0 100 2.22E-19 3.30E-18 0.151 0.498274 
CARD11 AC_000182.1 0 100 2.22E-19 3.30E-18 0.036 0.584971 
LFNG AC_000182.1 0 100 2.22E-19 3.30E-18 1.155 2.2758 
LFNG AC_000182.1 0 100 2.22E-19 3.30E-18 1.155 2.2758 
LFNG AC_000182.1 0 100 2.22E-19 3.30E-18 1.155 2.2758 
LFNG AC_000182.1 0 100 2.22E-19 3.30E-18 1.155 2.2758 
MAD1L1 AC_000182.1 0 100 2.22E-19 3.30E-18 0.594 2.44948 
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MAD1L1 AC_000182.1 0 100 2.22E-19 3.30E-18 0.594 2.44948 
MAD1L1 AC_000182.1 0 100 2.22E-19 3.30E-18 0.594 2.44948 
MAD1L1 AC_000182.1 0 87 7.02E-17 9.70E-16 0.594 2.44948 
TMEM184A AC_000182.1 0 100 2.22E-19 3.30E-18 0.062 0.466166 
TMEM184A AC_000182.1 0 100 2.22E-19 3.30E-18 0.062 0.466166 
TMEM184A AC_000182.1 0 100 2.22E-19 3.30E-18 0.062 0.466166 
MICALL2 AC_000182.1 0 100 2.22E-19 3.30E-18 0.551 0.182125 
MICALL2 AC_000182.1 0 100 2.22E-19 3.30E-18 0.551 0.182125 
MICALL2 AC_000182.1 0 100 2.22E-19 3.30E-18 0.551 0.182125 
MICALL2 AC_000182.1 20 100 2.92E-08 1.72E-07 0.551 0.182125 
MICALL2 AC_000182.1 20 80 6.94E-06 2.81E-05 0.551 0.182125 
ADAP1 AC_000182.1 0 100 2.22E-19 3.30E-18 28.765 0.734833 
ADAP1 AC_000182.1 0 100 2.22E-19 3.30E-18 28.765 0.734833 
ADAP1 AC_000182.1 0 83 3.95E-16 4.80E-15 28.765 0.734833 
MYOF AC_000183.1 100 9 3.27E-12 2.95E-11 6.025 12.114 
CRTAC1 AC_000183.1 0 100 2.22E-19 3.30E-18 0.289 0.0517082 
CRTAC1 AC_000183.1 0 100 2.22E-19 3.30E-18 0.289 0.0517082 
LOXL4 AC_000183.1 0 100 2.22E-19 3.30E-18 0.014 0.144052 
SUFU AC_000183.1 0 100 2.22E-19 3.30E-18 2.698 3.82115 
SUFU AC_000183.1 20 100 2.92E-08 1.72E-07 2.698 3.82115 
SUFU AC_000183.1 75 6 8.00E-10 5.54E-09 2.698 3.82115 
SUFU AC_000183.1 0 100 2.22E-19 3.30E-18 2.698 3.82115 
SORCS3 AC_000183.1 0 100 2.22E-19 3.30E-18 8.191 20.632 
SORCS3 AC_000183.1 20 88 8.27E-07 3.96E-06 8.191 20.632 
SORCS3 AC_000183.1 0 100 2.22E-19 3.30E-18 8.191 20.632 
SORCS3 AC_000183.1 0 100 2.22E-19 3.30E-18 8.191 20.632 
SORCS3 AC_000183.1 0 83 3.95E-16 4.80E-15 8.191 20.632 
SORCS3 AC_000183.1 0 100 2.22E-19 3.30E-18 8.191 20.632 
SORCS3 AC_000183.1 0 85 1.66E-16 2.20E-15 8.191 20.632 
SORCS3 AC_000183.1 0 80 1.24E-15 1.32E-14 8.191 20.632 
SORCS3 AC_000183.1 0 100 2.22E-19 3.30E-18 8.191 20.632 
SORCS3 AC_000183.1 0 80 1.24E-15 1.32E-14 8.191 20.632 
CTBP2 AC_000183.1 0 100 2.22E-19 3.30E-18 21.969 0.0139396 
PTPRE AC_000183.1 0 100 2.22E-19 3.30E-18 1.274 1.64891 
IRF2 AC_000184.1 0 100 2.22E-19 3.30E-18 0.511 4.58319 
CFAP97 AC_000184.1 80 0 1.24E-15 1.32E-14 20.386 67.3662 
WRN AC_000184.1 88 0 3.94E-17 5.58E-16 10.07 8.79611 
WRN AC_000184.1 80 0 1.24E-15 1.32E-14 10.07 8.79611 
WRN AC_000184.1 75 0 1.25E-14 1.28E-13 10.07 8.79611 
WRN AC_000184.1 100 5 1.69E-14 1.73E-13 10.07 8.79611 
WRN AC_000184.1 100 0 2.22E-19 3.30E-18 10.07 8.79611 
WRN AC_000184.1 83 0 3.95E-16 4.80E-15 10.07 8.79611 
WRN AC_000184.1 83 0 3.95E-16 4.80E-15 10.07 8.79611 
WRN AC_000184.1 80 0 1.24E-15 1.32E-14 10.07 8.79611 
WRN AC_000184.1 80 0 1.24E-15 1.32E-14 10.07 8.79611 
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WRN AC_000184.1 100 4 2.93E-15 3.09E-14 10.07 8.79611 
WRN AC_000184.1 78 0 2.95E-15 3.11E-14 10.07 8.79611 
WRN AC_000184.1 100 7 2.90E-13 2.83E-12 10.07 8.79611 
WRN AC_000184.1 91 6 1.77E-12 1.63E-11 10.07 8.79611 
WRN AC_000184.1 100 9 3.27E-12 2.95E-11 10.07 8.79611 
WRN AC_000184.1 100 13 1.74E-10 1.32E-09 10.07 8.79611 
WRN AC_000184.1 87 10 8.39E-10 5.80E-09 10.07 8.79611 
WRN AC_000184.1 81 14 1.53E-07 7.97E-07 10.07 8.79611 
WRN AC_000184.1 87 18 3.61E-07 1.80E-06 10.07 8.79611 
WRN AC_000184.1 85 18 5.63E-07 2.75E-06 10.07 8.79611 
WRN AC_000184.1 83 17 5.72E-07 2.80E-06 10.07 8.79611 
WRN AC_000184.1 100 0 2.22E-19 3.30E-18 10.07 8.79611 
WRN AC_000184.1 100 0 2.22E-19 3.30E-18 10.07 8.79611 
WRN AC_000184.1 83 0 3.95E-16 4.80E-15 10.07 8.79611 
WRN AC_000184.1 81 0 9.35E-16 1.13E-14 10.07 8.79611 
WRN AC_000184.1 80 0 1.24E-15 1.32E-14 10.07 8.79611 
WRN AC_000184.1 80 0 1.24E-15 1.32E-14 10.07 8.79611 
WRN AC_000184.1 80 2 2.15E-13 2.12E-12 10.07 8.79611 
WRN AC_000184.1 100 13 1.74E-10 1.32E-09 10.07 8.79611 
WRN AC_000184.1 89 12 2.24E-09 1.50E-08 10.07 8.79611 
WRN AC_000184.1 89 13 5.59E-09 3.66E-08 10.07 8.79611 
WRN AC_000184.1 100 20 2.92E-08 1.72E-07 10.07 8.79611 
WRN AC_000184.1 80 12 4.35E-08 2.36E-07 10.07 8.79611 
WRN AC_000184.1 90 19 2.52E-07 1.28E-06 10.07 8.79611 
WRN AC_000184.1 76 13 2.97E-07 1.49E-06 10.07 8.79611 
WRN AC_000184.1 88 25 1.06E-05 4.21E-05 10.07 8.79611 
WRN AC_000184.1 93 0 5.27E-18 7.78E-17 10.07 8.79611 
WRN AC_000184.1 82 0 5.25E-16 6.39E-15 10.07 8.79611 
WRN AC_000184.1 97 7 7.91E-13 7.35E-12 10.07 8.79611 
WRN AC_000184.1 85 7 6.35E-11 4.99E-10 10.07 8.79611 
WRN AC_000184.1 100 12 6.45E-11 5.03E-10 10.07 8.79611 
WRN AC_000184.1 75 5 2.05E-10 1.55E-09 10.07 8.79611 
WRN AC_000184.1 100 16 1.86E-09 1.25E-08 10.07 8.79611 
WRN AC_000184.1 87 12 5.03E-09 3.30E-08 10.07 8.79611 
WRN AC_000184.1 100 20 2.92E-08 1.72E-07 10.07 8.79611 
WRN AC_000184.1 83 22 9.08E-06 3.65E-05 10.07 8.79611 
RNF122 AC_000184.1 80 7 4.23E-10 3.12E-09 9.872 10.1717 
RNF122 AC_000184.1 100 20 2.92E-08 1.72E-07 9.872 10.1717 
RNF122 AC_000184.1 83 22 9.08E-06 3.65E-05 9.872 10.1717 
RNF122 AC_000184.1 0 100 2.22E-19 3.30E-18 9.872 10.1717 
RNF122 AC_000184.1 80 0 1.24E-15 1.32E-14 9.872 10.1717 
RNF122 AC_000184.1 75 14 9.09E-07 4.25E-06 9.872 10.1717 
RNF122 AC_000184.1 100 0 2.22E-19 3.30E-18 9.872 10.1717 
RNF122 AC_000184.1 83 0 3.95E-16 4.80E-15 9.872 10.1717 
RNF122 AC_000184.1 80 3 1.61E-12 1.48E-11 9.872 10.1717 
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RNF122 AC_000184.1 80 0 1.24E-15 1.32E-14 9.872 10.1717 
RNF122 AC_000184.1 80 0 1.24E-15 1.32E-14 9.872 10.1717 
RNF122 AC_000184.1 100 20 2.92E-08 1.72E-07 9.872 10.1717 
RNF122 AC_000184.1 20 91 3.85E-07 1.92E-06 9.872 10.1717 
RNF122 AC_000184.1 75 25 2.10E-04 6.57E-04 9.872 10.1717 
RNF122 AC_000184.1 75 25 2.10E-04 6.57E-04 9.872 10.1717 
RNF122 AC_000184.1 100 14 3.79E-10 2.81E-09 9.872 10.1717 
RNF122 AC_000184.1 90 25 6.49E-06 2.70E-05 9.872 10.1717 
RNF122 AC_000184.1 100 0 2.22E-19 3.30E-18 9.872 10.1717 
RNF122 AC_000184.1 80 0 1.24E-15 1.32E-14 9.872 10.1717 
RNF122 AC_000184.1 100 7 2.90E-13 2.83E-12 9.872 10.1717 
RNF122 AC_000184.1 80 11 2.08E-08 1.27E-07 9.872 10.1717 
RNF122 AC_000184.1 80 13 1.01E-07 5.30E-07 9.872 10.1717 
RNF122 AC_000184.1 83 20 3.33E-06 1.43E-05 9.872 10.1717 
RNF122 AC_000184.1 100 0 2.22E-19 3.30E-18 9.872 10.1717 
RNF122 AC_000184.1 0 80 1.24E-15 1.32E-14 9.872 10.1717 
RNF122 AC_000184.1 80 6 1.16E-10 8.91E-10 9.872 10.1717 
RNF122 AC_000184.1 80 20 6.94E-06 2.81E-05 9.872 10.1717 
RNF122 AC_000184.1 77 22 3.69E-05 1.34E-04 9.872 10.1717 
RNF122 AC_000184.1 100 9 3.27E-12 2.95E-11 9.872 10.1717 
RNF122 AC_000184.1 80 12 4.35E-08 2.36E-07 9.872 10.1717 
RNF122 AC_000184.1 88 25 1.06E-05 4.21E-05 9.872 10.1717 
RNF122 AC_000184.1 85 13 1.98E-08 1.21E-07 9.872 10.1717 
RNF122 AC_000184.1 80 11 2.08E-08 1.27E-07 9.872 10.1717 
RNF122 AC_000184.1 80 11 2.08E-08 1.27E-07 9.872 10.1717 
RNF122 AC_000184.1 80 16 7.24E-07 3.49E-06 9.872 10.1717 
RNF122 AC_000184.1 83 18 1.10E-06 5.02E-06 9.872 10.1717 
RNF122 AC_000184.1 0 85 1.66E-16 2.20E-15 9.872 10.1717 
RNF122 AC_000184.1 81 20 5.62E-06 2.36E-05 9.872 10.1717 
RNF122 AC_000184.1 80 25 7.02E-05 2.46E-04 9.872 10.1717 
RNF122 AC_000184.1 80 25 7.02E-05 2.46E-04 9.872 10.1717 
RNF122 AC_000184.1 83 11 7.24E-09 4.69E-08 9.872 10.1717 
RNF122 AC_000184.1 80 16 7.24E-07 3.49E-06 9.872 10.1717 
RNF122 AC_000184.1 0 100 2.22E-19 3.30E-18 9.872 10.1717 
RNF122 AC_000184.1 0 78 2.95E-15 3.11E-14 9.872 10.1717 
RNF122 AC_000184.1 80 4 7.32E-12 6.05E-11 9.872 10.1717 
RNF122 AC_000184.1 85 9 5.67E-10 3.93E-09 9.872 10.1717 
RNF122 AC_000184.1 75 14 9.09E-07 4.25E-06 9.872 10.1717 
RNF122 AC_000184.1 0 83 3.95E-16 4.80E-15 9.872 10.1717 
RNF122 AC_000184.1 80 0 1.24E-15 1.32E-14 9.872 10.1717 
RNF122 AC_000184.1 80 16 7.24E-07 3.49E-06 9.872 10.1717 
RNF122 AC_000184.1 100 0 2.22E-19 3.30E-18 9.872 10.1717 
RNF122 AC_000184.1 78 4 1.58E-11 1.30E-10 9.872 10.1717 
RNF122 AC_000184.1 75 9 1.70E-08 1.05E-07 9.872 10.1717 
RNF122 AC_000184.1 80 16 7.24E-07 3.49E-06 9.872 10.1717 
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RNF122 AC_000184.1 100 14 3.79E-10 2.81E-09 9.872 10.1717 
RNF122 AC_000184.1 80 9 3.43E-09 2.27E-08 9.872 10.1717 
RNF122 AC_000184.1 80 10 8.02E-09 5.15E-08 9.872 10.1717 
RNF122 AC_000184.1 80 15 4.06E-07 2.01E-06 9.872 10.1717 
RNF122 AC_000184.1 80 15 4.06E-07 2.01E-06 9.872 10.1717 
RNF122 AC_000184.1 77 16 1.60E-06 7.23E-06 9.872 10.1717 
RNF122 AC_000184.1 20 84 2.42E-06 1.06E-05 9.872 10.1717 
RNF122 AC_000184.1 80 4 7.32E-12 6.05E-11 9.872 10.1717 
RNF122 AC_000184.1 88 0 3.94E-17 5.58E-16 9.872 10.1717 
RNF122 AC_000184.1 85 0 1.66E-16 2.20E-15 9.872 10.1717 
RNF122 AC_000184.1 10 75 4.51E-08 2.45E-07 9.872 10.1717 
RNF122 AC_000184.1 80 18 2.38E-06 1.04E-05 9.872 10.1717 
RNF122 AC_000184.1 78 0 2.95E-15 3.11E-14 9.872 10.1717 
RNF122 AC_000184.1 100 7 2.90E-13 2.83E-12 9.872 10.1717 
RNF122 AC_000184.1 80 18 2.38E-06 1.04E-05 9.872 10.1717 
RNF122 AC_000184.1 0 80 1.24E-15 1.32E-14 9.872 10.1717 
RNF122 AC_000184.1 0 75 1.25E-14 1.28E-13 9.872 10.1717 
RNF122 AC_000184.1 100 15 9.23E-10 6.36E-09 9.872 10.1717 
RNF122 AC_000184.1 90 12 1.75E-09 1.20E-08 9.872 10.1717 
RNF122 AC_000184.1 75 11 9.55E-08 5.06E-07 9.872 10.1717 
RNF122 AC_000184.1 80 0 1.24E-15 1.32E-14 9.872 10.1717 
RNF122 AC_000184.1 80 9 3.43E-09 2.27E-08 9.872 10.1717 
RNF122 AC_000184.1 75 23 9.52E-05 3.26E-04 9.872 10.1717 
RNF122 AC_000184.1 90 0 1.66E-17 2.40E-16 9.872 10.1717 
RNF122 AC_000184.1 83 0 3.95E-16 4.80E-15 9.872 10.1717 
RNF122 AC_000184.1 80 4 7.32E-12 6.05E-11 9.872 10.1717 
RNF122 AC_000184.1 100 20 2.92E-08 1.72E-07 9.872 10.1717 
RNF122 AC_000184.1 85 17 3.24E-07 1.62E-06 9.872 10.1717 
RNF122 AC_000184.1 75 15 1.62E-06 7.31E-06 9.872 10.1717 
RNF122 AC_000184.1 80 19 4.34E-06 1.85E-05 9.872 10.1717 
RNF122 AC_000184.1 83 21 5.30E-06 2.22E-05 9.872 10.1717 
RNF122 AC_000184.1 83 0 3.95E-16 4.80E-15 9.872 10.1717 
RNF122 AC_000184.1 83 4 2.57E-12 2.35E-11 9.872 10.1717 
RNF122 AC_000184.1 88 18 2.56E-07 1.29E-06 9.872 10.1717 
RNF122 AC_000184.1 85 0 1.66E-16 2.20E-15 9.872 10.1717 
RNF122 AC_000184.1 85 10 1.65E-09 1.12E-08 9.872 10.1717 
RNF122 AC_000184.1 100 25 5.20E-07 2.55E-06 9.872 10.1717 
RNF122 AC_000184.1 92 24 2.34E-06 1.03E-05 9.872 10.1717 
RNF122 AC_000184.1 80 4 7.32E-12 6.05E-11 9.872 10.1717 
RNF122 AC_000184.1 88 16 7.03E-08 3.76E-07 9.872 10.1717 
RNF122 AC_000184.1 75 25 2.10E-04 6.57E-04 9.872 10.1717 
RNF122 AC_000184.1 80 16 7.24E-07 3.49E-06 9.872 10.1717 
RNF122 AC_000184.1 100 0 2.22E-19 3.30E-18 9.872 10.1717 
UNC5D AC_000184.1 100 1 5.75E-18 8.47E-17 9.564 0.293699 
UNC5D AC_000184.1 100 5 1.69E-14 1.73E-13 9.564 0.293699 
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UNC5D AC_000184.1 100 15 9.23E-10 6.36E-09 9.564 0.293699 
UNC5D AC_000184.1 97 15 2.19E-09 1.47E-08 9.564 0.293699 
UNC5D AC_000184.1 100 17 4.16E-09 2.74E-08 9.564 0.293699 
UNC5D AC_000184.1 88 18 2.56E-07 1.29E-06 9.564 0.293699 
UNC5D AC_000184.1 100 24 2.94E-07 1.48E-06 9.564 0.293699 
UNC5D AC_000184.1 100 24 2.94E-07 1.48E-06 9.564 0.293699 
FGFR1 AC_000184.1 0 100 2.22E-19 3.30E-18 1.222 4.27163 
FGFR1 AC_000184.1 0 100 2.22E-19 3.30E-18 1.222 4.27163 
SFRP1 AC_000184.1 0 75 1.25E-14 1.28E-13 4.191 0.563249 
ARV1 AC_000185.1 100 0 2.22E-19 3.30E-18 6.677 41.2131 
SYT15 AC_000185.1 0 83 3.95E-16 4.80E-15 0.017 0.0270671 
ROBO4 AC_000186.1 0 100 2.22E-19 3.30E-18 0.264 1.91423 
ST14 AC_000186.1 0 83 3.95E-16 4.80E-15 0.066 0.233181 
FADS2 AC_000186.1 0 100 2.22E-19 3.30E-18 0.051 34.409 
FADS2 AC_000186.1 0 100 2.22E-19 3.30E-18 0.051 34.409 
MACROD1 AC_000186.1 0 80 1.24E-15 1.32E-14 5.449 8.30819 
MACROD1 AC_000186.1 0 100 2.22E-19 3.30E-18 5.449 8.30819 
MACROD1 AC_000186.1 0 100 2.22E-19 3.30E-18 5.449 8.30819 
MACROD1 AC_000186.1 0 83 3.95E-16 4.80E-15 5.449 8.30819 
MACROD1 AC_000186.1 0 80 1.24E-15 1.32E-14 5.449 8.30819 
MACROD1 AC_000186.1 0 80 1.24E-15 1.32E-14 5.449 8.30819 
MACROD1 AC_000186.1 0 100 2.22E-19 3.30E-18 5.449 8.30819 
NRXN2 AC_000186.1 0 100 2.22E-19 3.30E-18 0.23 4.57515 
LTBP3 AC_000186.1 80 0 1.24E-15 1.32E-14 0.2 4.5186 
KCNK7 AC_000186.1 0 100 2.22E-19 3.30E-18 5.012 0.153702 
KCNK7 AC_000186.1 0 100 2.22E-19 3.30E-18 5.012 0.153702 
MAP3K11 AC_000186.1 20 100 2.92E-08 1.72E-07 3.373 1.86971 
KLC2 AC_000186.1 75 0 1.25E-14 1.28E-13 0.59 19.3057 
ALDH3B1 AC_000186.1 0 80 1.24E-15 1.32E-14 0.14 1.67588 
GAL AC_000186.1 0 100 2.22E-19 3.30E-18 0.129 0.502274 
ANO1 AC_000186.1 0 100 2.22E-19 3.30E-18 0.03 52.6666 
ANO1 AC_000186.1 0 100 2.22E-19 3.30E-18 0.03 52.6666 
ANO1 AC_000186.1 0 100 2.22E-19 3.30E-18 0.03 52.6666 
TSPAN4 AC_000186.1 0 100 2.22E-19 3.30E-18 0.216 2.43992 
CD151 AC_000186.1 0 100 2.22E-19 3.30E-18 5.355 2.44507 
PKP3 AC_000186.1 0 100 2.22E-19 3.30E-18 0.108 0.0558369 
IFITM3 AC_000186.1 0 100 2.22E-19 3.30E-18 0.745 19.5725 
IFITM3 AC_000186.1 0 100 2.22E-19 3.30E-18 0.745 19.5725 
IGSF9 AC_000160.1 0 83 3.95E-16 4.80E-15 0.148 0.376391 
IGSF9 AC_000160.1 0 100 2.22E-19 3.30E-18 0.148 0.376391 
IGSF9 AC_000160.1 0 80 1.24E-15 1.32E-14 0.148 0.376391 
MUC1 AC_000160.1 0 88 3.94E-17 5.58E-16 0.529 0.33369 
PHGDH AC_000160.1 0 100 2.22E-19 3.30E-18 0.183 8.71506 
ATP1A1 AC_000160.1 85 11 3.76E-09 2.48E-08 68.749 148.908 
ATP1A1 AC_000160.1 88 18 2.56E-07 1.29E-06 68.749 148.908 
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TRIM33 AC_000160.1 100 14 3.79E-10 2.81E-09 64.699 18.3993 
MYBPHL AC_000160.1 0 100 2.22E-19 3.30E-18 0.121 0.238176 
SLC44A5 AC_000160.1 80 0 1.24E-15 1.32E-14 15.46 7.84819 
LRP8 AC_000160.1 0 100 2.22E-19 3.30E-18 0.404 27.1152 
ERI3 AC_000160.1 0 100 2.22E-19 3.30E-18 16.469 8.40504 
ERI3 AC_000160.1 0 100 2.22E-19 3.30E-18 16.469 8.40504 
SLC6A9 AC_000160.1 25 100 5.20E-07 2.55E-06 0.4 0.408613 
SLC6A9 AC_000160.1 25 100 5.20E-07 2.55E-06 0.4 0.408613 
PTPRF AC_000160.1 0 83 3.95E-16 4.80E-15 1.055 4.93606 
PTPRF AC_000160.1 11 100 2.69E-11 2.18E-10 1.055 4.93606 
PTPRF AC_000160.1 0 100 2.22E-19 3.30E-18 1.055 4.93606 
PTPRF AC_000160.1 0 100 2.22E-19 3.30E-18 1.055 4.93606 
YBX1 AC_000160.1 100 0 2.22E-19 3.30E-18 167.373 136.83 
SCLY AC_000160.1 0 85 1.66E-16 2.20E-15 5.341 1.3474 
HES6 AC_000160.1 100 20 2.92E-08 1.72E-07 0.019 1.23965 
PPP1R7 AC_000160.1 100 11 2.69E-11 2.18E-10 1.141 49.8063 
THAP4 AC_000160.1 100 9 3.27E-12 2.95E-11 11.392 3.32E-10 
THAP4 AC_000160.1 0 80 1.24E-15 1.32E-14 11.392 3.32E-10 
PDCD1 AC_000160.1 0 100 2.22E-19 3.30E-18 0.018 0.19741 
GRB10 AC_000161.1 0 100 2.22E-19 3.30E-18 1.866 0.612057 
ZPBP AC_000161.1 0 87 7.02E-17 9.70E-16 10.6 139.982 
ASB4 AC_000161.1 100 2 5.84E-17 8.25E-16 0.292 2.29124 
ASB4 AC_000161.1 90 4 1.49E-13 1.47E-12 0.292 2.29124 
ASB4 AC_000161.1 100 10 8.84E-12 7.26E-11 0.292 2.29124 
ASB4 AC_000161.1 83 6 3.47E-11 2.75E-10 0.292 2.29124 
ASB4 AC_000161.1 75 4 5.64E-11 4.44E-10 0.292 2.29124 
ASB4 AC_000161.1 92 18 8.16E-08 4.36E-07 0.292 2.29124 
KIAA1324L AC_000161.1 85 11 3.76E-09 2.48E-08 14.742 26.3772 
KIAA1324L AC_000161.1 80 15 4.06E-07 2.01E-06 14.742 26.3772 
KIAA1324L AC_000161.1 75 17 5.30E-06 2.22E-05 14.742 26.3772 
KIAA1324L AC_000161.1 80 0 1.24E-15 1.32E-14 14.742 26.3772 
LHFPL3 AC_000161.1 77 0 5.26E-15 5.50E-14 88.447 0.712787 
LHFPL3 AC_000161.1 80 12 4.35E-08 2.36E-07 88.447 0.712787 
LHFPL3 AC_000161.1 14 83 8.33E-08 4.44E-07 88.447 0.712787 
LHFPL3 AC_000161.1 76 22 4.90E-05 1.77E-04 88.447 0.712787 
PIK3CG AC_000161.1 100 9 3.27E-12 2.95E-11 0.008 2.34793 
MET AC_000161.1 100 17 4.16E-09 2.74E-08 0.14 3.35075 
MET AC_000161.1 93 15 7.59E-09 4.91E-08 0.14 3.35075 
MET AC_000161.1 80 11 2.08E-08 1.27E-07 0.14 3.35075 
MET AC_000161.1 87 18 3.61E-07 1.80E-06 0.14 3.35075 
HOXA3 AC_000161.1 100 0 2.22E-19 3.30E-18 7.99 0.576763 
GTPBP10 AC_000161.1 0 100 2.22E-19 3.30E-18 36.996 16.8739 
GTPBP10 AC_000161.1 83 0 3.95E-16 4.80E-15 36.996 16.8739 
GTPBP10 AC_000161.1 0 100 2.22E-19 3.30E-18 36.996 16.8739 
ADCY1 AC_000161.1 0 90 1.66E-17 2.40E-16 0.047 2.7462 
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CAMK2B AC_000161.1 0 100 2.22E-19 3.30E-18 0.723 0.127235 
CAMK2B AC_000161.1 0 100 2.22E-19 3.30E-18 0.723 0.127235 
CAMK2B AC_000161.1 12 100 6.45E-11 5.03E-10 0.723 0.127235 
CAMK2B AC_000161.1 0 100 2.22E-19 3.30E-18 0.723 0.127235 
CAMK2B AC_000161.1 0 100 2.22E-19 3.30E-18 0.723 0.127235 
CDK13 AC_000161.1 100 4 2.93E-15 3.09E-14 20.688 15.9006 
CDK13 AC_000161.1 100 8 9.20E-13 8.52E-12 20.688 15.9006 
CDK13 AC_000161.1 80 11 2.08E-08 1.27E-07 20.688 15.9006 
CDK13 AC_000161.1 81 15 2.83E-07 1.43E-06 20.688 15.9006 
CDK13 AC_000161.1 100 4 2.93E-15 3.09E-14 20.688 15.9006 
CDK13 AC_000161.1 100 8 9.20E-13 8.52E-12 20.688 15.9006 
CDK13 AC_000161.1 80 11 2.08E-08 1.27E-07 20.688 15.9006 
CDK13 AC_000161.1 81 15 2.83E-07 1.43E-06 20.688 15.9006 
FLNC AC_000161.1 0 100 2.22E-19 3.30E-18 25.289 0.616482 
SMO AC_000161.1 16 100 1.86E-09 1.25E-08 0.345 4.28726 
COPG2 AC_000161.1 100 0 2.22E-19 3.30E-18 81.719 38.8886 
MKLN1 AC_000161.1 80 20 6.94E-06 2.81E-05 122.779 54.2709 
LRGUK AC_000161.1 83 10 3.22E-09 2.14E-08 2.844 4.2307 
LRGUK AC_000161.1 80 0 1.24E-15 1.32E-14 2.844 4.2307 
LRGUK AC_000161.1 100 16 1.86E-09 1.25E-08 2.844 4.2307 
LRGUK AC_000161.1 100 25 5.20E-07 2.55E-06 2.844 4.2307 
LRGUK AC_000161.1 80 16 7.24E-07 3.49E-06 2.844 4.2307 
LRGUK AC_000161.1 83 20 3.33E-06 1.43E-05 2.844 4.2307 
LRGUK AC_000161.1 85 0 1.66E-16 2.20E-15 2.844 4.2307 
LRGUK AC_000161.1 0 75 1.25E-14 1.28E-13 2.844 4.2307 
LRGUK AC_000161.1 75 0 1.25E-14 1.28E-13 2.844 4.2307 
LRGUK AC_000161.1 77 11 5.04E-08 2.73E-07 2.844 4.2307 
LRGUK AC_000161.1 80 14 1.93E-07 9.80E-07 2.844 4.2307 
LRGUK AC_000161.1 90 20 4.80E-07 2.36E-06 2.844 4.2307 
LRGUK AC_000161.1 75 16 3.16E-06 1.36E-05 2.844 4.2307 
LRGUK AC_000161.1 80 8 1.14E-09 7.86E-09 2.844 4.2307 
LRGUK AC_000161.1 100 19 1.64E-08 1.02E-07 2.844 4.2307 
LRGUK AC_000161.1 77 22 3.69E-05 1.34E-04 2.844 4.2307 
SLC13A4 AC_000161.1 0 100 2.22E-19 3.30E-18 0.01 0.0585892 
UBN2 AC_000161.1 92 10 1.40E-10 1.07E-09 55.015 3.21039 
UBN2 AC_000161.1 77 0 5.26E-15 5.50E-14 55.015 3.21039 
UBN2 AC_000161.1 84 2 4.19E-14 4.26E-13 55.015 3.21039 
UBN2 AC_000161.1 96 10 3.54E-11 2.80E-10 55.015 3.21039 
UBN2 AC_000161.1 76 5 1.27E-10 9.69E-10 55.015 3.21039 
UBN2 AC_000161.1 100 16 1.86E-09 1.25E-08 55.015 3.21039 
UBN2 AC_000161.1 83 21 5.30E-06 2.22E-05 55.015 3.21039 
UBN2 AC_000161.1 80 7 4.23E-10 3.12E-09 55.015 3.21039 
UBN2 AC_000161.1 84 12 1.22E-08 7.78E-08 55.015 3.21039 
UBN2 AC_000161.1 80 12 4.35E-08 2.36E-07 55.015 3.21039 
SSPO AC_000161.1 0 80 1.24E-15 1.32E-14 0.002 6.73901 
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SSPO AC_000161.1 20 100 2.92E-08 1.72E-07 0.002 6.73901 
LRRC61 AC_000161.1 0 100 2.22E-19 3.30E-18 0.447 0.902497 
ASIC3 AC_000161.1 0 100 2.22E-19 3.30E-18 0.247 0.0670749 
CDK5 AC_000161.1 0 80 1.24E-15 1.32E-14 117.235 3.36212 
TMUB1 AC_000161.1 12 100 6.45E-11 5.03E-10 3.563 0.833155 
GALNTL5 AC_000161.1 100 14 3.79E-10 2.81E-09 0.18 0.229288 
SP7 AC_000162.1 0 100 2.22E-19 3.30E-18 0.01 0.0416708 
SPRYD3 AC_000162.1 80 0 1.24E-15 1.32E-14 1.286 10.0505 
NR4A1 AC_000162.1 0 100 2.22E-19 3.30E-18 27.527 59.1168 
ENDOU AC_000162.1 0 80 1.24E-15 1.32E-14 0.548 0.858649 
CD63 AC_000162.1 100 0 2.22E-19 3.30E-18 121.698 43.8496 
ITPR2 AC_000162.1 100 14 3.79E-10 2.81E-09 2.054 0.00624904 
CHD4 AC_000162.1 100 20 2.92E-08 1.72E-07 21.262 32.8897 
TNFRSF1A AC_000162.1 80 0 1.24E-15 1.32E-14 0.315 15.1137 
TNFRSF1A AC_000162.1 0 100 2.22E-19 3.30E-18 0.315 15.1137 
SCNN1A AC_000162.1 80 0 1.24E-15 1.32E-14 4.3 1.35987 
TSPAN11 AC_000162.1 0 100 2.22E-19 3.30E-18 0.029 0.189952 
DCP1B AC_000162.1 25 100 5.20E-07 2.55E-06 0.063 13.4787 
3-Sep AC_000162.1 0 100 2.22E-19 3.30E-18 18.311 6.71972 
PARVB AC_000162.1 0 100 2.22E-19 3.30E-18 0.016 0.260424 
PARVB AC_000162.1 0 85 1.66E-16 2.20E-15 0.016 0.260424 
PARVB AC_000162.1 0 83 3.95E-16 4.80E-15 0.016 0.260424 
PARVB AC_000162.1 0 100 2.22E-19 3.30E-18 0.016 0.260424 
TTC38 AC_000162.1 0 100 2.22E-19 3.30E-18 0.036 1.79398 
TBC1D22A AC_000162.1 0 100 2.22E-19 3.30E-18 0.875 8.54892 
TBC1D22A AC_000162.1 0 100 2.22E-19 3.30E-18 0.875 8.54892 
TBC1D22A AC_000162.1 0 100 2.22E-19 3.30E-18 0.875 8.54892 
HDAC10 AC_000162.1 0 100 2.22E-19 3.30E-18 3.22 3.73E-07 
MAPK12 AC_000162.1 0 87 7.02E-17 9.70E-16 0.075 0.340854 
MAPK12 AC_000162.1 0 85 1.66E-16 2.20E-15 0.075 0.340854 
PDE5A AC_000163.1 100 13 1.74E-10 1.32E-09 20.575 14.8399 
PDE5A AC_000163.1 12 80 4.35E-08 2.36E-07 20.575 14.8399 
PDE5A AC_000163.1 83 20 3.33E-06 1.43E-05 20.575 14.8399 
PDE5A AC_000163.1 25 79 8.51E-05 2.97E-04 20.575 14.8399 
PDE5A AC_000163.1 80 7 4.23E-10 3.12E-09 20.575 14.8399 
PDE5A AC_000163.1 90 15 1.78E-08 1.10E-07 20.575 14.8399 
PDE5A AC_000163.1 90 22 1.43E-06 6.46E-06 20.575 14.8399 
PDE5A AC_000163.1 83 8 4.40E-10 3.24E-09 20.575 14.8399 
NFKB1 AC_000163.1 80 0 1.24E-15 1.32E-14 5.368 2.82109 
NFKB1 AC_000163.1 83 3 4.30E-13 4.19E-12 5.368 2.82109 
NFKB1 AC_000163.1 83 25 3.36E-05 1.23E-04 5.368 2.82109 
ADAMTS3 AC_000163.1 81 0 9.35E-16 1.13E-14 0.48 0.815374 
ADAMTS3 AC_000163.1 100 13 1.74E-10 1.32E-09 0.48 0.815374 
ADAMTS3 AC_000163.1 93 13 1.56E-09 1.07E-08 0.48 0.815374 
ADAMTS3 AC_000163.1 87 11 1.94E-09 1.31E-08 0.48 0.815374 
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ADAMTS3 AC_000163.1 75 8 7.09E-09 4.60E-08 0.48 0.815374 
ADAMTS3 AC_000163.1 85 13 1.98E-08 1.21E-07 0.48 0.815374 
ADAMTS3 AC_000163.1 90 20 4.80E-07 2.36E-06 0.48 0.815374 
ADAMTS3 AC_000163.1 100 0 2.22E-19 3.30E-18 0.48 0.815374 
ADAMTS3 AC_000163.1 83 0 3.95E-16 4.80E-15 0.48 0.815374 
ADAMTS3 AC_000163.1 76 2 1.10E-12 1.02E-11 0.48 0.815374 
ADAMTS3 AC_000163.1 87 7 3.08E-11 2.44E-10 0.48 0.815374 
ADAMTS3 AC_000163.1 80 7 3.48E-10 2.61E-09 0.48 0.815374 
ADAMTS3 AC_000163.1 94 12 4.73E-10 3.48E-09 0.48 0.815374 
ADAMTS3 AC_000163.1 100 16 1.86E-09 1.25E-08 0.48 0.815374 
ADAMTS3 AC_000163.1 87 15 4.73E-08 2.57E-07 0.48 0.815374 
ADAMTS3 AC_000163.1 77 11 5.04E-08 2.73E-07 0.48 0.815374 
ADAMTS3 AC_000163.1 76 13 2.97E-07 1.49E-06 0.48 0.815374 
ADAMTS3 AC_000163.1 82 16 4.07E-07 2.02E-06 0.48 0.815374 
ADAMTS3 AC_000163.1 100 25 5.20E-07 2.55E-06 0.48 0.815374 
ADAMTS3 AC_000163.1 75 16 3.16E-06 1.36E-05 0.48 0.815374 
ADAMTS3 AC_000163.1 80 6 1.16E-10 8.91E-10 0.48 0.815374 
SH3BP2 AC_000163.1 0 100 2.22E-19 3.30E-18 0.027 1.04775 
TNIP2 AC_000163.1 0 100 2.22E-19 3.30E-18 1.456 0.0316418 
TNIP2 AC_000163.1 0 100 2.22E-19 3.30E-18 1.456 0.0316418 
TNIP2 AC_000163.1 0 100 2.22E-19 3.30E-18 1.456 0.0316418 
PCGF3 AC_000163.1 0 100 2.22E-19 3.30E-18 18.068 4.38092 
GAK AC_000163.1 0 100 2.22E-19 3.30E-18 5.639 47.1206 
CD38 AC_000163.1 100 0 2.22E-19 3.30E-18 0.024 0.885186 
ADAMTS2 AC_000164.1 0 100 2.22E-19 3.30E-18 0.317 1.22682 
EPS15L1 AC_000164.1 0 100 2.22E-19 3.30E-18 80.258 1.85987 
KANK2 AC_000164.1 0 100 2.22E-19 3.30E-18 1.231 2.5804 
ACP5 AC_000164.1 0 100 2.22E-19 3.30E-18 0.11 4.61674 
LRRC8E AC_000164.1 0 100 2.22E-19 3.30E-18 12.207 0.158038 
VAV1 AC_000164.1 0 80 1.24E-15 1.32E-14 0.209 5.27356 
C3 AC_000164.1 0 100 2.22E-19 3.30E-18 0.049 1.40461 
C3 AC_000164.1 0 100 2.22E-19 3.30E-18 0.049 1.40461 
GNA15 AC_000164.1 0 100 2.22E-19 3.30E-18 0.135 0.126829 
SLC12A2 AC_000164.1 100 0 2.22E-19 3.30E-18 22.906 23.0761 
CLTB AC_000164.1 0 100 2.22E-19 3.30E-18 4.821 1.73103 
DBN1 AC_000164.1 100 0 2.22E-19 3.30E-18 5.413 15.3577 
C7H19orf24 AC_000164.1 100 0 2.22E-19 3.30E-18 4.371 1.72247 
CTNNA1 AC_000164.1 85 17 3.24E-07 1.62E-06 282.447 29.6623 
CTNNA1 AC_000164.1 80 20 6.94E-06 2.81E-05 282.447 29.6623 
PCDH1 AC_000164.1 0 100 2.22E-19 3.30E-18 2.623 1.2975 
GRIA1 AC_000164.1 81 22 1.37E-05 5.36E-05 0.245 0.551824 
GLRX AC_000164.1 0 80 1.24E-15 1.32E-14 53.395 4.6074 
UHRF2 AC_000165.1 80 5 3.50E-11 2.77E-10 405.262 6.3504 
UHRF2 AC_000165.1 83 12 1.81E-08 1.11E-07 405.262 6.3504 
HR AC_000165.1 0 100 2.22E-19 3.30E-18 0.059 0.110229 
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HR AC_000165.1 0 85 1.66E-16 2.20E-15 0.059 0.110229 
PDLIM2 AC_000165.1 14 100 3.79E-10 2.81E-09 24.276 1.36257 
RHOBTB2 AC_000165.1 16 100 1.86E-09 1.25E-08 0.079 1.10532 
RHOBTB2 AC_000165.1 0 100 2.22E-19 3.30E-18 0.079 1.10532 
CHMP7 AC_000165.1 25 92 3.96E-06 1.69E-05 26.863 22.6218 
SEMA4D AC_000165.1 100 0 2.22E-19 3.30E-18 4.448 1.15805 
TMEM246 AC_000165.1 86 20 1.42E-06 6.42E-06 0.276 0.61765 
COL27A1 AC_000165.1 0 100 2.22E-19 3.30E-18 0.064 1.08769 
COL27A1 AC_000165.1 0 100 2.22E-19 3.30E-18 0.064 1.08769 
TNC AC_000165.1 100 20 2.92E-08 1.72E-07 0.397 9.43E-06 
GSN AC_000165.1 0 100 2.22E-19 3.30E-18 0.032 26.6831 
GSN AC_000165.1 0 100 2.22E-19 3.30E-18 0.032 26.6831 
GSN AC_000165.1 5 100 1.69E-14 1.73E-13 0.032 26.6831 
GSN AC_000165.1 0 100 2.22E-19 3.30E-18 0.032 26.6831 
GSN AC_000165.1 5 100 1.69E-14 1.73E-13 0.032 26.6831 
ASCC3 AC_000166.1 100 14 3.79E-10 2.81E-09 31.562 6.19346 
ASCC3 AC_000166.1 87 21 1.86E-06 8.35E-06 31.562 6.19346 
ASCC3 AC_000166.1 83 24 2.27E-05 8.60E-05 31.562 6.19346 
ASCC3 AC_000166.1 100 17 4.16E-09 2.74E-08 31.562 6.19346 
MAP3K5 AC_000166.1 0 100 2.22E-19 3.30E-18 0.694 3.75012 
MAP3K5 AC_000166.1 0 100 2.22E-19 3.30E-18 0.694 3.75012 
UTRN AC_000166.1 0 83 3.95E-16 4.80E-15 15.018 6.83952 
AGPAT4 AC_000166.1 0 100 2.22E-19 3.30E-18 0.047 0.391436 
RPS6KA2 AC_000166.1 0 87 7.02E-17 9.70E-16 0.203 1.24944 
RPS6KA2 AC_000166.1 0 100 2.22E-19 3.30E-18 0.203 1.24944 
RPS6KA2 AC_000166.1 0 100 2.22E-19 3.30E-18 0.203 1.24944 
RPS6KA2 AC_000166.1 0 100 2.22E-19 3.30E-18 0.203 1.24944 
RPS6KA2 AC_000166.1 0 83 3.95E-16 4.80E-15 0.203 1.24944 
RPS6KA2 AC_000166.1 0 100 2.22E-19 3.30E-18 0.203 1.24944 
RPS6KA2 AC_000166.1 3 77 4.67E-12 4.20E-11 0.203 1.24944 
RPS6KA2 AC_000166.1 0 100 2.22E-19 3.30E-18 0.203 1.24944 
THBS2 AC_000166.1 0 100 2.22E-19 3.30E-18 0.046 1.91925 
THBS2 AC_000166.1 0 100 2.22E-19 3.30E-18 0.046 1.91925 
THBS2 AC_000166.1 0 100 2.22E-19 3.30E-18 0.046 1.91925 
THBS2 AC_000166.1 100 0 2.22E-19 3.30E-18 0.046 1.91925 
THBS2 AC_000166.1 0 100 2.22E-19 3.30E-18 0.046 1.91925 
THBS2 AC_000166.1 20 100 2.92E-08 1.72E-07 0.046 1.91925 
THBS2 AC_000166.1 0 100 2.22E-19 3.30E-18 0.046 1.91925 
ZNF75D AC_000187.1 81 4 5.58E-12 5.00E-11 109.846 66.9043 
ZNF75D AC_000187.1 14 100 3.79E-10 2.81E-09 109.846 66.9043 
ZNF75D AC_000187.1 0 100 2.22E-19 3.30E-18 109.846 66.9043 
ZNF75D AC_000187.1 7 100 2.90E-13 2.83E-12 109.846 66.9043 
FLNA AC_000187.1 0 100 2.22E-19 3.30E-18 0.091 2.68062 
ARMCX3 AC_000187.1 100 0 2.22E-19 3.30E-18 0.119 22.8209 
MAGED4B AC_000187.1 0 80 1.24E-15 1.32E-14 0.253 28.9642 
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MSN AC_000187.1 77 9 8.67E-09 5.57E-08 42.143 9.52565 
MSN AC_000187.1 81 12 2.94E-08 1.73E-07 42.143 9.52565 
MSN AC_000187.1 81 16 5.78E-07 2.83E-06 42.143 9.52565 
MOSPD2 AC_000187.1 16 85 1.60E-07 8.31E-07 23.626 6.82811 
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Table S7.2 Gene expression for DMRs between sperm vs. in vivo MII 
Gene expression in DMRs from in vivo MII vs. Sperm     
Gene Chr In vivo MII_me Sperm_me p-value q-value In vivo MII expression Spmer expression 
KCNJ15 AC_000158.1 0 100 2.22E-19 4.69E-18 0.053 0.289892 
DNAJC17 AC_000167.1 0 83 3.95E-16 6.84E-15 50.793 3.12752 
ITPKA AC_000167.1 100 0 2.22E-19 4.69E-18 0.015 1.33639 
DYSF AC_000168.1 83 7 1.31E-10 1.29E-09 0.004 2.59209 
CAMKMT AC_000168.1 100 5 1.69E-14 2.45E-13 0.25 13.4428 
OSR1 AC_000168.1 0 100 2.22E-19 4.69E-18 0.157 3.88409 
OSR1 AC_000168.1 0 100 2.22E-19 4.69E-18 0.157 3.88409 
NAIF1 AC_000168.1 0 100 2.22E-19 4.69E-18 0.538 0.59891 
ASS1 AC_000168.1 0 100 2.22E-19 4.69E-18 0.739 2.18424 
ASS1 AC_000168.1 0 100 2.22E-19 4.69E-18 0.739 2.18424 
ASS1 AC_000168.1 0 100 2.22E-19 4.69E-18 0.739 2.18424 
INPP5E AC_000168.1 0 100 2.22E-19 4.69E-18 0.252 8.13702 
INPP5E AC_000168.1 0 100 2.22E-19 4.69E-18 0.252 8.13702 
TPT1 AC_000169.1 100 0 2.22E-19 4.69E-18 201.573 216.619 
RNF6 AC_000169.1 100 20 2.92E-08 2.12E-07 2.473 106.775 
DOCK9 AC_000169.1 80 11 2.08E-08 1.55E-07 11.036 5.15748 
RAB20 AC_000169.1 0 100 2.22E-19 4.69E-18 0.142 0.975288 
TFDP1 AC_000169.1 20 92 2.77E-07 1.65E-06 8.96 7.1083 
RASA3 AC_000169.1 0 100 2.22E-19 4.69E-18 0.565 1.43627 
RASA3 AC_000169.1 0 100 2.22E-19 4.69E-18 0.565 1.43627 
RASA3 AC_000169.1 0 100 2.22E-19 4.69E-18 0.565 1.43627 
RASA3 AC_000169.1 0 85 1.66E-16 3.11E-15 0.565 1.43627 
PLCB1 AC_000170.1 75 10 4.51E-08 2.95E-07 0.06 1.56312 
PLCB1 AC_000170.1 91 2 2.71E-15 4.07E-14 0.06 1.56312 
PLCB1 AC_000170.1 88 21 1.50E-06 7.92E-06 0.06 1.56312 
PFKP AC_000170.1 0 100 2.22E-19 4.69E-18 0.048 30.7787 
RBM38 AC_000170.1 0 100 2.22E-19 4.69E-18 102.274 3.80514 
CHMP4B AC_000170.1 80 5 3.50E-11 3.63E-10 8.831 17.6036 
PPP1R16B AC_000170.1 0 100 2.22E-19 4.69E-18 0.004 1.50396 
KCNB1 AC_000170.1 0 100 2.22E-19 4.69E-18 0.022 0.595133 
NRBP2 AC_000171.1 0 100 2.22E-19 4.69E-18 0.205 0.416031 
VAMP2 AC_000171.1 0 100 2.22E-19 4.69E-18 0.552 5.04003 
ASAP1 AC_000171.1 20 95 1.27E-07 8.00E-07 6.048 4.84221 
CPQ AC_000171.1 0 100 2.22E-19 4.69E-18 0.857 65.1425 
  170 
CPQ AC_000171.1 0 100 2.22E-19 4.69E-18 0.857 65.1425 
NCAM1 AC_000172.1 0 100 2.22E-19 4.69E-18 0.014 7.27085 
NCAM1 AC_000172.1 0 100 2.22E-19 4.69E-18 0.014 7.27085 
PHLDB1 AC_000172.1 100 0 2.22E-19 4.69E-18 0.203 2.4146 
BCL9L AC_000172.1 0 100 2.22E-19 4.69E-18 0.078 2.06981 
APBB1 AC_000172.1 0 100 2.22E-19 4.69E-18 0.036 2.96761 
ARHGEF17 AC_000172.1 0 83 3.95E-16 6.84E-15 0.029 2.78951 
SLCO2B1 AC_000172.1 0 100 2.22E-19 4.69E-18 0.014 2.77052 
CAPN5 AC_000172.1 0 100 2.22E-19 4.69E-18 0.013 2.56793 
EXT2 AC_000172.1 0 80 1.24E-15 1.87E-14 48.201 9.74457 
IKBKE AC_000173.1 14 92 4.81E-09 3.93E-08 0.036 0.151946 
RGL1 AC_000173.1 76 22 4.90E-05 1.99E-04 5.433 32.4076 
LAMB3 AC_000173.1 100 0 2.22E-19 4.69E-18 0.007 0.36457 
AP1B1 AC_000174.1 0 100 2.22E-19 4.69E-18 2.302 31.4239 
OSBP2 AC_000174.1 0 80 1.24E-15 1.87E-14 0.035 14.0231 
OSBP2 AC_000174.1 0 100 2.22E-19 4.69E-18 0.035 14.0231 
OSBP2 AC_000174.1 0 100 2.22E-19 4.69E-18 0.035 14.0231 
SMTN AC_000174.1 0 100 2.22E-19 4.69E-18 0.011 3.96868 
SMTN AC_000174.1 0 80 1.24E-15 1.87E-14 0.011 3.96868 
GNB1L AC_000174.1 0 100 2.22E-19 4.69E-18 0.027 0.53128 
ZNF423 AC_000175.1 0 75 1.25E-14 1.81E-13 0.225 1.49701 
ZNF423 AC_000175.1 0 100 2.22E-19 4.69E-18 0.225 1.49701 
ZNF423 AC_000175.1 0 100 2.22E-19 4.69E-18 0.225 1.49701 
ZNF423 AC_000175.1 0 100 2.22E-19 4.69E-18 0.225 1.49701 
LIPE AC_000175.1 0 80 1.24E-15 1.87E-14 11.61 8.02781 
IRGQ AC_000175.1 100 0 2.22E-19 4.69E-18 0.214 1.15819 
TRAPPC6A AC_000175.1 0 80 1.24E-15 1.87E-14 0.017 0.966851 
KLC3 AC_000175.1 14 90 8.99E-09 7.07E-08 0.15 0.6625 
IGLON5 AC_000175.1 0 85 1.66E-16 3.11E-15 0.078 14.9143 
TTYH1 AC_000175.1 0 83 3.95E-16 6.84E-15 0.017 53.4688 
TTYH1 AC_000175.1 0 100 2.22E-19 4.69E-18 0.017 53.4688 
ZIM2 AC_000175.1 80 0 1.24E-15 1.87E-14 9.323 0.068638 
IGF2BP1 AC_000176.1 0 100 2.22E-19 4.69E-18 0.137 1.60696 
COPZ2 AC_000176.1 0 100 2.22E-19 4.69E-18 0.879 3.59874 
COPZ2 AC_000176.1 0 100 2.22E-19 4.69E-18 0.879 3.59874 
RPL19 AC_000176.1 80 0 1.24E-15 1.87E-14 27.609 133.855 
FBXL20 AC_000176.1 100 16 1.86E-09 1.56E-08 52.768 6.7384 
FBXL20 AC_000176.1 100 10 8.84E-12 9.63E-11 52.768 6.7384 
ITGA2B AC_000176.1 16 100 1.86E-09 1.56E-08 0.052 0.65249 
MRC2 AC_000176.1 0 87 7.02E-17 1.38E-15 0.04 0.917673 
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RBFOX3 AC_000176.1 0 83 3.95E-16 6.84E-15 0.664 0.0541617 
RAB37 AC_000176.1 0 100 2.22E-19 4.69E-18 0.14 0.531397 
RAB37 AC_000176.1 100 11 2.69E-11 2.88E-10 0.14 0.531397 
RAB37 AC_000176.1 80 6 1.16E-10 1.15E-09 0.14 0.531397 
RAB37 AC_000176.1 20 87 1.14E-06 6.08E-06 0.14 0.531397 
SLC39A11 AC_000176.1 0 100 2.22E-19 4.69E-18 2.317 10.2451 
SLC39A11 AC_000176.1 0 100 2.22E-19 4.69E-18 2.317 10.2451 
SLC39A11 AC_000176.1 0 80 1.24E-15 1.87E-14 2.317 10.2451 
AXIN2 AC_000176.1 0 100 2.22E-19 4.69E-18 2.758 0.321127 
FAM168B AC_000159.1 0 100 2.22E-19 4.69E-18 34.317 15.9093 
AGPS AC_000159.1 100 0 2.22E-19 4.69E-18 71.586 20.5211 
CERS6 AC_000159.1 75 15 1.62E-06 8.53E-06 0.031 2.91735 
TMEM177 AC_000159.1 0 100 2.22E-19 4.69E-18 0.039 1.3049 
INO80D AC_000159.1 16 83 2.86E-07 1.71E-06 2.769 1.99658 
UNC80 AC_000159.1 90 22 1.43E-06 7.53E-06 0.064 1.09951 
SPEG AC_000159.1 100 20 2.92E-08 2.12E-07 4.833 0.286045 
OBSL1 AC_000159.1 0 100 2.22E-19 4.69E-18 0.014 1.48814 
PHC2 AC_000159.1 0 100 2.22E-19 4.69E-18 8.287 29.4464 
TRIM62 AC_000159.1 100 0 2.22E-19 4.69E-18 0.037 1.09498 
EPHB2 AC_000159.1 0 83 3.95E-16 6.84E-15 0.22 0.528627 
ALPL AC_000159.1 100 0 2.22E-19 4.69E-18 0.059 1.66984 
PADI4 AC_000159.1 0 100 2.22E-19 4.69E-18 0.022 0.107179 
PADI4 AC_000159.1 0 100 2.22E-19 4.69E-18 0.022 0.107179 
PADI4 AC_000159.1 0 100 2.22E-19 4.69E-18 0.022 0.107179 
SLC38A9 AC_000177.1 80 4 7.32E-12 8.01E-11 10.109 12.0679 
MRPS11 AC_000178.1 100 15 9.23E-10 8.02E-09 1.443 1.91452 
MRPS11 AC_000178.1 100 23 1.80E-07 1.10E-06 1.443 1.91452 
MRPS11 AC_000178.1 87 21 1.86E-06 9.75E-06 1.443 1.91452 
ARNT2 AC_000178.1 0 83 3.95E-16 6.84E-15 0.972 2.29686 
FRMD5 AC_000178.1 100 6 6.67E-14 9.52E-13 3.842 0.203298 
FRMD5 AC_000178.1 80 12 4.35E-08 2.85E-07 3.842 0.203298 
FRMD5 AC_000178.1 75 23 9.52E-05 3.61E-04 3.842 0.203298 
FRMD5 AC_000178.1 80 0 1.24E-15 1.87E-14 3.842 0.203298 
FRMD5 AC_000178.1 83 16 3.25E-07 1.92E-06 3.842 0.203298 
FRMD5 AC_000178.1 83 14 8.33E-08 5.33E-07 3.842 0.203298 
BEGAIN AC_000178.1 20 91 3.85E-07 2.27E-06 0.046 0.239427 
AMN AC_000178.1 80 25 7.02E-05 2.74E-04 0.036 0.179502 
C21H14orf180 AC_000178.1 0 100 2.22E-19 4.69E-18 0.011 0.0973423 
C21H14orf180 AC_000178.1 0 100 2.22E-19 4.69E-18 0.011 0.0973423 
C21H14orf180 AC_000178.1 0 94 2.96E-18 6.21E-17 0.011 0.0973423 
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SLC4A7 AC_000179.1 80 23 3.02E-05 1.25E-04 11.245 12.9901 
SCN5A AC_000179.1 0 83 3.95E-16 6.84E-15 0.75 0.949517 
SCN5A AC_000179.1 0 100 2.22E-19 4.69E-18 0.75 0.949517 
BRPF1 AC_000179.1 0 100 2.22E-19 4.69E-18 1.437 2.63067 
SUMF1 AC_000179.1 16 100 1.86E-09 1.56E-08 7.417 11.0717 
SYNPR AC_000179.1 100 20 2.92E-08 2.12E-07 3.006 0.493366 
SYNPR AC_000179.1 87 21 1.86E-06 9.75E-06 3.006 0.493366 
ERC2 AC_000179.1 75 16 3.16E-06 1.58E-05 1.022 0.399069 
DUSP7 AC_000179.1 80 0 1.24E-15 1.87E-14 15.385 1.07444 
QRICH1 AC_000179.1 0 100 2.22E-19 4.69E-18 14.186 20.7372 
NUP210 AC_000179.1 0 100 2.22E-19 4.69E-18 0.161 2.69E-06 
NUP210 AC_000179.1 0 100 2.22E-19 4.69E-18 0.161 2.69E-06 
EEFSEC AC_000179.1 0 100 2.22E-19 4.69E-18 0.028 3.16696 
MGLL AC_000179.1 0 100 2.22E-19 4.69E-18 0.045 4.96885 
MGLL AC_000179.1 0 100 2.22E-19 4.69E-18 0.045 4.96885 
MGLL AC_000179.1 0 100 2.22E-19 4.69E-18 0.045 4.96885 
MGLL AC_000179.1 0 100 2.22E-19 4.69E-18 0.045 4.96885 
MGLL AC_000179.1 0 100 2.22E-19 4.69E-18 0.045 4.96885 
MGLL AC_000179.1 0 100 2.22E-19 4.69E-18 0.045 4.96885 
MGLL AC_000179.1 0 83 3.95E-16 6.84E-15 0.045 4.96885 
NRM AC_000180.1 0 100 2.22E-19 4.69E-18 0.581 0.0629649 
ATP9B AC_000181.1 0 83 3.95E-16 6.84E-15 0.513 20.9405 
FHOD3 AC_000181.1 100 14 3.79E-10 3.60E-09 6.035 3.32774 
BCL2 AC_000181.1 83 16 2.86E-07 1.71E-06 0.091 2.29554 
RHBDF1 AC_000182.1 0 100 2.22E-19 4.69E-18 0.628 1.15272 
RABEP2 AC_000182.1 100 0 2.22E-19 4.69E-18 1.15 3.18206 
ATXN2L AC_000182.1 0 80 1.24E-15 1.87E-14 14.898 142.313 
YPEL3 AC_000182.1 0 100 2.22E-19 4.69E-18 10.012 12.0849 
TBC1D10B AC_000182.1 0 100 2.22E-19 4.69E-18 0.371 9.56179 
ELN AC_000182.1 0 100 2.22E-19 4.69E-18 5.444 89.7002 
TRIM50 AC_000182.1 0 100 2.22E-19 4.69E-18 0.231 0.36161 
EPHB4 AC_000182.1 0 100 2.22E-19 4.69E-18 0.2 2.07076 
SLC29A4 AC_000182.1 100 14 3.79E-10 3.60E-09 0.407 0.192267 
MAD1L1 AC_000182.1 20 100 2.92E-08 2.12E-07 0.132 2.44948 
INTS1 AC_000182.1 100 0 2.22E-19 4.69E-18 0.031 16.9102 
C25H7orf50 AC_000182.1 0 83 3.95E-16 6.84E-15 1.179 3.55481 
GPR146 AC_000182.1 0 83 3.95E-16 6.84E-15 1.013 1.0669 
PRKG1 AC_000183.1 87 7 3.08E-11 3.21E-10 34.973 2.01529 
MYOF AC_000183.1 100 9 3.27E-12 3.99E-11 0.805 12.114 
SUFU AC_000183.1 0 87 7.02E-17 1.38E-15 1.731 3.82115 
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SUFU AC_000183.1 0 100 2.22E-19 4.69E-18 1.731 3.82115 
SORCS3 AC_000183.1 0 100 2.22E-19 4.69E-18 2.896 20.632 
SORCS3 AC_000183.1 0 100 2.22E-19 4.69E-18 2.896 20.632 
SORCS3 AC_000183.1 0 100 2.22E-19 4.69E-18 2.896 20.632 
SORCS3 AC_000183.1 100 0 2.22E-19 4.69E-18 2.896 20.632 
SORCS3 AC_000183.1 100 12 6.45E-11 6.57E-10 2.896 20.632 
SORCS3 AC_000183.1 0 100 2.22E-19 4.69E-18 2.896 20.632 
HTRA1 AC_000183.1 0 100 2.22E-19 4.69E-18 0.013 34.0764 
WRN AC_000184.1 85 0 1.66E-16 3.11E-15 1.63 8.79611 
WRN AC_000184.1 80 0 1.24E-15 1.87E-14 1.63 8.79611 
WRN AC_000184.1 75 0 1.25E-14 1.81E-13 1.63 8.79611 
WRN AC_000184.1 100 5 1.69E-14 2.45E-13 1.63 8.79611 
WRN AC_000184.1 100 15 9.23E-10 8.02E-09 1.63 8.79611 
WRN AC_000184.1 100 18 7.85E-09 6.23E-08 1.63 8.79611 
WRN AC_000184.1 80 10 8.02E-09 6.31E-08 1.63 8.79611 
WRN AC_000184.1 100 0 2.22E-19 4.69E-18 1.63 8.79611 
WRN AC_000184.1 90 0 1.66E-17 3.40E-16 1.63 8.79611 
WRN AC_000184.1 88 0 3.94E-17 7.96E-16 1.63 8.79611 
WRN AC_000184.1 85 0 1.66E-16 3.11E-15 1.63 8.79611 
WRN AC_000184.1 80 0 1.24E-15 1.87E-14 1.63 8.79611 
WRN AC_000184.1 100 4 2.93E-15 4.38E-14 1.63 8.79611 
WRN AC_000184.1 76 0 6.99E-15 1.04E-13 1.63 8.79611 
WRN AC_000184.1 80 3 1.61E-12 2.01E-11 1.63 8.79611 
WRN AC_000184.1 94 17 2.51E-08 1.86E-07 1.63 8.79611 
WRN AC_000184.1 88 18 2.56E-07 1.53E-06 1.63 8.79611 
WRN AC_000184.1 100 0 2.22E-19 4.69E-18 1.63 8.79611 
WRN AC_000184.1 100 0 2.22E-19 4.69E-18 1.63 8.79611 
WRN AC_000184.1 93 0 5.27E-18 1.10E-16 1.63 8.79611 
WRN AC_000184.1 83 3 4.30E-13 5.86E-12 1.63 8.79611 
WRN AC_000184.1 96 12 2.44E-10 2.37E-09 1.63 8.79611 
WRN AC_000184.1 95 13 8.16E-10 7.14E-09 1.63 8.79611 
WRN AC_000184.1 88 13 7.12E-09 5.68E-08 1.63 8.79611 
WRN AC_000184.1 83 12 1.81E-08 1.36E-07 1.63 8.79611 
WRN AC_000184.1 100 20 2.92E-08 2.12E-07 1.63 8.79611 
WRN AC_000184.1 90 19 2.83E-07 1.69E-06 1.63 8.79611 
WRN AC_000184.1 100 25 5.20E-07 2.99E-06 1.63 8.79611 
WRN AC_000184.1 97 0 9.38E-19 1.97E-17 1.63 8.79611 
WRN AC_000184.1 95 3 3.52E-15 5.26E-14 1.63 8.79611 
WRN AC_000184.1 100 5 1.69E-14 2.45E-13 1.63 8.79611 
WRN AC_000184.1 97 7 7.91E-13 1.01E-11 1.63 8.79611 
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WRN AC_000184.1 88 7 1.93E-11 2.08E-10 1.63 8.79611 
WRN AC_000184.1 86 12 6.41E-09 5.18E-08 1.63 8.79611 
WRN AC_000184.1 100 20 2.92E-08 2.12E-07 1.63 8.79611 
WRN AC_000184.1 85 16 1.81E-07 1.10E-06 1.63 8.79611 
RNF122 AC_000184.1 0 83 3.95E-16 6.84E-15 2.269 10.1717 
RNF122 AC_000184.1 75 14 9.09E-07 4.97E-06 2.269 10.1717 
RNF122 AC_000184.1 88 22 2.41E-06 1.24E-05 2.269 10.1717 
RNF122 AC_000184.1 83 5 1.01E-11 1.10E-10 2.269 10.1717 
RNF122 AC_000184.1 87 11 1.94E-09 1.63E-08 2.269 10.1717 
RNF122 AC_000184.1 100 0 2.22E-19 4.69E-18 2.269 10.1717 
RNF122 AC_000184.1 80 5 3.50E-11 3.63E-10 2.269 10.1717 
RNF122 AC_000184.1 14 100 3.79E-10 3.60E-09 2.269 10.1717 
RNF122 AC_000184.1 88 25 9.72E-06 4.45E-05 2.269 10.1717 
RNF122 AC_000184.1 83 12 1.81E-08 1.36E-07 2.269 10.1717 
RNF122 AC_000184.1 20 87 1.14E-06 6.08E-06 2.269 10.1717 
RNF122 AC_000184.1 100 14 3.79E-10 3.60E-09 2.269 10.1717 
RNF122 AC_000184.1 0 87 7.02E-17 1.38E-15 2.269 10.1717 
RNF122 AC_000184.1 80 0 1.24E-15 1.87E-14 2.269 10.1717 
RNF122 AC_000184.1 80 0 1.24E-15 1.87E-14 2.269 10.1717 
RNF122 AC_000184.1 80 10 8.02E-09 6.31E-08 2.269 10.1717 
RNF122 AC_000184.1 11 80 2.08E-08 1.55E-07 2.269 10.1717 
RNF122 AC_000184.1 100 22 9.72E-08 6.15E-07 2.269 10.1717 
RNF122 AC_000184.1 20 80 6.94E-06 3.22E-05 2.269 10.1717 
RNF122 AC_000184.1 100 25 5.20E-07 2.99E-06 2.269 10.1717 
RNF122 AC_000184.1 80 18 2.38E-06 1.22E-05 2.269 10.1717 
RNF122 AC_000184.1 80 18 2.38E-06 1.22E-05 2.269 10.1717 
RNF122 AC_000184.1 83 13 3.69E-08 2.57E-07 2.269 10.1717 
RNF122 AC_000184.1 83 10 2.71E-09 2.26E-08 2.269 10.1717 
RNF122 AC_000184.1 85 20 1.96E-06 1.02E-05 2.269 10.1717 
RNF122 AC_000184.1 100 10 8.84E-12 9.63E-11 2.269 10.1717 
RNF122 AC_000184.1 16 100 1.86E-09 1.56E-08 2.269 10.1717 
RNF122 AC_000184.1 83 20 3.33E-06 1.65E-05 2.269 10.1717 
RNF122 AC_000184.1 100 8 9.20E-13 1.16E-11 2.269 10.1717 
RNF122 AC_000184.1 75 16 3.16E-06 1.58E-05 2.269 10.1717 
RNF122 AC_000184.1 80 8 1.14E-09 9.88E-09 2.269 10.1717 
RNF122 AC_000184.1 80 20 6.94E-06 3.22E-05 2.269 10.1717 
RNF122 AC_000184.1 10 85 1.65E-09 1.41E-08 2.269 10.1717 
RNF122 AC_000184.1 80 10 8.02E-09 6.31E-08 2.269 10.1717 
RNF122 AC_000184.1 20 78 1.17E-05 5.25E-05 2.269 10.1717 
RNF122 AC_000184.1 100 12 6.45E-11 6.57E-10 2.269 10.1717 
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RNF122 AC_000184.1 83 14 8.33E-08 5.33E-07 2.269 10.1717 
RNF122 AC_000184.1 80 14 1.93E-07 1.16E-06 2.269 10.1717 
RNF122 AC_000184.1 90 11 7.82E-10 6.86E-09 2.269 10.1717 
RNF122 AC_000184.1 100 16 1.86E-09 1.56E-08 2.269 10.1717 
RNF122 AC_000184.1 85 22 5.47E-06 2.64E-05 2.269 10.1717 
RNF122 AC_000184.1 100 0 2.22E-19 4.69E-18 2.269 10.1717 
RNF122 AC_000184.1 80 4 7.32E-12 8.01E-11 2.269 10.1717 
RNF122 AC_000184.1 84 16 2.28E-07 1.37E-06 2.269 10.1717 
RNF122 AC_000184.1 0 84 2.22E-16 4.13E-15 2.269 10.1717 
RNF122 AC_000184.1 80 0 1.24E-15 1.87E-14 2.269 10.1717 
RNF122 AC_000184.1 75 0 1.25E-14 1.81E-13 2.269 10.1717 
RNF122 AC_000184.1 100 0 2.22E-19 4.69E-18 2.269 10.1717 
RNF122 AC_000184.1 100 0 2.22E-19 4.69E-18 2.269 10.1717 
RNF122 AC_000184.1 90 0 1.66E-17 3.40E-16 2.269 10.1717 
RNF122 AC_000184.1 90 0 1.66E-17 3.40E-16 2.269 10.1717 
RNF122 AC_000184.1 100 8 9.20E-13 1.16E-11 2.269 10.1717 
RNF122 AC_000184.1 80 11 2.08E-08 1.55E-07 2.269 10.1717 
RNF122 AC_000184.1 100 24 2.94E-07 1.75E-06 2.269 10.1717 
RNF122 AC_000184.1 21 75 3.99E-05 1.63E-04 2.269 10.1717 
RNF122 AC_000184.1 75 7 2.27E-09 1.90E-08 2.269 10.1717 
RNF122 AC_000184.1 80 11 2.08E-08 1.55E-07 2.269 10.1717 
RNF122 AC_000184.1 85 11 3.76E-09 3.11E-08 2.269 10.1717 
RNF122 AC_000184.1 80 23 3.02E-05 1.25E-04 2.269 10.1717 
RNF122 AC_000184.1 85 5 4.73E-12 5.76E-11 2.269 10.1717 
RNF122 AC_000184.1 100 9 3.27E-12 3.99E-11 2.269 10.1717 
RNF122 AC_000184.1 25 85 2.09E-05 9.03E-05 2.269 10.1717 
RNF122 AC_000184.1 80 0 1.24E-15 1.87E-14 2.269 10.1717 
RNF122 AC_000184.1 80 14 1.93E-07 1.16E-06 2.269 10.1717 
RNF122 AC_000184.1 83 17 5.72E-07 3.28E-06 2.269 10.1717 
RNF122 AC_000184.1 100 16 1.86E-09 1.56E-08 2.269 10.1717 
RNF122 AC_000184.1 16 75 3.16E-06 1.58E-05 2.269 10.1717 
RNF122 AC_000184.1 80 10 8.02E-09 6.31E-08 2.269 10.1717 
RNF122 AC_000184.1 75 10 4.51E-08 2.95E-07 2.269 10.1717 
RNF122 AC_000184.1 75 12 2.23E-07 1.34E-06 2.269 10.1717 
RNF122 AC_000184.1 100 25 5.20E-07 2.99E-06 2.269 10.1717 
RNF122 AC_000184.1 76 24 1.14E-04 4.26E-04 2.269 10.1717 
UNC5D AC_000184.1 100 5 1.69E-14 2.45E-13 3.119 0.293699 
UNC5D AC_000184.1 95 15 4.09E-09 3.37E-08 3.119 0.293699 
UNC5D AC_000184.1 97 18 2.03E-08 1.52E-07 3.119 0.293699 
LDB3 AC_000185.1 0 100 2.22E-19 4.69E-18 0.931 0.28762 
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FADS2 AC_000186.1 0 100 2.22E-19 4.69E-18 0.01 34.409 
FADS2 AC_000186.1 16 100 1.86E-09 1.56E-08 0.01 34.409 
MACROD1 AC_000186.1 0 100 2.22E-19 4.69E-18 0.955 8.30819 
MACROD1 AC_000186.1 0 100 2.22E-19 4.69E-18 0.955 8.30819 
MACROD1 AC_000186.1 0 80 1.24E-15 1.87E-14 0.955 8.30819 
MACROD1 AC_000186.1 0 100 2.22E-19 4.69E-18 0.955 8.30819 
NRXN2 AC_000186.1 0 100 2.22E-19 4.69E-18 0.016 4.57515 
VPS51 AC_000186.1 100 0 2.22E-19 4.69E-18 0.408 16.563 
RELA AC_000186.1 100 0 2.22E-19 4.69E-18 40.482 15.7251 
ANO1 AC_000186.1 12 100 6.45E-11 6.57E-10 0.227 52.6666 
ANO1 AC_000186.1 0 100 2.22E-19 4.69E-18 0.227 52.6666 
NADSYN1 AC_000186.1 0 85 1.66E-16 3.11E-15 0.047 1.3615 
CARS AC_000186.1 20 97 7.26E-08 4.66E-07 0.776 12.83 
PHRF1 AC_000186.1 0 83 3.95E-16 6.84E-15 1.394 0.489806 
CHRNB2 AC_000160.1 100 0 2.22E-19 4.69E-18 10.768 0.0575072 
CELF3 AC_000160.1 20 80 6.94E-06 3.22E-05 0.124 0.743221 
ATP1A1 AC_000160.1 100 11 2.69E-11 2.88E-10 24.236 148.908 
ATP1A1 AC_000160.1 93 18 5.75E-08 3.72E-07 24.236 148.908 
RNF220 AC_000160.1 0 100 2.22E-19 4.69E-18 8.801 0.0276694 
PTPRF AC_000160.1 0 87 7.02E-17 1.38E-15 3.076 4.93606 
GRIK3 AC_000160.1 0 100 2.22E-19 4.69E-18 0.01 0.0418562 
SH3BP4 AC_000160.1 20 100 2.92E-08 2.12E-07 0.189 5.17138 
PER2 AC_000160.1 0 80 1.24E-15 1.87E-14 0.539 2.68266 
KIAA1324L AC_000161.1 83 14 8.33E-08 5.33E-07 3.943 26.3772 
KIAA1324L AC_000161.1 80 18 2.38E-06 1.22E-05 3.943 26.3772 
MET AC_000161.1 85 11 3.76E-09 3.11E-08 0.156 3.35075 
MET AC_000161.1 80 15 4.06E-07 2.38E-06 0.156 3.35075 
MET AC_000161.1 83 17 5.72E-07 3.28E-06 0.156 3.35075 
ADCY1 AC_000161.1 0 100 2.22E-19 4.69E-18 0.016 2.7462 
ADCY1 AC_000161.1 0 100 2.22E-19 4.69E-18 0.016 2.7462 
ADCY1 AC_000161.1 0 100 2.22E-19 4.69E-18 0.016 2.7462 
CDK13 AC_000161.1 88 3 5.16E-14 7.39E-13 4.127 15.9006 
CDK13 AC_000161.1 88 15 3.75E-08 2.57E-07 4.127 15.9006 
CDK13 AC_000161.1 88 3 5.16E-14 7.39E-13 4.127 15.9006 
CDK13 AC_000161.1 88 15 3.75E-08 2.57E-07 4.127 15.9006 
LRGUK AC_000161.1 80 6 1.16E-10 1.15E-09 0.074 4.2307 
LRGUK AC_000161.1 100 20 2.92E-08 2.12E-07 0.074 4.2307 
LRGUK AC_000161.1 76 14 6.34E-07 3.63E-06 0.074 4.2307 
LRGUK AC_000161.1 100 6 6.67E-14 9.52E-13 0.074 4.2307 
LRGUK AC_000161.1 100 7 2.90E-13 3.97E-12 0.074 4.2307 
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LRGUK AC_000161.1 100 12 6.45E-11 6.57E-10 0.074 4.2307 
LRGUK AC_000161.1 87 20 1.14E-06 6.08E-06 0.074 4.2307 
LRGUK AC_000161.1 16 75 3.16E-06 1.58E-05 0.074 4.2307 
UBN2 AC_000161.1 100 0 2.22E-19 4.69E-18 3.553 3.21039 
UBN2 AC_000161.1 100 2 5.84E-17 1.18E-15 3.553 3.21039 
UBN2 AC_000161.1 90 5 6.30E-13 8.01E-12 3.553 3.21039 
UBN2 AC_000161.1 100 10 8.84E-12 9.63E-11 3.553 3.21039 
UBN2 AC_000161.1 80 7 4.23E-10 3.99E-09 3.553 3.21039 
UBN2 AC_000161.1 100 21 5.72E-08 3.70E-07 3.553 3.21039 
UBN2 AC_000161.1 92 12 9.13E-10 7.97E-09 3.553 3.21039 
RHEBL1 AC_000162.1 100 0 2.22E-19 4.69E-18 63.627 0.755525 
GLS2 AC_000162.1 0 100 2.22E-19 4.69E-18 85.077 0.903068 
NABP2 AC_000162.1 100 0 2.22E-19 4.69E-18 11.492 4.72175 
IKZF4 AC_000162.1 0 100 2.22E-19 4.69E-18 0.166 2.6742 
ITPR2 AC_000162.1 75 6 8.00E-10 7.01E-09 1.345 0.00624904 
PHB2 AC_000162.1 0 100 2.22E-19 4.69E-18 10.422 6.06531 
PIANP AC_000162.1 20 100 2.92E-08 2.12E-07 0.108 0.763825 
PPARA AC_000162.1 0 85 1.66E-16 3.11E-15 0.821 1.65248 
HDAC10 AC_000162.1 0 100 2.22E-19 4.69E-18 0.076 3.73E-07 
PDE5A AC_000163.1 80 14 1.93E-07 1.16E-06 6.356 14.8399 
PDE5A AC_000163.1 83 20 3.33E-06 1.65E-05 6.356 14.8399 
PDE5A AC_000163.1 100 0 2.22E-19 4.69E-18 6.356 14.8399 
PDE5A AC_000163.1 80 10 8.02E-09 6.31E-08 6.356 14.8399 
PDE5A AC_000163.1 80 12 4.35E-08 2.85E-07 6.356 14.8399 
PDE5A AC_000163.1 80 0 1.24E-15 1.87E-14 6.356 14.8399 
PDE5A AC_000163.1 100 23 1.80E-07 1.10E-06 6.356 14.8399 
NFKB1 AC_000163.1 80 3 1.61E-12 2.01E-11 10.451 2.82109 
NFKB1 AC_000163.1 100 12 6.45E-11 6.57E-10 10.451 2.82109 
NFKB1 AC_000163.1 90 11 7.82E-10 6.86E-09 10.451 2.82109 
METAP1 AC_000163.1 80 13 1.01E-07 6.33E-07 11.068 9.01996 
ADAMTS3 AC_000163.1 100 0 2.22E-19 4.69E-18 0.026 0.815374 
ADAMTS3 AC_000163.1 100 8 9.20E-13 1.16E-11 0.026 0.815374 
ADAMTS3 AC_000163.1 95 13 8.16E-10 7.14E-09 0.026 0.815374 
ADAMTS3 AC_000163.1 87 11 1.94E-09 1.63E-08 0.026 0.815374 
ADAMTS3 AC_000163.1 80 13 1.01E-07 6.33E-07 0.026 0.815374 
ADAMTS3 AC_000163.1 100 2 5.84E-17 1.18E-15 0.026 0.815374 
ADAMTS3 AC_000163.1 75 0 1.25E-14 1.81E-13 0.026 0.815374 
ADAMTS3 AC_000163.1 80 7 3.48E-10 3.35E-09 0.026 0.815374 
ADAMTS3 AC_000163.1 100 15 9.23E-10 8.02E-09 0.026 0.815374 
ADAMTS3 AC_000163.1 80 13 1.01E-07 6.33E-07 0.026 0.815374 
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ADAMTS3 AC_000163.1 80 16 7.24E-07 4.12E-06 0.026 0.815374 
ADAMTS3 AC_000163.1 85 25 2.09E-05 9.03E-05 0.026 0.815374 
ADAMTS3 AC_000163.1 75 6 8.00E-10 7.01E-09 0.026 0.815374 
TNIP2 AC_000163.1 0 100 2.22E-19 4.69E-18 2.49 0.0316418 
TNIP2 AC_000163.1 0 100 2.22E-19 4.69E-18 2.49 0.0316418 
TNIP2 AC_000163.1 0 100 2.22E-19 4.69E-18 2.49 0.0316418 
TNIP2 AC_000163.1 0 100 2.22E-19 4.69E-18 2.49 0.0316418 
TNIP2 AC_000163.1 14 100 3.79E-10 3.60E-09 2.49 0.0316418 
CCDC96 AC_000163.1 100 0 2.22E-19 4.69E-18 0.013 66.6834 
CCDC96 AC_000163.1 85 0 1.66E-16 3.11E-15 0.013 66.6834 
ADAMTS2 AC_000164.1 0 100 2.22E-19 4.69E-18 0.066 1.22682 
ADAMTS2 AC_000164.1 0 100 2.22E-19 4.69E-18 0.066 1.22682 
KANK2 AC_000164.1 0 100 2.22E-19 4.69E-18 4.933 2.5804 
KANK2 AC_000164.1 0 100 2.22E-19 4.69E-18 4.933 2.5804 
C3 AC_000164.1 100 0 2.22E-19 4.69E-18 0.018 1.40461 
ZBTB7A AC_000164.1 100 20 2.92E-08 2.12E-07 0.081 1.57111 
PDLIM4 AC_000164.1 16 100 1.86E-09 1.56E-08 0.175 4.14576 
SBNO2 AC_000164.1 100 0 2.22E-19 4.69E-18 0.183 2.25867 
GFRA3 AC_000164.1 83 18 1.10E-06 5.87E-06 0.024 1.93982 
GFRA3 AC_000164.1 80 21 1.20E-05 5.39E-05 0.024 1.93982 
EGR1 AC_000164.1 16 87 8.86E-08 5.65E-07 0.357 97.3863 
CTNNA1 AC_000164.1 83 0 3.95E-16 6.84E-15 782.826 29.6623 
ZNF395 AC_000165.1 85 25 2.09E-05 9.03E-05 0.043 3.82017 
MOB3B AC_000165.1 100 0 2.22E-19 4.69E-18 0.981 2.09704 
KLF9 AC_000165.1 80 0 1.24E-15 1.87E-14 0.372 8.86346 
RHOBTB2 AC_000165.1 16 100 1.86E-09 1.56E-08 0.129 1.10532 
FANCC AC_000165.1 83 23 1.39E-05 6.16E-05 4.859 2.9906 
ASCC3 AC_000166.1 100 17 4.16E-09 3.41E-08 6.901 6.19346 
PTPRK AC_000166.1 83 20 3.33E-06 1.65E-05 2.563 7.58014 
LRP11 AC_000166.1 0 100 2.22E-19 4.69E-18 1.06 1.14334 
RPS6KA2 AC_000166.1 0 80 1.24E-15 1.87E-14 0.216 1.24944 
RPS6KA2 AC_000166.1 0 100 2.22E-19 4.69E-18 0.216 1.24944 
GPC3 AC_000187.1 77 0 5.26E-15 7.81E-14 4.36 8.81999 
ZNF75D AC_000187.1 83 0 3.95E-16 6.84E-15 204.013 66.9043 
ZNF75D AC_000187.1 83 11 7.24E-09 5.76E-08 204.013 66.9043 
ZNF75D AC_000187.1 0 75 1.25E-14 1.81E-13 204.013 66.9043 
TMEM185A AC_000187.1 100 0 2.22E-19 4.69E-18 60.753 0.15763 
MSN AC_000187.1 80 0 1.24E-15 1.87E-14 5.118 9.52565 
MSN AC_000187.1 100 6 6.67E-14 9.52E-13 5.118 9.52565 
MSN AC_000187.1 80 7 4.23E-10 3.99E-09 5.118 9.52565 
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MSN AC_000187.1 80 16 7.24E-07 4.12E-06 5.118 9.52565 
PHEX AC_000187.1 85 0 1.66E-16 3.11E-15 0.032 1.12563 
MOSPD2 AC_000187.1 75 13 4.30E-07 2.51E-06 2.568 6.82811 
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Table S7.3 Gene expression for DMRs between sperm vs. in vitro MII 
Gene expression in DMRs from in vitro MII vs. Sperm     
Gene Chr In vitr MII_me Sperm_me p-value q-value In vitr MII expression Spmer expression 
ADCY5 AC_000158.1 0 100 2.22E-19 2.32E-18 0.06 5.65265 
BDH1 AC_000158.1 0 100 2.22E-19 2.32E-18 0.802 11.332 
XXYLT1 AC_000158.1 0 100 2.22E-19 2.32E-18 9.236 2.88536 
KPNA6 AC_000158.1 0 100 2.22E-19 2.32E-18 17.299 3.88082 
UBASH3A AC_000158.1 18 100 7.85E-09 4.28E-08 16.101 0.164468 
PFKL AC_000158.1 0 100 2.22E-19 2.32E-18 0.129 0.197475 
PFKL AC_000158.1 0 100 2.22E-19 2.32E-18 0.129 0.197475 
PDXK AC_000158.1 0 100 2.22E-19 2.32E-18 3.386 1.29524 
PDXK AC_000158.1 0 83 3.95E-16 3.44E-15 3.386 1.29524 
COL18A1 AC_000158.1 0 100 2.22E-19 2.32E-18 0.071 19.4062 
COL18A1 AC_000158.1 0 100 2.22E-19 2.32E-18 0.071 19.4062 
COL18A1 AC_000158.1 0 100 2.22E-19 2.32E-18 0.071 19.4062 
COL18A1 AC_000158.1 0 100 2.22E-19 2.32E-18 0.071 19.4062 
COL18A1 AC_000158.1 0 100 2.22E-19 2.32E-18 0.071 19.4062 
COL18A1 AC_000158.1 0 100 2.22E-19 2.32E-18 0.071 19.4062 
COL18A1 AC_000158.1 0 100 2.22E-19 2.32E-18 0.071 19.4062 
COL18A1 AC_000158.1 0 100 2.22E-19 2.32E-18 0.071 19.4062 
SPATC1L AC_000158.1 100 18 7.85E-09 4.28E-08 0.019 16.2154 
RUNX1 AC_000158.1 20 100 2.92E-08 1.49E-07 0.42 0.393924 
RUNX1 AC_000158.1 0 100 2.22E-19 2.32E-18 0.42 0.393924 
BTD AC_000158.1 100 0 2.22E-19 2.32E-18 3.236 2.48654 
BTD AC_000158.1 100 0 2.22E-19 2.32E-18 3.236 2.48654 
OXNAD1 AC_000158.1 0 100 2.22E-19 2.32E-18 1.977 10.5107 
OXNAD1 AC_000158.1 0 100 2.22E-19 2.32E-18 1.977 10.5107 
OXNAD1 AC_000158.1 0 80 1.24E-15 9.79E-15 1.977 10.5107 
OXNAD1 AC_000158.1 0 100 2.22E-19 2.32E-18 1.977 10.5107 
OXNAD1 AC_000158.1 0 100 2.22E-19 2.32E-18 1.977 10.5107 
OXNAD1 AC_000158.1 0 100 2.22E-19 2.32E-18 1.977 10.5107 
OXNAD1 AC_000158.1 0 100 2.22E-19 2.32E-18 1.977 10.5107 
PLCL2 AC_000158.1 0 100 2.22E-19 2.32E-18 10.364 45.9542 
PLCL2 AC_000158.1 0 100 2.22E-19 2.32E-18 10.364 45.9542 
PLCL2 AC_000158.1 0 83 3.95E-16 3.44E-15 10.364 45.9542 
TXNDC16 AC_000167.1 0 100 2.22E-19 2.32E-18 2.544 5.12414 
NOX5 AC_000167.1 0 100 2.22E-19 2.32E-18 0.728 0.104699 
BCL2L2 AC_000167.1 0 100 2.22E-19 2.32E-18 5.42 10.4149 
TEP1 AC_000167.1 0 92 7.02E-18 7.27E-17 0.165 0.898197 
KATNBL1 AC_000167.1 80 14 1.93E-07 8.74E-07 22.924 19.9724 
TMEM229B AC_000167.1 100 0 2.22E-19 2.32E-18 0.197 2.78354 
  181 
VASH1 AC_000167.1 0 100 2.22E-19 2.32E-18 0.301 2.02373 
CNNM4 AC_000168.1 20 92 2.77E-07 1.24E-06 11.71 6.86361 
FHL2 AC_000168.1 0 100 2.22E-19 2.32E-18 2.757 8.26512 
FHL2 AC_000168.1 0 100 2.22E-19 2.32E-18 2.757 8.26512 
FHL2 AC_000168.1 0 100 2.22E-19 2.32E-18 2.757 8.26512 
LOXL3 AC_000168.1 0 100 2.22E-19 2.32E-18 0.279 0.975324 
DYSF AC_000168.1 80 20 6.94E-06 2.60E-05 0.44 2.59209 
CAMKMT AC_000168.1 100 5 1.69E-14 1.30E-13 2.258 13.4428 
EMILIN1 AC_000168.1 0 100 2.22E-19 2.32E-18 0.05 2.56389 
ADCY3 AC_000168.1 0 100 2.22E-19 2.32E-18 0.876 2.50149 
RALGPS1 AC_000168.1 80 0 1.24E-15 9.79E-15 2.29 23.5689 
ENG AC_000168.1 0 100 2.22E-19 2.32E-18 0.057 5.34783 
NTNG2 AC_000168.1 0 100 2.22E-19 2.32E-18 0.26 0.683614 
NTNG2 AC_000168.1 0 100 2.22E-19 2.32E-18 0.26 0.683614 
AK8 AC_000168.1 0 85 1.66E-16 1.56E-15 0.032 44.5611 
AK8 AC_000168.1 20 100 2.92E-08 1.49E-07 0.032 44.5611 
AK8 AC_000168.1 0 100 2.22E-19 2.32E-18 0.032 44.5611 
AK8 AC_000168.1 0 80 1.24E-15 9.79E-15 0.032 44.5611 
GFI1B AC_000168.1 0 100 2.22E-19 2.32E-18 0.57 0.0413428 
GFI1B AC_000168.1 0 83 3.95E-16 3.44E-15 0.57 0.0413428 
INPP5E AC_000168.1 0 100 2.22E-19 2.32E-18 0.14 8.13702 
INPP5E AC_000168.1 0 100 2.22E-19 2.32E-18 0.14 8.13702 
INPP5E AC_000168.1 0 100 2.22E-19 2.32E-18 0.14 8.13702 
SARDH AC_000168.1 0 100 2.22E-19 2.32E-18 0.042 0.12003 
SARDH AC_000168.1 0 83 3.95E-16 3.44E-15 0.042 0.12003 
SARDH AC_000168.1 14 100 3.79E-10 2.31E-09 0.042 0.12003 
SARDH AC_000168.1 0 100 2.22E-19 2.32E-18 0.042 0.12003 
SARDH AC_000168.1 0 83 3.95E-16 3.44E-15 0.042 0.12003 
CACNA1B AC_000168.1 100 0 2.22E-19 2.32E-18 0.477 0.0635291 
TPRN AC_000168.1 0 100 2.22E-19 2.32E-18 0.685 1.47106 
SLC7A1 AC_000169.1 0 100 2.22E-19 2.32E-18 0.518 16.1771 
TNFRSF19 AC_000169.1 0 83 3.95E-16 3.44E-15 0.037 0.107024 
DOCK9 AC_000169.1 88 0 3.94E-17 3.96E-16 27.006 5.15748 
DOCK9 AC_000169.1 80 11 2.08E-08 1.09E-07 27.006 5.15748 
DOCK9 AC_000169.1 75 20 2.62E-05 9.12E-05 27.006 5.15748 
RAB20 AC_000169.1 0 100 2.22E-19 2.32E-18 0.304 0.975288 
RASA3 AC_000169.1 0 100 2.22E-19 2.32E-18 0.302 1.43627 
RASA3 AC_000169.1 0 100 2.22E-19 2.32E-18 0.302 1.43627 
PLCB1 AC_000170.1 100 11 2.69E-11 1.74E-10 0.538 1.56312 
PLCB1 AC_000170.1 88 10 5.48E-10 3.19E-09 0.538 1.56312 
PLCB1 AC_000170.1 100 22 9.72E-08 4.57E-07 0.538 1.56312 
PLCB1 AC_000170.1 93 25 2.95E-06 1.17E-05 0.538 1.56312 
PLCB1 AC_000170.1 95 2 5.23E-16 4.55E-15 0.538 1.56312 
PLCB1 AC_000170.1 100 21 5.72E-08 2.73E-07 0.538 1.56312 
ISM1 AC_000170.1 0 100 2.22E-19 2.32E-18 0.191 2.60195 
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CUBN AC_000170.1 92 4 6.82E-14 5.22E-13 0.097 4.77637 
CUBN AC_000170.1 83 6 4.28E-11 2.72E-10 0.097 4.77637 
CUBN AC_000170.1 75 14 9.09E-07 3.87E-06 0.097 4.77637 
CUBN AC_000170.1 75 14 9.09E-07 3.87E-06 0.097 4.77637 
PFKP AC_000170.1 0 100 2.22E-19 2.32E-18 0.159 30.7787 
SLC4A11 AC_000170.1 80 0 1.24E-15 9.79E-15 0.637 12.4908 
PCMTD2 AC_000170.1 0 100 2.22E-19 2.32E-18 30.34 23.5781 
OPRL1 AC_000170.1 21 75 3.99E-05 1.35E-04 0.088 2.42345 
OPRL1 AC_000170.1 21 75 3.99E-05 1.35E-04 0.088 2.42345 
RBM38 AC_000170.1 14 100 3.79E-10 2.31E-09 22.426 3.80514 
CHMP4B AC_000170.1 75 12 2.23E-07 1.01E-06 6.574 17.6036 
CHMP4B AC_000170.1 90 25 6.49E-06 2.48E-05 6.574 17.6036 
RBL1 AC_000170.1 0 100 2.22E-19 2.32E-18 2.118 9.51603 
RBL1 AC_000170.1 0 80 1.24E-15 9.79E-15 2.118 9.51603 
KCNB1 AC_000170.1 0 83 3.95E-16 3.44E-15 0.148 0.595133 
DOK5 AC_000170.1 0 100 2.22E-19 2.32E-18 0.076 1.18619 
TONSL AC_000171.1 0 100 2.22E-19 2.32E-18 2.864 1.07664 
SLC39A4 AC_000171.1 0 85 1.66E-16 1.56E-15 0.012 0.49789 
VAMP2 AC_000171.1 0 100 2.22E-19 2.32E-18 5.115 5.04003 
VAMP2 AC_000171.1 0 100 2.22E-19 2.32E-18 5.115 5.04003 
VAMP2 AC_000171.1 0 100 2.22E-19 2.32E-18 5.115 5.04003 
VAMP2 AC_000171.1 0 100 2.22E-19 2.32E-18 5.115 5.04003 
VAMP2 AC_000171.1 100 0 2.22E-19 2.32E-18 5.115 5.04003 
VAMP2 AC_000171.1 14 83 8.33E-08 3.95E-07 5.115 5.04003 
VAMP2 AC_000171.1 0 100 2.22E-19 2.32E-18 5.115 5.04003 
VAMP2 AC_000171.1 0 93 5.27E-18 5.48E-17 5.115 5.04003 
VAMP2 AC_000171.1 0 100 2.22E-19 2.32E-18 5.115 5.04003 
VAMP2 AC_000171.1 0 100 2.22E-19 2.32E-18 5.115 5.04003 
VAMP2 AC_000171.1 0 100 2.22E-19 2.32E-18 5.115 5.04003 
VAMP2 AC_000171.1 0 100 2.22E-19 2.32E-18 5.115 5.04003 
VAMP2 AC_000171.1 14 100 3.79E-10 2.31E-09 5.115 5.04003 
TSNARE1 AC_000171.1 0 100 2.22E-19 2.32E-18 1.863 0.00898524 
TSNARE1 AC_000171.1 0 100 2.22E-19 2.32E-18 1.863 0.00898524 
TSNARE1 AC_000171.1 0 100 2.22E-19 2.32E-18 1.863 0.00898524 
PTP4A3 AC_000171.1 0 100 2.22E-19 2.32E-18 1.208 0.747433 
PTP4A3 AC_000171.1 0 100 2.22E-19 2.32E-18 1.208 0.747433 
PTP4A3 AC_000171.1 16 100 1.86E-09 1.05E-08 1.208 0.747433 
NDRG1 AC_000171.1 0 100 2.22E-19 2.32E-18 0.022 8.90479 
NDRG1 AC_000171.1 0 100 2.22E-19 2.32E-18 0.022 8.90479 
NDRG1 AC_000171.1 0 100 2.22E-19 2.32E-18 0.022 8.90479 
ASAP1 AC_000171.1 0 95 2.22E-18 2.32E-17 38.082 4.84221 
ASAP1 AC_000171.1 0 92 7.02E-18 7.27E-17 38.082 4.84221 
TTPA AC_000171.1 100 22 9.72E-08 4.57E-07 0.127 1.44846 
PREX2 AC_000171.1 87 10 8.39E-10 4.88E-09 0.204 1.02787 
CPQ AC_000171.1 0 100 2.22E-19 2.32E-18 4.798 65.1425 
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CPQ AC_000171.1 0 80 1.24E-15 9.79E-15 4.798 65.1425 
MAML2 AC_000172.1 0 100 2.22E-19 2.32E-18 0.035 0.898364 
NCAM1 AC_000172.1 0 100 2.22E-19 2.32E-18 0.052 7.27085 
NCAM1 AC_000172.1 0 100 2.22E-19 2.32E-18 0.052 7.27085 
NCAM1 AC_000172.1 0 100 2.22E-19 2.32E-18 0.052 7.27085 
NCAM1 AC_000172.1 0 100 2.22E-19 2.32E-18 0.052 7.27085 
UPK2 AC_000172.1 0 100 2.22E-19 2.32E-18 0.076 0.915982 
UPK2 AC_000172.1 0 100 2.22E-19 2.32E-18 0.076 0.915982 
UPK2 AC_000172.1 0 100 2.22E-19 2.32E-18 0.076 0.915982 
PHLDB1 AC_000172.1 0 100 2.22E-19 2.32E-18 0.626 2.4146 
MCAM AC_000172.1 0 100 2.22E-19 2.32E-18 0.287 0.514236 
GRAMD1B AC_000172.1 0 100 2.22E-19 2.32E-18 10.286 9.43855 
SPON1 AC_000172.1 100 16 1.86E-09 1.05E-08 5.547 36.0375 
HPX AC_000172.1 0 100 2.22E-19 2.32E-18 0.034 2.16298 
APBB1 AC_000172.1 0 100 2.22E-19 2.32E-18 0.01 2.96761 
PDE2A AC_000172.1 0 100 2.22E-19 2.32E-18 0.052 2.68373 
PDE2A AC_000172.1 0 100 2.22E-19 2.32E-18 0.052 2.68373 
ARRB1 AC_000172.1 0 100 2.22E-19 2.32E-18 0.553 0.862835 
ARRB1 AC_000172.1 0 100 2.22E-19 2.32E-18 0.553 0.862835 
CAPN5 AC_000172.1 0 100 2.22E-19 2.32E-18 0.013 2.56793 
CAPN5 AC_000172.1 0 100 2.22E-19 2.32E-18 0.013 2.56793 
CD82 AC_000172.1 0 100 2.22E-19 2.32E-18 0.012 17.878 
CD82 AC_000172.1 0 100 2.22E-19 2.32E-18 0.012 17.878 
CD82 AC_000172.1 0 100 2.22E-19 2.32E-18 0.012 17.878 
CD82 AC_000172.1 0 100 2.22E-19 2.32E-18 0.012 17.878 
CD82 AC_000172.1 0 100 2.22E-19 2.32E-18 0.012 17.878 
CD82 AC_000172.1 22 94 4.95E-07 2.18E-06 0.012 17.878 
CD82 AC_000172.1 0 100 2.22E-19 2.32E-18 0.012 17.878 
MAPK8IP1 AC_000172.1 0 100 2.22E-19 2.32E-18 0.236 6.49307 
MAPK8IP1 AC_000172.1 0 100 2.22E-19 2.32E-18 0.236 6.49307 
ATG13 AC_000172.1 20 100 2.92E-08 1.49E-07 4.369 17.2482 
MYBPC3 AC_000172.1 0 100 2.22E-19 2.32E-18 0.042 0.272787 
MYBPC3 AC_000172.1 0 85 1.66E-16 1.56E-15 0.042 0.272787 
RAPSN AC_000172.1 0 100 2.22E-19 2.32E-18 0.068 0.345906 
SLC43A3 AC_000172.1 20 100 2.92E-08 1.49E-07 0.271 0.656248 
SLC43A3 AC_000172.1 0 100 2.22E-19 2.32E-18 0.271 0.656248 
SLC43A3 AC_000172.1 0 80 1.24E-15 9.79E-15 0.271 0.656248 
UBE2L6 AC_000172.1 0 85 1.66E-16 1.56E-15 3.465 1.79197 
ZDHHC5 AC_000172.1 20 100 2.92E-08 1.49E-07 11.02 9.20832 
NCAPD3 AC_000172.1 0 100 2.22E-19 2.32E-18 13.269 29.5086 
IKBKE AC_000173.1 0 80 1.24E-15 9.79E-15 0.026 0.151946 
IL10 AC_000173.1 0 100 2.22E-19 2.32E-18 0.598 2.08477 
LEFTY2 AC_000173.1 0 83 3.95E-16 3.44E-15 0.091 0.377381 
RGS7 AC_000173.1 87 7 3.08E-11 1.96E-10 0.034 0.674704 
RGS7 AC_000173.1 100 6 6.67E-14 5.10E-13 0.034 0.674704 
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RGS7 AC_000173.1 77 10 1.99E-08 1.05E-07 0.034 0.674704 
RGS7 AC_000173.1 75 15 1.62E-06 6.65E-06 0.034 0.674704 
PLOD1 AC_000173.1 100 0 2.22E-19 2.32E-18 0.255 13.5712 
SLC2A5 AC_000173.1 0 90 1.66E-17 1.70E-16 0.043 1.0146 
ACOT7 AC_000173.1 0 100 2.22E-19 2.32E-18 6.274 92.1376 
NMNAT2 AC_000173.1 0 100 2.22E-19 2.32E-18 0.051 11.5046 
NCF2 AC_000173.1 0 100 2.22E-19 2.32E-18 12.602 0.711148 
LAMB3 AC_000173.1 0 100 2.22E-19 2.32E-18 0.106 0.36457 
PLXNA2 AC_000173.1 0 100 2.22E-19 2.32E-18 0.028 2.16689 
PLXNA2 AC_000173.1 0 100 2.22E-19 2.32E-18 0.028 2.16689 
PLXNA2 AC_000173.1 0 100 2.22E-19 2.32E-18 0.028 2.16689 
PLXNA2 AC_000173.1 0 100 2.22E-19 2.32E-18 0.028 2.16689 
PITPNM2 AC_000174.1 0 100 2.22E-19 2.32E-18 3.483 2.33325 
PITPNM2 AC_000174.1 0 100 2.22E-19 2.32E-18 3.483 2.33325 
PITPNM2 AC_000174.1 0 83 3.95E-16 3.44E-15 3.483 2.33325 
PITPNM2 AC_000174.1 0 100 2.22E-19 2.32E-18 3.483 2.33325 
PITPNM2 AC_000174.1 0 100 2.22E-19 2.32E-18 3.483 2.33325 
PITPNM2 AC_000174.1 0 83 3.95E-16 3.44E-15 3.483 2.33325 
RHOF AC_000174.1 0 100 2.22E-19 2.32E-18 1.357 1.26635 
CUX2 AC_000174.1 0 100 2.22E-19 2.32E-18 50.403 0.223335 
CUX2 AC_000174.1 0 100 2.22E-19 2.32E-18 50.403 0.223335 
RAB35 AC_000174.1 0 90 1.66E-17 1.70E-16 18.804 5.9147 
RAB35 AC_000174.1 16 100 1.86E-09 1.05E-08 18.804 5.9147 
TRPV4 AC_000174.1 0 100 2.22E-19 2.32E-18 0.085 0.254707 
TRPV4 AC_000174.1 0 100 2.22E-19 2.32E-18 0.085 0.254707 
TRPV4 AC_000174.1 0 100 2.22E-19 2.32E-18 0.085 0.254707 
TRPV4 AC_000174.1 0 100 2.22E-19 2.32E-18 0.085 0.254707 
TRPV4 AC_000174.1 0 100 2.22E-19 2.32E-18 0.085 0.254707 
TMEM119 AC_000174.1 100 0 2.22E-19 2.32E-18 3.219 0.865139 
LIF AC_000174.1 0 100 2.22E-19 2.32E-18 0.019 0.442617 
CCDC157 AC_000174.1 0 100 2.22E-19 2.32E-18 0.086 20.239 
CCDC157 AC_000174.1 0 100 2.22E-19 2.32E-18 0.086 20.239 
CCDC157 AC_000174.1 0 100 2.22E-19 2.32E-18 0.086 20.239 
OSBP2 AC_000174.1 0 100 2.22E-19 2.32E-18 0.359 14.0231 
OSBP2 AC_000174.1 0 100 2.22E-19 2.32E-18 0.359 14.0231 
OSBP2 AC_000174.1 0 100 2.22E-19 2.32E-18 0.359 14.0231 
SMTN AC_000174.1 0 100 2.22E-19 2.32E-18 0.083 3.96868 
SMTN AC_000174.1 0 100 2.22E-19 2.32E-18 0.083 3.96868 
GGT5 AC_000174.1 0 100 2.22E-19 2.32E-18 0.174 0.631976 
GGT5 AC_000174.1 0 80 1.24E-15 9.79E-15 0.174 0.631976 
GGT5 AC_000174.1 0 100 2.22E-19 2.32E-18 0.174 0.631976 
GGT5 AC_000174.1 0 100 2.22E-19 2.32E-18 0.174 0.631976 
GGT5 AC_000174.1 16 100 1.86E-09 1.05E-08 0.174 0.631976 
SDF2L1 AC_000174.1 0 87 7.02E-17 6.88E-16 2.915 6.17688 
CCDC116 AC_000174.1 100 0 2.22E-19 2.32E-18 0.556 8.55385 
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SLC7A4 AC_000174.1 0 100 2.22E-19 2.32E-18 0.014 0.587754 
MZT2B AC_000174.1 20 100 2.92E-08 1.49E-07 0.19 1.20482 
ARVCF AC_000174.1 0 80 1.24E-15 9.79E-15 0.241 0.0686743 
VAC14 AC_000175.1 0 100 2.22E-19 2.32E-18 0.848 5.18937 
VAC14 AC_000175.1 0 80 1.24E-15 9.79E-15 0.848 5.18937 
PDPR AC_000175.1 0 100 2.22E-19 2.32E-18 7.187 5.03969 
PDPR AC_000175.1 0 100 2.22E-19 2.32E-18 7.187 5.03969 
SLC38A8 AC_000175.1 0 100 2.22E-19 2.32E-18 21.463 0.203353 
COTL1 AC_000175.1 0 100 2.22E-19 2.32E-18 0.614 7.3541 
COTL1 AC_000175.1 100 0 2.22E-19 2.32E-18 0.614 7.3541 
FOXC2 AC_000175.1 100 0 2.22E-19 2.32E-18 0.358 0.366771 
SLC7A5 AC_000175.1 0 100 2.22E-19 2.32E-18 0.039 22.6674 
SLC7A5 AC_000175.1 0 100 2.22E-19 2.32E-18 0.039 22.6674 
SLC7A5 AC_000175.1 0 85 1.66E-16 1.56E-15 0.039 22.6674 
DPEP1 AC_000175.1 0 85 1.66E-16 1.56E-15 0.061 5.56081 
DPEP1 AC_000175.1 0 83 3.95E-16 3.44E-15 0.061 5.56081 
DPEP1 AC_000175.1 11 100 2.69E-11 1.74E-10 0.061 5.56081 
ZNF423 AC_000175.1 0 100 2.22E-19 2.32E-18 0.044 1.49701 
ZNF423 AC_000175.1 0 85 1.66E-16 1.56E-15 0.044 1.49701 
ZNF423 AC_000175.1 0 75 1.25E-14 9.63E-14 0.044 1.49701 
ZNF423 AC_000175.1 0 100 2.22E-19 2.32E-18 0.044 1.49701 
ZNF423 AC_000175.1 0 100 2.22E-19 2.32E-18 0.044 1.49701 
ZNF423 AC_000175.1 0 100 2.22E-19 2.32E-18 0.044 1.49701 
ZNF423 AC_000175.1 0 100 2.22E-19 2.32E-18 0.044 1.49701 
ZNF423 AC_000175.1 0 100 2.22E-19 2.32E-18 0.044 1.49701 
ZNF423 AC_000175.1 0 100 2.22E-19 2.32E-18 0.044 1.49701 
ZNF423 AC_000175.1 0 100 2.22E-19 2.32E-18 0.044 1.49701 
ZNF423 AC_000175.1 0 100 2.22E-19 2.32E-18 0.044 1.49701 
ZNF423 AC_000175.1 0 100 2.22E-19 2.32E-18 0.044 1.49701 
MMP2 AC_000175.1 0 100 2.22E-19 2.32E-18 0.043 11.6334 
SLC12A3 AC_000175.1 0 100 2.22E-19 2.32E-18 0.912 0.238977 
SLC12A3 AC_000175.1 0 88 3.94E-17 3.96E-16 0.912 0.238977 
DRC7 AC_000175.1 0 100 2.22E-19 2.32E-18 195.295 14.7228 
NDRG4 AC_000175.1 100 20 2.92E-08 1.49E-07 8.888 16.7646 
EXOC3L1 AC_000175.1 0 88 3.94E-17 3.96E-16 0.412 1.44007 
SMPD3 AC_000175.1 20 100 2.92E-08 1.49E-07 0.034 1.30709 
PEPD AC_000175.1 0 100 2.22E-19 2.32E-18 0.154 3.74324 
PEPD AC_000175.1 0 100 2.22E-19 2.32E-18 0.154 3.74324 
PEPD AC_000175.1 0 100 2.22E-19 2.32E-18 0.154 3.74324 
PEPD AC_000175.1 0 81 9.35E-16 8.12E-15 0.154 3.74324 
PEPD AC_000175.1 0 100 2.22E-19 2.32E-18 0.154 3.74324 
GPI AC_000175.1 80 0 1.24E-15 9.79E-15 86.567 52.6938 
IGFLR1 AC_000175.1 100 14 3.79E-10 2.31E-09 1.824 2.01574 
SHKBP1 AC_000175.1 100 0 2.22E-19 2.32E-18 7.656 6.43168 
CYP2S1 AC_000175.1 0 100 2.22E-19 2.32E-18 2.047 0.065393 
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CEACAM19 AC_000175.1 80 0 1.24E-15 9.79E-15 6.162 0.0432857 
PPP1R37 AC_000175.1 100 0 2.22E-19 2.32E-18 5.595 16.1979 
PPP1R37 AC_000175.1 100 9 3.27E-12 2.29E-11 5.595 16.1979 
DHX34 AC_000175.1 0 100 2.22E-19 2.32E-18 0.444 7.09385 
DHX34 AC_000175.1 0 100 2.22E-19 2.32E-18 0.444 7.09385 
TULP2 AC_000175.1 100 0 2.22E-19 2.32E-18 0.794 16.9575 
FCGRT AC_000175.1 0 87 7.02E-17 6.88E-16 1.853 0.128583 
RCN3 AC_000175.1 0 100 2.22E-19 2.32E-18 2.171 3.84027 
TSKS AC_000175.1 100 20 2.92E-08 1.49E-07 0.185 40.0046 
TBC1D17 AC_000175.1 100 0 2.22E-19 2.32E-18 0.524 5.25401 
KLK12 AC_000175.1 0 100 2.22E-19 2.32E-18 0.207 0.021982 
FIZ1 AC_000175.1 100 0 2.22E-19 2.32E-18 0.346 0.0353889 
NAT14 AC_000175.1 20 100 2.92E-08 1.49E-07 0.065 0.546189 
PPP6R1 AC_000175.1 0 83 3.95E-16 3.44E-15 0.638 31.2632 
TNNI3 AC_000175.1 100 0 2.22E-19 2.32E-18 0.331 11.6081 
TTYH1 AC_000175.1 0 90 1.66E-17 1.70E-16 1.491 53.4688 
TTYH1 AC_000175.1 0 83 3.95E-16 3.44E-15 1.491 53.4688 
TTYH1 AC_000175.1 0 80 1.24E-15 9.79E-15 1.491 53.4688 
MBOAT7 AC_000175.1 20 87 1.14E-06 4.73E-06 4.474 0.113894 
TMC4 AC_000175.1 0 80 1.24E-15 9.79E-15 9.292 0.246617 
ZIM2 AC_000175.1 0 85 1.66E-16 1.56E-15 39.328 0.068638 
ZIM2 AC_000175.1 14 75 9.09E-07 3.87E-06 39.328 0.068638 
ZIM2 AC_000175.1 80 0 1.24E-15 9.79E-15 39.328 0.068638 
ZNF583 AC_000175.1 14 75 9.09E-07 3.87E-06 57.418 0.178527 
MSI2 AC_000176.1 0 100 2.22E-19 2.32E-18 0.929 3.4265 
MSI2 AC_000176.1 0 81 9.35E-16 8.12E-15 0.929 3.4265 
MSI2 AC_000176.1 0 100 2.22E-19 2.32E-18 0.929 3.4265 
MSI2 AC_000176.1 0 100 2.22E-19 2.32E-18 0.929 3.4265 
MSI2 AC_000176.1 0 100 2.22E-19 2.32E-18 0.929 3.4265 
RNF43 AC_000176.1 0 80 1.24E-15 9.79E-15 0.831 0.584618 
RNF43 AC_000176.1 20 100 2.92E-08 1.49E-07 0.831 0.584618 
C19H17orf64 AC_000176.1 0 100 2.22E-19 2.32E-18 0.075 32.1067 
GAS2L2 AC_000176.1 0 100 2.22E-19 2.32E-18 0.038 0.147563 
LGALS9 AC_000176.1 0 100 2.22E-19 2.32E-18 0.127 0.82207 
LGALS9 AC_000176.1 0 100 2.22E-19 2.32E-18 0.127 0.82207 
NOS2 AC_000176.1 0 100 2.22E-19 2.32E-18 14.803 0.0757853 
UNC119 AC_000176.1 0 100 2.22E-19 2.32E-18 37.376 8.00687 
TRAF4 AC_000176.1 80 16 7.24E-07 3.14E-06 13.713 2.96348 
FLOT2 AC_000176.1 0 81 9.35E-16 8.12E-15 21.125 3.41417 
TRPV3 AC_000176.1 0 100 2.22E-19 2.32E-18 0.687 0.436797 
CAMKK1 AC_000176.1 0 100 2.22E-19 2.32E-18 0.194 0.879351 
CAMKK1 AC_000176.1 20 100 2.92E-08 1.49E-07 0.194 0.879351 
ATP2A3 AC_000176.1 0 100 2.22E-19 2.32E-18 0.053 8.57103 
SLC13A5 AC_000176.1 0 100 2.22E-19 2.32E-18 0.016 0.0628505 
WSCD1 AC_000176.1 0 100 2.22E-19 2.32E-18 0.044 4.50593 
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SPEM1 AC_000176.1 0 100 2.22E-19 2.32E-18 0.029 12.3162 
GUCY2D AC_000176.1 0 75 1.25E-14 9.63E-14 0.197 0.0841453 
NTN1 AC_000176.1 0 100 2.22E-19 2.32E-18 0.574 0.550449 
GAS7 AC_000176.1 0 100 2.22E-19 2.32E-18 6.404 3.74942 
DNAH9 AC_000176.1 0 100 2.22E-19 2.32E-18 0.097 0.0143802 
FAM83G AC_000176.1 0 100 2.22E-19 2.32E-18 0.022 1.55324 
CACNA1G AC_000176.1 11 100 2.69E-11 1.74E-10 0.054 0.704679 
CACNA1G AC_000176.1 11 100 2.69E-11 1.74E-10 0.054 0.704679 
SP2 AC_000176.1 0 100 2.22E-19 2.32E-18 52.222 3.75422 
SP2 AC_000176.1 0 100 2.22E-19 2.32E-18 52.222 3.75422 
RPL19 AC_000176.1 80 23 3.02E-05 1.03E-04 622.381 133.855 
FBXL20 AC_000176.1 77 9 8.67E-09 4.71E-08 27.908 6.7384 
FBXL20 AC_000176.1 80 14 1.93E-07 8.74E-07 27.908 6.7384 
FBXL20 AC_000176.1 20 83 3.33E-06 1.30E-05 27.908 6.7384 
ERBB2 AC_000176.1 0 100 2.22E-19 2.32E-18 0.006 1.35771 
RARA AC_000176.1 100 0 2.22E-19 2.32E-18 5.363 10.1415 
KRT19 AC_000176.1 0 100 2.22E-19 2.32E-18 5.702 0.105565 
JUP AC_000176.1 0 100 2.22E-19 2.32E-18 0.111 3.69015 
FKBP10 AC_000176.1 0 100 2.22E-19 2.32E-18 0.139 3.3218 
DHX58 AC_000176.1 0 85 1.66E-16 1.56E-15 33.229 0.249484 
HDAC5 AC_000176.1 0 100 2.22E-19 2.32E-18 0.17 7.63568 
MAPT AC_000176.1 0 100 2.22E-19 2.32E-18 0.795 0.731686 
DCXR AC_000176.1 0 81 9.35E-16 8.12E-15 1.349 2.01575 
CCDC137 AC_000176.1 100 0 2.22E-19 2.32E-18 2.166 1.53063 
BAIAP2 AC_000176.1 0 100 2.22E-19 2.32E-18 20.545 3.97209 
BAIAP2 AC_000176.1 0 80 1.24E-15 9.79E-15 20.545 3.97209 
TBC1D16 AC_000176.1 20 100 2.92E-08 1.49E-07 0.174 0.690348 
TBC1D16 AC_000176.1 0 100 2.22E-19 2.32E-18 0.174 0.690348 
RBFOX3 AC_000176.1 0 85 1.66E-16 1.56E-15 0.362 0.0541617 
RBFOX3 AC_000176.1 0 100 2.22E-19 2.32E-18 0.362 0.0541617 
RBFOX3 AC_000176.1 0 100 2.22E-19 2.32E-18 0.362 0.0541617 
RBFOX3 AC_000176.1 0 100 2.22E-19 2.32E-18 0.362 0.0541617 
RBFOX3 AC_000176.1 0 100 2.22E-19 2.32E-18 0.362 0.0541617 
RBFOX3 AC_000176.1 0 100 2.22E-19 2.32E-18 0.362 0.0541617 
RBFOX3 AC_000176.1 0 100 2.22E-19 2.32E-18 0.362 0.0541617 
RBFOX3 AC_000176.1 0 100 2.22E-19 2.32E-18 0.362 0.0541617 
RBFOX3 AC_000176.1 0 100 2.22E-19 2.32E-18 0.362 0.0541617 
TIMP2 AC_000176.1 25 100 5.20E-07 2.28E-06 1.267 273.458 
TRIM47 AC_000176.1 0 100 2.22E-19 2.32E-18 0.015 1.20996 
TRIM47 AC_000176.1 0 100 2.22E-19 2.32E-18 0.015 1.20996 
TRIM47 AC_000176.1 0 100 2.22E-19 2.32E-18 0.015 1.20996 
TRIM47 AC_000176.1 20 100 2.92E-08 1.49E-07 0.015 1.20996 
TRIM47 AC_000176.1 0 100 2.22E-19 2.32E-18 0.015 1.20996 
GALK1 AC_000176.1 0 100 2.22E-19 2.32E-18 0.572 3.79491 
MIF4GD AC_000176.1 0 100 2.22E-19 2.32E-18 24.332 2.68766 
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MRPS7 AC_000176.1 0 100 2.22E-19 2.32E-18 16.342 0.682308 
CDR2L AC_000176.1 80 0 1.24E-15 9.79E-15 1.002 0.619825 
FADS6 AC_000176.1 0 100 2.22E-19 2.32E-18 0.374 2.77879 
RAB37 AC_000176.1 100 22 9.72E-08 4.57E-07 2.856 0.531397 
RAB37 AC_000176.1 75 17 5.30E-06 2.04E-05 2.856 0.531397 
RAB37 AC_000176.1 85 0 1.66E-16 1.56E-15 2.856 0.531397 
RAB37 AC_000176.1 75 7 2.27E-09 1.28E-08 2.856 0.531397 
RAB37 AC_000176.1 100 22 9.72E-08 4.57E-07 2.856 0.531397 
RAB37 AC_000176.1 23 87 5.11E-06 1.98E-05 2.856 0.531397 
RAB37 AC_000176.1 75 22 6.49E-05 2.14E-04 2.856 0.531397 
RAB37 AC_000176.1 75 25 2.10E-04 6.22E-04 2.856 0.531397 
RAB37 AC_000176.1 75 10 4.51E-08 2.16E-07 2.856 0.531397 
TTYH2 AC_000176.1 0 100 2.22E-19 2.32E-18 0.01 2.69215 
TTYH2 AC_000176.1 0 100 2.22E-19 2.32E-18 0.01 2.69215 
TTYH2 AC_000176.1 0 85 1.66E-16 1.56E-15 0.01 2.69215 
TTYH2 AC_000176.1 0 100 2.22E-19 2.32E-18 0.01 2.69215 
SLC39A11 AC_000176.1 0 100 2.22E-19 2.32E-18 0.182 10.2451 
SLC39A11 AC_000176.1 0 100 2.22E-19 2.32E-18 0.182 10.2451 
SLC39A11 AC_000176.1 0 100 2.22E-19 2.32E-18 0.182 10.2451 
SLC39A11 AC_000176.1 0 100 2.22E-19 2.32E-18 0.182 10.2451 
SLC39A11 AC_000176.1 0 100 2.22E-19 2.32E-18 0.182 10.2451 
SLC39A11 AC_000176.1 0 100 2.22E-19 2.32E-18 0.182 10.2451 
ARSG AC_000176.1 0 100 2.22E-19 2.32E-18 0.088 0.503372 
ARSG AC_000176.1 0 83 3.95E-16 3.44E-15 0.088 0.503372 
ARSG AC_000176.1 0 85 1.66E-16 1.56E-15 0.088 0.503372 
RGS9 AC_000176.1 83 0 3.95E-16 3.44E-15 0.307 0.266382 
RGS9 AC_000176.1 0 100 2.22E-19 2.32E-18 0.307 0.266382 
RGS9 AC_000176.1 0 100 2.22E-19 2.32E-18 0.307 0.266382 
PRKCA AC_000176.1 0 100 2.22E-19 2.32E-18 3.412 1.8482 
LIMS2 AC_000159.1 0 80 1.24E-15 9.79E-15 0.03 12.1793 
BIN1 AC_000159.1 0 100 2.22E-19 2.32E-18 0.059 2.75044 
BIN1 AC_000159.1 20 87 1.14E-06 4.73E-06 0.059 2.75044 
BIN1 AC_000159.1 0 100 2.22E-19 2.32E-18 0.059 2.75044 
BIN1 AC_000159.1 0 100 2.22E-19 2.32E-18 0.059 2.75044 
BIN1 AC_000159.1 0 100 2.22E-19 2.32E-18 0.059 2.75044 
BIN1 AC_000159.1 0 88 3.94E-17 3.96E-16 0.059 2.75044 
BIN1 AC_000159.1 16 100 1.86E-09 1.05E-08 0.059 2.75044 
BIN1 AC_000159.1 0 100 2.22E-19 2.32E-18 0.059 2.75044 
BIN1 AC_000159.1 0 100 2.22E-19 2.32E-18 0.059 2.75044 
GAD1 AC_000159.1 100 0 2.22E-19 2.32E-18 10.777 0.625979 
GLI2 AC_000159.1 0 100 2.22E-19 2.32E-18 2.17 0.233586 
TFCP2L1 AC_000159.1 0 100 2.22E-19 2.32E-18 0.037 1.95606 
TFCP2L1 AC_000159.1 0 100 2.22E-19 2.32E-18 0.037 1.95606 
4-Mar AC_000159.1 0 100 2.22E-19 2.32E-18 0.089 0.0251621 
TNS1 AC_000159.1 0 100 2.22E-19 2.32E-18 0.237 8.80054 
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TNS1 AC_000159.1 0 85 1.66E-16 1.56E-15 0.237 8.80054 
TNS1 AC_000159.1 20 100 2.92E-08 1.49E-07 0.237 8.80054 
TNS1 AC_000159.1 20 100 2.92E-08 1.49E-07 0.237 8.80054 
SPEG AC_000159.1 0 100 2.22E-19 2.32E-18 0.872 0.286045 
OBSL1 AC_000159.1 0 100 2.22E-19 2.32E-18 0.406 1.48814 
OBSL1 AC_000159.1 0 100 2.22E-19 2.32E-18 0.406 1.48814 
SLC4A3 AC_000159.1 0 100 2.22E-19 2.32E-18 0.033 1.40557 
TMEM54 AC_000159.1 0 100 2.22E-19 2.32E-18 0.367 0.0103144 
FGR AC_000159.1 0 100 2.22E-19 2.32E-18 4.108 0.765796 
FGR AC_000159.1 0 85 1.66E-16 1.56E-15 4.108 0.765796 
UBXN11 AC_000159.1 0 100 2.22E-19 2.32E-18 1.157 25.2103 
RUNX3 AC_000159.1 0 100 2.22E-19 2.32E-18 0.047 1.51401 
EPHB2 AC_000159.1 0 100 2.22E-19 2.32E-18 0.42 0.528627 
EPHB2 AC_000159.1 0 100 2.22E-19 2.32E-18 0.42 0.528627 
EPHB2 AC_000159.1 0 100 2.22E-19 2.32E-18 0.42 0.528627 
EPHB2 AC_000159.1 0 100 2.22E-19 2.32E-18 0.42 0.528627 
EPHB2 AC_000159.1 0 100 2.22E-19 2.32E-18 0.42 0.528627 
RAP1GAP AC_000159.1 0 100 2.22E-19 2.32E-18 0.052 2.88221 
RAP1GAP AC_000159.1 0 100 2.22E-19 2.32E-18 0.052 2.88221 
RAP1GAP AC_000159.1 0 100 2.22E-19 2.32E-18 0.052 2.88221 
RAP1GAP AC_000159.1 0 100 2.22E-19 2.32E-18 0.052 2.88221 
RAP1GAP AC_000159.1 0 85 1.66E-16 1.56E-15 0.052 2.88221 
RAP1GAP AC_000159.1 16 100 1.86E-09 1.05E-08 0.052 2.88221 
KIF17 AC_000159.1 0 83 3.95E-16 3.44E-15 1.718 4.03725 
KIF17 AC_000159.1 0 100 2.22E-19 2.32E-18 1.718 4.03725 
KIF17 AC_000159.1 0 100 2.22E-19 2.32E-18 1.718 4.03725 
AKR7A2 AC_000159.1 0 100 2.22E-19 2.32E-18 20.822 10.6193 
AKR7A2 AC_000159.1 0 100 2.22E-19 2.32E-18 20.822 10.6193 
PADI1 AC_000159.1 0 100 2.22E-19 2.32E-18 0.039 0.00684407 
LCP2 AC_000177.1 80 12 4.35E-08 2.09E-07 1.715 0.857954 
LCP2 AC_000177.1 75 20 2.62E-05 9.12E-05 1.715 0.857954 
SLC38A9 AC_000177.1 80 0 1.24E-15 9.79E-15 23.787 12.0679 
SLC9A3 AC_000177.1 0 100 2.22E-19 2.32E-18 0.518 0.282475 
MRPS11 AC_000178.1 75 21 3.99E-05 1.35E-04 5.9 1.91452 
SLC28A1 AC_000178.1 100 15 9.23E-10 5.35E-09 23.765 0.0796632 
RASGRF1 AC_000178.1 0 100 2.22E-19 2.32E-18 5.526 0.237718 
APBA2 AC_000178.1 0 100 2.22E-19 2.32E-18 0.009 0.122996 
SNX33 AC_000178.1 0 100 2.22E-19 2.32E-18 0.025 2.69601 
LOXL1 AC_000178.1 0 100 2.22E-19 2.32E-18 0.117 5.00407 
LOXL1 AC_000178.1 0 100 2.22E-19 2.32E-18 0.117 5.00407 
LOXL1 AC_000178.1 0 80 1.24E-15 9.79E-15 0.117 5.00407 
FRMD5 AC_000178.1 88 14 1.67E-08 8.86E-08 5.627 0.203298 
FRMD5 AC_000178.1 100 25 5.20E-07 2.28E-06 5.627 0.203298 
FRMD5 AC_000178.1 80 20 6.94E-06 2.60E-05 5.627 0.203298 
IFI27 AC_000178.1 0 100 2.22E-19 2.32E-18 2.061 0.682495 
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KRTCAP2 AC_000178.1 0 100 2.22E-19 2.32E-18 66.354 13.6621 
BEGAIN AC_000178.1 0 100 2.22E-19 2.32E-18 0.026 0.239427 
EXOC3L4 AC_000178.1 0 100 2.22E-19 2.32E-18 0.104 0.202865 
TNFAIP2 AC_000178.1 0 100 2.22E-19 2.32E-18 0.041 3.27001 
TNFAIP2 AC_000178.1 0 100 2.22E-19 2.32E-18 0.041 3.27001 
SCN5A AC_000179.1 0 100 2.22E-19 2.32E-18 8.015 0.949517 
SCN5A AC_000179.1 0 100 2.22E-19 2.32E-18 8.015 0.949517 
SLC25A38 AC_000179.1 0 100 2.22E-19 2.32E-18 6.859 2.83743 
SYNPR AC_000179.1 83 22 9.08E-06 3.37E-05 0.827 0.493366 
SYNPR AC_000179.1 75 20 2.62E-05 9.12E-05 0.827 0.493366 
ERC2 AC_000179.1 83 0 3.95E-16 3.44E-15 6.3 0.399069 
ERC2 AC_000179.1 80 16 7.24E-07 3.14E-06 6.3 0.399069 
POC1A AC_000179.1 0 83 3.95E-16 3.44E-15 24.123 18.5052 
GRM2 AC_000179.1 0 80 1.24E-15 9.79E-15 0.412 0.063472 
SLC38A3 AC_000179.1 0 100 2.22E-19 2.32E-18 1.596 0.00938683 
LAMB2 AC_000179.1 0 100 2.22E-19 2.32E-18 0.037 0.0489692 
LAMB2 AC_000179.1 0 83 3.95E-16 3.44E-15 0.037 0.0489692 
LAMB2 AC_000179.1 16 100 1.86E-09 1.05E-08 0.037 0.0489692 
CSPG5 AC_000179.1 0 100 2.22E-19 2.32E-18 2.17 21.0075 
CSPG5 AC_000179.1 0 100 2.22E-19 2.32E-18 2.17 21.0075 
CSPG5 AC_000179.1 0 80 1.24E-15 9.79E-15 2.17 21.0075 
PTH1R AC_000179.1 0 100 2.22E-19 2.32E-18 0.034 1.46063 
PTH1R AC_000179.1 0 80 1.24E-15 9.79E-15 0.034 1.46063 
PTH1R AC_000179.1 0 100 2.22E-19 2.32E-18 0.034 1.46063 
PTH1R AC_000179.1 0 100 2.22E-19 2.32E-18 0.034 1.46063 
PTH1R AC_000179.1 0 100 2.22E-19 2.32E-18 0.034 1.46063 
LIMD1 AC_000179.1 0 100 2.22E-19 2.32E-18 0.854 0.771372 
ATP2B2 AC_000179.1 0 100 2.22E-19 2.32E-18 0.009 0.118503 
ATP2B2 AC_000179.1 0 100 2.22E-19 2.32E-18 0.009 0.118503 
ATP2B2 AC_000179.1 0 100 2.22E-19 2.32E-18 0.009 0.118503 
RHO AC_000179.1 0 100 2.22E-19 2.32E-18 0.131 0.102191 
SLC6A6 AC_000179.1 0 100 2.22E-19 2.32E-18 0.039 8.29457 
SLC6A6 AC_000179.1 0 100 2.22E-19 2.32E-18 0.039 8.29457 
SLC6A6 AC_000179.1 0 100 2.22E-19 2.32E-18 0.039 8.29457 
SLC6A6 AC_000179.1 0 100 2.22E-19 2.32E-18 0.039 8.29457 
SLC6A6 AC_000179.1 0 100 2.22E-19 2.32E-18 0.039 8.29457 
SLC6A6 AC_000179.1 0 100 2.22E-19 2.32E-18 0.039 8.29457 
TMEM43 AC_000179.1 0 100 2.22E-19 2.32E-18 39.068 14.655 
HDAC11 AC_000179.1 0 83 3.95E-16 3.44E-15 4.063 28.2128 
NUP210 AC_000179.1 0 100 2.22E-19 2.32E-18 0.36 2.69E-06 
NUP210 AC_000179.1 0 100 2.22E-19 2.32E-18 0.36 2.69E-06 
NUP210 AC_000179.1 0 100 2.22E-19 2.32E-18 0.36 2.69E-06 
NUP210 AC_000179.1 0 100 2.22E-19 2.32E-18 0.36 2.69E-06 
NUP210 AC_000179.1 0 100 2.22E-19 2.32E-18 0.36 2.69E-06 
NUP210 AC_000179.1 0 100 2.22E-19 2.32E-18 0.36 2.69E-06 
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NUP210 AC_000179.1 0 100 2.22E-19 2.32E-18 0.36 2.69E-06 
NUP210 AC_000179.1 0 100 2.22E-19 2.32E-18 0.36 2.69E-06 
NUP210 AC_000179.1 0 100 2.22E-19 2.32E-18 0.36 2.69E-06 
GATA2 AC_000179.1 0 100 2.22E-19 2.32E-18 21.446 1.24153 
EEFSEC AC_000179.1 0 100 2.22E-19 2.32E-18 0.386 3.16696 
EEFSEC AC_000179.1 0 100 2.22E-19 2.32E-18 0.386 3.16696 
EEFSEC AC_000179.1 0 100 2.22E-19 2.32E-18 0.386 3.16696 
EEFSEC AC_000179.1 0 100 2.22E-19 2.32E-18 0.386 3.16696 
EEFSEC AC_000179.1 0 100 2.22E-19 2.32E-18 0.386 3.16696 
EEFSEC AC_000179.1 0 85 1.66E-16 1.56E-15 0.386 3.16696 
KLF15 AC_000179.1 100 0 2.22E-19 2.32E-18 0.159 2.02475 
ITPR3 AC_000180.1 0 100 2.22E-19 2.32E-18 0.419 15.3446 
LEMD2 AC_000180.1 20 87 1.14E-06 4.73E-06 0.012 4.92624 
NFKBIE AC_000180.1 0 100 2.22E-19 2.32E-18 13.733 4.98304 
MSH5 AC_000180.1 0 100 2.22E-19 2.32E-18 32.708 4.41634 
HIST1H1C AC_000180.1 80 12 4.35E-08 2.09E-07 154.3 0.347191 
TFAP2A AC_000180.1 100 0 2.22E-19 2.32E-18 0.195 0.580145 
NRN1 AC_000180.1 0 100 2.22E-19 2.32E-18 0.097 0.237949 
PXDC1 AC_000180.1 0 100 2.22E-19 2.32E-18 0.098 0.305641 
PXDC1 AC_000180.1 0 100 2.22E-19 2.32E-18 0.098 0.305641 
PXDC1 AC_000180.1 0 100 2.22E-19 2.32E-18 0.098 0.305641 
SLC22A23 AC_000180.1 0 100 2.22E-19 2.32E-18 0.015 1.59637 
SLC22A23 AC_000180.1 0 100 2.22E-19 2.32E-18 0.015 1.59637 
SLC22A23 AC_000180.1 0 88 3.94E-17 3.96E-16 0.015 1.59637 
GMDS AC_000180.1 20 100 2.92E-08 1.49E-07 1.399 29.0845 
GMDS AC_000180.1 0 80 1.24E-15 9.79E-15 1.399 29.0845 
NFATC1 AC_000181.1 0 100 2.22E-19 2.32E-18 0.291 0.256695 
NFATC1 AC_000181.1 0 100 2.22E-19 2.32E-18 0.291 0.256695 
NFATC1 AC_000181.1 0 100 2.22E-19 2.32E-18 0.291 0.256695 
NFATC1 AC_000181.1 0 100 2.22E-19 2.32E-18 0.291 0.256695 
NFATC1 AC_000181.1 0 100 2.22E-19 2.32E-18 0.291 0.256695 
NFATC1 AC_000181.1 0 100 2.22E-19 2.32E-18 0.291 0.256695 
NFATC1 AC_000181.1 0 87 7.02E-17 6.88E-16 0.291 0.256695 
NFATC1 AC_000181.1 0 87 7.02E-17 6.88E-16 0.291 0.256695 
NFATC1 AC_000181.1 0 83 3.95E-16 3.44E-15 0.291 0.256695 
NFATC1 AC_000181.1 20 100 2.92E-08 1.49E-07 0.291 0.256695 
NFATC1 AC_000181.1 0 100 2.22E-19 2.32E-18 0.291 0.256695 
CELF4 AC_000181.1 0 100 2.22E-19 2.32E-18 0.169 0.498227 
CELF4 AC_000181.1 0 100 2.22E-19 2.32E-18 0.169 0.498227 
CELF4 AC_000181.1 0 100 2.22E-19 2.32E-18 0.169 0.498227 
CELF4 AC_000181.1 0 100 2.22E-19 2.32E-18 0.169 0.498227 
CELF4 AC_000181.1 100 14 3.79E-10 2.31E-09 0.169 0.498227 
CELF4 AC_000181.1 0 100 2.22E-19 2.32E-18 0.169 0.498227 
CELF4 AC_000181.1 0 100 2.22E-19 2.32E-18 0.169 0.498227 
CELF4 AC_000181.1 0 100 2.22E-19 2.32E-18 0.169 0.498227 
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CELF4 AC_000181.1 0 100 2.22E-19 2.32E-18 0.169 0.498227 
CELF4 AC_000181.1 0 100 2.22E-19 2.32E-18 0.169 0.498227 
CELF4 AC_000181.1 0 100 2.22E-19 2.32E-18 0.169 0.498227 
CELF4 AC_000181.1 0 100 2.22E-19 2.32E-18 0.169 0.498227 
CELF4 AC_000181.1 0 100 2.22E-19 2.32E-18 0.169 0.498227 
CELF4 AC_000181.1 0 100 2.22E-19 2.32E-18 0.169 0.498227 
CELF4 AC_000181.1 0 90 1.66E-17 1.70E-16 0.169 0.498227 
RHBDF1 AC_000182.1 100 0 2.22E-19 2.32E-18 1.067 1.15272 
RHBDF1 AC_000182.1 100 0 2.22E-19 2.32E-18 1.067 1.15272 
ABCA3 AC_000182.1 0 100 2.22E-19 2.32E-18 0.347 5.89378 
CORO7 AC_000182.1 0 85 1.66E-16 1.56E-15 0.265 2.71946 
CORO7 AC_000182.1 0 83 3.95E-16 3.44E-15 0.265 2.71946 
RBFOX1 AC_000182.1 80 22 1.84E-05 6.52E-05 0.646 0.038647 
RBFOX1 AC_000182.1 0 100 2.22E-19 2.32E-18 0.646 0.038647 
ABAT AC_000182.1 20 100 2.92E-08 1.49E-07 9.507 13.3077 
ABCC6 AC_000182.1 0 100 2.22E-19 2.32E-18 0.027 8.03E-08 
RABEP2 AC_000182.1 0 80 1.24E-15 9.79E-15 2.217 3.18206 
ELN AC_000182.1 0 100 2.22E-19 2.32E-18 8.902 89.7002 
ELN AC_000182.1 0 100 2.22E-19 2.32E-18 8.902 89.7002 
COL26A1 AC_000182.1 0 100 2.22E-19 2.32E-18 0.018 0.355506 
TRIM56 AC_000182.1 0 100 2.22E-19 2.32E-18 0.621 0.267774 
TRIM56 AC_000182.1 0 85 1.66E-16 1.56E-15 0.621 0.267774 
ACHE AC_000182.1 0 100 2.22E-19 2.32E-18 0.018 2.36354 
MEPCE AC_000182.1 100 0 2.22E-19 2.32E-18 20.474 134.825 
SLC29A4 AC_000182.1 0 100 2.22E-19 2.32E-18 24.313 0.192267 
CARD11 AC_000182.1 0 100 2.22E-19 2.32E-18 0.007 0.584971 
CARD11 AC_000182.1 20 80 6.94E-06 2.60E-05 0.007 0.584971 
CARD11 AC_000182.1 0 100 2.22E-19 2.32E-18 0.007 0.584971 
MICALL2 AC_000182.1 0 100 2.22E-19 2.32E-18 0.044 0.182125 
C25H7orf50 AC_000182.1 0 83 3.95E-16 3.44E-15 1.02 3.55481 
C25H7orf50 AC_000182.1 0 100 2.22E-19 2.32E-18 1.02 3.55481 
PRKG1 AC_000183.1 83 0 3.95E-16 3.44E-15 25.31 2.01529 
SUFU AC_000183.1 0 100 2.22E-19 2.32E-18 1.2 3.82115 
SUFU AC_000183.1 0 100 2.22E-19 2.32E-18 1.2 3.82115 
SUFU AC_000183.1 0 87 7.02E-17 6.88E-16 1.2 3.82115 
SUFU AC_000183.1 0 100 2.22E-19 2.32E-18 1.2 3.82115 
SUFU AC_000183.1 0 100 2.22E-19 2.32E-18 1.2 3.82115 
NEURL1 AC_000183.1 0 100 2.22E-19 2.32E-18 0.024 2.93028 
SORCS3 AC_000183.1 0 100 2.22E-19 2.32E-18 7.95 20.632 
SORCS3 AC_000183.1 14 100 3.79E-10 2.31E-09 7.95 20.632 
SORCS3 AC_000183.1 0 100 2.22E-19 2.32E-18 7.95 20.632 
SORCS3 AC_000183.1 100 12 6.45E-11 4.07E-10 7.95 20.632 
SORCS3 AC_000183.1 0 100 2.22E-19 2.32E-18 7.95 20.632 
SORCS3 AC_000183.1 0 100 2.22E-19 2.32E-18 7.95 20.632 
SORCS3 AC_000183.1 12 100 6.45E-11 4.07E-10 7.95 20.632 
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LHPP AC_000183.1 0 83 3.95E-16 3.44E-15 0.303 2.59394 
LHPP AC_000183.1 0 100 2.22E-19 2.32E-18 0.303 2.59394 
LHPP AC_000183.1 0 100 2.22E-19 2.32E-18 0.303 2.59394 
MYOM2 AC_000184.1 0 100 2.22E-19 2.32E-18 0.057 0.0286405 
MYOM2 AC_000184.1 0 80 1.24E-15 9.79E-15 0.057 0.0286405 
MYOM2 AC_000184.1 0 100 2.22E-19 2.32E-18 0.057 0.0286405 
MYOM2 AC_000184.1 0 100 2.22E-19 2.32E-18 0.057 0.0286405 
MYOM2 AC_000184.1 0 100 2.22E-19 2.32E-18 0.057 0.0286405 
MYOM2 AC_000184.1 0 90 1.66E-17 1.70E-16 0.057 0.0286405 
WRN AC_000184.1 87 0 7.02E-17 6.88E-16 20.063 8.79611 
WRN AC_000184.1 75 0 1.25E-14 9.63E-14 20.063 8.79611 
WRN AC_000184.1 77 5 9.69E-11 6.06E-10 20.063 8.79611 
WRN AC_000184.1 100 0 2.22E-19 2.32E-18 20.063 8.79611 
WRN AC_000184.1 85 0 1.66E-16 1.56E-15 20.063 8.79611 
WRN AC_000184.1 75 0 1.25E-14 9.63E-14 20.063 8.79611 
WRN AC_000184.1 84 4 1.55E-12 1.10E-11 20.063 8.79611 
WRN AC_000184.1 100 13 1.74E-10 1.08E-09 20.063 8.79611 
WRN AC_000184.1 93 17 3.16E-08 1.61E-07 20.063 8.79611 
WRN AC_000184.1 75 10 4.51E-08 2.16E-07 20.063 8.79611 
WRN AC_000184.1 94 18 4.57E-08 2.19E-07 20.063 8.79611 
WRN AC_000184.1 100 0 2.22E-19 2.32E-18 20.063 8.79611 
WRN AC_000184.1 100 0 2.22E-19 2.32E-18 20.063 8.79611 
WRN AC_000184.1 87 0 7.02E-17 6.88E-16 20.063 8.79611 
WRN AC_000184.1 75 0 1.25E-14 9.63E-14 20.063 8.79611 
WRN AC_000184.1 100 6 6.67E-14 5.10E-13 20.063 8.79611 
WRN AC_000184.1 100 13 1.74E-10 1.08E-09 20.063 8.79611 
WRN AC_000184.1 92 12 9.13E-10 5.30E-09 20.063 8.79611 
WRN AC_000184.1 93 13 1.56E-09 8.97E-09 20.063 8.79611 
WRN AC_000184.1 100 17 4.16E-09 2.32E-08 20.063 8.79611 
WRN AC_000184.1 87 13 1.05E-08 5.72E-08 20.063 8.79611 
WRN AC_000184.1 100 21 5.72E-08 2.73E-07 20.063 8.79611 
WRN AC_000184.1 93 20 2.22E-07 1.00E-06 20.063 8.79611 
WRN AC_000184.1 78 25 1.11E-04 3.51E-04 20.063 8.79611 
WRN AC_000184.1 93 0 5.27E-18 5.48E-17 20.063 8.79611 
WRN AC_000184.1 100 5 1.69E-14 1.30E-13 20.063 8.79611 
WRN AC_000184.1 100 7 2.90E-13 2.15E-12 20.063 8.79611 
WRN AC_000184.1 85 7 6.35E-11 4.03E-10 20.063 8.79611 
WRN AC_000184.1 100 12 6.45E-11 4.07E-10 20.063 8.79611 
WRN AC_000184.1 86 12 6.41E-09 3.54E-08 20.063 8.79611 
WRN AC_000184.1 83 16 3.25E-07 1.45E-06 20.063 8.79611 
WRN AC_000184.1 80 22 1.84E-05 6.52E-05 20.063 8.79611 
RNF122 AC_000184.1 75 0 1.25E-14 9.63E-14 8.137 10.1717 
RNF122 AC_000184.1 100 12 6.45E-11 4.07E-10 8.137 10.1717 
RNF122 AC_000184.1 100 23 1.80E-07 8.23E-07 8.137 10.1717 
RNF122 AC_000184.1 20 83 3.33E-06 1.30E-05 8.137 10.1717 
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RNF122 AC_000184.1 80 22 1.84E-05 6.52E-05 8.137 10.1717 
RNF122 AC_000184.1 85 0 1.66E-16 1.56E-15 8.137 10.1717 
RNF122 AC_000184.1 100 11 2.69E-11 1.74E-10 8.137 10.1717 
RNF122 AC_000184.1 100 20 2.92E-08 1.49E-07 8.137 10.1717 
RNF122 AC_000184.1 80 16 7.24E-07 3.14E-06 8.137 10.1717 
RNF122 AC_000184.1 83 0 3.95E-16 3.44E-15 8.137 10.1717 
RNF122 AC_000184.1 80 0 1.24E-15 9.79E-15 8.137 10.1717 
RNF122 AC_000184.1 77 0 5.26E-15 4.10E-14 8.137 10.1717 
RNF122 AC_000184.1 100 0 2.22E-19 2.32E-18 8.137 10.1717 
RNF122 AC_000184.1 87 0 7.02E-17 6.88E-16 8.137 10.1717 
RNF122 AC_000184.1 80 0 1.24E-15 9.79E-15 8.137 10.1717 
RNF122 AC_000184.1 0 91 1.25E-17 1.29E-16 8.137 10.1717 
RNF122 AC_000184.1 83 0 3.95E-16 3.44E-15 8.137 10.1717 
RNF122 AC_000184.1 100 20 2.92E-08 1.49E-07 8.137 10.1717 
RNF122 AC_000184.1 82 25 4.09E-05 1.38E-04 8.137 10.1717 
RNF122 AC_000184.1 100 14 3.79E-10 2.31E-09 8.137 10.1717 
RNF122 AC_000184.1 80 0 1.24E-15 9.79E-15 8.137 10.1717 
RNF122 AC_000184.1 80 7 4.23E-10 2.58E-09 8.137 10.1717 
RNF122 AC_000184.1 100 17 4.16E-09 2.32E-08 8.137 10.1717 
RNF122 AC_000184.1 100 20 2.92E-08 1.49E-07 8.137 10.1717 
RNF122 AC_000184.1 100 0 2.22E-19 2.32E-18 8.137 10.1717 
RNF122 AC_000184.1 80 7 4.23E-10 2.58E-09 8.137 10.1717 
RNF122 AC_000184.1 75 6 8.00E-10 4.66E-09 8.137 10.1717 
RNF122 AC_000184.1 90 14 8.99E-09 4.88E-08 8.137 10.1717 
RNF122 AC_000184.1 80 11 2.08E-08 1.09E-07 8.137 10.1717 
RNF122 AC_000184.1 100 16 1.86E-09 1.05E-08 8.137 10.1717 
RNF122 AC_000184.1 85 11 3.76E-09 2.10E-08 8.137 10.1717 
RNF122 AC_000184.1 88 13 7.12E-09 3.90E-08 8.137 10.1717 
RNF122 AC_000184.1 75 12 2.23E-07 1.01E-06 8.137 10.1717 
RNF122 AC_000184.1 85 18 6.32E-07 2.76E-06 8.137 10.1717 
RNF122 AC_000184.1 83 0 3.95E-16 3.44E-15 8.137 10.1717 
RNF122 AC_000184.1 87 15 4.73E-08 2.27E-07 8.137 10.1717 
RNF122 AC_000184.1 87 17 1.82E-07 8.30E-07 8.137 10.1717 
RNF122 AC_000184.1 100 7 2.90E-13 2.15E-12 8.137 10.1717 
RNF122 AC_000184.1 87 10 7.04E-10 4.10E-09 8.137 10.1717 
RNF122 AC_000184.1 81 20 5.62E-06 2.16E-05 8.137 10.1717 
RNF122 AC_000184.1 100 0 2.22E-19 2.32E-18 8.137 10.1717 
RNF122 AC_000184.1 100 9 3.27E-12 2.29E-11 8.137 10.1717 
RNF122 AC_000184.1 80 23 3.02E-05 1.03E-04 8.137 10.1717 
RNF122 AC_000184.1 80 25 7.02E-05 2.30E-04 8.137 10.1717 
RNF122 AC_000184.1 83 0 3.95E-16 3.44E-15 8.137 10.1717 
RNF122 AC_000184.1 80 8 1.14E-09 6.61E-09 8.137 10.1717 
RNF122 AC_000184.1 11 75 9.55E-08 4.50E-07 8.137 10.1717 
RNF122 AC_000184.1 80 20 6.94E-06 2.60E-05 8.137 10.1717 
RNF122 AC_000184.1 0 75 1.25E-14 9.63E-14 8.137 10.1717 
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RNF122 AC_000184.1 100 13 1.74E-10 1.08E-09 8.137 10.1717 
RNF122 AC_000184.1 80 14 1.93E-07 8.74E-07 8.137 10.1717 
RNF122 AC_000184.1 80 20 6.94E-06 2.60E-05 8.137 10.1717 
RNF122 AC_000184.1 80 6 1.16E-10 7.26E-10 8.137 10.1717 
RNF122 AC_000184.1 80 17 1.41E-06 5.80E-06 8.137 10.1717 
RNF122 AC_000184.1 83 20 3.33E-06 1.30E-05 8.137 10.1717 
RNF122 AC_000184.1 80 23 3.02E-05 1.03E-04 8.137 10.1717 
RNF122 AC_000184.1 0 83 3.95E-16 3.44E-15 8.137 10.1717 
RNF122 AC_000184.1 80 0 1.24E-15 9.79E-15 8.137 10.1717 
RNF122 AC_000184.1 100 9 3.27E-12 2.29E-11 8.137 10.1717 
RNF122 AC_000184.1 100 11 2.69E-11 1.74E-10 8.137 10.1717 
RNF122 AC_000184.1 80 14 1.93E-07 8.74E-07 8.137 10.1717 
RNF122 AC_000184.1 75 16 3.16E-06 1.24E-05 8.137 10.1717 
RNF122 AC_000184.1 86 22 4.04E-06 1.58E-05 8.137 10.1717 
RNF122 AC_000184.1 83 23 1.39E-05 5.01E-05 8.137 10.1717 
RNF122 AC_000184.1 85 0 1.66E-16 1.56E-15 8.137 10.1717 
RNF122 AC_000184.1 80 0 1.24E-15 9.79E-15 8.137 10.1717 
RNF122 AC_000184.1 100 16 1.86E-09 1.05E-08 8.137 10.1717 
RNF122 AC_000184.1 87 18 3.61E-07 1.61E-06 8.137 10.1717 
RNF122 AC_000184.1 83 22 9.08E-06 3.37E-05 8.137 10.1717 
RNF122 AC_000184.1 80 0 1.24E-15 9.79E-15 8.137 10.1717 
RNF122 AC_000184.1 83 12 1.81E-08 9.56E-08 8.137 10.1717 
RNF122 AC_000184.1 16 77 1.60E-06 6.57E-06 8.137 10.1717 
RNF122 AC_000184.1 75 20 2.62E-05 9.12E-05 8.137 10.1717 
RNF122 AC_000184.1 88 0 3.94E-17 3.96E-16 8.137 10.1717 
RNF122 AC_000184.1 80 14 1.93E-07 8.74E-07 8.137 10.1717 
RNF122 AC_000184.1 87 24 8.58E-06 3.19E-05 8.137 10.1717 
RNF122 AC_000184.1 78 0 2.95E-15 2.32E-14 8.137 10.1717 
RNF122 AC_000184.1 88 16 7.03E-08 3.34E-07 8.137 10.1717 
RNF122 AC_000184.1 14 80 1.93E-07 8.74E-07 8.137 10.1717 
RNF122 AC_000184.1 92 12 9.13E-10 5.30E-09 8.137 10.1717 
RNF122 AC_000184.1 83 18 1.10E-06 4.57E-06 8.137 10.1717 
RNF122 AC_000184.1 88 21 1.36E-06 5.60E-06 8.137 10.1717 
RNF122 AC_000184.1 100 0 2.22E-19 2.32E-18 8.137 10.1717 
RNF122 AC_000184.1 85 0 1.66E-16 1.56E-15 8.137 10.1717 
RNF122 AC_000184.1 85 0 1.66E-16 1.56E-15 8.137 10.1717 
RNF122 AC_000184.1 100 7 2.90E-13 2.15E-12 8.137 10.1717 
RNF122 AC_000184.1 83 5 1.01E-11 6.62E-11 8.137 10.1717 
RNF122 AC_000184.1 80 15 4.06E-07 1.80E-06 8.137 10.1717 
RNF122 AC_000184.1 80 0 1.24E-15 9.79E-15 8.137 10.1717 
RNF122 AC_000184.1 100 11 2.69E-11 1.74E-10 8.137 10.1717 
RNF122 AC_000184.1 75 9 1.70E-08 8.98E-08 8.137 10.1717 
RNF122 AC_000184.1 80 15 4.06E-07 1.80E-06 8.137 10.1717 
RNF122 AC_000184.1 80 23 3.02E-05 1.03E-04 8.137 10.1717 
RNF122 AC_000184.1 87 14 2.45E-08 1.29E-07 8.137 10.1717 
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RNF122 AC_000184.1 100 20 2.92E-08 1.49E-07 8.137 10.1717 
RNF122 AC_000184.1 77 17 3.06E-06 1.21E-05 8.137 10.1717 
RNF122 AC_000184.1 80 20 6.94E-06 2.60E-05 8.137 10.1717 
RNF122 AC_000184.1 75 22 6.49E-05 2.14E-04 8.137 10.1717 
RNF122 AC_000184.1 88 18 2.56E-07 1.15E-06 8.137 10.1717 
RNF122 AC_000184.1 25 75 2.10E-04 6.22E-04 8.137 10.1717 
RNF122 AC_000184.1 100 0 2.22E-19 2.32E-18 8.137 10.1717 
RNF122 AC_000184.1 100 10 8.84E-12 5.80E-11 8.137 10.1717 
RNF122 AC_000184.1 100 10 8.84E-12 5.80E-11 8.137 10.1717 
RNF122 AC_000184.1 88 8 6.85E-11 4.32E-10 8.137 10.1717 
RNF122 AC_000184.1 85 10 1.65E-09 9.47E-09 8.137 10.1717 
RNF122 AC_000184.1 88 12 3.36E-09 1.88E-08 8.137 10.1717 
RNF122 AC_000184.1 77 20 1.58E-05 5.68E-05 8.137 10.1717 
RNF122 AC_000184.1 100 0 2.22E-19 2.32E-18 8.137 10.1717 
RNF122 AC_000184.1 80 12 4.35E-08 2.09E-07 8.137 10.1717 
RNF122 AC_000184.1 88 16 7.03E-08 3.34E-07 8.137 10.1717 
RNF122 AC_000184.1 75 6 8.00E-10 4.66E-09 8.137 10.1717 
RNF122 AC_000184.1 87 10 8.39E-10 4.88E-09 8.137 10.1717 
RNF122 AC_000184.1 100 16 1.86E-09 1.05E-08 8.137 10.1717 
RNF122 AC_000184.1 88 16 7.03E-08 3.34E-07 8.137 10.1717 
RNF122 AC_000184.1 100 18 7.85E-09 4.28E-08 8.137 10.1717 
RNF122 AC_000184.1 90 20 4.80E-07 2.11E-06 8.137 10.1717 
UNC5D AC_000184.1 100 5 1.69E-14 1.30E-13 5.798 0.293699 
UNC5D AC_000184.1 96 15 3.22E-09 1.80E-08 5.798 0.293699 
UNC5D AC_000184.1 100 24 2.94E-07 1.32E-06 5.798 0.293699 
UNC5D AC_000184.1 83 24 2.27E-05 7.98E-05 5.798 0.293699 
FGFR1 AC_000184.1 0 100 2.22E-19 2.32E-18 1.128 4.27163 
FGFR1 AC_000184.1 12 100 6.45E-11 4.07E-10 1.128 4.27163 
SFRP1 AC_000184.1 0 100 2.22E-19 2.32E-18 2.73 0.563249 
SFRP1 AC_000184.1 0 100 2.22E-19 2.32E-18 2.73 0.563249 
CSGALNACT1 AC_000184.1 0 100 2.22E-19 2.32E-18 0.037 2.32425 
ADAMTS14 AC_000185.1 0 80 1.24E-15 9.79E-15 0.207 0.0820264 
CDH23 AC_000185.1 100 0 2.22E-19 2.32E-18 20.334 0.962554 
CDH23 AC_000185.1 0 100 2.22E-19 2.32E-18 20.334 0.962554 
ANXA8L1 AC_000185.1 0 100 2.22E-19 2.32E-18 0.02 0.00748011 
ANXA8L1 AC_000185.1 0 100 2.22E-19 2.32E-18 0.02 0.00748011 
PKNOX2 AC_000186.1 0 100 2.22E-19 2.32E-18 0.007 1.20047 
PKNOX2 AC_000186.1 0 100 2.22E-19 2.32E-18 0.007 1.20047 
KIRREL3 AC_000186.1 0 83 3.95E-16 3.44E-15 0.014 0.26713 
KIRREL3 AC_000186.1 77 7 1.12E-09 6.47E-09 0.014 0.26713 
KIRREL3 AC_000186.1 95 14 2.01E-09 1.14E-08 0.014 0.26713 
KIRREL3 AC_000186.1 80 18 2.38E-06 9.54E-06 0.014 0.26713 
KIRREL3 AC_000186.1 76 18 7.00E-06 2.61E-05 0.014 0.26713 
KIRREL3 AC_000186.1 80 22 1.84E-05 6.52E-05 0.014 0.26713 
KIRREL3 AC_000186.1 75 22 6.49E-05 2.14E-04 0.014 0.26713 
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KIRREL3 AC_000186.1 80 18 2.38E-06 9.54E-06 0.014 0.26713 
KIRREL3 AC_000186.1 83 22 9.08E-06 3.37E-05 0.014 0.26713 
KIRREL3 AC_000186.1 75 9 1.70E-08 8.98E-08 0.014 0.26713 
KIRREL3 AC_000186.1 90 16 3.88E-08 1.88E-07 0.014 0.26713 
KIRREL3 AC_000186.1 87 22 3.28E-06 1.29E-05 0.014 0.26713 
KIRREL3 AC_000186.1 88 24 6.41E-06 2.45E-05 0.014 0.26713 
KIRREL3 AC_000186.1 80 25 7.02E-05 2.30E-04 0.014 0.26713 
KIRREL3 AC_000186.1 85 9 5.67E-10 3.30E-09 0.014 0.26713 
KIRREL3 AC_000186.1 100 15 9.23E-10 5.35E-09 0.014 0.26713 
KIRREL3 AC_000186.1 80 10 8.02E-09 4.36E-08 0.014 0.26713 
KIRREL3 AC_000186.1 90 16 3.88E-08 1.88E-07 0.014 0.26713 
KIRREL3 AC_000186.1 78 11 3.96E-08 1.91E-07 0.014 0.26713 
KIRREL3 AC_000186.1 100 22 9.72E-08 4.57E-07 0.014 0.26713 
KIRREL3 AC_000186.1 83 17 5.72E-07 2.51E-06 0.014 0.26713 
KIRREL3 AC_000186.1 83 17 5.72E-07 2.51E-06 0.014 0.26713 
KIRREL3 AC_000186.1 81 25 5.36E-05 1.79E-04 0.014 0.26713 
KIRREL3 AC_000186.1 83 10 2.71E-09 1.53E-08 0.014 0.26713 
KIRREL3 AC_000186.1 83 14 8.33E-08 3.95E-07 0.014 0.26713 
KIRREL3 AC_000186.1 80 15 4.06E-07 1.80E-06 0.014 0.26713 
KIRREL3 AC_000186.1 75 16 3.16E-06 1.24E-05 0.014 0.26713 
KIRREL3 AC_000186.1 100 0 2.22E-19 2.32E-18 0.014 0.26713 
KIRREL3 AC_000186.1 80 7 4.23E-10 2.58E-09 0.014 0.26713 
KIRREL3 AC_000186.1 76 10 3.00E-08 1.53E-07 0.014 0.26713 
KIRREL3 AC_000186.1 100 24 2.94E-07 1.32E-06 0.014 0.26713 
KIRREL3 AC_000186.1 76 16 2.25E-06 9.06E-06 0.014 0.26713 
KIRREL3 AC_000186.1 76 6 5.02E-10 3.04E-09 0.014 0.26713 
KIRREL3 AC_000186.1 80 8 1.14E-09 6.61E-09 0.014 0.26713 
KIRREL3 AC_000186.1 80 11 2.08E-08 1.09E-07 0.014 0.26713 
KIRREL3 AC_000186.1 83 0 3.95E-16 3.44E-15 0.014 0.26713 
KIRREL3 AC_000186.1 81 21 8.86E-06 3.29E-05 0.014 0.26713 
KIRREL3 AC_000186.1 77 11 5.04E-08 2.42E-07 0.014 0.26713 
KIRREL3 AC_000186.1 83 10 3.22E-09 1.80E-08 0.014 0.26713 
KIRREL3 AC_000186.1 100 18 7.85E-09 4.28E-08 0.014 0.26713 
KIRREL3 AC_000186.1 83 24 2.27E-05 7.98E-05 0.014 0.26713 
KIRREL3 AC_000186.1 75 22 6.49E-05 2.14E-04 0.014 0.26713 
KIRREL3 AC_000186.1 0 100 2.22E-19 2.32E-18 0.014 0.26713 
TMEM132A AC_000186.1 0 100 2.22E-19 2.32E-18 0.101 2.9154 
TMEM258 AC_000186.1 0 100 2.22E-19 2.32E-18 6.39 34.137 
FADS2 AC_000186.1 0 100 2.22E-19 2.32E-18 0.022 34.409 
FADS2 AC_000186.1 0 100 2.22E-19 2.32E-18 0.022 34.409 
FADS2 AC_000186.1 0 100 2.22E-19 2.32E-18 0.022 34.409 
MACROD1 AC_000186.1 0 100 2.22E-19 2.32E-18 3.035 8.30819 
MACROD1 AC_000186.1 0 100 2.22E-19 2.32E-18 3.035 8.30819 
MACROD1 AC_000186.1 0 100 2.22E-19 2.32E-18 3.035 8.30819 
MACROD1 AC_000186.1 0 100 2.22E-19 2.32E-18 3.035 8.30819 
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MACROD1 AC_000186.1 0 100 2.22E-19 2.32E-18 3.035 8.30819 
MACROD1 AC_000186.1 0 100 2.22E-19 2.32E-18 3.035 8.30819 
MACROD1 AC_000186.1 0 80 1.24E-15 9.79E-15 3.035 8.30819 
MACROD1 AC_000186.1 0 100 2.22E-19 2.32E-18 3.035 8.30819 
MACROD1 AC_000186.1 0 100 2.22E-19 2.32E-18 3.035 8.30819 
MACROD1 AC_000186.1 0 100 2.22E-19 2.32E-18 3.035 8.30819 
MACROD1 AC_000186.1 0 100 2.22E-19 2.32E-18 3.035 8.30819 
MACROD1 AC_000186.1 20 100 2.92E-08 1.49E-07 3.035 8.30819 
MACROD1 AC_000186.1 0 100 2.22E-19 2.32E-18 3.035 8.30819 
MACROD1 AC_000186.1 0 100 2.22E-19 2.32E-18 3.035 8.30819 
MACROD1 AC_000186.1 0 80 1.24E-15 9.79E-15 3.035 8.30819 
MACROD1 AC_000186.1 0 100 2.22E-19 2.32E-18 3.035 8.30819 
MACROD1 AC_000186.1 0 100 2.22E-19 2.32E-18 3.035 8.30819 
FKBP2 AC_000186.1 100 11 2.69E-11 1.74E-10 2.701 43.4495 
FKBP2 AC_000186.1 100 11 2.69E-11 1.74E-10 2.701 43.4495 
NRXN2 AC_000186.1 0 83 3.95E-16 3.44E-15 0.031 4.57515 
NRXN2 AC_000186.1 0 100 2.22E-19 2.32E-18 0.031 4.57515 
EHBP1L1 AC_000186.1 0 100 2.22E-19 2.32E-18 0.063 1.11711 
ANKRD13D AC_000186.1 100 25 5.20E-07 2.28E-06 0.273 0.307814 
TMEM134 AC_000186.1 0 85 1.66E-16 1.56E-15 1.769 0.00026075 
ALDH3B1 AC_000186.1 0 100 2.22E-19 2.32E-18 0.043 1.67588 
ALDH3B1 AC_000186.1 0 100 2.22E-19 2.32E-18 0.043 1.67588 
ALDH3B1 AC_000186.1 0 85 1.66E-16 1.56E-15 0.043 1.67588 
MRGPRF AC_000186.1 0 100 2.22E-19 2.32E-18 0.028 0.0658296 
MRGPRF AC_000186.1 0 100 2.22E-19 2.32E-18 0.028 0.0658296 
ANO1 AC_000186.1 0 100 2.22E-19 2.32E-18 0.11 52.6666 
ANO1 AC_000186.1 20 85 1.96E-06 7.96E-06 0.11 52.6666 
ANO1 AC_000186.1 0 100 2.22E-19 2.32E-18 0.11 52.6666 
ANO1 AC_000186.1 0 85 1.66E-16 1.56E-15 0.11 52.6666 
ANO1 AC_000186.1 0 85 1.66E-16 1.56E-15 0.11 52.6666 
DHCR7 AC_000186.1 0 100 2.22E-19 2.32E-18 2.574 1.67939 
TSSC4 AC_000186.1 0 83 3.95E-16 3.44E-15 0.6 0.0114462 
TSSC4 AC_000186.1 0 83 3.95E-16 3.44E-15 0.6 0.0114462 
TH AC_000186.1 0 100 2.22E-19 2.32E-18 0.215 0.230183 
TH AC_000186.1 0 91 1.25E-17 1.29E-16 0.215 0.230183 
TH AC_000186.1 0 83 3.95E-16 3.44E-15 0.215 0.230183 
IGF2 AC_000186.1 0 100 2.22E-19 2.32E-18 0.037 31.6633 
IGF2 AC_000186.1 0 100 2.22E-19 2.32E-18 0.037 31.6633 
IGF2 AC_000186.1 0 100 2.22E-19 2.32E-18 0.037 31.6633 
PNPLA2 AC_000186.1 100 25 5.20E-07 2.28E-06 0.752 8.83435 
HRAS AC_000186.1 8 100 9.20E-13 6.56E-12 1.46 1.73E-06 
HRAS AC_000186.1 8 100 9.20E-13 6.56E-12 1.46 1.73E-06 
PKP3 AC_000186.1 0 100 2.22E-19 2.32E-18 0.211 0.0558369 
PKP3 AC_000186.1 0 100 2.22E-19 2.32E-18 0.211 0.0558369 
ADAMTS4 AC_000160.1 0 100 2.22E-19 2.32E-18 8.259 13.4961 
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PEAR1 AC_000160.1 0 90 1.66E-17 1.70E-16 0.017 3.50785 
ATP1A1 AC_000160.1 96 11 1.05E-10 6.54E-10 72.836 148.908 
ATP1A1 AC_000160.1 95 18 3.21E-08 1.63E-07 72.836 148.908 
SLC44A5 AC_000160.1 83 0 3.95E-16 3.44E-15 26.817 7.84819 
EFHD1 AC_000160.1 0 100 2.22E-19 2.32E-18 12.044 61.7899 
INPP5D AC_000160.1 0 100 2.22E-19 2.32E-18 0.005 0.417505 
INPP5D AC_000160.1 0 100 2.22E-19 2.32E-18 0.005 0.417505 
BOK AC_000160.1 0 100 2.22E-19 2.32E-18 0.023 0.290115 
BOK AC_000160.1 0 80 1.24E-15 9.79E-15 0.023 0.290115 
BOK AC_000160.1 20 100 2.92E-08 1.49E-07 0.023 0.290115 
THAP4 AC_000160.1 100 9 3.27E-12 2.29E-11 5.406 3.32E-10 
ASB4 AC_000161.1 100 2 5.84E-17 5.86E-16 0.059 2.29124 
ASB4 AC_000161.1 94 4 3.11E-14 2.39E-13 0.059 2.29124 
ASB4 AC_000161.1 83 6 3.47E-11 2.22E-10 0.059 2.29124 
ASB4 AC_000161.1 95 18 3.21E-08 1.63E-07 0.059 2.29124 
ASB4 AC_000161.1 83 13 3.69E-08 1.88E-07 0.059 2.29124 
KIAA1324L AC_000161.1 80 14 1.93E-07 8.74E-07 8.885 26.3772 
KIAA1324L AC_000161.1 75 19 1.53E-05 5.52E-05 8.885 26.3772 
LHFPL3 AC_000161.1 77 0 5.26E-15 4.10E-14 99.227 0.712787 
LHFPL3 AC_000161.1 77 0 5.26E-15 4.10E-14 99.227 0.712787 
MET AC_000161.1 100 11 2.69E-11 1.74E-10 0.49 3.35075 
MET AC_000161.1 83 18 1.10E-06 4.57E-06 0.49 3.35075 
MET AC_000161.1 80 17 1.41E-06 5.80E-06 0.49 3.35075 
CRHR2 AC_000161.1 100 0 2.22E-19 2.32E-18 0.576 0.21157 
GTPBP10 AC_000161.1 0 100 2.22E-19 2.32E-18 28.986 16.8739 
ADCY1 AC_000161.1 0 90 1.66E-17 1.70E-16 0.016 2.7462 
ADCY1 AC_000161.1 0 100 2.22E-19 2.32E-18 0.016 2.7462 
ADCY1 AC_000161.1 0 100 2.22E-19 2.32E-18 0.016 2.7462 
CAMK2B AC_000161.1 0 100 2.22E-19 2.32E-18 0.187 0.127235 
CAMK2B AC_000161.1 0 100 2.22E-19 2.32E-18 0.187 0.127235 
CAMK2B AC_000161.1 16 100 1.86E-09 1.05E-08 0.187 0.127235 
CAMK2B AC_000161.1 0 100 2.22E-19 2.32E-18 0.187 0.127235 
CAMK2B AC_000161.1 0 100 2.22E-19 2.32E-18 0.187 0.127235 
CAMK2B AC_000161.1 0 100 2.22E-19 2.32E-18 0.187 0.127235 
CAMK2B AC_000161.1 0 100 2.22E-19 2.32E-18 0.187 0.127235 
CAMK2B AC_000161.1 0 87 7.02E-17 6.88E-16 0.187 0.127235 
CAMK2B AC_000161.1 16 100 1.86E-09 1.05E-08 0.187 0.127235 
CAMK2B AC_000161.1 20 83 3.33E-06 1.30E-05 0.187 0.127235 
CAMK2B AC_000161.1 0 100 2.22E-19 2.32E-18 0.187 0.127235 
GCK AC_000161.1 0 100 2.22E-19 2.32E-18 0.055 0.419373 
CDK13 AC_000161.1 78 15 6.41E-07 2.80E-06 22.109 15.9006 
CDK13 AC_000161.1 78 15 6.41E-07 2.80E-06 22.109 15.9006 
PLXNA4 AC_000161.1 0 85 1.66E-16 1.56E-15 0.799 0.523385 
LRGUK AC_000161.1 83 0 3.95E-16 3.44E-15 2.29 4.2307 
LRGUK AC_000161.1 94 14 2.56E-09 1.44E-08 2.29 4.2307 
  200 
LRGUK AC_000161.1 83 12 1.81E-08 9.56E-08 2.29 4.2307 
LRGUK AC_000161.1 86 25 1.71E-05 6.13E-05 2.29 4.2307 
LRGUK AC_000161.1 83 0 3.95E-16 3.44E-15 2.29 4.2307 
LRGUK AC_000161.1 100 11 2.69E-11 1.74E-10 2.29 4.2307 
LRGUK AC_000161.1 83 16 2.86E-07 1.29E-06 2.29 4.2307 
LRGUK AC_000161.1 80 16 7.24E-07 3.14E-06 2.29 4.2307 
LRGUK AC_000161.1 100 14 3.79E-10 2.31E-09 2.29 4.2307 
LRGUK AC_000161.1 100 17 4.16E-09 2.32E-08 2.29 4.2307 
LRGUK AC_000161.1 83 18 1.10E-06 4.57E-06 2.29 4.2307 
LRGUK AC_000161.1 78 20 1.17E-05 4.26E-05 2.29 4.2307 
LRGUK AC_000161.1 83 19 1.84E-06 7.50E-06 2.29 4.2307 
UBN2 AC_000161.1 80 10 8.02E-09 4.36E-08 46.853 3.21039 
UBN2 AC_000161.1 100 10 8.84E-12 5.80E-11 46.853 3.21039 
UBN2 AC_000161.1 100 11 2.69E-11 1.74E-10 46.853 3.21039 
UBN2 AC_000161.1 85 21 3.15E-06 1.24E-05 46.853 3.21039 
UBN2 AC_000161.1 75 17 5.30E-06 2.04E-05 46.853 3.21039 
UBN2 AC_000161.1 100 6 6.67E-14 5.10E-13 46.853 3.21039 
UBN2 AC_000161.1 93 12 6.06E-10 3.53E-09 46.853 3.21039 
SSPO AC_000161.1 0 83 3.95E-16 3.44E-15 0.01 6.73901 
SSPO AC_000161.1 0 83 3.95E-16 3.44E-15 0.01 6.73901 
SSPO AC_000161.1 0 100 2.22E-19 2.32E-18 0.01 6.73901 
RARRES2 AC_000161.1 0 83 3.95E-16 3.44E-15 4.624 5.74164 
RARRES2 AC_000161.1 0 80 1.24E-15 9.79E-15 4.624 5.74164 
RARRES2 AC_000161.1 0 75 1.25E-14 9.63E-14 4.624 5.74164 
NOS3 AC_000161.1 0 100 2.22E-19 2.32E-18 0.32 1.16742 
TMUB1 AC_000161.1 0 100 2.22E-19 2.32E-18 0.297 0.833155 
PAXIP1 AC_000161.1 0 100 2.22E-19 2.32E-18 21.428 1.97E-07 
RAPGEF3 AC_000162.1 0 100 2.22E-19 2.32E-18 0.919 1.38967 
STAT6 AC_000162.1 0 100 2.22E-19 2.32E-18 0.117 1.92315 
PTPN6 AC_000162.1 0 100 2.22E-19 2.32E-18 0.146 0.552625 
TNFRSF1A AC_000162.1 78 20 1.17E-05 4.26E-05 0.649 15.1137 
SCNN1A AC_000162.1 78 20 1.17E-05 4.26E-05 1.772 1.35987 
VWF AC_000162.1 0 85 1.66E-16 1.56E-15 2.671 4.28453 
VWF AC_000162.1 0 85 1.66E-16 1.56E-15 2.671 4.28453 
SLC6A12 AC_000162.1 0 100 2.22E-19 2.32E-18 0.009 1.19542 
DCP1B AC_000162.1 0 100 2.22E-19 2.32E-18 0.08 13.4787 
DCP1B AC_000162.1 0 100 2.22E-19 2.32E-18 0.08 13.4787 
DCP1B AC_000162.1 0 100 2.22E-19 2.32E-18 0.08 13.4787 
JOSD1 AC_000162.1 80 0 1.24E-15 9.79E-15 29.302 17.061 
TBC1D22A AC_000162.1 0 100 2.22E-19 2.32E-18 0.421 8.54892 
HDAC10 AC_000162.1 0 100 2.22E-19 2.32E-18 0.293 3.73E-07 
MAPK12 AC_000162.1 0 100 2.22E-19 2.32E-18 0.03 0.340854 
PDE5A AC_000163.1 100 0 2.22E-19 2.32E-18 20.064 14.8399 
PDE5A AC_000163.1 76 0 6.99E-15 5.45E-14 20.064 14.8399 
PDE5A AC_000163.1 10 80 8.02E-09 4.36E-08 20.064 14.8399 
  201 
PDE5A AC_000163.1 85 13 1.98E-08 1.04E-07 20.064 14.8399 
PDE5A AC_000163.1 75 0 1.25E-14 9.63E-14 20.064 14.8399 
PDE5A AC_000163.1 88 10 5.48E-10 3.19E-09 20.064 14.8399 
PDE5A AC_000163.1 75 7 2.27E-09 1.28E-08 20.064 14.8399 
PDE5A AC_000163.1 83 15 1.57E-07 7.27E-07 20.064 14.8399 
PDE5A AC_000163.1 80 21 1.20E-05 4.38E-05 20.064 14.8399 
PDE5A AC_000163.1 75 21 3.99E-05 1.35E-04 20.064 14.8399 
CASP6 AC_000163.1 100 0 2.22E-19 2.32E-18 214.923 2.46198 
CASP6 AC_000163.1 100 16 1.86E-09 1.05E-08 214.923 2.46198 
NFKB1 AC_000163.1 93 11 2.63E-10 1.63E-09 6.486 2.82109 
NFKB1 AC_000163.1 75 12 2.23E-07 1.01E-06 6.486 2.82109 
NFKB1 AC_000163.1 85 25 2.09E-05 7.36E-05 6.486 2.82109 
ADAMTS3 AC_000163.1 94 0 2.96E-18 3.08E-17 0.202 0.815374 
ADAMTS3 AC_000163.1 100 13 1.74E-10 1.08E-09 0.202 0.815374 
ADAMTS3 AC_000163.1 97 13 4.27E-10 2.60E-09 0.202 0.815374 
ADAMTS3 AC_000163.1 80 8 1.14E-09 6.61E-09 0.202 0.815374 
ADAMTS3 AC_000163.1 87 11 1.94E-09 1.10E-08 0.202 0.815374 
ADAMTS3 AC_000163.1 75 9 1.70E-08 8.98E-08 0.202 0.815374 
ADAMTS3 AC_000163.1 85 13 1.98E-08 1.04E-07 0.202 0.815374 
ADAMTS3 AC_000163.1 100 20 2.92E-08 1.49E-07 0.202 0.815374 
ADAMTS3 AC_000163.1 80 13 1.01E-07 4.71E-07 0.202 0.815374 
ADAMTS3 AC_000163.1 75 20 2.62E-05 9.12E-05 0.202 0.815374 
ADAMTS3 AC_000163.1 83 0 3.95E-16 3.44E-15 0.202 0.815374 
ADAMTS3 AC_000163.1 78 2 4.86E-13 3.60E-12 0.202 0.815374 
ADAMTS3 AC_000163.1 87 7 3.08E-11 1.96E-10 0.202 0.815374 
ADAMTS3 AC_000163.1 83 7 1.31E-10 8.14E-10 0.202 0.815374 
ADAMTS3 AC_000163.1 77 11 5.04E-08 2.42E-07 0.202 0.815374 
ADAMTS3 AC_000163.1 88 16 7.03E-08 3.34E-07 0.202 0.815374 
ADAMTS3 AC_000163.1 77 15 9.12E-07 3.87E-06 0.202 0.815374 
ADAMTS3 AC_000163.1 77 25 1.34E-04 4.21E-04 0.202 0.815374 
ADAMTS3 AC_000163.1 75 6 8.00E-10 4.66E-09 0.202 0.815374 
JAKMIP1 AC_000163.1 0 100 2.22E-19 2.32E-18 0.935 0.04102 
JAKMIP1 AC_000163.1 0 100 2.22E-19 2.32E-18 0.935 0.04102 
JAKMIP1 AC_000163.1 0 100 2.22E-19 2.32E-18 0.935 0.04102 
TNIP2 AC_000163.1 0 100 2.22E-19 2.32E-18 0.492 0.0316418 
TNIP2 AC_000163.1 0 100 2.22E-19 2.32E-18 0.492 0.0316418 
TNIP2 AC_000163.1 0 100 2.22E-19 2.32E-18 0.492 0.0316418 
TNIP2 AC_000163.1 0 100 2.22E-19 2.32E-18 0.492 0.0316418 
TNIP2 AC_000163.1 0 100 2.22E-19 2.32E-18 0.492 0.0316418 
TNIP2 AC_000163.1 0 100 2.22E-19 2.32E-18 0.492 0.0316418 
TNIP2 AC_000163.1 0 100 2.22E-19 2.32E-18 0.492 0.0316418 
TNIP2 AC_000163.1 0 100 2.22E-19 2.32E-18 0.492 0.0316418 
TNIP2 AC_000163.1 0 80 1.24E-15 9.79E-15 0.492 0.0316418 
TBC1D14 AC_000163.1 0 83 3.95E-16 3.44E-15 61.99 13.8021 
CRTC1 AC_000164.1 0 100 2.22E-19 2.32E-18 1.328 1.00504 
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CRTC1 AC_000164.1 0 100 2.22E-19 2.32E-18 1.328 1.00504 
MVB12A AC_000164.1 100 0 2.22E-19 2.32E-18 2.818 2.91305 
CACNA1A AC_000164.1 0 100 2.22E-19 2.32E-18 0.415 0.723295 
IER2 AC_000164.1 100 0 2.22E-19 2.32E-18 0.043 16.2488 
COL5A3 AC_000164.1 0 100 2.22E-19 2.32E-18 0.1 2.99264 
S1PR5 AC_000164.1 83 0 3.95E-16 3.44E-15 0.185 0.920123 
LDLR AC_000164.1 0 100 2.22E-19 2.32E-18 2.294 8.06501 
EVI5L AC_000164.1 0 80 1.24E-15 9.79E-15 1.675 12.5533 
ANGPTL4 AC_000164.1 0 100 2.22E-19 2.32E-18 0.067 0.499163 
C3 AC_000164.1 0 100 2.22E-19 2.32E-18 0.01 1.40461 
RFX2 AC_000164.1 0 100 2.22E-19 2.32E-18 0.075 42.5618 
RFX2 AC_000164.1 0 100 2.22E-19 2.32E-18 0.075 42.5618 
TJP3 AC_000164.1 20 100 2.92E-08 1.49E-07 0.072 1.60424 
PTBP1 AC_000164.1 0 100 2.22E-19 2.32E-18 107.244 6.34773 
PTBP1 AC_000164.1 0 100 2.22E-19 2.32E-18 107.244 6.34773 
EGR1 AC_000164.1 85 0 1.66E-16 1.56E-15 14.139 97.3863 
CTNNA1 AC_000164.1 87 0 7.02E-17 6.88E-16 359.821 29.6623 
CTNNA1 AC_000164.1 80 0 1.24E-15 9.79E-15 359.821 29.6623 
CTNNA1 AC_000164.1 83 13 3.69E-08 1.88E-07 359.821 29.6623 
PCDH1 AC_000164.1 0 100 2.22E-19 2.32E-18 0.542 1.2975 
GRIA1 AC_000164.1 85 23 8.46E-06 3.15E-05 0.377 0.551824 
EFNA5 AC_000164.1 0 80 1.24E-15 9.79E-15 0.397 29.9675 
ZNF395 AC_000165.1 80 0 1.24E-15 9.79E-15 5.019 3.82017 
ZNF395 AC_000165.1 80 8 1.14E-09 6.61E-09 5.019 3.82017 
ZNF395 AC_000165.1 80 12 4.35E-08 2.09E-07 5.019 3.82017 
ZNF395 AC_000165.1 80 18 2.38E-06 9.54E-06 5.019 3.82017 
SCARA5 AC_000165.1 100 0 2.22E-19 2.32E-18 0.093 3.45835 
SCARA5 AC_000165.1 0 100 2.22E-19 2.32E-18 0.093 3.45835 
SHB AC_000165.1 0 80 1.24E-15 9.79E-15 10.368 0.272166 
SHB AC_000165.1 0 80 1.24E-15 9.79E-15 10.368 0.272166 
RHOBTB2 AC_000165.1 0 100 2.22E-19 2.32E-18 0.412 1.10532 
RHOBTB2 AC_000165.1 0 100 2.22E-19 2.32E-18 0.412 1.10532 
RHOBTB2 AC_000165.1 0 85 1.66E-16 1.56E-15 0.412 1.10532 
RHOBTB2 AC_000165.1 0 96 1.25E-18 1.30E-17 0.412 1.10532 
AQP7 AC_000165.1 0 85 1.66E-16 1.56E-15 0.018 16.045 
AQP7 AC_000165.1 20 100 2.92E-08 1.49E-07 0.018 16.045 
CNTFR AC_000165.1 0 100 2.22E-19 2.32E-18 1.272 0.401799 
RPP25L AC_000165.1 100 20 2.92E-08 1.49E-07 0.022 9.72948 
TMEM246 AC_000165.1 78 20 1.17E-05 4.26E-05 0.048 0.61765 
COL27A1 AC_000165.1 0 100 2.22E-19 2.32E-18 0.199 1.08769 
COL27A1 AC_000165.1 0 100 2.22E-19 2.32E-18 0.199 1.08769 
COL27A1 AC_000165.1 0 100 2.22E-19 2.32E-18 0.199 1.08769 
COL27A1 AC_000165.1 20 100 2.92E-08 1.49E-07 0.199 1.08769 
PHF19 AC_000165.1 0 90 1.66E-17 1.70E-16 0.213 2.04815 
GSN AC_000165.1 0 100 2.22E-19 2.32E-18 0.529 26.6831 
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GSN AC_000165.1 0 100 2.22E-19 2.32E-18 0.529 26.6831 
GSN AC_000165.1 0 100 2.22E-19 2.32E-18 0.529 26.6831 
GSN AC_000165.1 0 100 2.22E-19 2.32E-18 0.529 26.6831 
GSN AC_000165.1 0 100 2.22E-19 2.32E-18 0.529 26.6831 
GSN AC_000165.1 0 100 2.22E-19 2.32E-18 0.529 26.6831 
LAMA4 AC_000166.1 80 14 1.93E-07 8.74E-07 1.364 2.82183 
ASCC3 AC_000166.1 88 14 1.67E-08 8.86E-08 34.241 6.19346 
ASCC3 AC_000166.1 83 21 5.30E-06 2.04E-05 34.241 6.19346 
ENPP3 AC_000166.1 77 9 8.67E-09 4.71E-08 0.191 2.2943 
ENPP3 AC_000166.1 85 20 1.76E-06 7.20E-06 0.191 2.2943 
ZDHHC14 AC_000166.1 0 85 1.66E-16 1.56E-15 0.565 6.51905 
RPS6KA2 AC_000166.1 0 100 2.22E-19 2.32E-18 0.225 1.24944 
RPS6KA2 AC_000166.1 0 100 2.22E-19 2.32E-18 0.225 1.24944 
RPS6KA2 AC_000166.1 0 83 3.95E-16 3.44E-15 0.225 1.24944 
RPS6KA2 AC_000166.1 0 100 2.22E-19 2.32E-18 0.225 1.24944 
RPS6KA2 AC_000166.1 0 100 2.22E-19 2.32E-18 0.225 1.24944 
RPS6KA2 AC_000166.1 0 100 2.22E-19 2.32E-18 0.225 1.24944 
RPS6KA2 AC_000166.1 0 83 3.95E-16 3.44E-15 0.225 1.24944 
RPS6KA2 AC_000166.1 0 80 1.24E-15 9.79E-15 0.225 1.24944 
RPS6KA2 AC_000166.1 0 100 2.22E-19 2.32E-18 0.225 1.24944 
RPS6KA2 AC_000166.1 0 77 5.26E-15 4.10E-14 0.225 1.24944 
RPS6KA2 AC_000166.1 5 100 1.69E-14 1.30E-13 0.225 1.24944 
RPS6KA2 AC_000166.1 0 100 2.22E-19 2.32E-18 0.225 1.24944 
RPS6KA2 AC_000166.1 0 100 2.22E-19 2.32E-18 0.225 1.24944 
THBS2 AC_000166.1 0 100 2.22E-19 2.32E-18 1.311 1.91925 
THBS2 AC_000166.1 100 0 2.22E-19 2.32E-18 1.311 1.91925 
ERMARD AC_000166.1 0 88 3.94E-17 3.96E-16 2.539 9.29923 
ZNF75D AC_000187.1 14 85 3.93E-08 1.89E-07 140.532 66.9043 
ZNF75D AC_000187.1 83 0 3.95E-16 3.44E-15 140.532 66.9043 
ZNF75D AC_000187.1 0 85 1.66E-16 1.56E-15 140.532 66.9043 
ZNF75D AC_000187.1 0 100 2.22E-19 2.32E-18 140.532 66.9043 
ABCD1 AC_000187.1 0 100 2.22E-19 2.32E-18 0.088 4.01559 
TMEM164 AC_000187.1 100 0 2.22E-19 2.32E-18 1.617 2.99726 
PAK3 AC_000187.1 14 78 3.50E-07 1.56E-06 12.109 2.90494 
MSN AC_000187.1 91 9 7.07E-11 4.45E-10 34.72 9.52565 
MSN AC_000187.1 77 20 1.58E-05 5.68E-05 34.72 9.52565 
MOSPD2 AC_000187.1 18 85 6.32E-07 2.76E-06 27.71 6.82811 
STS AC_000187.1 0 100 2.22E-19 2.32E-18 0.282 0.38815 
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Table S7.4 Gene expression for DMRs between GV vs. in vivo MII 
Gene expression in DMRs from GV vs. in vivo MII      
Gene Chr GV_me In vivo MII_me p-value q-value GV expression In vivo MII expression 
SENP7 AC_000158.1 20 100 2.92E-08 4.20E-07 28.275 1.328 
MYCBP2 AC_000169.1 75 14 9.09E-07 8.19E-06 11.59 6.121 
DOCK9 AC_000169.1 14 80 1.93E-07 2.06E-06 21.342 11.036 
SERTAD4 AC_000173.1 0 100 2.22E-19 4.19E-17 0.377 0.386 
ZNF524 AC_000175.1 0 100 2.22E-19 4.19E-17 3.733 0.517 
RPL19 AC_000176.1 77 20 1.58E-05 1.10E-04 1281.436 27.609 
RAB37 AC_000176.1 0 80 1.24E-15 8.79E-14 5.424 0.14 
RAB37 AC_000176.1 85 16 1.60E-07 1.79E-06 5.424 0.14 
RAB37 AC_000176.1 87 21 1.86E-06 1.61E-05 5.424 0.14 
TRIM62 AC_000159.1 0 100 2.22E-19 4.19E-17 10.799 0.037 
LCP2 AC_000177.1 0 100 2.22E-19 4.19E-17 1.083 0.162 
SLC38A9 AC_000177.1 25 80 7.02E-05 4.25E-04 23.88 10.109 
MRPS11 AC_000178.1 20 100 2.92E-08 4.20E-07 24.469 1.443 
MRPS11 AC_000178.1 22 100 9.72E-08 1.10E-06 24.469 1.443 
FRMD5 AC_000178.1 100 25 5.20E-07 5.31E-06 8.882 3.842 
FRMD5 AC_000178.1 100 16 1.86E-09 3.35E-08 8.882 3.842 
FRMD5 AC_000178.1 80 15 4.06E-07 4.23E-06 8.882 3.842 
SLC4A7 AC_000179.1 0 80 1.24E-15 8.79E-14 7.76 11.245 
ERC2 AC_000179.1 80 16 7.24E-07 7.27E-06 5.638 1.022 
DUSP7 AC_000179.1 0 80 1.24E-15 8.79E-14 129.436 15.385 
PTPN23 AC_000179.1 23 80 3.02E-05 1.94E-04 9.137 1.502 
MGLL AC_000179.1 83 0 3.95E-16 4.34E-14 0.776 0.045 
HIST1H1C AC_000180.1 80 20 6.94E-06 5.05E-05 168.516 8.217 
ATP9B AC_000181.1 100 0 2.22E-19 4.19E-17 1.054 0.513 
KCTD1 AC_000181.1 100 0 2.22E-19 4.19E-17 3.893 6.366 
LOXL4 AC_000183.1 0 100 2.22E-19 4.19E-17 0.014 0.052 
SUFU AC_000183.1 75 0 1.25E-14 8.05E-13 2.698 1.731 
SORCS3 AC_000183.1 0 80 1.24E-15 8.79E-14 8.191 2.896 
SORCS3 AC_000183.1 0 100 2.22E-19 4.19E-17 8.191 2.896 
WRN AC_000184.1 80 15 4.06E-07 4.23E-06 10.07 1.63 
WRN AC_000184.1 93 16 1.47E-08 2.45E-07 10.07 1.63 
RNF122 AC_000184.1 80 0 1.24E-15 8.79E-14 9.872 2.269 
RNF122 AC_000184.1 15 80 4.06E-07 4.23E-06 9.872 2.269 
RNF122 AC_000184.1 87 0 7.02E-17 1.15E-14 9.872 2.269 
RNF122 AC_000184.1 100 14 3.79E-10 8.76E-09 9.872 2.269 
RNF122 AC_000184.1 100 7 2.90E-13 1.60E-11 9.872 2.269 
RNF122 AC_000184.1 100 20 2.92E-08 4.20E-07 9.872 2.269 
RNF122 AC_000184.1 83 20 3.33E-06 2.69E-05 9.872 2.269 
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RNF122 AC_000184.1 0 100 2.22E-19 4.19E-17 9.872 2.269 
RNF122 AC_000184.1 100 0 2.22E-19 4.19E-17 9.872 2.269 
RNF122 AC_000184.1 83 11 7.24E-09 1.23E-07 9.872 2.269 
RNF122 AC_000184.1 80 20 6.94E-06 5.05E-05 9.872 2.269 
RNF122 AC_000184.1 0 80 1.24E-15 8.79E-14 9.872 2.269 
RNF122 AC_000184.1 20 80 6.94E-06 5.05E-05 9.872 2.269 
RNF122 AC_000184.1 80 20 6.94E-06 5.05E-05 9.872 2.269 
RNF122 AC_000184.1 100 0 2.22E-19 4.19E-17 9.872 2.269 
RNF122 AC_000184.1 14 83 8.33E-08 9.57E-07 9.872 2.269 
RNF122 AC_000184.1 80 20 6.94E-06 5.05E-05 9.872 2.269 
RNF122 AC_000184.1 100 20 2.92E-08 4.20E-07 9.872 2.269 
RNF122 AC_000184.1 83 20 3.33E-06 2.69E-05 9.872 2.269 
RNF122 AC_000184.1 16 80 7.24E-07 7.27E-06 9.872 2.269 
RNF122 AC_000184.1 0 83 3.95E-16 4.34E-14 9.872 2.269 
RNF122 AC_000184.1 80 0 1.24E-15 8.79E-14 9.872 2.269 
RNF122 AC_000184.1 14 100 3.79E-10 8.76E-09 9.872 2.269 
RNF122 AC_000184.1 0 100 2.22E-19 4.19E-17 9.872 2.269 
RNF122 AC_000184.1 25 90 6.49E-06 5.05E-05 9.872 2.269 
RNF122 AC_000184.1 25 85 2.09E-05 1.41E-04 9.872 2.269 
RNF122 AC_000184.1 100 0 2.22E-19 4.19E-17 9.872 2.269 
RNF122 AC_000184.1 100 20 2.92E-08 4.20E-07 9.872 2.269 
RNF122 AC_000184.1 80 0 1.24E-15 8.79E-14 9.872 2.269 
RNF122 AC_000184.1 5 80 3.50E-11 9.03E-10 9.872 2.269 
RNF122 AC_000184.1 100 20 2.92E-08 4.20E-07 9.872 2.269 
RNF122 AC_000184.1 80 20 6.94E-06 5.05E-05 9.872 2.269 
RNF122 AC_000184.1 20 80 6.94E-06 5.05E-05 9.872 2.269 
RNF122 AC_000184.1 80 20 6.94E-06 5.05E-05 9.872 2.269 
RNF122 AC_000184.1 80 0 1.24E-15 8.79E-14 9.872 2.269 
RNF122 AC_000184.1 76 16 2.25E-06 1.91E-05 9.872 2.269 
RNF122 AC_000184.1 81 0 9.35E-16 8.79E-14 9.872 2.269 
RNF122 AC_000184.1 20 100 2.92E-08 4.20E-07 9.872 2.269 
RNF122 AC_000184.1 20 100 2.92E-08 4.20E-07 9.872 2.269 
RNF122 AC_000184.1 20 80 6.94E-06 5.05E-05 9.872 2.269 
RNF122 AC_000184.1 80 16 7.24E-07 7.27E-06 9.872 2.269 
RNF122 AC_000184.1 80 14 1.93E-07 2.06E-06 9.872 2.269 
RNF122 AC_000184.1 0 100 2.22E-19 4.19E-17 9.872 2.269 
RNF122 AC_000184.1 0 80 1.24E-15 8.79E-14 9.872 2.269 
RNF122 AC_000184.1 88 0 3.94E-17 6.82E-15 9.872 2.269 
RNF122 AC_000184.1 80 0 1.24E-15 8.79E-14 9.872 2.269 
RNF122 AC_000184.1 20 80 6.94E-06 5.05E-05 9.872 2.269 
RNF122 AC_000184.1 100 25 5.20E-07 5.31E-06 9.872 2.269 
UNC5D AC_000184.1 100 0 2.22E-19 4.19E-17 9.564 3.119 
MACROD1 AC_000186.1 0 100 2.22E-19 4.19E-17 5.449 0.955 
PC AC_000186.1 100 0 2.22E-19 4.19E-17 0.961 0.042 
CARS AC_000186.1 77 20 1.58E-05 1.10E-04 3.16 0.776 
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MAGI3 AC_000160.1 80 0 1.24E-15 8.79E-14 68.672 7.925 
KIAA1324L AC_000161.1 85 9 5.67E-10 1.06E-08 14.742 3.943 
KIAA1324L AC_000161.1 80 25 7.02E-05 4.25E-04 14.742 3.943 
KIAA1324L AC_000161.1 22 83 9.08E-06 6.54E-05 14.742 3.943 
MET AC_000161.1 87 20 1.14E-06 1.00E-05 0.14 0.156 
GTPBP10 AC_000161.1 83 0 3.95E-16 4.34E-14 36.996 1.259 
LRGUK AC_000161.1 0 100 2.22E-19 4.19E-17 2.844 0.074 
LRGUK AC_000161.1 20 100 2.92E-08 4.20E-07 2.844 0.074 
LRGUK AC_000161.1 80 14 1.93E-07 2.06E-06 2.844 0.074 
LRGUK AC_000161.1 80 20 6.94E-06 5.05E-05 2.844 0.074 
LRGUK AC_000161.1 77 20 1.58E-05 1.10E-04 2.844 0.074 
LRGUK AC_000161.1 75 20 2.62E-05 1.76E-04 2.844 0.074 
LRGUK AC_000161.1 100 20 2.92E-08 4.20E-07 2.844 0.074 
UBN2 AC_000161.1 16 100 1.86E-09 3.35E-08 55.015 3.553 
ITPR2 AC_000162.1 23 75 9.52E-05 5.55E-04 2.054 1.345 
TNFRSF1A AC_000162.1 80 16 7.24E-07 7.27E-06 0.315 0.058 
SCNN1A AC_000162.1 80 16 7.24E-07 7.27E-06 4.3 0.279 
PDE5A AC_000163.1 83 0 3.95E-16 4.34E-14 20.575 6.356 
PDE5A AC_000163.1 12 80 4.35E-08 5.03E-07 20.575 6.356 
PDE5A AC_000163.1 80 14 1.93E-07 2.06E-06 20.575 6.356 
PDE5A AC_000163.1 16 80 7.24E-07 7.27E-06 20.575 6.356 
PDE5A AC_000163.1 90 23 2.50E-06 2.11E-05 20.575 6.356 
METAP1 AC_000163.1 20 80 6.94E-06 5.05E-05 10.854 11.068 
ADAMTS3 AC_000163.1 87 20 1.14E-06 1.00E-05 0.48 0.026 
CCDC96 AC_000163.1 20 85 1.96E-06 1.68E-05 0.902 0.013 
SLC12A2 AC_000164.1 100 0 2.22E-19 4.19E-17 22.906 9.346 
DBN1 AC_000164.1 100 0 2.22E-19 4.19E-17 5.413 2.981 
EGR1 AC_000164.1 100 16 1.86E-09 3.35E-08 23.657 0.357 
CTNNA1 AC_000164.1 100 20 2.92E-08 4.20E-07 282.447 782.826 
CTNNA1 AC_000164.1 85 20 1.96E-06 1.68E-05 282.447 782.826 
CTNNA1 AC_000164.1 81 25 5.36E-05 3.34E-04 282.447 782.826 
GRIA1 AC_000164.1 81 0 9.35E-16 8.79E-14 0.245 0.088 
MSN AC_000187.1 77 9 8.67E-09 1.45E-07 42.143 5.118 
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Table S7.5 Gene expression for DMRs between GV vs. in vitro MII 
Gene expression in DMRs from GV vs. in vitro MII      
Gene Chr GV_me In vitro MII_me p-value q-value GV expression In vitro MII expression 
CNNM4 AC_000168.1 85 20 1.96E-06 1.95E-05 23.617 11.71 
DYSF AC_000168.1 20 80 6.94E-06 5.87E-05 0.372 0.44 
DYSF AC_000168.1 80 20 6.94E-06 5.87E-05 0.372 0.44 
RALGPS1 AC_000168.1 80 16 7.24E-07 8.28E-06 2.175 2.29 
DOCK9 AC_000169.1 14 80 1.93E-07 2.37E-06 21.342 27.006 
PLCB1 AC_000170.1 85 0 1.66E-16 1.71E-14 2.134 0.538 
MACROD2 AC_000170.1 87 12 4.29E-09 8.34E-08 6.478 6.667 
MACROD2 AC_000170.1 77 12 1.04E-07 1.34E-06 6.478 6.667 
CUBN AC_000170.1 25 83 3.36E-05 2.50E-04 0.254 0.097 
CUBN AC_000170.1 100 22 9.72E-08 1.26E-06 0.254 0.097 
DEPTOR AC_000171.1 100 0 2.22E-19 3.28E-17 4.076 1.409 
CD82 AC_000172.1 100 0 2.22E-19 3.28E-17 0.07 0.012 
RGS7 AC_000173.1 0 100 2.22E-19 3.28E-17 1.014 0.034 
PKP1 AC_000173.1 83 0 3.95E-16 3.29E-14 0.483 0.111 
CPE AC_000174.1 75 25 2.10E-04 0.00122266 5.305 5.301 
PRODH AC_000174.1 0 100 2.22E-19 3.28E-17 1.218 0.165 
CCDC116 AC_000174.1 0 100 2.22E-19 3.28E-17 0.377 0.556 
FOXC2 AC_000175.1 0 100 2.22E-19 3.28E-17 0.521 0.358 
MNT AC_000176.1 100 0 2.22E-19 3.28E-17 4.813 2.52 
FAM83G AC_000176.1 100 0 2.22E-19 3.28E-17 0.014 0.022 
FBXL20 AC_000176.1 0 80 1.24E-15 7.34E-14 29.104 27.908 
RAB37 AC_000176.1 0 100 2.22E-19 3.28E-17 5.424 2.856 
RAB37 AC_000176.1 80 9 3.43E-09 6.69E-08 5.424 2.856 
RAB37 AC_000176.1 83 0 3.95E-16 3.29E-14 5.424 2.856 
RAB37 AC_000176.1 20 100 2.92E-08 4.73E-07 5.424 2.856 
RAB37 AC_000176.1 83 15 1.57E-07 2.01E-06 5.424 2.856 
4-Mar AC_000159.1 100 0 2.22E-19 3.28E-17 0.525 0.089 
SLC38A9 AC_000177.1 83 0 3.95E-16 3.29E-14 23.88 23.787 
SLC38A9 AC_000177.1 20 80 6.94E-06 5.87E-05 23.88 23.787 
SKIV2L2 AC_000177.1 80 0 1.24E-15 7.34E-14 15.244 16.212 
MRPS11 AC_000178.1 83 5 1.01E-11 2.96E-10 24.469 5.9 
MRPS11 AC_000178.1 20 100 2.92E-08 4.73E-07 24.469 5.9 
FRMD5 AC_000178.1 0 80 1.24E-15 7.34E-14 8.882 5.627 
FRMD5 AC_000178.1 14 100 3.79E-10 9.40E-09 8.882 5.627 
PTPN23 AC_000179.1 80 16 7.24E-07 8.28E-06 9.137 3.856 
ATP2B2 AC_000179.1 100 0 2.22E-19 3.28E-17 0.003 0.009 
KLF15 AC_000179.1 0 100 2.22E-19 3.28E-17 0.233 0.159 
PXDC1 AC_000180.1 80 0 1.24E-15 7.34E-14 0.076 0.098 
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GMDS AC_000180.1 0 100 2.22E-19 3.28E-17 1.846 1.399 
FBXL16 AC_000182.1 20 100 2.92E-08 4.73E-07 0.915 0.279 
PRKG1 AC_000183.1 14 83 8.33E-08 1.09E-06 21.133 25.31 
SORCS3 AC_000183.1 0 100 2.22E-19 3.28E-17 8.191 7.95 
SORCS3 AC_000183.1 0 100 2.22E-19 3.28E-17 8.191 7.95 
RNF122 AC_000184.1 12 100 6.45E-11 1.73E-09 9.872 8.137 
RNF122 AC_000184.1 100 14 3.79E-10 9.40E-09 9.872 8.137 
RNF122 AC_000184.1 9 100 3.27E-12 1.23E-10 9.872 8.137 
RNF122 AC_000184.1 80 16 7.24E-07 8.28E-06 9.872 8.137 
RNF122 AC_000184.1 0 85 1.66E-16 1.71E-14 9.872 8.137 
RNF122 AC_000184.1 100 20 2.92E-08 4.73E-07 9.872 8.137 
RNF122 AC_000184.1 80 15 4.06E-07 4.81E-06 9.872 8.137 
RNF122 AC_000184.1 25 87 1.29E-05 1.05E-04 9.872 8.137 
RNF122 AC_000184.1 20 83 3.33E-06 3.08E-05 9.872 8.137 
RNF122 AC_000184.1 80 16 7.24E-07 8.28E-06 9.872 8.137 
RNF122 AC_000184.1 0 80 1.24E-15 7.34E-14 9.872 8.137 
RNF122 AC_000184.1 20 100 2.92E-08 4.73E-07 9.872 8.137 
RNF122 AC_000184.1 16 83 2.86E-07 3.43E-06 9.872 8.137 
RNF122 AC_000184.1 16 80 7.24E-07 8.28E-06 9.872 8.137 
RNF122 AC_000184.1 0 100 2.22E-19 3.28E-17 9.872 8.137 
RNF122 AC_000184.1 80 0 1.24E-15 7.34E-14 9.872 8.137 
RNF122 AC_000184.1 75 0 1.25E-14 6.66E-13 9.872 8.137 
RNF122 AC_000184.1 85 12 8.19E-09 1.53E-07 9.872 8.137 
RNF122 AC_000184.1 75 20 2.62E-05 2.02E-04 9.872 8.137 
RNF122 AC_000184.1 0 100 2.22E-19 3.28E-17 9.872 8.137 
RNF122 AC_000184.1 0 90 1.66E-17 2.26E-15 9.872 8.137 
RNF122 AC_000184.1 80 0 1.24E-15 7.34E-14 9.872 8.137 
RNF122 AC_000184.1 0 83 3.95E-16 3.29E-14 9.872 8.137 
RNF122 AC_000184.1 20 80 6.94E-06 5.87E-05 9.872 8.137 
RNF122 AC_000184.1 25 86 1.71E-05 1.38E-04 9.872 8.137 
RNF122 AC_000184.1 75 0 1.25E-14 6.66E-13 9.872 8.137 
RNF122 AC_000184.1 20 100 2.92E-08 4.73E-07 9.872 8.137 
RNF122 AC_000184.1 20 85 1.96E-06 1.95E-05 9.872 8.137 
RNF122 AC_000184.1 80 0 1.24E-15 7.34E-14 9.872 8.137 
RNF122 AC_000184.1 80 11 2.08E-08 3.55E-07 9.872 8.137 
RNF122 AC_000184.1 20 100 2.92E-08 4.73E-07 9.872 8.137 
RNF122 AC_000184.1 20 85 1.96E-06 1.95E-05 9.872 8.137 
RNF122 AC_000184.1 80 14 1.93E-07 2.37E-06 9.872 8.137 
RNF122 AC_000184.1 20 80 6.94E-06 5.87E-05 9.872 8.137 
RNF122 AC_000184.1 25 85 2.09E-05 1.63E-04 9.872 8.137 
RNF122 AC_000184.1 76 25 1.74E-04 0.00110776 9.872 8.137 
RNF122 AC_000184.1 16 100 1.86E-09 3.70E-08 9.872 8.137 
RNF122 AC_000184.1 16 80 7.24E-07 8.28E-06 9.872 8.137 
RNF122 AC_000184.1 20 87 1.14E-06 1.16E-05 9.872 8.137 
RNF122 AC_000184.1 100 0 2.22E-19 3.28E-17 9.872 8.137 
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RNF122 AC_000184.1 80 0 1.24E-15 7.34E-14 9.872 8.137 
RNF122 AC_000184.1 0 78 2.95E-15 1.73E-13 9.872 8.137 
RNF122 AC_000184.1 0 77 5.26E-15 3.00E-13 9.872 8.137 
RNF122 AC_000184.1 16 100 1.86E-09 3.70E-08 9.872 8.137 
RNF122 AC_000184.1 80 25 7.02E-05 4.91E-04 9.872 8.137 
RNF122 AC_000184.1 0 85 1.66E-16 1.71E-14 9.872 8.137 
RNF122 AC_000184.1 0 80 1.24E-15 7.34E-14 9.872 8.137 
RNF122 AC_000184.1 0 80 1.24E-15 7.34E-14 9.872 8.137 
RNF122 AC_000184.1 0 75 1.25E-14 6.66E-13 9.872 8.137 
RNF122 AC_000184.1 16 80 7.24E-07 8.28E-06 9.872 8.137 
RNF122 AC_000184.1 83 0 3.95E-16 3.29E-14 9.872 8.137 
RNF122 AC_000184.1 83 20 3.33E-06 3.08E-05 9.872 8.137 
RNF122 AC_000184.1 0 100 2.22E-19 3.28E-17 9.872 8.137 
RNF122 AC_000184.1 0 88 3.94E-17 5.09E-15 9.872 8.137 
RNF122 AC_000184.1 83 0 3.95E-16 3.29E-14 9.872 8.137 
RNF122 AC_000184.1 20 100 2.92E-08 4.73E-07 9.872 8.137 
RNF122 AC_000184.1 0 100 2.22E-19 3.28E-17 9.872 8.137 
RNF122 AC_000184.1 80 14 1.93E-07 2.37E-06 9.872 8.137 
RNF122 AC_000184.1 16 80 7.24E-07 8.28E-06 9.872 8.137 
RNF122 AC_000184.1 20 75 2.62E-05 2.02E-04 9.872 8.137 
RNF122 AC_000184.1 16 100 1.86E-09 3.70E-08 9.872 8.137 
RNF122 AC_000184.1 100 11 2.69E-11 7.78E-10 9.872 8.137 
UNC5D AC_000184.1 100 20 2.92E-08 4.73E-07 9.564 5.798 
MACROD1 AC_000186.1 0 87 7.02E-17 8.06E-15 5.449 3.035 
MACROD1 AC_000186.1 0 85 1.66E-16 1.71E-14 5.449 3.035 
NRXN2 AC_000186.1 0 100 2.22E-19 3.28E-17 0.23 0.031 
KLC2 AC_000186.1 75 0 1.25E-14 6.66E-13 0.59 0.89 
MAGI3 AC_000160.1 80 0 1.24E-15 7.34E-14 68.672 59.519 
YBX1 AC_000160.1 100 20 2.92E-08 4.73E-07 167.373 157.381 
KIAA1324L AC_000161.1 80 20 6.94E-06 5.87E-05 14.742 8.885 
LHFPL3 AC_000161.1 76 14 6.34E-07 7.37E-06 88.447 99.227 
MET AC_000161.1 87 0 7.02E-17 8.06E-15 0.14 0.49 
LRGUK AC_000161.1 85 0 1.66E-16 1.71E-14 2.844 2.29 
LRGUK AC_000161.1 75 0 1.25E-14 6.66E-13 2.844 2.29 
LRGUK AC_000161.1 16 80 7.24E-07 8.28E-06 2.844 2.29 
LRGUK AC_000161.1 75 14 9.09E-07 9.50E-06 2.844 2.29 
UBN2 AC_000161.1 88 0 3.94E-17 5.09E-15 55.015 46.853 
TOM1 AC_000162.1 83 0 3.95E-16 3.29E-14 4.641 2.929 
TNFRSF1A AC_000162.1 80 20 6.94E-06 5.87E-05 0.315 0.649 
SCNN1A AC_000162.1 80 20 6.94E-06 5.87E-05 4.3 1.772 
PDE5A AC_000163.1 0 76 6.99E-15 3.93E-13 20.575 20.064 
PDE5A AC_000163.1 100 25 5.20E-07 6.07E-06 20.575 20.064 
PDE5A AC_000163.1 20 83 3.33E-06 3.08E-05 20.575 20.064 
PDE5A AC_000163.1 0 87 7.02E-17 8.06E-15 20.575 20.064 
PDE5A AC_000163.1 12 80 4.35E-08 5.78E-07 20.575 20.064 
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NFKB1 AC_000163.1 80 0 1.24E-15 7.34E-14 5.368 6.486 
NSG1 AC_000163.1 100 0 2.22E-19 3.28E-17 12.347 5.216 
PRDX2 AC_000164.1 100 0 2.22E-19 3.28E-17 541.593 139.339 
SLC12A2 AC_000164.1 100 0 2.22E-19 3.28E-17 22.906 24.104 
CTNNA1 AC_000164.1 100 20 2.92E-08 4.73E-07 282.447 359.821 
CTNNA1 AC_000164.1 20 83 3.33E-06 3.08E-05 282.447 359.821 
GRIA1 AC_000164.1 81 23 2.27E-05 1.78E-04 0.245 0.377 
ZNF395 AC_000165.1 14 80 1.93E-07 2.37E-06 6.707 5.019 
ZNF395 AC_000165.1 20 80 6.94E-06 5.87E-05 6.707 5.019 
RHOBTB2 AC_000165.1 0 100 2.22E-19 3.28E-17 0.079 0.412 
RPS6KA2 AC_000166.1 100 0 2.22E-19 3.28E-17 0.203 0.225 
THBS2 AC_000166.1 100 0 2.22E-19 3.28E-17 0.046 1.311 
HS6ST2 AC_000187.1 85 20 1.96E-06 1.95E-05 0.774 0.364 
ZNF75D AC_000187.1 80 10 8.02E-09 1.50E-07 109.846 140.532 
ZNF75D AC_000187.1 81 20 5.62E-06 5.11E-05 109.846 140.532 
TMEM164 AC_000187.1 0 100 2.22E-19 3.28E-17 6.522 1.617 
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Table S6.6 Gene expression for DMRs between in vivo MII vs. in vitro MII 
Gene expression in DMRs from in vivo MII vs. in vitro MII      
Gene Chr In vivo MII_me In vitro MII_me p-value q-value In vivo MII expression In vitro MII expression 
DOCK9 AC_000169.1 14 88 1.67E-08 2.48E-07 11.036 27.006 
CHMP4B AC_000170.1 20 75 2.62E-05 1.79E-04 8.831 6.574 
ZW10 AC_000172.1 75 25 2.10E-04 0.00106068 74.41 27.922 
PHLDB1 AC_000172.1 100 0 2.22E-19 2.71E-17 0.203 0.626 
CAPN5 AC_000172.1 20 100 2.92E-08 4.16E-07 0.013 0.013 
OSBP2 AC_000174.1 0 100 2.22E-19 2.71E-17 0.035 0.359 
SLC7A5 AC_000175.1 100 0 2.22E-19 2.71E-17 0.029 0.039 
ZNF423 AC_000175.1 100 0 2.22E-19 2.71E-17 0.225 0.044 
ZNF423 AC_000175.1 100 0 2.22E-19 2.71E-17 0.225 0.044 
TTYH1 AC_000175.1 0 100 2.22E-19 2.71E-17 0.017 1.491 
COPZ2 AC_000176.1 0 100 2.22E-19 2.71E-17 0.879 2.322 
COPZ2 AC_000176.1 0 100 2.22E-19 2.71E-17 0.879 2.322 
RPL19 AC_000176.1 20 80 6.94E-06 5.31E-05 27.609 622.381 
RARA AC_000176.1 0 100 2.22E-19 2.71E-17 0.389 5.363 
CDR2L AC_000176.1 0 80 1.24E-15 6.96E-14 0.017 1.002 
RAB37 AC_000176.1 20 75 2.62E-05 1.79E-04 0.14 2.856 
RAB37 AC_000176.1 80 0 1.24E-15 6.96E-14 0.14 2.856 
RAB37 AC_000176.1 16 75 3.16E-06 2.68E-05 0.14 2.856 
RAB37 AC_000176.1 21 75 3.99E-05 2.55E-04 0.14 2.856 
LCP2 AC_000177.1 100 0 2.22E-19 2.71E-17 0.162 1.715 
SKIV2L2 AC_000177.1 20 80 6.94E-06 5.31E-05 0.801 16.212 
SKIV2L2 AC_000177.1 100 0 2.22E-19 2.71E-17 0.801 16.212 
FRMD5 AC_000178.1 80 0 1.24E-15 6.96E-14 3.842 5.627 
FRMD5 AC_000178.1 13 80 1.01E-07 1.17E-06 3.842 5.627 
SYNPR AC_000179.1 87 25 1.29E-05 9.32E-05 3.006 0.827 
ERC2 AC_000179.1 16 83 2.86E-07 3.08E-06 1.022 6.3 
PTPN23 AC_000179.1 80 18 2.38E-06 2.09E-05 1.502 3.856 
KLF15 AC_000179.1 0 100 2.22E-19 2.71E-17 1.162 0.159 
HIST1H1C AC_000180.1 20 80 6.94E-06 5.31E-05 8.217 154.3 
LHPP AC_000183.1 80 0 1.24E-15 6.96E-14 0.171 0.303 
LHPP AC_000183.1 100 0 2.22E-19 2.71E-17 0.171 0.303 
RNF122 AC_000184.1 0 100 2.22E-19 2.71E-17 2.269 8.137 
RNF122 AC_000184.1 0 83 3.95E-16 3.04E-14 2.269 8.137 
RNF122 AC_000184.1 0 80 1.24E-15 6.96E-14 2.269 8.137 
RNF122 AC_000184.1 20 77 1.58E-05 1.13E-04 2.269 8.137 
RNF122 AC_000184.1 0 81 9.35E-16 6.96E-14 2.269 8.137 
RNF122 AC_000184.1 0 100 2.22E-19 2.71E-17 2.269 8.137 
RNF122 AC_000184.1 7 81 2.68E-10 5.96E-09 2.269 8.137 
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RNF122 AC_000184.1 0 100 2.22E-19 2.71E-17 2.269 8.137 
RNF122 AC_000184.1 0 80 1.24E-15 6.96E-14 2.269 8.137 
RNF122 AC_000184.1 11 100 2.69E-11 7.05E-10 2.269 8.137 
RNF122 AC_000184.1 0 90 1.66E-17 1.86E-15 2.269 8.137 
RNF122 AC_000184.1 11 100 2.69E-11 7.05E-10 2.269 8.137 
RNF122 AC_000184.1 25 80 7.02E-05 4.29E-04 2.269 8.137 
RNF122 AC_000184.1 83 8 4.40E-10 9.35E-09 2.269 8.137 
RNF122 AC_000184.1 9 85 5.67E-10 1.02E-08 2.269 8.137 
RNF122 AC_000184.1 0 83 3.95E-16 3.04E-14 2.269 8.137 
RNF122 AC_000184.1 83 20 3.33E-06 2.78E-05 2.269 8.137 
RNF122 AC_000184.1 22 75 6.49E-05 4.02E-04 2.269 8.137 
RNF122 AC_000184.1 20 100 2.92E-08 4.16E-07 2.269 8.137 
RNF122 AC_000184.1 0 100 2.22E-19 2.71E-17 2.269 8.137 
RNF122 AC_000184.1 0 100 2.22E-19 2.71E-17 2.269 8.137 
RNF122 AC_000184.1 16 100 1.86E-09 3.23E-08 2.269 8.137 
RNF122 AC_000184.1 0 100 2.22E-19 2.71E-17 2.269 8.137 
RNF122 AC_000184.1 100 0 2.22E-19 2.71E-17 2.269 8.137 
RNF122 AC_000184.1 0 80 1.24E-15 6.96E-14 2.269 8.137 
RNF122 AC_000184.1 80 0 1.24E-15 6.96E-14 2.269 8.137 
RNF122 AC_000184.1 10 83 3.22E-09 5.45E-08 2.269 8.137 
RNF122 AC_000184.1 20 100 2.92E-08 4.16E-07 2.269 8.137 
RNF122 AC_000184.1 25 83 3.36E-05 2.19E-04 2.269 8.137 
RNF122 AC_000184.1 80 25 7.02E-05 4.29E-04 2.269 8.137 
RNF122 AC_000184.1 20 83 3.33E-06 2.78E-05 2.269 8.137 
RNF122 AC_000184.1 0 88 3.94E-17 4.13E-15 2.269 8.137 
RNF122 AC_000184.1 12 100 6.45E-11 1.56E-09 2.269 8.137 
RNF122 AC_000184.1 20 87 1.14E-06 1.04E-05 2.269 8.137 
RNF122 AC_000184.1 0 100 2.22E-19 2.71E-17 2.269 8.137 
RNF122 AC_000184.1 0 100 2.22E-19 2.71E-17 2.269 8.137 
RNF122 AC_000184.1 75 7 2.27E-09 3.91E-08 2.269 8.137 
RNF122 AC_000184.1 11 80 2.08E-08 3.05E-07 2.269 8.137 
RNF122 AC_000184.1 20 100 2.92E-08 4.16E-07 2.269 8.137 
RNF122 AC_000184.1 100 0 2.22E-19 2.71E-17 2.269 8.137 
RNF122 AC_000184.1 12 100 6.45E-11 1.56E-09 2.269 8.137 
RNF122 AC_000184.1 16 85 1.60E-07 1.85E-06 2.269 8.137 
RNF122 AC_000184.1 20 80 6.94E-06 5.31E-05 2.269 8.137 
RNF122 AC_000184.1 0 85 1.66E-16 1.48E-14 2.269 8.137 
RNF122 AC_000184.1 0 80 1.24E-15 6.96E-14 2.269 8.137 
RNF122 AC_000184.1 100 25 5.20E-07 5.45E-06 2.269 8.137 
RNF122 AC_000184.1 80 16 7.24E-07 7.46E-06 2.269 8.137 
RNF122 AC_000184.1 14 83 8.33E-08 9.92E-07 2.269 8.137 
RNF122 AC_000184.1 0 88 3.94E-17 4.13E-15 2.269 8.137 
RNF122 AC_000184.1 11 100 2.69E-11 7.05E-10 2.269 8.137 
RNF122 AC_000184.1 0 88 3.94E-17 4.13E-15 2.269 8.137 
RNF122 AC_000184.1 14 75 9.09E-07 8.53E-06 2.269 8.137 
  213 
FGFR1 AC_000184.1 100 12 6.45E-11 1.56E-09 2.2 1.128 
MACROD1 AC_000186.1 100 0 2.22E-19 2.71E-17 0.955 3.035 
CARS AC_000186.1 20 81 5.62E-06 4.60E-05 0.776 4.071 
KIAA1324L AC_000161.1 0 88 3.94E-17 4.13E-15 3.943 8.885 
LRGUK AC_000161.1 12 80 4.35E-08 5.27E-07 0.074 2.29 
LRGUK AC_000161.1 14 83 8.33E-08 9.92E-07 0.074 2.29 
LRGUK AC_000161.1 100 22 9.72E-08 1.14E-06 0.074 2.29 
LRGUK AC_000161.1 20 83 3.33E-06 2.78E-05 0.074 2.29 
UBN2 AC_000161.1 100 20 2.92E-08 4.16E-07 3.553 46.853 
UBN2 AC_000161.1 16 75 3.16E-06 2.68E-05 3.553 46.853 
UBN2 AC_000161.1 85 0 1.66E-16 1.48E-14 3.553 46.853 
PDE5A AC_000163.1 83 16 2.86E-07 3.08E-06 6.356 20.064 
PDE5A AC_000163.1 80 0 1.24E-15 6.96E-14 6.356 20.064 
PDE5A AC_000163.1 14 75 9.09E-07 8.53E-06 6.356 20.064 
PDE5A AC_000163.1 80 10 8.02E-09 1.29E-07 6.356 20.064 
ADAMTS3 AC_000163.1 20 83 3.33E-06 2.78E-05 0.026 0.202 
EGR1 AC_000164.1 0 85 1.66E-16 1.48E-14 0.357 14.139 
EGR1 AC_000164.1 16 100 1.86E-09 3.23E-08 0.357 14.139 
CTNNA1 AC_000164.1 0 87 7.02E-17 6.88E-15 782.826 359.821 
ZNF395 AC_000165.1 0 80 1.24E-15 6.96E-14 0.043 5.019 
RPS6KA2 AC_000166.1 100 0 2.22E-19 2.71E-17 0.216 0.225 
RPS6KA2 AC_000166.1 100 0 2.22E-19 2.71E-17 0.216 0.225 
HS6ST2 AC_000187.1 83 0 3.95E-16 3.04E-14 0.013 0.364 
ZNF75D AC_000187.1 83 16 2.86E-07 3.08E-06 204.013 140.532 
SYN1 AC_000187.1 85 0 1.66E-16 1.48E-14 1.073 15.124 
MSN AC_000187.1 9 91 7.07E-11 1.65E-09 5.118 34.72 
MSN AC_000187.1 80 23 3.02E-05 1.97E-04 5.118 34.72 








Figure S1. Methylome profiles of bovine gametes and in vivo developed embryos 
The Pearson correlation heatmap (A) between stages. Color key: purple low correlation, red high correlation. Heatmaps of the 
numbers (Color key: purple: low CpG number, red high CpG numbers) (B) and methylation levels (Color key: purple: 
hypomethylation, red hypermethylation) (C) of captured CpGs in each chromosome. Circos plot (D) visualization of all methylated 
300-bp tiles of each stage of pre-implantation embryonic development. a. sperm, b. GV oocytes, c. in vivo MII oocytes, d. in vitro MII 
oocytes, e. 2-cell, f. 4-cell, g. 8-cell, h. 16-cell. The number (E) of total captured 300-bp tiles in each stage. Bar plot (F) of non-CpG 
methylation level and bisulfite non-conversion rate of each stage. GV: germinal vesicle oocytes; MII: matured oocytes.   
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Figure S2. Relationship between transcriptomes and methylomes of bovine gametes and in vivo developed embryos 
Correlation between gene expression and methylation of the promoters (A), gene bodies, exons, introns, CGIs (B). Line plots of DNA 
methylation (C) and RNA expression levels (D) of repetitive elements LINEs, SINEs, and LTR in each development stage. GV: 
germinal vesicle oocytes; MII: matured oocytes.   
  216 
 
Figure S3. Commonly and uniquely methylated regions in bovine gametes and in vivo developed embryos 
The numbers (A) of uniquely methylated 300-bp tiles in each development stage. Pie plot (B) of the distribution of uniquely 
methylated tiles in sperm categorized by genomic regions and the associated GO terms. Stack bar plot (C) of uniquely methylated 
300-bp tiles in each stage categorized by genomic regions. Heatmap (E) of DMRs between the 8- and 16-cell stages that were 
hypermethylated in the 8-cell (upper) or 16-cell (lower) and their GO term representatives. GV: germinal vesicle oocytes; MII: 
matured oocytes. (Color key: purple: hypomethylation, red hypermethylation)   
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Figure S4. DMRs between different types of gametes and their GO term representatives. 
Heatmaps of DMRs: sperm vs. GV (A), sperm vs. in vivo MII (B), sperm vs. in vitro MII (C), GV vs. in vivo MII (D), GV vs. in vitro 






Figure S5. Visualization of gene body methylation of XIST gene. GV: germinal vesicle 
oocytes; MII: matured oocytes.  
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Chapter Five 
Conclusions  
  220 
This dissertation reported three aspects of epigenetic regulation in domestic ruminants: 1) 
The effect of maternal nutrition on imprinted gene expression and genomic imprinting pattern in 
sheep, 2) X chromosome dosage upregulation in bovine germlines, preimplantation embryos, and 
somatic tissues, 3) Methylome dynamic in bovine early embryos and gametes. Specifically, the 
following conclusions are made: 
1. Maternal diets affected imprinted gene expression while the parental-of-origin 
expression pattern was not affected. These data suggest that gene expression levels and imprinted 
patterns may be regulated through different epigenetic mechanisms. 
2. In bovine germline, embryos and somatic tissues expression of X-linked genes, 
especially those that are housekeeping or ‘dosage-sensitive’ genes were up-regulated, supporting 
a balanced expression between a single active X and autosome pairs. 
3. During bovine embryo development, global demethylation was observed up to the 8-
cell stage and de novo methylation at 16-cell stage, refining the current knowledge on bovine 
embryo DNA methylation dynamics and providing valuable resources for future studies. 
Our studies of epigenetic regulations in domestic ruminants will provide insights for 
animal prenatal nutrition management and optimal in vitro culture condition for early embryo 
development. Future investigations on how the uterine environment influences fetal development, 
epigenetic regulation, and germline differentiation are needed. Future studies should also include 
more details in studying the onset of imprinted XCI after fertilization and transition to random 
XCI during early embryonic development. Moreover, differential genomic markers could be 
identified from the comparison of epigenetic markers between in vivo and in vitro produced 
oocytes and embryos.  
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